Graduate School of Life Sciences
Refine
Is part of the Bibliography
- yes (1034)
Year of publication
Document Type
- Doctoral Thesis (1024)
- Journal article (9)
- Book (1)
Language
- English (803)
- German (230)
- Multiple languages (1)
Keywords
- Maus (38)
- Thrombozyt (33)
- T-Lymphozyt (30)
- Tissue Engineering (29)
- Taufliege (21)
- Dendritische Zelle (19)
- Genexpression (18)
- Myc (17)
- Angst (16)
- Entzündung (16)
- Angststörung (15)
- Arteriosklerose (15)
- Signaltransduktion (15)
- Aufmerksamkeit (13)
- Biene (13)
- Drosophila (13)
- Melanom (13)
- Staphylococcus aureus (13)
- Candida albicans (12)
- G-Protein gekoppelte Rezeptoren (12)
- Immunologie (12)
- Kernspintomografie (12)
- Schlaganfall (12)
- Serotonin (12)
- Fluoreszenzmikroskopie (11)
- Krebs <Medizin> (11)
- Mikroskopie (11)
- Stress (11)
- Transkriptionsfaktor (11)
- ADHD (10)
- DNS-Reparatur (10)
- Depression (10)
- Epigenetik (10)
- Furcht (10)
- GPCR (10)
- Microscopy (10)
- Plasmozytom (10)
- Regulation (10)
- Therapie (10)
- Thrombose (10)
- Zellskelett (10)
- miRNS (10)
- Apoptosis (9)
- Escherichia coli (9)
- Fluoreszenz-Resonanz-Energie-Transfer (9)
- Fuchsbandwurm (9)
- Megakaryozyt (9)
- Motoneuron (9)
- Multiples Myelom (9)
- Stammzelle (9)
- Tagesrhythmus (9)
- Zellzyklus (9)
- platelets (9)
- Aspergillus fumigatus (8)
- Elektrophysiologie (8)
- Immuntherapie (8)
- Induzierte pluripotente Stammzelle (8)
- Inhibitor (8)
- Kognition (8)
- Konditionierung (8)
- Lernen (8)
- Neisseria meningitidis (8)
- Regulatorischer T-Lymphozyt (8)
- Rezeptor (8)
- Spinale Muskelatrophie (8)
- Synapse (8)
- Transplantat-Wirt-Reaktion (8)
- Alzheimerkrankheit (7)
- Arzneimitteldesign (7)
- Biomarker (7)
- CRISPR/Cas-Methode (7)
- DNS-Schädigung (7)
- EEG (7)
- Funktionelle Kernspintomografie (7)
- Genetik (7)
- Herzinfarkt (7)
- Herzinsuffizienz (7)
- Kutikula (7)
- Lungenkrebs (7)
- Makrophage (7)
- Molekularbiologie (7)
- Small RNA (7)
- Transcription (7)
- Transkription (7)
- Transkription <Genetik> (7)
- Trypanosoma brucei (7)
- Ubiquitin (7)
- Verhalten (7)
- Zellkultur (7)
- dendritic cells (7)
- fMRI (7)
- Antigen CD28 (6)
- Atherosclerosis (6)
- Bacteria (6)
- Bakterien (6)
- Bildgebendes Verfahren (6)
- Blut-Hirn-Schranke (6)
- Calcium (6)
- DNA damage (6)
- Diabetes mellitus (6)
- Drosophila melanogaster (6)
- Entwicklung (6)
- Evolution (6)
- Hippocampus (6)
- Inflammation (6)
- Inhibition (6)
- MRI (6)
- MYC (6)
- Masernvirus (6)
- Monoklonaler Antikörper (6)
- Multiple Sklerose (6)
- Mutagenität (6)
- Oxidativer Stress (6)
- Platelet (6)
- Platelets (6)
- Ratte (6)
- Thrombosis (6)
- Tiermodell (6)
- Transkriptomanalyse (6)
- Virtuelle Realität (6)
- Zellmigration (6)
- cancer (6)
- platelet (6)
- 3D-Druck (5)
- Aufmerksamkeits-Defizit-Syndrom (5)
- Aufmerksamkeitsdefizit-Syndrom (5)
- Autoantikörper (5)
- B-Lymphozyt (5)
- Biologie (5)
- Brain-derived neurotrophic factor (5)
- CRISPR/Cas9 (5)
- Cancer (5)
- Cataglyphis (5)
- Chlamydia trachomatis (5)
- Chronobiologie (5)
- Cytoskeleton (5)
- Dendritic cells (5)
- Dünndarm (5)
- Einzelmolekülmikroskopie (5)
- Gefühl (5)
- Genetics (5)
- Genotoxizität (5)
- Gephyrin (5)
- HIV (5)
- Immunology (5)
- Immunsystem (5)
- In-vitro-Kultur (5)
- Infektion (5)
- MAP-Kinase (5)
- Maschinelles Lernen (5)
- Metabolismus (5)
- NFATc1 (5)
- Neurodegeneration (5)
- Neuroethologie (5)
- Polymorphismus (5)
- Resistenz (5)
- Schmerz (5)
- Sphingolipide (5)
- Zelldifferenzierung (5)
- virtual reality (5)
- ADHS (4)
- Actin (4)
- Anxiety (4)
- Atherosklerose (4)
- Aurora-A (4)
- Autoimmunität (4)
- Biofabrication (4)
- Biofilm (4)
- Bioinformatics (4)
- Biomaterial (4)
- Brustkrebs (4)
- Cadherine (4)
- Chromatin (4)
- Chronophin (4)
- Cytokine (4)
- Darm (4)
- Dendritic cell (4)
- Dendritische Zellen (4)
- Echinococcus multilocularis (4)
- Elektroencephalographie (4)
- Emotion (4)
- FRET (4)
- Fettsäurestoffwechsel (4)
- Fibroblastenwachstumsfaktor (4)
- Furchtgeneralisierung (4)
- Furchtkonditionierung (4)
- G-Protein gekoppelter Rezeptor (4)
- GPVI (4)
- Genregulation (4)
- Glucosetransportproteine (4)
- Graft-versus-host-disease (4)
- GvHD (4)
- Helicasen (4)
- Herzmuskelzelle (4)
- Hämostase (4)
- Immunmodulation (4)
- Immunreaktion (4)
- Immunsuppression (4)
- In vitro (4)
- Insulin (4)
- Interleukin 6 (4)
- Ionenkanal (4)
- Jugend (4)
- Kind (4)
- Knockout <Molekulargenetik> (4)
- MMB (4)
- MYCN (4)
- Malaria (4)
- Mausmodell (4)
- Meeresschwämme (4)
- Mitochondrium (4)
- Mitose (4)
- Molekulargenetik (4)
- Myokardinfarkt (4)
- Natürliche Killerzelle (4)
- Neurobiologie (4)
- Neuroblastom (4)
- Neuropeptide (4)
- Neurowissenschaften (4)
- Opiatrezeptor (4)
- Panikstörung (4)
- Parkinson-Krankheit (4)
- Plasmodium falciparum (4)
- Posttranskriptionelle Regulation (4)
- Probiotikum (4)
- Proteasen (4)
- Proteine (4)
- RNS-Bindungsproteine (4)
- Ribosom (4)
- SMN (4)
- Salmonella (4)
- Sepsis (4)
- Soziale Insekten (4)
- Stoffwechsel (4)
- TFIIH (4)
- Treg (4)
- TrkB (4)
- Tumor (4)
- Virulenz (4)
- Zelle (4)
- active zone (4)
- division of labor (4)
- genotoxicity (4)
- honeybee (4)
- inflammation (4)
- magnetic resonance imaging (4)
- measles virus (4)
- miRNA (4)
- microRNA (4)
- myocardial infarction (4)
- neuroblastoma (4)
- olfaction (4)
- regulation (4)
- 3D tissue model (3)
- Ackerschmalwand (3)
- Adjuvans (3)
- Altern (3)
- Amygdala (3)
- Angiogenese (3)
- Angsterkrankungen (3)
- Animal model (3)
- Antibody (3)
- Antigen CD8 (3)
- Antikörper (3)
- Arabidopsis thaliana (3)
- B-MYB (3)
- B-Zell-Lymphom (3)
- Bacillus subtilis (3)
- Bakterielle Infektion (3)
- Biochemie (3)
- Biodiversität (3)
- Bioinformatik (3)
- Bioinks (3)
- Biologische Uhr (3)
- Biomedicine (3)
- Bioreaktor (3)
- Blutstammzelle (3)
- Blutstillung (3)
- CD1d (3)
- CD28 (3)
- CIDP (3)
- Campylobacter jejuni (3)
- Ceramid (3)
- Chemotherapie (3)
- Cognition (3)
- Cyclo-AMP (3)
- Dimerisierung (3)
- E. coli Nissle 1917 (3)
- Echinococcus (3)
- Ecology (3)
- Einzelzellanalyse (3)
- Electroencephalographie (3)
- Emotionsregulation (3)
- Endocytose (3)
- Endothel (3)
- Enzym (3)
- Expansion Microscopy (3)
- Expositionstherapie (3)
- Extinktion (3)
- Fettzelle (3)
- Fibromyalgie (3)
- Fluorescence Microscopy (3)
- Gehirn (3)
- Gehirn-Computer-Schnittstelle (3)
- Generalisierung (3)
- Genmutation (3)
- Genom (3)
- Geruch (3)
- Geruchssinn (3)
- Gewebekultur (3)
- Gewebemodell (3)
- Glioblastom (3)
- Glycinrezeptor (3)
- Graft-versus-host disease (3)
- Helicobacter pylori (3)
- Herzfrequenzvariabilität (3)
- Herzhypertrophie (3)
- Heubacillus (3)
- Histone (3)
- Hyaliner Knorpel (3)
- Hyaluronsäure (3)
- Hydrogel (3)
- Immunotherapy (3)
- Immuntoleranz (3)
- Informationsverarbeitung (3)
- Knorpel (3)
- Komplement <Immunologie> (3)
- Koronare Herzkrankheit (3)
- Kristallstruktur (3)
- Kutikularwachs (3)
- Latrophilin (3)
- Learning (3)
- Lunge (3)
- MRSA (3)
- MRT (3)
- Magnetresonanztomographie (3)
- Massenspektrometrie (3)
- Megakaryocyte (3)
- Metagenom (3)
- Metalloproteinasen (3)
- Mitochondria (3)
- Miz1 (3)
- Molekulare Bildgebung (3)
- Multiproteinkomplex (3)
- Muscarinrezeptor (3)
- N-Myc (3)
- NIR-Spektroskopie (3)
- NMR-Tomographie (3)
- Nephroblastom (3)
- Nervennetz (3)
- Nervenzelle (3)
- Neuroanatomie (3)
- Neurogenese (3)
- Neuroinflammation (3)
- Neuronale Plastizität (3)
- Neuropathischer Schmerz (3)
- Neutrophiler Granulozyt (3)
- Non-coding RNA (3)
- Obesity (3)
- Oligomerisation (3)
- Oncostatin M (3)
- Opioide (3)
- Orientierung (3)
- PDXP (3)
- PET (3)
- Paniksyndrom (3)
- Parkinson's disease (3)
- Pathogenität (3)
- Pathophysiologie (3)
- Permeabilität (3)
- Peyer's patch (3)
- Phosphatase (3)
- Phosphoglykolatphosphatase (3)
- Phospholipide (3)
- Phosphorylierung (3)
- Physiologie (3)
- Pilzkörper (3)
- Plastizität (3)
- Pneumolysin (3)
- Proteinkinase D (3)
- Präfrontaler Cortex (3)
- Prävention (3)
- Psychische Störung (3)
- RNS (3)
- Raf-Kinasen (3)
- Rho-Proteine (3)
- Rhodopsin (3)
- Salmonella enterica (3)
- Schmerzforschung (3)
- Secretion (3)
- Stressreaktion (3)
- Structural Biology (3)
- T cell activation (3)
- T-Zelle (3)
- T-Zellen (3)
- TNF (3)
- Thrombozytenaggregation (3)
- Transpiration <Pflanzen> (3)
- Transposon (3)
- Tumor-Nekrose-Faktor (3)
- Tumorzelle (3)
- Typ 1 (3)
- Ubiquitinierung (3)
- Visuelle Aufmerksamkeit (3)
- Wundheilung (3)
- Zebrabärbling (3)
- Zellkern (3)
- Zentralnervensystem (3)
- adrenocortical carcinoma (3)
- apoptosis (3)
- atherosclerosis (3)
- attention (3)
- behaviour (3)
- cAMP (3)
- cell wall (3)
- circadian rhythms (3)
- cytoskeleton (3)
- dopamine (3)
- expression (3)
- fear conditioning (3)
- fear generalization (3)
- gp130 (3)
- iPSC (3)
- ischemic stroke (3)
- learning (3)
- learning and memory (3)
- lung cancer (3)
- megakaryocyte (3)
- megakaryopoiesis (3)
- neurobiology (3)
- pancreas (3)
- protease (3)
- regulatorische T-Zellen (3)
- regulatory T cells (3)
- signalling (3)
- super-resolution microscopy (3)
- translation (3)
- virulence (3)
- Ökologie (3)
- 3 D bioprinting (2)
- 3D Modell (2)
- 3D cell culture (2)
- 3D-Zellkultur (2)
- 53BP1 (2)
- ALS (2)
- APOBEC3G (2)
- ASM (2)
- Acetylation (2)
- Actin-bindende Proteine (2)
- Actinomyceten (2)
- Actinomycetes (2)
- Adaptation (2)
- Adaptorproteine (2)
- Adenosinrezeptor (2)
- Adhesion GPCR (2)
- Adipogenesis (2)
- Adjuvant (2)
- Adrenalin (2)
- Adrenerger Rezeptor (2)
- Adventitia (2)
- Affekt (2)
- Analgesie (2)
- Angeborene Immunität (2)
- Angewandte Mikrobiologie (2)
- Antennallobus (2)
- Antiangiogenese (2)
- Antibiotikum (2)
- Antigen CD40 (2)
- Antigen CD95 (2)
- Anxiety disorder (2)
- Aorta (2)
- Apis mellifera (2)
- Apolipoprotein E (2)
- Apoptose (2)
- Arbeitsgedächtnis (2)
- Arbeitsteilung (2)
- Arrestine (2)
- Aspergillus (2)
- Assoziation (2)
- Assoziatives Lernen (2)
- Astrozyt (2)
- Audiologie (2)
- Augenbewegung (2)
- Autoaggressionskrankheit (2)
- Autophagy (2)
- Aversive Konditionierung (2)
- Axon (2)
- B cells (2)
- B-Zellen (2)
- BAD (2)
- BCI (2)
- BOLD signal (2)
- BRET (2)
- Bacterial infection (2)
- Bakterielle Hirnhautentzündung (2)
- Bakteriengift (2)
- Bauchspeicheldrüsenkrebs (2)
- Beta-1-Rezeptor (2)
- Beta-Rezeptor (2)
- Bildverarbeitung (2)
- Biogenese (2)
- Biomechanics (2)
- Bioprinting (2)
- Bioreactor (2)
- Blickbewegung (2)
- Blut-Nerven-Barriere (2)
- Blutgerinnung (2)
- Bortezomib (2)
- Brain-computer interface (2)
- CD28 Superagonist (2)
- CD8+ T-Zellen (2)
- CD84 (2)
- CDH13 (2)
- COVID-19 (2)
- CRISPR Cas9 (2)
- CRPS (2)
- CXCR4 (2)
- Calciumkanal (2)
- Calciumtransport (2)
- Camponotus floridanus (2)
- Cancer immunotherapy (2)
- Cardiomyocyte (2)
- Cartilage Tissue Engineering (2)
- Cell cycle (2)
- Cell migration (2)
- Cement (2)
- Ceramide (2)
- Cholesterinstoffwechsel (2)
- Chronische Niereninsuffizienz (2)
- Ciliary neurotrophic factor (2)
- Circadian Rhythms (2)
- Co-culture (2)
- Cochlear-Implantat (2)
- Colonkrebs (2)
- Compressed Sensing (2)
- Contactin-1 (2)
- Corpus amygdaloideum (2)
- Corti-Organ (2)
- Crosstalk (2)
- Cryptochrom (2)
- Cushing-Syndrom (2)
- Cuticle (2)
- Cuticular waxes (2)
- DNA Repair (2)
- DNA repair (2)
- DNA-Reparatur (2)
- DNS (2)
- DNS-Bindung (2)
- DNS-Doppelstrangbruch (2)
- DRG (2)
- DROSHA (2)
- Darmwandnervensystem (2)
- Deep sequencing (2)
- Diabetische Polyneuropathie (2)
- Diagnostik (2)
- Dichtegewichtung (2)
- Differentiation (2)
- Diffusion coefficient (2)
- Diffusionsgewichtete Magnetresonanztomografie (2)
- Dopamin (2)
- Dosimetrie (2)
- E. coli Nissle (2)
- EHEC (2)
- Echokardiographie (2)
- Elektroencephalogramm (2)
- Elektrospinning (2)
- Emotionen (2)
- Emotionsverarbeitung (2)
- Encephalomyelitis (2)
- Endozytose (2)
- Enterobacteriaceae (2)
- Epigenetic (2)
- Ereigniskorreliertes Potenzial (2)
- Erwachsener (2)
- Extrazelluläre Matrix (2)
- FKBP52 (2)
- Fabry-Krankheit (2)
- Farbensehen (2)
- Fear (2)
- Fettsucht (2)
- Fettsäurebiosynthese (2)
- Fitness (2)
- Fluconazol (2)
- Fluconazole (2)
- Fluorescence (2)
- Fluoreszenzkorrelationsspektroskopie (2)
- Fluoxetin (2)
- Frühdiagnostik (2)
- Fusobacterium nucleatum (2)
- Förster Resonanz Energie Transfer (2)
- G-protein-coupled receptors (2)
- GABA-Rezeptor (2)
- Galectine (2)
- Gametogenese (2)
- Gastrointestinaltrakt (2)
- Gedächtnis (2)
- Gelenkknorpel (2)
- Genomics (2)
- Genotoxicity (2)
- Gerinnungsfaktor XII (2)
- Glia (2)
- Glioblastoma (2)
- Gliom (2)
- Glukose (2)
- Glutamat-Decarboxylase (2)
- Glykosylierung (2)
- Golgi-Apparat (2)
- Graft versus host disease (2)
- Growth (2)
- Guanylatcyclase (2)
- HUWE1 (2)
- Harnwegsinfektion (2)
- Hautleitfähigkeit (2)
- Hemostasis (2)
- Herz (2)
- Herzmuskel (2)
- Herzmuskelkrankheit (2)
- Herzschrittmacher (2)
- Hfq (2)
- High throughput screening (2)
- Hippo pathway (2)
- Hirnhautentzündung (2)
- Honeybee (2)
- Host-pathogen interaction (2)
- Hydrogels (2)
- Hypertrophie (2)
- Hypothalamus (2)
- Hypoxia (2)
- Hypoxie (2)
- Immunisierung (2)
- Immunität <Medizin> (2)
- Immunological synapse (2)
- Impfung (2)
- Impulsivität (2)
- Induced pluripotent stem cells (2)
- Infektionsmodell (2)
- Inhibitorische Synapse (2)
- Inhibitory synapse (2)
- Innate immunity (2)
- Innere Uhr (2)
- Insekten (2)
- Interaktion (2)
- Interferon (2)
- Interferon <gamma-> (2)
- Interleukin 2 (2)
- Intrazellulärraum (2)
- Invasion (2)
- Ischemic stroke (2)
- Japankärpfling (2)
- K-Ras (2)
- Kardiologie (2)
- Kardiomyozyt (2)
- Kardiovaskuläre Krankheit (2)
- Keratinozyt (2)
- Kernspintomographie (2)
- Klassische Konditionierung (2)
- Kleinkern (2)
- Klimaänderung (2)
- Knochen-Morphogenese-Proteine (2)
- Knochenmark (2)
- Knochenmarktransplantation (2)
- Knockout (2)
- Knockout-Maus (2)
- Komplement C5a (2)
- Konfokale Mikroskopie (2)
- Kontextkonditionierung (2)
- Kostimulation (2)
- Kraniosynostose (2)
- Krankheit (2)
- Krebsforschung (2)
- Krebsimmuntherapie (2)
- Kristallographie (2)
- LC-MS (2)
- Lactatdehydrogenase (2)
- Larve (2)
- Leishmania (2)
- Leishmania major (2)
- Leishmaniose (2)
- Lidschlag (2)
- Ligand <Biochemie> (2)
- Lipide (2)
- Lung (2)
- Lysosom (2)
- Macrophages (2)
- Magnetische Resonanz (2)
- Malaria tropica (2)
- Manisch-depressive Krankheit (2)
- Marine sponges (2)
- Mechanosensation (2)
- Medizinphysik (2)
- Megakaryopoese (2)
- Melt Electrowriting (2)
- Melt electrowriting (2)
- Membrane transporters (2)
- Membrantransporter (2)
- Meningitis (2)
- Mensch (2)
- Merkel cell carcinoma (2)
- Mesenchymzelle (2)
- Metabolomik (2)
- Metastase (2)
- Methylierung (2)
- Mikrotubuli (2)
- Modification (2)
- Monarchfalter (2)
- Monozyt (2)
- Motoneuron-Krankheit (2)
- Motorisches Lernen (2)
- Mouse Model (2)
- Multidrug-Resistenz (2)
- Multiple Myeloma (2)
- Mutation (2)
- Myatrophische Lateralsklerose (2)
- N-MYC (2)
- NFAT (2)
- NNMT (2)
- Na+/K+-ATPase (2)
- NaV1.9 (2)
- Nahrungserwerb (2)
- Nanoparticles (2)
- Natriumkanal (2)
- Navigation (2)
- Neisseria gonorrhoeae (2)
- Nervendegeneration (2)
- Nervensystem (2)
- Nestbau (2)
- Neuralgie (2)
- Neurofascin (2)
- Neuromodulation (2)
- Neuropathie (2)
- Neuroscience (2)
- Neutrophils (2)
- Nicht-kleinzelliges Bronchialkarzinom (2)
- Nicht-kleinzelliges Bronchialkarzinom (NSCLC) (2)
- Nociceptor (2)
- Nozizeptor (2)
- Nuklearmedizin (2)
- Nukleotid-Exzisions-Reparatur (2)
- Olfaction (2)
- Onkogen (2)
- Optogenetik (2)
- Organische Synthese (2)
- Organoid (2)
- Osteogenesis (2)
- Oxidative stress (2)
- P300 (2)
- PAF1c (2)
- PVM (2)
- Parathormon (2)
- Peptide (2)
- Peptidsynthese (2)
- Pflanzen (2)
- Pflanzenschutzmittel (2)
- Phosphatasen (2)
- Phospholipase D (2)
- Phylogenie (2)
- Phänologie (2)
- Plant Protection (2)
- Plant cuticle (2)
- Plasmamembran (2)
- Polyneuropathie (2)
- Positronen-Emissions-Tomographie (2)
- Post-transcriptional regulation (2)
- Probiotic (2)
- Progenitor (2)
- Prognose (2)
- Proliferation (2)
- Protein (2)
- Protein-Protein-Wechselwirkung (2)
- Proteinsynthese (2)
- Proteintyrosinphosphatase (2)
- Proteolyse (2)
- Proteom (2)
- Psychologie (2)
- Pyrrolizidinalkaloide (2)
- RNA (2)
- RNA helicase (2)
- RNA modifications (2)
- RNA polymerase II (2)
- RNA-binding proteins (2)
- RNS-Interferenz (2)
- RNS-Viren (2)
- ROS (2)
- RS-Virus (2)
- RS1 (2)
- Radionuklid (2)
- Ranvier-Schnürring (2)
- Regenerative Medizin (2)
- Regulatorische T-Zellen (2)
- Resilienz (2)
- Rheumatoid arthritis (2)
- RhoA (2)
- Ribosome (2)
- Risikofaktoren (2)
- Röntgenkristallographie (2)
- SARS-CoV-2 (2)
- SGLT1 (2)
- SOCE (2)
- SPECT (2)
- Salmonella Typhimurium (2)
- Salmonella typhimurium (2)
- Schlaf (2)
- Schwertkärpfling (2)
- Schädel-Hirn-Trauma (2)
- Screening (2)
- Sekundärkrankheit (2)
- Sekundärmetabolit (2)
- Sequenzanalyse (2)
- Serotonerge Nervenzelle (2)
- Signalkette (2)
- Sinneszelle (2)
- Sozialangst (2)
- Soziale Wahrnehmung (2)
- Sphingomyelin (2)
- Spinal Muscular Atrophy (2)
- Spred-Proteine (2)
- Staphylococcus (2)
- Stickstoff (2)
- Streptococcus pneumoniae (2)
- Symbiose (2)
- Synthese (2)
- T cells (2)
- T-Lymphozyten-Rezeptor (2)
- TFIIIC (2)
- TLR3 (2)
- TWEAK (2)
- Therapieresistenz (2)
- Thrombo-inflammation (2)
- Thrombopoiesis (2)
- Tissue engineering (2)
- Toleranz (2)
- Toll-like-Rezeptoren (2)
- Transcriptome (2)
- Transforming Growth Factor beta (2)
- Transgener Organismus (2)
- Transkriptom (2)
- Translation <Genetik> (2)
- Tuberkelbakterium (2)
- Tumor-Nekrose-Faktor <alpha> (2)
- Turbo Spin Echo (2)
- USP (2)
- Ubiquitin-Protein-Ligase (2)
- VSG (2)
- Vaccine (2)
- Vermeidungsreaktion (2)
- Wahrnehmung (2)
- Wilms tumor (2)
- Wirkstoffdesign (2)
- X-ray crystallography (2)
- Xeroderma pigmentosum (2)
- Xiphophorus (2)
- Zebrafish (2)
- Zellteilung (2)
- Zellwand (2)
- Zement (2)
- Zink-Finger-Proteine (2)
- Zytoskelett (2)
- adipocytes (2)
- adult neurogenesis (2)
- amygdala (2)
- antennal lobe (2)
- anxiety (2)
- anxiety disorders (2)
- autophagy (2)
- bee (2)
- behavior (2)
- biased agonism (2)
- bioinformatics (2)
- biology (2)
- biomedical applications (2)
- biomedicine (2)
- bioreactor (2)
- blood brain barrier (2)
- bone marrow (2)
- brain (2)
- calcium (2)
- cardiac hypertrophy (2)
- cell (2)
- ceramide (2)
- chlamydia (2)
- cytokines (2)
- cytokinesis (2)
- deep brain stimulation (2)
- dendritic cell (2)
- dendritische Zelle (2)
- depression (2)
- development (2)
- developmental differentiation (2)
- diet (2)
- dosimetry (2)
- drug development (2)
- drug repurposing (2)
- ecology (2)
- electron microscopy (2)
- electrophysiology (2)
- emotion (2)
- emotion processing (2)
- emotion regulation (2)
- endosomal trafficking (2)
- endothelial cells (2)
- epigenetics (2)
- evolution (2)
- experimental autoimmune encephalomyelitis (2)
- extracellular matrix (2)
- fMRI time series (2)
- fear extinction (2)
- foxtapeworm (2)
- funktionelle Kernspintomographie (2)
- gamma-H2AX (2)
- genetics (2)
- genomics (2)
- gephyrin (2)
- glucose (2)
- hippocampus (2)
- host-pathogen interaction (2)
- immunologische Synapse (2)
- in vitro (2)
- infection (2)
- inflammatory pain (2)
- insulin (2)
- intestinal in vitro model (2)
- kinase (2)
- lipid rafts (2)
- machine learning (2)
- malaria (2)
- mass spectrometry (2)
- medical physics (2)
- melanoma (2)
- mesenchymal stem cells (2)
- metabolism (2)
- metagenomics (2)
- mitosis (2)
- mitotic gene expression (2)
- monoclonal antibodies (2)
- monoklonale Antikörper (2)
- motoneuron (2)
- mouse model (2)
- mouse models (2)
- multi-unit recording (2)
- multiple myeloma (2)
- neuroethology (2)
- neuropathy (2)
- nuclear medicine (2)
- oligomerization (2)
- opioid receptors (2)
- p53 (2)
- p97 (2)
- peptide (2)
- perception (2)
- phosphatase (2)
- receptor (2)
- regulatory t cells (2)
- resistance (2)
- serotonergic system (2)
- shRNA (2)
- signal transduction (2)
- single particle tracking (2)
- skin equivalent (2)
- small RNA (2)
- snRNP (2)
- social anxiety (2)
- social attention (2)
- social insects (2)
- sphingolipids (2)
- spontaneous blinks (2)
- stress (2)
- stroke (2)
- symbiosis (2)
- synaptic plasticity (2)
- synaptic proteins (2)
- synaptische Proteine (2)
- t cells (2)
- tDCS (2)
- targeted therapy (2)
- thrombopoiesis (2)
- tissue engineering (2)
- transcription (2)
- transkranielle Gleichstromstimulation (2)
- vascularization (2)
- virtuelle Realität (2)
- wild bees (2)
- working memory (2)
- wound healing (2)
- Übergewicht (2)
- "Lipid Rafts" (1)
- (hem)ITAM signaling (1)
- 13C-isotopologue profiling (1)
- 177Lu-OPS201 (1)
- 18S rRNA (1)
- 19F-NMR (1)
- 2-point Dixon (1)
- 3-D liver model (1)
- 3D Gewebemodelle (1)
- 3D Printing (1)
- 3D Tumormodell (1)
- 3D image analysis (1)
- 3D model (1)
- 3D models (1)
- 3D muscle (1)
- 3D printing (1)
- 3D spheroid culture (1)
- 3D tumour model (1)
- 3D-Elektrode (1)
- 3D-Gewebemodell (1)
- 3D-Kultur (1)
- 3D-Modell (1)
- 4-HNE (1)
- 5' UTR (1)
- 5-FU (1)
- 5`-UTR (1)
- 68Ga-OPS202 (1)
- 7 T (1)
- 7SK (1)
- 7T (1)
- A-RAF (1)
- A2B adenosine receptor (1)
- A2BAR (1)
- AAC (1)
- ABC-Transporter (1)
- ACC (1)
- ACL (1)
- ADGRL3 (1)
- ADORA2A (1)
- ADP (1)
- AI (1)
- AMPK (1)
- AMP‐activated protein kinase (1)
- ARF6 GTPase (1)
- ASM-Inhibition (1)
- ATF5 (1)
- ATGL (1)
- ATR-FTIR (1)
- ATRA (1)
- Absorbed Doses (1)
- Accelerated imaging (1)
- Acetylcholinrezeptor (1)
- Acetylierung (1)
- Acid adaptation (1)
- Actin Dynamics (1)
- Actin binding proteins (1)
- Actin cytoskeleton-related protein (1)
- Actinomyces (1)
- Acute myeloid leukemia (AML) (1)
- Acyrthosiphon pisum (1)
- Adapterprotein (1)
- Adenomatous-polyposis-coli-Protein (1)
- Adenosine receptors (1)
- Adhesion and Invasion (1)
- Adhesion and degranulation promoting adapter protein (1)
- Adhesion-GPCR (1)
- Adhesive Hydrogels (1)
- Adhärenz (1)
- Adhäsion (1)
- Adipose (1)
- Adipose Tissue Engineering (1)
- Adipose-Derived Stromal/Stem Cells (1)
- Adipositas (1)
- Administered Activities (1)
- Adrenergic receptor (1)
- Adrenocortical Carcinoma (1)
- Adrenokortikales Karzinom (1)
- Adulte Neurogenese (1)
- Adultschlupfes (1)
- Advanced Therapy Medicinal Products (ATMP) (1)
- Affinity probe (1)
- Agaphelin (1)
- Agarose (1)
- Aggregation (1)
- Agoraphobie (1)
- Agrobacterium vitis (1)
- Aiolos (1)
- Airway epithelia (1)
- Aktive Implantate (1)
- Aktivierung <Physiologie> (1)
- Aktivierungsenergie (1)
- Aktivitätstest (1)
- Akute lymphatische Leukämie (1)
- Akute myeloische Leukämie (1)
- Akzeptanz (1)
- Akzeptanz- und Commitment Therapie (1)
- Algorithmus (1)
- Aliphatics (1)
- Alkaloid (1)
- Allergie (1)
- Allergy (1)
- Allgemeine Zelle (1)
- Alloantigen (1)
- Alloantigen Expression (1)
- Allogene Zelle (1)
- Allogeneic stem cell transplantation (1)
- Allogenic hematopoietic stem cell transplantation (1)
- Allosterie (1)
- Alpaca (1)
- Alpha (1)
- Alpha Neurofeedback (1)
- Alpha power (1)
- Alpha-Aktivität (1)
- Alternative polyadenylation (1)
- Alternative zum Tierversuch (1)
- Altersunterschied (1)
- Alveolar Echinococcosis (1)
- Alveoläre Echinokokkose (1)
- Alzheimer's Dementia (1)
- Alzheimer's disease (1)
- Alzheimer`s disease (1)
- AmGr1, AmGr2, AmGr3 (1)
- Ambrosia beetles (1)
- Ambrosiakäfer (1)
- Ameise (1)
- Ameisen (1)
- Ameisenstaat (1)
- Aminobisphosphonat (1)
- Aminobisphosphonate (1)
- Aminobuttersäure <gamma-> (1)
- Ammoniumpermease (1)
- Amphibien (1)
- Amyotrophe Lateralsklerose (1)
- Amyotrophic lateral sclerosis (1)
- Analyse (1)
- Anaphylatoxine (1)
- Anaphylatoxinrezeptoren (1)
- Anastomoseninsuffizienz (1)
- Ancistrocladaceae (1)
- Ancistrocladus (1)
- Androstadienon (1)
- Aneuploidy (1)
- Angewandte Toxikologie (1)
- Angiogenesis (1)
- Angiotensin II (1)
- Angst als Eigenschaft (1)
- Angst als Zustand (1)
- Angsterkrankung (1)
- Angstreaktionen (1)
- Angstsensitivität (1)
- Angstverhalten (1)
- Animal behavior IntelliCage system (1)
- Animales Nervensystem (1)
- Anisotropic structures (1)
- Annotation (1)
- Anoikis (1)
- Anpassung (1)
- Ant (1)
- Anthocyane (1)
- Anthropocene (1)
- Anti-CD52-Antikörper (1)
- Anti-infective (1)
- Antibiotic (1)
- Antibodies (1)
- Antifungal (1)
- Antigen CD3 (1)
- Antigen CD4 (1)
- Antigen CD44 (1)
- Antigen presentation (1)
- Antigen recognition (1)
- Antigenpräsentation (1)
- Antigenrezeptor (1)
- Antikörper-Antwort (1)
- Antimicrobial activities (1)
- Antimicrobial activity (1)
- Antimicrobial proteins (1)
- Antimikrobielle Aktivitäten (1)
- Antimikrobieller Wirkstoff (1)
- Antimykotika (1)
- Antimykotikum (1)
- Antioxidantien (1)
- Antivirale Substanzen (1)
- Antworthemmung (1)
- Antwortverhalten (1)
- Anxiety Disorders (1)
- Anxiety disorders (1)
- Aortenaneurysma (1)
- Apallisches Syndrom (1)
- Aplysina aerophoba (1)
- Approved immunomodulators (1)
- Archaea (1)
- Archaebakterien (1)
- Arginine (1)
- Arid biomes (1)
- ArsZ (1)
- Artefakt (1)
- Artenreichtum (1)
- Arterielles Blut (1)
- Artery Models (1)
- Artesunate (1)
- Arthrose (1)
- Arthrosis deformans (1)
- Arzneimittel (1)
- Arzneimittelzulassung (1)
- Aspartatprotease (1)
- Aspergillose (1)
- Aspergillosis (1)
- Associative learning (1)
- Assoziatives Gedächtnis (1)
- AstA (1)
- Atemwege (1)
- Atemwegsschleimhaut (1)
- Atherogenese (1)
- Atmungsinsuffizienz (1)
- Atomic-force-microscopy (1)
- Atriales natriuretisches Hormon (1)
- Atta vollenweideri (1)
- Attention (1)
- Attention deficit / hyperactivity disorder (1)
- Attentional Avoidance (1)
- Attentional Bias (1)
- Attentional bias (1)
- Attraction (1)
- Attraktion (1)
- AuNPs (1)
- Auditorische Neuropathie (1)
- Auditorischer Kortex (1)
- Aufmerksamkeitsprozesse (1)
- Aurora B (1)
- Aurora-A-MYCN-Komplex (1)
- Ausbreitungsverhalten (1)
- Aussterbedynamik (1)
- Autoantigen (1)
- Autofocus (1)
- Autoimmunity (1)
- Autoinhibition (1)
- Automatische Klassifikation (1)
- Autophagie (1)
- Autophagie <Physiologie> (1)
- Autophagosom (1)
- Autophagozytose (1)
- Autoproteolysis (1)
- Autotransporter (1)
- Autotransporterprotein (1)
- Avoidance (1)
- Awareness (1)
- Axon Branching (1)
- B Lymphocytes (1)
- B-Lymphozyten (1)
- B0 (1)
- B0 correction (1)
- B0-Korrektur (1)
- B7-H1 (1)
- BCG (1)
- BCL-2 Familie (1)
- BCL-2 family (1)
- BCMA (1)
- BDNF (1)
- BDNF stimulation (1)
- BH3-only proteins (1)
- BIN2 (1)
- BMP (1)
- BMP signaling pathway (1)
- BMP-2 (1)
- BMP-Signaltransduktionsweg (1)
- BMP2 (1)
- BMS-5 (1)
- BRAF (1)
- BRCA1 (1)
- BTB domain (1)
- BTN3A1 and Phospho-antigen presentation (1)
- Bach (1)
- Bacteria-Host Cell Interaction (1)
- Bacterial Toxins (1)
- Bacterial community analysis (1)
- Bacterial meningitis (1)
- Bacteroides thetaiotaomicron (1)
- Baff (1)
- Baghdadite (1)
- Bahnung (1)
- Bakterielle Nanocellulose (1)
- Bakterienzellwand (1)
- Bakteriophagen (1)
- Bandwürmer (1)
- Bariatric surgery (1)
- Barth Syndrome (1)
- Barth syndrome (1)
- Basal Ganglia (1)
- Basalganglien (1)
- Basalmembran (1)
- Basement membrane (1)
- Basic leucine zipper (1)
- Basigin (1)
- Batten disease (1)
- Bauchspeicheldrüse (1)
- Baum (1)
- Baumphysiologie (1)
- Bcl-2-Proteinfamilie (1)
- Bed nucleus of stria terminalis (1)
- Behavior (1)
- Behaviour (1)
- Benzimidazolderivate (1)
- Benzoate (1)
- Benzoate degradation (1)
- Beschleunigte Bildgebung (1)
- Bestimmung des Relaxations-Parameters in der Magnetresonanztomografie (1)
- Bestrahlung (1)
- Bestärkendes Lernen <Künstliche Intelligenz> (1)
- Bestäubung (1)
- Bestäubung Pollination Honigbiene Hummel (1)
- Beta-1-receptor (1)
- Beta-2-Rezeptor (1)
- Beta-Adrenergic Receptor (1)
- Beta-Adrenozeptor (1)
- Bevacizumab (1)
- Bewegungsstörung (1)
- Bienen <Familie> (1)
- Bienen Dressur Lernen (1)
- Bierhefe (1)
- Bildanalyse (1)
- Bildartefakte (1)
- Bildbearbeitung (1)
- Bilderzeugung (1)
- Bildgebung intakten Knochens (1)
- Bimolekulare Lipidschicht (1)
- Bindegewebe (1)
- Binge-Eating-Störung (1)
- Binge-eating Disorder (1)
- BioVaSc (1)
- Biochemische Analyse (1)
- Biochemistry (1)
- Biodistribution (1)
- Biodiversity assessment (1)
- Biodiversity conservation (1)
- Biofabrikation (1)
- Biofilm formation (1)
- Biofilmarchitektur (1)
- Biofilms (1)
- Bioink (1)
- Biokinetics (1)
- Biolayerinterferometrie (1)
- Biologie / Zellbiologie (1)
- Biologischer Abbau (1)
- Biologisches Modell (1)
- Biology (1)
- Bioluminescence resonance energy transfer (1)
- Biolumineszenzmessung (1)
- Biomechanik (1)
- Biomedizin (1)
- Bioprozessmethode (1)
- Bioreaktorplattform (1)
- Biosynthese der aromatischen Aminosäuren (1)
- Biosynthese-Genclustern (1)
- Biotransformation (1)
- Bipolar (1)
- Bipolar Disorder (1)
- Bisphosphonate (1)
- Bitopic Ligands (1)
- Bitopische Liganden (1)
- Blick (1)
- Blickinteraktion (1)
- Blimp-1 (1)
- Blinatumomab (1)
- Blood nerve barrier (1)
- Blood-brain barrier (1)
- Blumeria graminis (1)
- Blut-Liquor-Schranke (1)
- Blut-Rückenmarkschranke (1)
- Blutgefäßsystem (1)
- Blutgerinnungsfaktor XII (1)
- Bluthirnschranke (1)
- Body movement (1)
- Bone (1)
- Bone Marrow Dosimetry (1)
- Bone Quantification (1)
- Bone marrow stromal cell (1)
- Bone marrow stromal cell (BMSC) (1)
- Bone marrow transplantation (1)
- Bone morphogenetic protein 2 (1)
- Bone morphogenetic proteins (1)
- Bone regeneration (1)
- Bone-replacement (1)
- Bordetella (1)
- Borkenkäfer (1)
- Borneo (1)
- Borrelia (1)
- Bovine Mastitis (1)
- Brain (1)
- Brain derived neurotorphic factor (1)
- Brain endothelial cells (1)
- Brownsche Bewegung (1)
- Bruchpilot (1)
- Brustdrüsenentzündung (1)
- Burkholderia (1)
- Burkholderia pseudomallei (1)
- Burkitt Lymphom (1)
- Burkitt Lymphoma (1)
- Butyrophilin (1)
- Bäckerhefe (1)
- Bärtierchen (1)
- C. albicans (1)
- C. elegans (1)
- C/EBP (1)
- C1-inibitor (1)
- C4da (1)
- C5aR1-Antagonist (1)
- CA3 (1)
- CAMP production (1)
- CAR T Zellen (1)
- CAR T cell (1)
- CAR T-Zelltherapie (1)
- CAR T-cells (1)
- CAR-T cell (1)
- CAR-T-Zell-Therapie (1)
- CCR4 (1)
- CD11b+ myeloid cells (1)
- CD147 (1)
- CD150 (1)
- CD28 Molekül (1)
- CD28 Superagonisten (1)
- CD28 antigen (1)
- CD28-SA (1)
- CD28-Superagonist (1)
- CD28-superagonist (1)
- CD4 T-Zellen (1)
- CD4 positiv T cells (1)
- CD4+ (1)
- CD4+ T cell activation (1)
- CD40 gerichteter bifunktioneller scFv-TRAIL Fusionsproteine (1)
- CD40-targeted bifunctional scFv-TRAIL fusion proteins (1)
- CD44 (1)
- CD8 Effektorfunktionen (1)
- CD8 Gedächtnisreaktionen (1)
- CD8 T cell (1)
- CD8 T-Zelle (1)
- CD8 T-Zellen (1)
- CD8+ T cell differentiation (1)
- CD8+ T cells (1)
- CD95 (1)
- CD95L (1)
- CDC42 (1)
- CDK4 Inhibitor (1)
- CDK4 inhibitor (1)
- CDR1-Effluxpumpe (1)
- CE Proteaes (1)
- CIP2A (1)
- CLEC-2 (1)
- CLEC16A (1)
- CMT1A (1)
- CMV (1)
- CNBP (1)
- COMT polymorphism (1)
- CRHR1 (1)
- CRISPR (1)
- CRISPR Cas9 system (1)
- CRISPR-Cas (1)
- CTLA-4 (1)
- CVT (1)
- CX-5461 (1)
- CXCL13 (1)
- CXCR5 (1)
- CYP24A1 (1)
- CYP7A1 (1)
- CaCo-2 cell (1)
- Cadherin 13 (1)
- Cadherin-13 (1)
- Caenorhabditis elegans (1)
- Calcium Phosphate (1)
- Calcium phosphate-based biomaterials (1)
- Calcium signalling (1)
- Calcium-bindende Proteine (1)
- Calciumhomöostase (1)
- Calciumphosphat (1)
- Camponotus (1)
- Camponotus rufipes (1)
- Cancer Immune Therapy (1)
- Cancer Metabolism (1)
- Cancer biology (1)
- Cancer models (1)
- Cancer therapeutic resistance (1)
- Cannabinoide (1)
- Cannabinoids (1)
- Carabid beetles (1)
- Carcinogenese (1)
- Cardiac (1)
- Cardiac Efficiency (1)
- Cardiac MRI (1)
- Cardiac hypertrophy (1)
- Cardiac imaging (1)
- Cardiolipin (1)
- Cardiomyocytes (1)
- Cardiomyopathy (1)
- Carotis Intima Media Dicke (1)
- Cartiage Integration (1)
- Cartilage (1)
- Cartilage Regeneration (1)
- Cartilage defect (1)
- Cas9 (1)
- Caspr-1 (1)
- Catechol-0-Methyltransferase (1)
- Catechol-O-Methyltransferase (1)
- Catecholmethyltransferase <Catechol-0-Methyltransferase> (1)
- Cation Homeostasis (1)
- Caveolin-1 (1)
- Ccr4-Not (1)
- Cdh13 (1)
- Celecoxib (1)
- Cell (1)
- Cell Cycle (1)
- Cell Sheet Engineering (1)
- Cell adhesion (1)
- Cell culture (1)
- Cell differentiation (1)
- Cell line (1)
- Cell-Assisted Lipotransfer (1)
- Cells (1)
- Cellular invasion (1)
- Ceramides (1)
- Cerebrospinal fluid (CSF) (1)
- ChIP-Seq (1)
- ChIP-sequencing (1)
- Chaetomium thermophilum (1)
- Chain-length distribution (1)
- Characterization (1)
- Charcot-Marie-Tooth 1A (1)
- Chemische Synapsen (1)
- Chemokin CXCL10 (1)
- Chemokin CXCL12 (1)
- Chemokine (1)
- Chemokine receptors (1)
- Chemoresistenz (1)
- Chemotaxis (1)
- Chemotherapeutic resistance (1)
- Children (1)
- Chimeric Antigen Receptor (1)
- Chimeric antigen receptor (1)
- Chimeric antigen receptor (CAR) (1)
- Chimpanzee (1)
- Chimärer Antigenrezeptor (1)
- Chirurgie (1)
- Chlamydia (1)
- Chlamydienkrankheit (1)
- Cholesterintransporter (1)
- Chondrogenic Differentiation (1)
- Chordontonal organ (1)
- Chromatinremodeling (1)
- Chromatinremodelling (1)
- Chromosom 6 (1)
- Chromosome 6 (1)
- Chronic Mild Stres (1)
- Chronisch-myeloische Leukämie (1)
- Chronische Nierenerkrankung (1)
- Chronischer Schmerz (1)
- Chylomicron (1)
- Chylomicrons (1)
- Circadian (1)
- Circadian Clock (1)
- Circadian clock (1)
- Circadiane Uhr (1)
- Circadianer Rhythmus (1)
- Citalopram (1)
- Claudin (1)
- Click-Chemie (1)
- Climate change (1)
- Clonal competition assay (1)
- Clostridium difficile (1)
- Cluster (1)
- Co-Analgetika (1)
- Co-Kultur (1)
- Co-culture system (1)
- CoQ10 (1)
- Coactosin-like (1)
- Coffin-Lowry syndrome (1)
- Cofilin (1)
- Cognitive Distortions (1)
- Cognitive consistency (1)
- Cognitive processing (1)
- Cognitive profile (1)
- Collagen gels (1)
- Colliculus inferior (1)
- Collybistin (1)
- Colon cancer (1)
- Colorectal cancer (1)
- Commensalism (1)
- Comorbidity (1)
- Comoé National Park (1)
- Complement system (1)
- Complex Regional Pain Syndrome (1)
- Complexes (1)
- Complexome (1)
- Compound eyes (1)
- Compressed sensing (1)
- Computational Fluid Dynamics (1)
- Computational Psychiatry (1)
- Computational drug design (1)
- Computersimulation (1)
- Computerunterstütztes Verfahren (1)
- Conditioning (1)
- Contact-Kinin System (1)
- Contrast Agent Bolus Based Perfusion Magnetic Resonance Imaging (1)
- Convolutional Neural Network (1)
- Coronary heart disease (1)
- Correlative microscopy (1)
- Cortico-striatal projection neurons (1)
- Corticoliberin (1)
- Counting (1)
- Coxiella burnetii (1)
- Craniosynostosis (1)
- Craving (1)
- CsrA (1)
- Cul4b (1)
- Cuticular transpiration (1)
- Cuticular water permeabilities (1)
- Cyanobacteria (1)
- Cyanobakterien (1)
- Cyclic peptides (1)
- Cyclics (1)
- Cystein (1)
- Cysteinproteasen (1)
- Cytologie (1)
- Cytomegalie-Virus (1)
- Cytoplasma (1)
- Cytotoxic T cell (1)
- D-4F (1)
- DC (1)
- DC/T-Zell-Konjugate (1)
- DEQCT (1)
- DExD/H box protein (1)
- DG diacyglycerol (1)
- DGCR8 (1)
- DHX30 (1)
- DNA Barcoding (1)
- DNA Damage (1)
- DNA Doppelstrangbrüche (1)
- DNA Schaden (1)
- DNA Sekundärstruktur (1)
- DNA crosslink (1)
- DNA double strand breaks (1)
- DNA lesion (1)
- DNA methylation (1)
- DNA secondary structure (1)
- DNA-Methylierung (1)
- DNA-Schaden (1)
- DNA-Schäden (1)
- DNA-Vernetzung (1)
- DNS-Bindungsproteine (1)
- DNS-Schaden (1)
- DNS-Sequenz (1)
- DOT1 (1)
- DREAM (1)
- DREAM complex (1)
- DSIF (1)
- DTI (1)
- DUB (1)
- DUB Mutante (1)
- DYT-TOR1A (1)
- Danaus plexippus (1)
- Danio rerio (1)
- Darmepithel (1)
- Darmflora (1)
- Dasatinib (1)
- Datenbank (1)
- Decapping (1)
- Deep-sequencing (1)
- Deeplearning (1)
- Defensine (1)
- Defäkographie (1)
- Degradation (1)
- Deletion (1)
- Denaturierende Gradienten-Gelelektrophorese (1)
- Denaturing Gradient Gel Electrophoresis (1)
- Dendra2 (1)
- Density Weighting (1)
- Deoxyribozymes (1)
- Dephosphorylierung (1)
- Depletion (1)
- Dereplicaiton (1)
- Desmoglein 2 (1)
- Desmoglein 3 (1)
- Desmogleine (1)
- Desmosom (1)
- Deubiquitination (1)
- Development (1)
- Developmental plasticity (1)
- Dexamethason (1)
- Diabetes (1)
- Diabetes Typ 1 (1)
- Diabetes mellitus Typ 1 (1)
- Diabetic painful neuropathy (1)
- Diabetic polyneuropathy (1)
- Diagnostic Imaging Exams (1)
- Dickdarmkrebs (1)
- Differential scanning calorimetry (1)
- Differentielle Genexpression (1)
- Differentielle Ressourcenallokation (1)
- Differenzierung (1)
- Differenzierungszustand (1)
- Diffusion (1)
- Diffusion Tensor Imaging (1)
- Diffusionskoeffizient (1)
- Dihydrooxazole (1)
- Dilated cardiomyopathy (1)
- Dimension 3 (1)
- Dimere (1)
- Dimeric Naphthylisoquinoline Alkaloids (1)
- Diphenylether (1)
- Diskriminationslernen (1)
- Diskriminationstraining (1)
- Dispersal (1)
- Disulfidbrücken (1)
- Diversifikation <Biologie> (1)
- Diversity (1)
- Dolutegravir (1)
- Domäne <Biochemie> (1)
- Domänenprotein (1)
- Dopamin-Transporter (1)
- Dopamine transporter (1)
- Dopaminstoffwechsel (1)
- Dopamintransporter (1)
- Dorsal Root Ganglion (1)
- Dorsal root ganglion (1)
- Dosimetry (1)
- Double Negative B cells (1)
- Dreidimensionales Modell (1)
- Droseraceae (1)
- Drosophila Larva (1)
- Drosophila Larve (1)
- Drosophila Myc transcription growth PAF1 (1)
- Drug Delivery (1)
- Drug delivery system (DDS) (1)
- Drug resistance (1)
- Drug targets (1)
- Drug testing (1)
- Dual RNA-seq (1)
- Dual RNA-seq data analysis (1)
- Dual-setting (1)
- Dualstere Liganden (1)
- Dualsteric Ligands (1)
- Duodenal Jejunal Bypass (1)
- Duplikation (1)
- Durchflusscytometrie (1)
- Dynabeads (1)
- Dynamic MR imaging (1)
- Dynamics of ribosome assembly (1)
- Dynamik (1)
- Dynamik von Membranrezeptoren (1)
- Dynamische MR-Bildgebung (1)
- Dynein Light Chain (1)
- Dystonie (1)
- Dürrestress (1)
- E.coli Nissle 1917 (1)
- E1 inhibitoren (1)
- E1 inhibitors (1)
- E2 (1)
- EAE (1)
- ECAP (1)
- ECG-gated PET (1)
- EGFR (1)
- ELISA (1)
- EMT (1)
- ER dynamics in axon terminals (1)
- ERK (1)
- Eap (1)
- Early-Life Stress (1)
- Echo Planar Imaging (1)
- Echo planar imaging (1)
- Echocardiography (1)
- Echoplanar-Bildgebung (1)
- Echtzeit (1)
- Echtzeitbildgebung (1)
- Eclosion (1)
- Eclosion hormone (1)
- Ecological Momentary Assessment (1)
- Ecological Momentary Assessments (1)
- Ecosystem services (1)
- Effect anticipation (1)
- Effektantizipation (1)
- Efflux pump (1)
- Effluxpumpen (1)
- Eierstockkrebs (1)
- Eierstocktumor (1)
- Einfühlung (1)
- Einfühlung <Motiv> (1)
- Eingeweidewürmer (1)
- Einsamkeit (1)
- Einzel-Molekül (1)
- Einzelpartikelverfolgung (1)
- Einzelzellgelelektrophorese (1)
- Electrochemical Impedance Spectroscopy (1)
- Electrode (1)
- Electroencephalography (1)
- Electromyography (1)
- Electrophysiology (1)
- Elektroakupunktur (1)
- Elektrode (1)
- Elektromyographie (1)
- Elektronencephalographie (1)
- Elektrospinnen (1)
- Elektrostimulation (1)
- Elektrotherapie (1)
- Elevated Plus-Maze (1)
- Elongation (Transkription) (1)
- Embryo (1)
- Embryonale Stammzelle (1)
- Emotionale Informationsverarbeitung (1)
- Emotionales Verhalten (1)
- Empfindlichkeit (1)
- Endobrachyösophagus (1)
- Endocytosis (1)
- Endogenous clock (1)
- Endokrinologie (1)
- Endophenotype (1)
- Endophänotyp (1)
- Endophänotypen (1)
- Endoplasmatisches Retikulum (1)
- Endorganschaden (1)
- Endosom (1)
- Endosomes (1)
- Endothelium (1)
- Endothelzelle (1)
- Enoyl-Reduktase (1)
- Enoyl-acyl-carrier-protein-Reductase (1)
- Enoyl-acyl-carrier-protein-Reductase <Enoyl-[acyl-carrier-protein]-Reductase> (1)
- Enterische Glia (1)
- Enterisches Nervensystem (1)
- Enterohemorrhagic Escherichia coli (1)
- Entscheidungsverhalten (1)
- Entwicklung chimärer Antigenrezeptor T-Zellen (1)
- Entzündungschmerz (1)
- Entzündungsreaktion (1)
- Entzündungsschmerz (1)
- Enzymaktivierung (1)
- Enzyminhibitor (1)
- Eosinophiler Granulozyt (1)
- EphA2 (1)
- Ephrin ligand (1)
- Ephrine (1)
- Epidemiologie (1)
- Epidermal growth factor receptor (1)
- Epigenetische Mechanismen (1)
- Epithel (1)
- Epithelial layer (1)
- Epithelial lineage (1)
- Epithelial-mesenchymale Transition (1)
- Epithelzelle (1)
- Erk1/2 (1)
- Erkennung (1)
- Erregbarkeit (1)
- Esophageal adenocarcinoma (1)
- Esophageal disease (1)
- Essgewohnheit (1)
- Essstörung (1)
- Essverhalten (1)
- Estrogens (1)
- Excitatory/inhibitory imbalance (1)
- Excitotoxicity (1)
- Exon Array (1)
- Expansion microscopy (1)
- Expansionsmikroskopie (1)
- Experimental Autoimmune Encephalomyelitis (EAE) (1)
- Experimentelle Autoimmune Enzephalomyelitis (1)
- Experimentelle Autoimmune Enzephalomyelitis (EAE) (1)
- Experimentelle autoimmune Enzephalomyelitis (1)
- Experimentellen Autoimmun-Enzephalomyelitis (1)
- Experimenteller Schlaganfall (1)
- Explainable AI (1)
- Explainable Artificial Intelligence (1)
- Explorationsverhalten (1)
- Exposition (1)
- Expositionslernen (1)
- Exposure treatment (1)
- Expression (1)
- Extracellular Matrix (1)
- Extracellular Vesicles (1)
- Extracellular matrix proteins (1)
- Extrazellulärmatrix (1)
- Exzitatorische Synapse (1)
- Eye irritation (1)
- FAS (1)
- FAS-II (1)
- FAT10ylation (1)
- FBXO6 (1)
- FCS (1)
- FGF (1)
- FGF Signaling (1)
- FLT3 inhibitor (1)
- FMMs (1)
- FMS-like tyrosine kinase 3 (FLT3) (1)
- FOXM1 (1)
- FOXP2 (1)
- FP635 (1)
- FRAP (1)
- FRET sensors (1)
- FT-IR-Spektroskopie (1)
- FabI (1)
- FabV (1)
- Fabry disease (1)
- Factor XII (1)
- Faktor XII (1)
- Fanconi Anemia (1)
- Fanconi-Anämie (1)
- Farnesyl Pyrophosphate Synthase (1)
- Farnesylpyrophosphatsynthase (FPPS) (1)
- Fas-Ligand (1)
- Fat Quantification (1)
- FcgR (1)
- FeS cluster (1)
- Fear Conditioning (1)
- Fear Extinction (1)
- Fear Generalization (1)
- Fear Learning (1)
- Fear conditioning (1)
- Fear generalization (1)
- Feedforward loop (1)
- FemX (1)
- Ferroptosis (1)
- Fertilization in angiosperm (1)
- Fettgewebe (1)
- Fettleber (1)
- Fettsäure-Synthase (1)
- Fibrinogen (1)
- Fibroblast (1)
- Fibroblasts (1)
- Fibromyalgia (1)
- Fibromyalgia syndrome (1)
- Fibromyalgiesyndrom (1)
- Fibrose (1)
- Filter (1)
- Flagelle (1)
- Flavonoide (1)
- Flavonoids (1)
- Flippase (1)
- Flotillin (1)
- Flow (1)
- Flugzeitmassenspektrometrie (1)
- FluidFM (1)
- Fluorescence Correlation Spectroscopy (1)
- Fluorescence Resonance Energy Transfer (1)
- Fluorescence correlation spectroscopy (1)
- Fluorescence microscopy (1)
- Fluorescence-resonance-energy-transfer (1)
- Fluorescent probes (1)
- Fluoreszenz (1)
- Fluoreszenzproteine (1)
- Fluoreszenzsonde (1)
- Fluoreszenzspektroskopie (1)
- Fluoreszierende Liganden (1)
- Fluoxetine (1)
- Fluss (1)
- Foamyviren (1)
- Folliculin (1)
- Forkhead Transcription Factors (1)
- Forkhead-Box-Proteine (1)
- Fox tapeworm (1)
- FoxO transcription factors (1)
- Foxo1 (1)
- Foxp3+CD4+ regulatorische T-Zelle (1)
- Foxp3+CD4+ regulatory T cell (1)
- Fragebogen (1)
- Fragmentscreening (1)
- Französische Feldwespe (1)
- Freezing (1)
- Freies Molekül (1)
- Fremdkörpermodell (1)
- Frizzled 5 (1)
- Frontal asymmetry (1)
- Froschlurche (1)
- Fructosebisphosphat-Aldolase (1)
- Fruit (1)
- Frühe Gene (1)
- Function (1)
- Functional analyses (1)
- Functioning Assessment Short Test (1)
- Funktionelle Annotation (1)
- Funktionelle Bildgebung (1)
- Funktionelle Kernspintomographie (1)
- Funktionelle Untersuchung (1)
- Funktionsausfälle (1)
- Furagieraktivität (1)
- Furchkonditionierung (1)
- Furchtentwicklung (1)
- Furchtextinktion (1)
- Fusarium (1)
- Förster Resonance Energy Transfer (1)
- G Protein-Coupled Receptor (1)
- G Protein-Coupled Receptors (1)
- G Protein-coupled receptor (1)
- G glycoprotein (1)
- G protein coupled receptor (1)
- G protein-coupled receptor kinase (1)
- G protein-coupled receptor kinase 2 (GRK2) (1)
- G protein-coupled receptors (1)
- G protein-gekoppelte Rezeptor Kinase 2 (GRK2) (1)
- G-Protein (1)
- G-Protein gekoppelte Rezeptor (1)
- G-Protein-gekoppelte Rezeptoren (1)
- G-protein (1)
- G-quadruplex (1)
- G2/M genes (1)
- GABA (1)
- GABA A Receptors (1)
- GABA A Rezeptoren (1)
- GABA receptor (1)
- GABA(A) receptor (1)
- GABAA-Rezeptor (1)
- GABAerge Nervenzelle (1)
- GAD1 (1)
- GAD65 (1)
- GAS2L3 (1)
- GC1 cells (1)
- GDF-15 (1)
- GLA KO mouse model (1)
- GLP-1 (1)
- GMP (1)
- GPCR Oligomerisierung (1)
- GPCR dimerisation (1)
- GPCR nanodomains (1)
- GPCR oligomerization (1)
- GPCR signaling (1)
- GPI-anchored protein (1)
- GRM8 (1)
- GWAS (1)
- Ga-68-labelled Peptides (1)
- Galactosidase <alpha-> (1)
- Galectin 1 (1)
- Gambler's Fallacy (1)
- Gametocyt (1)
- Gametozyt (1)
- Ganzkörperbestrahlung (1)
- Gap Junction (1)
- Gas chromatography (1)
- Gaschromatographie (1)
- Gastroesophageal reflux (1)
- Gastrointestinal tract (1)
- Gauss Prozess Klassifikation (1)
- Gaussian Process Classification (1)
- Gaze interaction (1)
- Gb3 accumulation (1)
- Gefrierstrukturierung (1)
- Gefäßalter (1)
- Gefäßwand (1)
- Gefäßwand-residente Stamm- und Vorläuferzellen (1)
- Gehirn-Computer Schnittstelle (1)
- Geißel <Biologie> (1)
- Gelernte Hilflosigkeit (1)
- Gemcitabin (1)
- Gen BRCA 1 (1)
- Gen Umweltinteraktion (1)
- Gen notch (1)
- Gen-Umwelt Interaktion (1)
- Gene by Environment (1)
- Gene expression regulation (1)
- Gene regulation (1)
- Gene therapy (1)
- General Transcription Factor II H (1)
- General amplifier model (1)
- Generalization (1)
- Genetic etiology (1)
- Genome Annotation (1)
- Genome Instability (1)
- Genome editing (1)
- Genomeditierung (1)
- Genomic Selection (1)
- Genomik (1)
- Genotyping (1)
- Gentoxizität (1)
- Geomagnetic Field (1)
- Gerinnungsfaktor (1)
- Germination and differentiation (1)
- Germinative Zellen (1)
- Geruchswahrnehmung (1)
- Geschlechtsunterschiede (1)
- Geschmack (1)
- Gestational diabetes (1)
- Gestationsdiabetes (1)
- Gewebe (1)
- Gewebemodelle (1)
- Gewohnheit (1)
- Glatte Muskulatur (1)
- Glatter Krallenfrosch (1)
- Glioblastomtherapie (1)
- Glioma (1)
- Global change (1)
- Glottoplastik (1)
- Glucocorticoids (1)
- Glucose Starvation (1)
- Glucose metabolism (1)
- Glucosetransport (1)
- Glucosetransporter (1)
- Glukosemetabolismus (1)
- Glukosetransporter -1 (1)
- Glutamin (1)
- Glutathion (1)
- Glycerin-3-phosphat (1)
- Glycerinphosphate (1)
- Glycin (1)
- Glycine Receptors (1)
- Glycocalyx (1)
- Glycolipid (1)
- Glycophyten (1)
- Glycoprotein GPV (1)
- Glycoprotein hormone (1)
- Glykane (1)
- Glykobiologie (1)
- Glykokalyx (1)
- Glykomodifizierung (1)
- Glykosyltransferase (1)
- Glyzin Rezeptoren (1)
- Glyzinrezeptor (1)
- Glücksspiel (1)
- Gold Nanoparticles (1)
- Golgi apparatus (1)
- Gonococcal invasion (1)
- Grad-seq (1)
- Gradient System Transfer Function (1)
- Graft versus Host Disease (1)
- Graft versus Host disease (1)
- Graft-versus-host disease (GvHD) (1)
- Graft-versus-leukemia (1)
- Gram-positive (1)
- Gram-positive bacteria (1)
- Granulozyten (1)
- Growth-differentiation Factor 15 (1)
- Guanin Nukleotid Austauschfaktor (1)
- Guanine nucleotide exchange factor (GEF) (1)
- Guaninnucleotid-Austauschfaktoren (1)
- Guanylyl cyclase A (1)
- Guillain-Barré-Syndrom (1)
- GvL (1)
- Gvhd (1)
- H2A.Z (1)
- HAD phosphatase (1)
- HASH (1)
- HBD2 (1)
- HCMV (1)
- HCT (1)
- HD5 (1)
- HDAC (1)
- HECTD1 (1)
- HERV (1)
- HFO-1123 (1)
- HFpEF (1)
- HIF1alpha (1)
- HIV Drug resistance (1)
- HIV South Africa (1)
- HIV-1 (1)
- HIV-1 Vif (1)
- HIV-associated neurocognitive disorder (HAND) (1)
- HIV-assoziierte neurokognitive Störung (HAND) (1)
- HLA-G (1)
- HMBPP (1)
- HNE (1)
- HP1432, Hpn2 (1)
- HPLC-MS (1)
- HRV (1)
- HSF1 (1)
- HST1 (1)
- HSV-1 (1)
- Haarzelle (1)
- Habits (1)
- Habituationstraining (1)
- Haemostasis (1)
- Haloacid dehalogenase (1)
- Halophyten (1)
- Halophytes (1)
- Harze (1)
- Hautkrebs (1)
- Hautmodell (1)
- Hautverbrennung (1)
- HeLa H2B-GFP cells (1)
- HeLa H2B-GFP-Zellen (1)
- Heart (1)
- Heart Failure (1)
- Heart Period (1)
- Heart development (1)
- Heart failure (1)
- Heat shock protein 90 (1)
- Heat stress (1)
- Heilmittel (1)
- Heilung (1)
- Heißhunger (1)
- Helferzelle (1)
- Helicase (1)
- Helikasen (1)
- Helminths (1)
- Hematopoietic Cell Transplantation (1)
- Hematopoietic Stem Cell (1)
- Hematopoietic cell transplantation (1)
- Hemmung der Proliferation schnell wachsender Krebszellen (1)
- Hemodynamics (1)
- Hemofiltration (1)
- HepG2 cells (1)
- HepG2-Zellen (1)
- Heparin (1)
- Hereditary spastic paraplegia (1)
- Hereditäre spastsiche Paraplegie (1)
- Herpes (1)
- Herpes simplex Virus DUB C65A (1)
- Herpes simplex virus C65A (1)
- Herpesviren (1)
- Herpesviruses (1)
- Herz-Kreislauf-Erkrankung (1)
- Herzbildgebung (1)
- Herzfrequenz (1)
- Herzfunktion (1)
- Herzratenvariabilität (1)
- Herzruptur (1)
- Heterogenität von Mikroorganismen (1)
- Hey Proteine (1)
- Hey proteins (1)
- Hi-C (1)
- Hic-5 (1)
- Hidden Markov Model (1)
- Hidden-Markov-Modell (1)
- High-thropughput screening (1)
- Himmelskompass (1)
- Hippokampus (1)
- Hirnendothelzellen (1)
- Hirnhaut (1)
- Hirnstimulation (1)
- Histatin 5 (1)
- Histon-Deacetylase (1)
- Histon-Methyltransferase (1)
- Histonacetyltransferase (1)
- Histone Acetylation (1)
- Histone modification (1)
- Histone variant (1)
- Histones (1)
- Hitzeschock Proteine (1)
- Hitzeschock-Proteine (1)
- Hitzeschockprotein 90 (1)
- Hitzeschocktranskriptionsfaktor (1)
- Hitzestress (1)
- Hochauflösende Mikroskopie (1)
- Hochauflösungsmikroskopie (1)
- Hochdurchsatz-Screening (1)
- Hochdurchsatzsequenzierung (1)
- Holobiont (1)
- Homing (1)
- Homöostase (1)
- Honigbiene (1)
- Honigbienen (1)
- Hormone Receptor Signaling (1)
- Hornhaut (1)
- Hornhautinfektionen (1)
- Hospitalismus <Hygiene> (1)
- Host Colonization (1)
- Host Genome Integrity (1)
- Host defense (1)
- Host-Pathogen Interactions (1)
- Hot Hand Fallacy (1)
- Huh6 (1)
- Human Herpesvirus 6 (1)
- Human Transcriptome (1)
- Human-pathogenic (1)
- Humanes Herpesvirus 6 (1)
- Humanparasitologie (1)
- Huwe1 (1)
- Hyaluronic Acid (1)
- Hyaluronic acid (1)
- Hybrid-Molecules (1)
- Hydrocortison (1)
- Hydroscape-Gebiet (1)
- Hyperactivity (1)
- Hyperekplexie (1)
- Hypertension (1)
- Hypertrophy (1)
- Hypoparathyreoidismus (1)
- Hyrogels (1)
- Hämatopoetische Stammzellen (1)
- Hämatopoetische Stammzelltransplantation (1)
- Hämodynamik (1)
- Hämophilie A (1)
- Hämsotase (1)
- Höhenangst (1)
- Hörbahn (1)
- Hörrinde (1)
- ICP22 (1)
- IE3 (1)
- IEG (1)
- IFN-g (1)
- IFNAR (1)
- IGF1 (1)
- IGF1R Mutationen (1)
- IKZF1 (1)
- IKZF3 (1)
- IL-12p70 (1)
- IL-2 (1)
- IL-23 (1)
- IL-4 (1)
- IL-4 Rezeptor alpha (1)
- IL-4 receptor alpha chain (1)
- IL-6 Inhibition (1)
- IMP1/ZBP1 (1)
- IP6 (1)
- IPP (1)
- IRAK2 (1)
- ITAM (1)
- ITAM-signalling (1)
- IVIG (1)
- Ibrutinib (1)
- Ideomotor gaze control (1)
- Ideomotorik (1)
- Ideomotorische Blickkontrolle (1)
- IgG-Subklasse (1)
- Ighmbp2 (1)
- Ikaros (1)
- Ileal Trasposition (1)
- Illumina HiSeq (1)
- Image Processing (1)
- Image Quality (1)
- Immunaktivierung (1)
- Immunantwort (1)
- Immune Checkpoint Therapy (1)
- Immune System (1)
- Immune Thrombocytopenia (1)
- Immune activation (1)
- Immune cell assays (1)
- Immune cells (1)
- Immune evasion (1)
- Immunevasion (1)
- Immunglobulin G (1)
- Immunkardiologie (1)
- Immunocardiology (1)
- Immunohistochemistry (1)
- Immunologe (1)
- Immunomodulation (1)
- Immunophilin (1)
- Immunosuppressant (1)
- Immunozyt (1)
- Immunpathogenese (1)
- Immunsuppressiva (1)
- Immunthrombozytopenie (1)
- Immunzellassays (1)
- Immunzellrekrutierung (1)
- Impfstoff (1)
- Implantatentwicklung (1)
- In vitro model (1)
- In vitro models (1)
- In vivo Imaging (1)
- Individual based model (IBM) (1)
- Individual differences (1)
- Individualisierte Medizin (1)
- Infection imaging (1)
- Infection models (1)
- Infectious diseases (1)
- Infektiologie (1)
- Infektionsbildgebung (1)
- Infektionsbiologie (1)
- Infektionsprozess (1)
- Infektionsstudien (1)
- Inferior colliculus (1)
- Inflamamtion (1)
- Inflammatory Pain (1)
- Inflammatory pain (1)
- Informationsnutzung (1)
- Infrared radiation (1)
- Inhibitory-postsynapse (1)
- Injectability (1)
- Insect (1)
- Insekt (1)
- Insektenstaaten (1)
- Instrumental Activities of Daily Living (1)
- Insulin-like Growth (1)
- Insulin-like Growth Factor I (1)
- Insulin-like-Growth-Factor-Binding-Protein-5 (1)
- Insulinresistenz (1)
- Insulinsekretion (1)
- Integrase inhibitor (1)
- Integrated Defensive States (1)
- Integrin (1)
- Integrine (1)
- Interaction analysis (1)
- Interaction of 7SK with the Smn complex modulates snRNP production (1)
- Interaktionsrezeptor (1)
- Interferon <Gamma-> (1)
- Interferonrezeptor (1)
- Interleukin (1)
- Interleukin 12 (1)
- Interleukin 17 (1)
- Interleukin 5 (1)
- Interleukin-4 Antagonist (1)
- Interleukin-6 type cytokines (1)
- Interleukin-6-Typ-Zytokine (1)
- Interleukine (1)
- Internal Dosimetry (1)
- Internalisierende Störung (1)
- Interozeption (1)
- Interozeptive Genauigkeit (1)
- Intestinal metaplasia (1)
- Intestinal stem cell (1)
- Intracellular bacteria (1)
- Intracellular virulence (1)
- Intratumorale Heterogenität (1)
- Intravoxel Incoherent Motion (1)
- Intrazelluläre Bakterien (1)
- Intrinsische Gerinnungskaskade (1)
- Ion channel function (1)
- Ionisierende Strahlung (1)
- Irradiation (1)
- Ischemia (1)
- Ischämischer Schlaganfall (1)
- Isolation (1)
- Isolation and Characterization (1)
- Isomer (1)
- Isopentenyl pyrophosphate (IPP) (1)
- Isopentenyl-pyrophosphat (IPP) (1)
- Isoprenoid Synthesis (1)
- Isoprenoide (1)
- Isoprenoidsynthese (1)
- Ixolaris (1)
- JNCL (1)
- JNK (1)
- JURKAT-Zelle (1)
- Judgment (1)
- Jugendliche (1)
- Jun (1)
- K-RAS (1)
- K5 capsule (1)
- KDELR2 (1)
- Kaliumkanal (1)
- Kallikrein-Kinin-System (1)
- Kardiale MR-Bildgebung (1)
- Kardiovaskuläre Komorbiditäten (1)
- Karotis-Intima-Media-Dicke (1)
- Kation (1)
- Kationen-Homöostase (1)
- Kehlkopfchirurgie (1)
- Keimzentrumsreaktion (1)
- Kern (1)
- Kidney (1)
- Kilimandscharo (1)
- Kinase (1)
- Kinase signaling (1)
- Kinasen (1)
- Kinder (1)
- Kinderpsychiatrie (1)
- Kinderschlaf (1)
- Kindesalter (1)
- Kindheit und Jugend (1)
- Kinetik (1)
- Klassifikations- und Regressionsbaum (1)
- Kleine Proteine (1)
- Kleinkind (1)
- Klima (1)
- Klimawandel (1)
- Klinischer Behandlungspfad (1)
- Kniegelenkarthrose (1)
- Knochenbildung (1)
- Knochenersatz (1)
- Knochenmarkzelle (1)
- Knochenmetastase (1)
- Knochenmetastasen (1)
- Kofaktorbindung (1)
- Koffein (1)
- Kognitive Beeinträchtigung (1)
- Kognitive Entwicklung (1)
- Kognitive Inhibition (1)
- Kognitive Störung (1)
- Kognitiver Prozess (1)
- Kognitives Lernen (1)
- Kohlendioxid (1)
- Kohlenhydrate (1)
- Kohlenstoff (1)
- Kohlenstofffaser (1)
- Kohlenstoffstoffwechsel (1)
- Kohlenwasserstoffe (1)
- Kollektive Invasion (1)
- Kolloid (1)
- Kolonieerkennung (1)
- Kolonkarzinom (1)
- Kommunikation (1)
- Kommunikationshilfe (1)
- Komorbidität (1)
- Kompass (1)
- Komplement (1)
- Komplement C3a (1)
- Komplement C5a Rezeptor 1 (1)
- Komplementsystem (1)
- Komplexauge (1)
- Komplexes regionales Schmerzsyndrom (1)
- Komprimierte Abtastung (1)
- Kongestive Herzmuskelkrankheit (1)
- Kongo (1)
- Konnektivitätsschätzung (1)
- Konsolidierung (1)
- Kontingenz (1)
- Kontrastmittel (1)
- Kontrastmittel-gestützte MRT-Perfusionsmessung (1)
- Kontrolle (1)
- Kopfschmerz (1)
- Kopienzahlvariation (1)
- Korrelative Mikroskopie (1)
- Krebs (1)
- Kryokonservierung (1)
- Kuh (1)
- Körperachsen (1)
- Körperliche Leistungsfähigkeit (1)
- Künstliche Ingelligenz (1)
- Künstliche Intelligenz (1)
- L-typ Calciumkanal Antagonist (1)
- LAD (1)
- LASP1 (1)
- LASP1 (LIM and SH3 Protein 1) (1)
- LASP1 (LIM und SH3 Protein 1) (1)
- LAT2 (1)
- LC-MS/MS (1)
- LDL-Rezeptor (1)
- LIMK (1)
- LIS (1)
- LPS (1)
- LPS Biosynthese (1)
- LV Function (1)
- Labeling (1)
- Lactobacillus reuteri (1)
- Lambdoide Prophagen (1)
- Langerhans cells (1)
- Langzeitgedächtnis (1)
- Lasermikrodissektion (1)
- Lasiocarpin (1)
- Lateral root development (1)
- Latrophilin receptor (1)
- Latrophilin-3 (1)
- Ldlr-Knockout (1)
- Leaf (1)
- Learning & Memory (1)
- Learning Walk (1)
- Learning walk (1)
- Lebendzellmikroskopie (1)
- Lebenslauf (1)
- Lebensmittelchemie (1)
- Lebensqualität (1)
- Leber-Metabolismus (1)
- Leberepithelzelle (1)
- Leichte kognitive Beeinträchtigung (1)
- Leitlinien (1)
- Lenalidomid (1)
- Lentiviral transgenesis (1)
- Leptomeningeal cells (1)
- Leptomeningealzellen (1)
- Lernverhalten (1)
- Letalität (1)
- Leukaemia-inhibitory factor (1)
- Lgr5 (1)
- Library Screening (1)
- Library of Phytochemicals (1)
- Library of plant species (1)
- Licht (1)
- Lichtblattmikroskopie (1)
- Lichtscheibenmikroskopie (1)
- Licl (1)
- Ligand uncaging (1)
- Light Sheet Fluorescence Microscopy (1)
- Light sheet microscopy (1)
- Lipid Raft (1)
- Lipid Rafts (1)
- Lipid Transfer Protein (1)
- Lipidom (1)
- Lipidomics (1)
- Lipidomik (1)
- Lipidumbau (1)
- Lipolysis (1)
- Lipoprotein (1)
- Liquor (1)
- Locomotor activity (1)
- Lokalanästhesie (1)
- Luftfeuchtigkeit (1)
- Lung Cancer (1)
- Lung Cancer metastasis (1)
- Lung cancer (1)
- Lung squamous cancer cells (1)
- Lungenentzündung (1)
- Lungentumor (1)
- Lurche (1)
- Lymphknoten (1)
- Lysin-Oxidase (1)
- Lysosome (1)
- Lysyl oxidases (1)
- Lysyloxidasen (1)
- Ländlicher Raum (1)
- M1 Muscarinic Receptor (1)
- MAP kinase (1)
- MAX (1)
- MCMV (1)
- MDR1 (1)
- MDSC (1)
- MDSCs (1)
- MEK5/ERK5 (1)
- MEK5/ERK5 cascade (1)
- MET-T-box riboswitch (1)
- MGMT (1)
- MIPs (1)
- MIZ1 (1)
- MLN7243 (1)
- MM (1)
- MMB complex (1)
- MMN (1)
- MMP (Matrix-Metalloproteasen) (1)
- MMP (Matrix-Metalloproteases) (1)
- MND (1)
- MRR1 (1)
- MS2-affinity purification and RNA-seq (1)
- MT02 (1)
- MYCN-amplified (1)
- Machine Learning (1)
- Macromolecular machine (1)
- Macrophage (1)
- Macrophage extracellular traps (1)
- Macrophytes (1)
- Magen (1)
- Magenchirurgie (1)
- Magenkrankheit (1)
- Magenkrebs (1)
- Magnetic Resonance Imaging (1)
- Magnetic Resonance Relaxometry (1)
- Magnetic resonance imaging (1)
- Magnetresonanz-Relaxometrie (1)
- Major depression (1)
- Makrokolonie (1)
- Makrophagen (1)
- Makrophyten (1)
- Malignant melanoma (1)
- Mamma carcinoma (1)
- Mammakarzinom (1)
- Mantle cell lymphoma (1)
- Marine natural products (1)
- Marine sponge (1)
- Marine sponge-derived actinomycetes (1)
- Marker (1)
- Marketing authorisation of pharmaceuticals (1)
- Marrow (1)
- Masern (1)
- Masern-Virus (1)
- Masernvirus-Infektion (1)
- Mass Spectrometry (1)
- Mass spectrometry (1)
- Massenspektrometrie/Proteomics (1)
- Masspectrometry (1)
- Mast cells (1)
- Mastzelle (1)
- Mathematical modeling (1)
- Mathematische Modellierung (1)
- Matrix-Metalloprotease (1)
- Matrix-Metalloproteasen (1)
- Matrix-Metalloproteinase (1)
- Mauerbiene (1)
- Mc4r (1)
- Measles virus (1)
- Mechanical deformation (1)
- Mechanisms of Social Attention (1)
- Mechanismus (1)
- Mechanistic model (1)
- Mechanorezeptor (1)
- Medaka (1)
- Mediator Komplex (1)
- Medium spiny neurons (1)
- Medizinprodukt (1)
- Medizintechnik (1)
- Medulloblastom (1)
- Megakaryocytes (1)
- Megakaryozytopoese (1)
- Mek5/Erk5-Signalweg (1)
- Melanin (1)
- Melanin release (1)
- Melanoma (1)
- Melanophor (1)
- Membrane Receptor Dynamics (1)
- Membranlipide (1)
- Membranproteine (1)
- Membranrezeptor (1)
- Memory (1)
- Memory B cells (1)
- Menaquinon-BIosynthese (1)
- Menaquinone Biosynthesis (1)
- Meninges (1)
- Meningitis cerebrospinalis epidemica (1)
- Meningitis, Meningococcal (1)
- Meningococci (1)
- Meningokokken-Sepsis (1)
- Meniskus (1)
- Meniskusimplantat (1)
- Meniskustransplantation (1)
- Mercapturic acid pathway (1)
- Merkel cell polyomavirus (1)
- Merkelzellkarzinom (1)
- Mesenchymal Stem Cell (1)
- Mesenchymal Stromal Cell (1)
- Mesenchymal Stromal Cells (1)
- Mesenchymal stem cell (1)
- Mesenchymal stromal cells (1)
- Mesenchymale Stammzelle (1)
- Mesenchymale Stromazelle (1)
- Messenger-RNS (1)
- Meta-barcoding (1)
- Metaanalyse (1)
- Metabolic Glycoengineering (1)
- Metabolic Labeling (1)
- Metabolic activation (1)
- Metabolic enzymes (1)
- Metabolism (1)
- Metabolite von Morphin (1)
- Metabolites of morphine (1)
- Metabolomics (1)
- Metagenomics (1)
- Metalloprotease (1)
- Metalloproteasen (1)
- Metalloproteases (1)
- Metalloproteinase (1)
- Metapopulation (1)
- Metastasierung (1)
- Metatranscriptomics (1)
- Methioninbiosynthese (1)
- Method development (1)
- Methodenentwicklung (1)
- Methylphenidat (1)
- Methyltransferase (1)
- Mevalonate Pathway (1)
- MgrB (1)
- MicF (1)
- MicroRNA (1)
- MicroRNAs (1)
- Microarray (1)
- Microbial community (1)
- Microbiota (1)
- Microglia (1)
- Micronuclei (1)
- Micronucleus (1)
- Microvesicle (1)
- Microwave Assisted Extraction (1)
- Migraine (1)
- Migration (1)
- Migräne (1)
- Mikroarray basierte vergleichende Genomhybridisierung (Array-CGH) (1)
- Mikrobiota (1)
- Mikroglia (1)
- Mikroglomeruli (1)
- Mikrokerne (1)
- Mikroorganismus (1)
- Mikrotubuli-assoziiertes Protein (MAP) (1)
- Mikrotubulus (1)
- Mimik (1)
- Minor histocompatibility antigen mismatch transplantation (1)
- Mitochondrien (1)
- Mitotic disturbance (1)
- Mittelohrimplantat (1)
- Mobie EEG (1)
- Mobile Crowdsensing (1)
- Mobile Health (1)
- Mobiles Endgerät (1)
- Mobilfunkstrahlung (1)
- Moco biosynthesis (1)
- Model (1)
- Model Based Reconstruction Algorithms in Magnetic Resonance Imaging (1)
- Model Organism (1)
- Model simulation (1)
- Modell (1)
- Modellbasierte-Rekonstruktionsalgorithmen in der Magnetresonanztomografie (1)
- Modellierung (1)
- Modellorganismus (1)
- Modellsystem (1)
- Moderator (1)
- Modifizierung (1)
- ModulationTregs (1)
- Molecular Pharmacology (1)
- Molecular Radiotherapy (1)
- Molekulare Charakterisierung (1)
- Molekulare Zielstrukturen (1)
- Mongolische Rennmaus (1)
- Monitoring (1)
- Monoklonale Gammopathie (1)
- Monoklonaler Antikoerper (1)
- Monoklonaler bispezifischer Antikörper (1)
- Moonlight (1)
- Moosfaserterminalen (1)
- Morbus Alzheimer (1)
- Morbus Fabry (1)
- Morphin (1)
- Morphology (1)
- Morris Water Maze (1)
- Motivation (1)
- Motoneuron diseases (1)
- Motoneuronenerkrankung (1)
- Motoneurons (1)
- Motor Memory (1)
- Motor learning (1)
- Motor neuron disease (1)
- Motorische Endplatte (1)
- Motorisches Gedächtnis (1)
- Mrap2 (1)
- Mrr1 (1)
- MscS (1)
- Mucorales (1)
- Mucormycosis (1)
- Mucormykose (1)
- Multi-Unit Aufnahmen (1)
- Multicellular aggregates (1)
- Multidrug-Resistance-Related Proteine (1)
- Multidrugresistant (1)
- Multilayered skin tissue model (1)
- Multiphotonenmikroskopie (1)
- Multiple Sclerosis (1)
- Multiple myeloma (1)
- Multizellulären Bakteriengemeinschaften (1)
- Mundschleimhautzellen (1)
- Murine models of thrombosis and haemostasis (1)
- Muskelin (1)
- Muskelzelle (1)
- Mustererkennungsrezeptoren (1)
- Myb-MuvB complex (1)
- Mycobacterium tuberculosis (1)
- Mycobacterium tuberculosis InhA (1)
- Myeloblast (1)
- Myeloid (1)
- Myeloid-derived suppressor cells (1)
- Myeloide Suppressorzellen (1)
- Myelom (1)
- Myeloma (1)
- Myocardial Work (1)
- Myocardial infarction (1)
- Myoferlin (1)
- Myokardiale Deformation (1)
- Myokarditis (1)
- Myosin IIA (1)
- Myrmecology (1)
- N-RAS (1)
- N2pc (1)
- N400 (1)
- NA (1)
- NAFLD (1)
- NEDMIAL (1)
- NES (1)
- NF-kB (1)
- NF-kappaB (1)
- NFATc3 (1)
- NHERF (1)
- NK (1)
- NK cell (1)
- NK-DC cross-talk (1)
- NKT (1)
- NLS (1)
- NMJ (neuromuscular junction) (1)
- NMR (1)
- NNMT activity assay (1)
- NO-GC (1)
- NOS-I (1)
- NOS1AP (1)
- NOTES <Chirurgie> (1)
- NRF2 (1)
- NSCLC (1)
- NSM2 (1)
- NTRK fusions (1)
- NaV1.9. oxidized phospholipids (1)
- Nachtschattengewächse (1)
- Nahrung (1)
- Nahrungsaufnahme (1)
- Nanofabrication (1)
- Nanofabrikation (1)
- Nanofaser (1)
- Nanomedicine (1)
- Nanomedizin (1)
- Nanopartikel (1)
- Nanotubes (1)
- Naphthalinderivate (1)
- Naphthochinonen (1)
- Naphthoquinones (1)
- Naphthylisochinolinalkaloide (1)
- Naphthylisoquinoline (1)
- Narrow escape problem (1)
- Nasenschleimhaut (1)
- Natrium-Kalium-Pumpe (1)
- Natrium-abhängigen Glukosetransporter-1 (1)
- Natriumoxamat (1)
- Natural pest control (1)
- Natural products (1)
- Natural walking (1)
- Nature-Insipired Synthesis (1)
- Naturschutz (1)
- Naturstoff (1)
- Near Miss (1)
- Nebenniere (1)
- Nebennierenrindenkarzinom (1)
- Nebennierenrindenkrebs (1)
- Nebennierentumor (1)
- Nectin4 (1)
- Neogenin-1 (1)
- Nephrogenese (1)
- Nerven (1)
- Nervenstimulation (1)
- Netrin-1 (1)
- Netzhaut (1)
- Netzwerkanalyse (1)
- Neuartige Arzneimittel (1)
- Neural Stem cells (1)
- Neurobiology (1)
- Neuroblastoma (1)
- Neurodegenerative Erkrankung (1)
- Neurodevelopment (1)
- Neurodevelopmental Disorder (1)
- Neurodevelopmental diseases (1)
- Neuroendokrines System (1)
- Neuroepigenomics (1)
- Neuroethology (1)
- Neurofeedback (1)
- Neurofilament (1)
- Neurogenesis (1)
- Neurogenetik (1)
- Neuroligin 2 (1)
- Neuromuskuläre Endplatte (1)
- Neuronale Stammzellen (1)
- Neuronales visuelles System (1)
- Neuropathic Pain (1)
- Neuropathic pain (1)
- Neuropathologie (1)
- Neuropathy (1)
- Neuropeptid S Rezeptor Gen (1)
- Neuropeptid Y (1)
- Neuropeptidom (1)
- Neurophysiologie (1)
- Neuroplasticity (1)
- Neuroprotection (1)
- Neuroprotektivum (1)
- Neurotransmitter Receptors (1)
- Neurotransmitter Rezeptoren (1)
- Neurotransmitter-Rezeptor (1)
- Neurotrophic factors (1)
- Neutrophil (1)
- Neutrophil granulocyte (1)
- Neutrophil granulocytes interaction (1)
- Newman strain sae (1)
- Next Generation Sequencing (NGS) (1)
- Nicht-kartesische Bildgebung (1)
- Nichtionisierende Strahlung (1)
- Nichtstrukturproteine (1)
- Nicotiana tabacum (1)
- Niere (1)
- Niereninsuffizienz (1)
- Nierenversagen (1)
- Nimodipin (1)
- Nitrogen (1)
- Nitrogen allocation (1)
- Nodo-Paranodopathie (1)
- Non-Hodgkin-Lymphom (1)
- Non-conventional T cell (1)
- Non-invasive imaging (1)
- Non-ribosomal peptide synthetase (1)
- Non-viral genome engineering (1)
- Noonan-Syndrom (1)
- Noradrenalin (1)
- Noradrenalinstoffwechsel (1)
- Nosocomial Infections (1)
- Nosokomiale Infektionen (1)
- Notch Signalweg (1)
- Notch signalling (1)
- Nozizeption (1)
- Nuclar Medicine (1)
- Nuclear Factor of Activated T cells (NFAT) (1)
- Nuclear Medicine (1)
- Nuclear imaging (1)
- Nuclease (1)
- Nucleasen (1)
- Nucleotide Excision Repair (1)
- Nucleotide excision repair (1)
- Nucleotide-Excision-Repair (1)
- Nucleus subthalamicus (1)
- Nuklearfaktor Kappa B (1)
- Nukleäre Hormonrezeptoren (1)
- Numerische Fluidmechanik (1)
- O(6)-Methylguanine-DNA Methyltransferase (1)
- OCT1 (1)
- OIS (1)
- OSM (1)
- OSMR (1)
- Oberflächenproteine der Sexualstadien (1)
- Olfaktion (1)
- Olfaktorik (1)
- Oligomerization (1)
- OmoMYC (1)
- Onchocerca volvulus (1)
- Onchozerkose (1)
- Oncogenes (1)
- Oncolytic Virotherapy (1)
- Oncoprotein (1)
- Oncostatin M receptor (1)
- Oncostatin-M-Rezeptor (1)
- Onkologie (1)
- Onkolyse (1)
- Onkoprotein (1)
- Oozyte (1)
- Open chromatin (1)
- Opioidpeptide (1)
- Opioidrezeptor (1)
- Optimal foraging (1)
- Optogenetics (1)
- Orai1 (1)
- Organ of Corti (1)
- Organoids (1)
- Orientia tsutsugamushi (1)
- Osmr-Knockout (1)
- Osteoporose (1)
- OxPL (1)
- Oxidative Stress (1)
- Oxidized Phospholipids (1)
- Oxidized phospholipids (1)
- Oxygen partial pressure (1)
- Oxytocin (1)
- Oxytosis (1)
- P4-ATPase (1)
- PAR-CLIP (1)
- PCDHGC3 (1)
- PD-L1 (1)
- PDE (1)
- PDI (1)
- PE Phosphoethanolamine (1)
- PEG (1)
- PER (1)
- PG neurons (1)
- PGE2 (1)
- PHMB (1)
- PI3K (1)
- PKA signaling (1)
- PLEKHG5 (1)
- PLP phosphatase (1)
- PP2A (1)
- PRKACA (1)
- PROTAC (1)
- PROTACs (1)
- PRR (1)
- PTH1R (1)
- PTMs (1)
- PTPN22 (1)
- PacBio sequencing (1)
- Palbociclib (1)
- Panic Disorder (1)
- Panik (1)
- Pankreas (1)
- Paranodopathie (1)
- Parasit (1)
- Parasitology (1)
- Parc National de la Comoé (1)
- Parkinson Krankheit (1)
- Partial Agonists (1)
- Partialagonismus (1)
- Paternal age and BMI effects (1)
- Pathogene Bakterien (1)
- Pathogenese (1)
- Pathogenesis (1)
- Pathogenicity (1)
- Pathogens (1)
- Pathologie (1)
- Pathology (1)
- Pathophysiologische Mechanismen (1)
- Patienten-orientierte Versorgung (1)
- Patientenklassifikation (1)
- Patientenorientierte Medizin (1)
- Pattern recognition receptors (1)
- Pattern-Recognition-Receptors (1)
- Patulin (1)
- Pause Release (1)
- Pediatric Nuclear Medicine (1)
- Pediatric Patients (1)
- Pemphigus (1)
- Peptides (1)
- Perforation <Medizin> (1)
- Perforine (1)
- Perfusion Bioreactor (1)
- Perianova, Irina (1)
- Periaqueductal gray (1)
- Period2 (1)
- Peripheral eosinophils (1)
- Periphere Analgesie (1)
- Periphere Stammzellentransplantation (1)
- Peripheres Nervensystem (1)
- Permeability (1)
- Permeation (1)
- Peroxisomen-Proliferator-aktivierter Rezeptor (1)
- Persistence (1)
- Pertussis (1)
- Pesticide (1)
- Peyersche Plaques (1)
- Pflanzen-Bienen-Netzwerke (1)
- Pflanzenaussterben (1)
- Pflanzenhydraulik (1)
- Pflanzenzelle (1)
- Pflanzenzellkulturen (1)
- Pflanzenökologie (1)
- PhD thesis pharmacology (1)
- Pharmaceutische Biologie (1)
- Pharmacology (1)
- Pharmakodynamik (1)
- Phasenvariation (1)
- Phenotypic switch (1)
- Pheromon (1)
- Phonochirurgie (1)
- Phosphatidylinositolkinase <Phosphatidylinositol-3-Kinase> (1)
- Phosphoantigen (1)
- Phosphodiesterase (1)
- Phosphoglykolat (1)
- Phosphoglykolat-Phosphatase (1)
- Phospholamban (1)
- Phosphorylation (1)
- Photoreceptor (1)
- Photoswitch (1)
- Photoswitchable (1)
- Phyllosphere (1)
- Phyllosphäre (1)
- Phylogeny (1)
- Pilze (1)
- PinT (1)
- Plant Biology (1)
- Plant Ecology (1)
- Plant cell cultures (1)
- Plant extracts (1)
- Plant hydraulic (1)
- Plants (1)
- Plasmonic (1)
- Plastin 3 (1)
- Platelet activating Factor (1)
- Platelet count (1)
- Platelet granules (1)
- Platelet-Membranglykoprotein p62 (1)
- Platy (1)
- Pluripotenz (1)
- Pmn mutant mouse (1)
- Pneumonievirus der Maus (1)
- Pneumoviruses (1)
- Point Spread Function (1)
- Polistes (1)
- Pollen (1)
- Polo-like kinase 1 (1)
- Poly(2-oxazoline) (1)
- Poly(2-oxazoline)s (1)
- Poly(glycidol) (1)
- Polyadenylierung (1)
- Polyethism (1)
- Polymer Science (1)
- Polymere (1)
- Polymers (1)
- Polyphosphate (1)
- Polysaccharide (1)
- Polysaccharide intercellular adhesin (PIA) (1)
- Pore (1)
- Pore formation (1)
- Pore-formation (1)
- Porenbildung (1)
- Porifera (1)
- Porins (1)
- Positron emission tomography (1)
- Positronen-Emissions-Tomografie (1)
- Posttranslationale Änderung (1)
- Powdery mildew fungus (1)
- Pra1 (1)
- Preclinical studies (1)
- Prefrontal cortex (1)
- Prefrontalt Cortex (1)
- Primaten (1)
- Primär-basierte immortalisierte Zelllinie (1)
- Primäre Ziliendyskinesie (1)
- Primärelement (1)
- Primärprevention (1)
- Primärtumor (1)
- Primärzellen (1)
- ProQ (1)
- Problem Gambling (1)
- Processing fluency (1)
- Profilin (1)
- Programmed Cell Death 1 (1)
- Programmed Cell Death Ligand 1 (1)
- Promotor (1)
- Prosoziales Verhalten (1)
- Prostaglandin E2 (1)
- Protease (1)
- Proteaseaktivität (1)
- Proteaseinhibitor (1)
- Proteases (1)
- Proteasom (1)
- Proteasomaler Abbau (1)
- Proteasome (1)
- Protein Disulfid Isomerase (1)
- Protein Kinase D2 (1)
- Protein TRPC6 (1)
- Protein chemistry (1)
- Protein crosslinking (1)
- Protein folding (1)
- Protein interactions (1)
- Protein interactor (1)
- Protein purification (1)
- Protein-Protein Interaktion (1)
- Protein-Protein-Interaktion (1)
- Protein-Tyrosin-Kinasen (1)
- Proteinen mit antimikrobieller Wirkung (1)
- Proteinfaltung (1)
- Proteininteraktion (1)
- Proteininteraktionen (1)
- Proteinkinase A (1)
- Proteinkinase C (1)
- Proteinmodifizierung (1)
- Proteinquervernetzungen (1)
- Proteolysis (1)
- Proteolysis-Targeting-Chimera (1)
- Proteomics (1)
- Prothoracic gland (1)
- Prothoracicotropic hormone (1)
- Prozessierung (1)
- Prädiktoren und Korrelate (1)
- Präklinische Bildgebung (1)
- Präklinische Studien (1)
- Pränatale Entwicklung (1)
- Präzisionsmedizin (1)
- Pseudouridin (1)
- Psoriasis (1)
- Psychische Belastung (1)
- Psychische Gesundheit (1)
- Psychobiologie (1)
- Psychotherapie (1)
- Ptpn22 (1)
- Puberty (1)
- Pubertät (1)
- Pulswelle (1)
- Punktmutation (1)
- Purinozeptor (1)
- Pyridoxal 5'-phosphate phosphatase (1)
- Pyridoxalphosphat (1)
- Pyrrolidinderivate (1)
- Pyrrolidine carboxamides (1)
- Pyrrolizidine alkaloids (1)
- QPCR (1)
- QTOF (1)
- Quadruplex-DNS (1)
- Qualität (1)
- Qualitätsindikator (1)
- Qualitätssicherung (1)
- Quantifizierung (1)
- Quantitation (1)
- Quantitative Genetics (1)
- Quartäre Bisnaphthalimide (1)
- Quaternary Bisnaphthalimide (1)
- RAF (1)
- RAF Kinasen (1)
- RAMP (1)
- REDD1 (1)
- REST-Complex (1)
- RESTORE protocol (1)
- RIL-seq (1)
- RIM1α (1)
- RNA Abbau (1)
- RNA G-quadruplex (1)
- RNA Polymerase II (RNAPII) (1)
- RNA Sequencing (1)
- RNA binding potein CNBP (1)
- RNA binding proteins (1)
- RNA decay (1)
- RNA metabolism (1)
- RNA protein interactions (1)
- RNA secondary structures (1)
- RNA sequencing (1)
- RNA structures (1)
- RNA virus (1)
- RNA-Protein Interaktom (1)
- RNA-RNA interactions (1)
- RNA-Seq (1)
- RNA-Sequenzierung (1)
- RNA-bindendes Protein (1)
- RNA-binding protein (1)
- RNA-protein interactome (1)
- RNAi (1)
- RNS Polymerase I (1)
- RNS-Polymerase II (1)
- RNS-Spleißen (1)
- ROR2 (1)
- RS1 Peptides (1)
- RS1 derived peptides (1)
- RSK2 (1)
- RSV (1)
- RYGB (1)
- Rac1 (1)
- Radiale MR-Bildgebung (1)
- Radiation Protection (1)
- Radiation-associated Cancer Risk (1)
- Radiologische Diagnostik (1)
- Radionuklidtherapie (1)
- Raf <Biochemie> (1)
- Raf Kinase Inhibitor Protein (RKIP) (1)
- Raf kinase inhibitor protein (1)
- Raf1 (1)
- Random Forest (1)
- Random-walk simulations (1)
- Raphe (1)
- Raphe Kerne (1)
- Rasterionenmikroskop (1)
- Rasterkraft-Mikroskopie (1)
- Rauch (1)
- Rbm8a (1)
- Read-through transcription (1)
- Reaktive Sauerstoffspezies (1)
- Real-time imaging (1)
- RecQ helicase (1)
- Receptor (1)
- Receptor Anchoring (1)
- Receptor dynamics (1)
- Receptor internalization (1)
- Receptor signaling (1)
- Recombinant defensins (1)
- Recycling- Endosomen (1)
- Red Sea (1)
- Regenerative Medicine (1)
- Regulation of Gene Expression (1)
- Regulator of G protein signaling 2 (1)
- Regulatory T Cells (1)
- Regulatory T cells (1)
- Regulatory T-cell (1)
- Rekombinante DNS (1)
- Rekonsolidierung (1)
- Rekonstruktion (1)
- Relaxation Parameter Mapping in Magnetic Resonance Imaging (1)
- Reliabilität (1)
- Remission (1)
- Remodeling (1)
- Renaturierung <Ökologie> (1)
- Repeats (1)
- Reperfusion (1)
- Reporter Cells (1)
- Reporterzellen (1)
- Repression (1)
- Repression <Genetik> (1)
- Reproducibility challenges (1)
- Reprogrammming (1)
- Rescue behaviour (1)
- Resistance (1)
- Resistenzmechanismen (1)
- Respiratorisches System (1)
- Response Inhibition (1)
- Ressourcenallokation (1)
- Restriktionsenzym (1)
- Resveratrol (1)
- Retinales S-Antigen (1)
- Retinoesäure (1)
- Retinoic acid (1)
- Reverse Transkriptase (1)
- Rezeptor Verankerung (1)
- Rezeptor-Tyrosinkinasen (1)
- Rezeptorblocker (1)
- Rezeptorpharmakologie (1)
- Rezidiv (1)
- Rgs2 (1)
- Rheologie (1)
- Rheology (1)
- Rheumatoider arthritis (1)
- Rhizopus arrhizus (1)
- Rho GTPase (1)
- Rho GTPasen (1)
- Rho GTPasw (1)
- Rho-GTPasen (1)
- Rho-Kinasen (1)
- RhoGTPase (1)
- Rhodopseudomonas palustris (1)
- Rhodopsin 7 (1)
- Ribonuclease H2 (1)
- Riboregulation (1)
- Ribosomale RNA (1)
- Ribosome biogenesis (1)
- Ribosome profiling (1)
- Ribozymes (1)
- Riesensynapsen (1)
- Risikoanalyse (1)
- Risk Assessment (1)
- Rituximab (1)
- Rodents (1)
- Rodung (1)
- Roscovitine (1)
- Rossameise (1)
- Rotes Meer (1)
- Rothmund-Thomson-Syndrome (1)
- Rupturen (1)
- Räumliches Gedächtnis (1)
- S1P (1)
- S1PR (1)
- SAP2 (1)
- SCV maturation (1)
- SEPHCHC Synthase (1)
- SERCA2a (1)
- SET7 (1)
- SGLT (1)
- SHIP-TREND (1)
- SIS-muc (1)
- SIX1 (1)
- SLC2A3 (1)
- SLFN5 (1)
- SMARD1 (1)
- SMN complex (1)
- SNAP-Rezeptor (1)
- SNPs (1)
- SOC (1)
- SOD1 (1)
- SPECT/CT (1)
- SR proteins (1)
- SREBP (1)
- STAAB Cohort Study (1)
- STAAB study (1)
- STAAB-Studie (1)
- STD patients (1)
- STEC (1)
- STED (1)
- STIM2 (1)
- STP1 (1)
- SUMOylation (1)
- SWI/SNF (1)
- Saatgutbeizung (1)
- Saccharomyces cerevisiae (1)
- Salmonellose (1)
- Samenschale (1)
- Sandminen (1)
- Sap47 (1)
- Satellite glial cell (1)
- Sauerstoffkonzentration (1)
- Saure Sphingomyelinase (1)
- Scaffold bone implant (1)
- Schaumzelle (1)
- Scherstress (1)
- Schilddrüse (1)
- Schimmelpilze (1)
- Schimpanse (1)
- Schizosaccharomyces pombe (1)
- Schlafstörung (1)
- Schlaganfallversorgung (1)
- Schließzellfunktion (1)
- Schmerztherapie (1)
- Schmerzverarbeitung (1)
- Schmetterlinge (1)
- Schnelle MR-Bildgebung (1)
- Schreckreaktion (1)
- Schuppenflechte (1)
- Schwamm (1)
- Schwämme (1)
- Sehen (1)
- Sekretion (1)
- Sekretion von Aspartatproteasen (1)
- Sekundäre Inflammation (1)
- Sekundärprävention (1)
- Sekundärstruktur (1)
- Selbstregulation (1)
- Selective extraction (1)
- Selektiver Serotonin Wiederaufnahmehemmer / SSRI (1)
- Senecionin (1)
- Seneciphyllin (1)
- Seneszenz (1)
- Sensory Gating (1)
- Sequence Analysis (1)
- Sequence-Structure (1)
- Sequenz (1)
- Sequenzanalyse <Chemie> (1)
- Sequenzdaten (1)
- Sequenzwiederholung (1)
- Serinprotease (1)
- Serotonin Transporter (1)
- Serotonin transporter (1)
- Serotonin-Reuptake-Hemmer (1)
- Serotonin-Wiederaufnahmehemmer (1)
- Serotonindefizienz (1)
- Serotonintransporter (1)
- Sertralin (1)
- Setting Control (1)
- Sexuelle Entwicklung (1)
- Sezernierte Faktoren (1)
- Sglt1 (1)
- Shear Stress (1)
- Shigella (1)
- Shigella flexneri (1)
- Shimming (1)
- Sialoadhesin (1)
- Sicherheit (1)
- Signal-Übertragung (1)
- Signaling (1)
- Signalregenerierung (1)
- Silica precursor (1)
- Simulation (1)
- Single Particle Tracking (1)
- Single-cell RNA Sequencing (1)
- Single-cell RNA-sequencing (1)
- Single-cell sequencing (1)
- Single-molecule (1)
- Single-molecule fluorescence microscopy (1)
- Single-molecule tracking (1)
- Sinusthrombose (1)
- Skin (1)
- Skin Tissue Engineering (1)
- Skin conductance (1)
- Sleep (1)
- Sleep in children (1)
- Sleeping Beauty Transposon System (1)
- Sleeping Beauty transposon (1)
- Smad (1)
- Small angle X-ray scattering (1)
- Small intestine (1)
- Small non-coding RNAs (1)
- Small non-messenger RNS (1)
- Small nuclear RNP (1)
- Small-angle X-ray Scattering (1)
- Smoke (1)
- SnRK1-bZIP complex (1)
- Snap25 (1)
- Social Buffering (1)
- Social Distancing (1)
- Social action effects (1)
- Social buffering (1)
- Sociomotor gaze control (1)
- Sodium dependent glucose transporter-1 (1)
- Sol-gel (1)
- Solanaceae (1)
- Solanum species (1)
- Solid-phase peptide synthesis (1)
- South Africa (1)
- Soziale Handlungseffekte (1)
- Soziale Phobie (1)
- Sozialer Kontakt (1)
- Soziobiologie (1)
- Soziomotorische Blickkontrolle (1)
- Spatial heterogeneity (1)
- Spatiotemporal analysis (1)
- Specialized pro resolving mediators (1)
- Species richness (1)
- Speckle Tracking (1)
- Speicheldrüse (1)
- Sphingolipid biology (1)
- Sphingolipidstoffwechsel (1)
- Sphingomyelinase (1)
- Sphingomyelinphosphodiesterase (1)
- Sphingosine 1-phosphate (1)
- Sphingosine 1-phosphate receptor (1)
- Sphingosine-1-phosphate (1)
- Sphingosine-1-phosphats (1)
- Sphingosinkinase (1)
- Spielsucht (1)
- Spinal muscular Atrophy (1)
- Spinal muscular atrophy (1)
- Spinal muscular atrophy (DLC) (1)
- Spinalganglion (1)
- Spirale (1)
- Spleen tyrosine kinase (1)
- Spliceosome (1)
- Splicing (1)
- Spo0A (1)
- Sponge diseases (1)
- Sponges (1)
- Sporenbildung (1)
- Sporulation (1)
- Spumaviren (1)
- Squamous cell carcinoma (1)
- Ssl1 (1)
- Stack-of-Stars Sequenz (1)
- Stack-of-Stars sequence (1)
- Stammzellen (1)
- Stammzelltransplantation (1)
- Staphylococci (1)
- Staphylococcus epidermidis (1)
- Stat3 (1)
- Stat5 (1)
- Stathmin (1)
- Staupevirus (1)
- SteC (1)
- Stechameisen (1)
- Stem Cells (1)
- Stem cells (1)
- Sterblichkeit (1)
- Steroide (1)
- Steroidhormon (1)
- Stickstoffkontrolle (1)
- Stickstoffmetabolismus (1)
- Stickstoffmonoxid-Synthase (1)
- Stickstoffwechsel (1)
- Stiff person syndrome (1)
- Stiff-Person Syndrom (1)
- Stiff-person syndrome (1)
- Stimmbandchirurgie (1)
- Stimmerhöhung (1)
- Stimulation (1)
- Stimulationsversuche (1)
- Stk (1)
- Stofftransport <Biologie> (1)
- Stoffwechselinhibitoren (1)
- Stomatenverschluss (1)
- Store-Operated (1)
- Stp (1)
- Strahlenpilze (1)
- Streptomyces (1)
- Stressresistenz (1)
- Striatum (1)
- Stroke (1)
- Stroke Unit (1)
- Stroma (1)
- Stroop-Verfahren (1)
- Structural elucidation (1)
- Structural organisation (1)
- Structure-based (1)
- Structured Illumination Microscopy (1)
- Struktur (1)
- Struktur-basiertes Wirkstoff Design (1)
- Strukturanalyse (1)
- Strukturbiologie (1)
- Strumpellin (1)
- Störabstand (1)
- Störung des Sozialverhaltens (1)
- Subitizing (1)
- Subtyp C (1)
- Sugar allocation (1)
- Sumo (1)
- Sumoylierung (1)
- Super-Resolution Microscopy (1)
- Super-resolution microscopy (1)
- Super-resolution microsopy (1)
- Superhochauflösende Mikroskopie (1)
- Superparamagnetische Eisenoxid Kontrastmittel (1)
- Superresolution microscopy (1)
- Suppressorzelle (1)
- Survival Motor Neuron (1)
- Suspensionskultur (1)
- Syap1 (1)
- Symbionts (1)
- Symbiosis (1)
- Synapse-associated protein (1)
- Synapsen assoziiert (1)
- Synapses (1)
- Synapsine (1)
- Synaptic plasticity (1)
- Synaptische Plastizität (1)
- Synaptische Transmission (1)
- Synaptische Vesikel (1)
- Synchronitätsmessung (1)
- Syncytin (1)
- Synthesis (1)
- Systematik (1)
- Systembiologie (1)
- Säugerzellen (1)
- Säugetiere (1)
- Südafrika (1)
- Südostasien (1)
- T Helper Cell (1)
- T Lymphocyte (1)
- T Zell Selektion (1)
- T Zellen (1)
- T cell (1)
- T cell cytotoxicity (1)
- T cell engaging Antibody (1)
- T cell homing (1)
- T cell migration (1)
- T cell receptor (1)
- T cell selection (1)
- T cell specificity (1)
- T zellen (1)
- T-Zell-Aktivierung (1)
- T-Zellaktivierung (1)
- T-Zellhoming (1)
- T-Zellmigration (1)
- T-cell (1)
- T-cell engineering (1)
- T-cell therapy (1)
- TAC (1)
- TCTP (1)
- TGF-ß (1)
- TGF-β (1)
- TGN1412 (1)
- TH2 Immunantwort (1)
- TIRF microscopy (1)
- TLR signaling (1)
- TMEM16F (1)
- TNBC (1)
- TNF-Rezeptor (1)
- TNFR2 (1)
- TNFRSF (1)
- TP53 (1)
- TP53 lesions (1)
- TRAIL mutants (1)
- TRPA1 (1)
- TRPA1 channel (1)
- TRPC (1)
- TRPC-Ionenkanäle (1)
- TRPC3 (1)
- TRPC6 (1)
- TRPM7 kinase (1)
- TRPV1 (1)
- TRRAP (1)
- TT-Fields (1)
- TTF (1)
- Tabakkonsum (1)
- Tageslänge (1)
- Tagesrhythmik (1)
- Tamoxifen (1)
- Tansania (1)
- Tanzania (1)
- Tapeworm (1)
- Targeted drug delivery (1)
- Targeted therapies (1)
- Targeted therapy (1)
- Tc-99m-MAG3 Scans (1)
- Telomer <Molekulargenetik> (1)
- Telomerase (1)
- Temperatur (1)
- Temperaturabhängigkeit (1)
- Temporal heterogeneity (1)
- Temporal predictability (1)
- Terahertzbereich (1)
- Terahertzstrahlung (1)
- Terpene (1)
- Test system (1)
- Tfb4 (1)
- Thebain (1)
- Theoretical Ecology (1)
- Theory of Mind (1)
- Therapeutical application (1)
- Therapieoutcome (1)
- Therapiesimulation (1)
- Therapy (1)
- Thermoregulation (1)
- Thermoresponsive Polymere (1)
- Thermotoleranz (1)
- Theta Burst Stimulation (1)
- Thigmotaxis (1)
- Think/No-Think (1)
- Thiolase (1)
- Thiostrepton (1)
- Thrombin (1)
- Thromboinflammation (1)
- Thrombopoese (1)
- Thrombozyten (1)
- Thrombozytenfunktion (1)
- Thrombozytenfunktionsanalyse (1)
- Thrombozytopathie (1)
- Thrombozytopenie (1)
- Thrombozytopoese (1)
- Thrombus (1)
- Thymocytes (1)
- Thymosin b4 (1)
- Thymus (1)
- Tierphysiologie (1)
- Tight Junction Proteins (1)
- Tight junction (1)
- Tight-Junction-Protein (1)
- Time-of-flight (1)
- Timing (1)
- Tissue staining (1)
- Tobacco smoking (1)
- Tolerance (1)
- Toleranz <Biologie> (1)
- Toxin (1)
- TraDIS (1)
- Tracer (1)
- Trailmaking Test (1)
- Transcranial Magnetic Stimulation (1)
- Transcription Factor (1)
- Transcription Regulation (1)
- Transcription elongation (1)
- Transcription factor (1)
- Transcriptional Stress Response (1)
- Transgenic mice (1)
- Transkriptomik anlyze (1)
- Transmission (1)
- Transmissionsblockierende Impfstoffe (1)
- Transpiration barrier (1)
- Transplantat-gegen-Wirt-Reaktion (1)
- Transplantatabstoßung (1)
- Transportbarriere (1)
- Transporters (1)
- Transsexualismus (1)
- Transthorakale Echokardiographie (1)
- Trauma (1)
- Traumatic neuropathy (1)
- Tree physiology (1)
- Trem2 (1)
- Trend (1)
- Trennungsangst (1)
- Triclosan (1)
- Trifluoroethene (1)
- Triglyceride (1)
- Tripartite Model (1)
- Trockenstress (1)
- Trophic Factors (1)
- Tropomyosin receptor kinase B (1)
- TruD (1)
- Trypanosoma (1)
- Trypanosoma Brucei (1)
- Trypanosoma brucei brucei (1)
- Trypanosomiasis (1)
- Tryptophan hydroxylase (1)
- Tryptophan hydroxylase 2 (1)
- Tuberkulose (1)
- Tumor Treating Fields (1)
- Tumor microenvironment (1)
- Tumorangiogenese (1)
- Tumorgefäßmorphologie (1)
- Tumorhypoxie (1)
- Tumorimmunologie (1)
- Tumormetabolismus (1)
- Tumormikroumgebung (1)
- Tumornekrosefaktor Rezeptor-Superfamilie (1)
- Tumortherapiefeld (1)
- Tumorwachstum (1)
- Tumorzellen (1)
- Tumour (1)
- Tumour angiogenesis (1)
- Twilight (1)
- Typ 2 (1)
- Type 1 Diabetes (1)
- Type 1 diabetes (1)
- Type II-C CRISPR/Cas (1)
- Type VIIb secretion system (1)
- Tyrosinkinaseinhibitor (1)
- U snRNPs (1)
- U1 snRNA (1)
- UBA6 (1)
- UBE2S (1)
- UBE2Z (1)
- UNC5B (1)
- UPEC (1)
- USA300 (1)
- USP28 (1)
- Ubiquitin Specific Protease 11 (1)
- Ubiquitin activating eznyme 1 (1)
- Ubiquitin system (1)
- Ubiquitin-PA (1)
- Ubiquitin-aktivierende Enzym 1 (1)
- Ubiquitin-conjugating enzyme (1)
- Ubiquitylation (1)
- Ultrahigh field (1)
- Ultraschall (1)
- Ultrashort echo time - UTE (1)
- Unconventional T cells (1)
- Unidirectional Freezing (1)
- Unique Selling Proposition (1)
- Untertyp (1)
- Uremic cardiomyopathy (1)
- Urinary tract infection (1)
- Urteilen (1)
- Urämie (1)
- Urämische Kardiomyopathie (1)
- VCAM (1)
- VE-Cadherin (1)
- VE-PTP (1)
- VLA-1 (1)
- VSMC (1)
- VW-SCs (1)
- Vaccinia-Virus (1)
- Vagus (1)
- Vagusnervstimulation (1)
- Vakuole (1)
- Vakzinen (1)
- Validierung (1)
- Validierungsstudie (1)
- Validität (1)
- Valscularization (1)
- Variant Surface Glycoprotein (1)
- Variant surface glycoprotein (1)
- Variants (1)
- Vascular system (1)
- Vaskularisation (1)
- Vaskularisierung (1)
- Vaskuläre Integrität (1)
- Vasopressin (1)
- Venusfliegenfalle (1)
- Verbreitungsökologie (1)
- Verhaltenplastizität (1)
- Verhaltenskontrolle (1)
- Verhaltensplastizität (1)
- Verhaltensstörung (1)
- Verkalkung (1)
- Vermehrung (1)
- Vermeidungsverhalten (1)
- Vernetzung <Chemie> (1)
- Versorgungsqualität (1)
- Verweildauer (1)
- Verwundbarkeit (1)
- Verwundbarkeitskurve (1)
- Very-long-chain aliphatic (1)
- Vesikel (1)
- Vesikelbildung (1)
- Vessel wall (1)
- Vg9Vd2 T Zellaktivierung (1)
- Vg9Vd2 T cell (1)
- Vgamma9Vdelta2 T cell (1)
- Vgamma9Vdelta2 T cells (1)
- Vibrationstraining (1)
- Vielfalt (1)
- Virologische Synapse (1)
- Virology (1)
- Virulenzfaktor (1)
- Virus infection (1)
- Virus-Transmission (1)
- Virusreplikation (1)
- Visual attention (1)
- Visuelle Orientierung (1)
- Visuelle Wahrnehmung (1)
- Visuelles Gedächtnis (1)
- Visuelles System (1)
- Vitamin D (1)
- Vitamin D-Rezeptor (1)
- Vitamin D3 (1)
- Voltage-Clamp-Methode (1)
- Vorhersage (1)
- Vorläufer (1)
- Vulnerable plaque (1)
- Vγ9Vδ2 T cells (1)
- WASH complex (1)
- WNT (1)
- WNT signaling (1)
- Wachstum (1)
- Wachstumsfaktor (1)
- Wachstumsrate (1)
- Waiting Impulsivity (1)
- Walking (1)
- Warburg, Otto (1)
- Warburg-Effekt (1)
- Wasser (1)
- Wasser Fett Trennung (1)
- Wasted Work (1)
- Water stress (1)
- Web services (1)
- Wechselwirkungen (1)
- Weinrebe (1)
- Wildbienen (1)
- Wilms Tumor (1)
- Wilms tumor protein 1 (1)
- Wilms-Tumor (1)
- Wirbelströme (1)
- Wirksamkeitsbewertung (1)
- Wirkstoff (1)
- Wirkstofftestung (1)
- Wirt-Erreger Interaktion (1)
- Wirt-Parasit-Beziehung (1)
- Wirt-Parasiten-Interaktion (1)
- Wirtszelle (1)
- Wnt-Proteine (1)
- Wnt-Signalweg (1)
- Wnt-pathway (1)
- Wurzelhalsgalle (1)
- Würmer (1)
- Wüstenpflanze (1)
- X-ray Crystallography (1)
- X-ray diffraction (1)
- XPD (1)
- Xenograft (1)
- Xerostomie (1)
- Xiphophorus Melanom (1)
- Xmrk (1)
- YAP (1)
- YB-1 (1)
- Yb1 (1)
- Yeast (1)
- Yersinia (1)
- Yersinia pestis (1)
- YnaI (1)
- ZFAND1 (1)
- Zebrafisch (1)
- Zeitgeber (1)
- Zell Migration (1)
- Zell-Migration (1)
- Zelladhäsion (1)
- Zellfilamente (1)
- Zellkernarchitektur (1)
- Zellkontakt (1)
- Zelllinie (1)
- Zellteilung (Zytokinese) (1)
- Zelltod (1)
- Zelltransport (1)
- Zielstruktur (1)
- Zink-Cluster-Transkriptionsfaktoren (1)
- Zytokin (1)
- Zytokingenpolymorphismus (1)
- Zytoskelettreorganisation (1)
- Zählen (1)
- aGPCR (1)
- acceptance-based strategies (1)
- acid sphingomyelinase (1)
- actin cytoskeleton (1)
- actin-binding proteins (1)
- actinomycetes (1)
- acute brain slices (1)
- acute graft-versus host disease (1)
- acute graft-versus-host disease (1)
- acute lymphoblastic leukaemia (1)
- adhesion (1)
- adhesion-GPCR (1)
- adipogenic differentiation (1)
- adipose (1)
- adipose-derived (1)
- adolescents (1)
- adrenal gland (1)
- adrenal incidentaloma (1)
- adrenerge Rezeptoren (1)
- adrenergic receptor (1)
- adrenergic receptors (1)
- adrenocortical adenoma (1)
- adult ADHD (1)
- adult attention deficit hyperactivity disorder (aADHD) (1)
- adult development (1)
- adulte Neurogenese (1)
- aggressive behavior (1)
- aging (1)
- agonist (1)
- airflow (1)
- airways (1)
- akute lymphatische Leukämie bei Kindern (1)
- alfa-cyano-4-hydroxycinnamat (1)
- alkaloids (1)
- allogen (1)
- allogeneic stem cell transplantation (1)
- allogenic (1)
- allogenic stem cell transplantation (1)
- allografts (1)
- alloreactive T cells (1)
- alltägliche Funktionsfähigkeit (1)
- alpha-IIb beta-3 (1)
- alternative intronic polyadenylation (1)
- ambrosia beetles (1)
- ammonium (1)
- ammonium permease (1)
- amphibia (1)
- amphiphysin (1)
- amplicon sequencing (1)
- amyotrophic lateral sclerosis (1)
- anaerobe (1)
- analysis (1)
- anaphylatoxin receptors (1)
- androstadienone (1)
- anoikis (1)
- anterior insula (1)
- anthocyanins (1)
- anti-Tumor Therapeutika (1)
- anti-hDEC205-WT1 antibody fusion protein (1)
- anti-infective (1)
- antigen (1)
- antigenic variation (1)
- antileukemia vaccine (1)
- antimicrobial (1)
- antithrombotic (1)
- antivirale Gene (1)
- anxiety conditioning (1)
- arf (1)
- aromatic amino acid biosynthesis (1)
- articular cartilage progenitor cells (1)
- artificial diet (1)
- artificial human skin (1)
- artifizielle Aktivierung (1)
- artifizielle Hautmodelle (1)
- asialoGM1 (1)
- aspartic protease (1)
- aspergillus fumigatus (1)
- assembly (1)
- association studies (1)
- astrocytoma (1)
- asymptomatic bacteriuria (1)
- atomic force microscopy (1)
- atopic diseases (1)
- atrial natriuretic peptide (1)
- attributable fraction (1)
- attributable risk (1)
- auditorisch (1)
- auditory (1)
- auditory cortex (1)
- auditory pathway (1)
- autoantibodies (1)
- autoantibody (1)
- autoimmunity (1)
- autophagocytose (1)
- autophagocytosis (1)
- autophagosome (1)
- autotransporter (1)
- bSSFP (1)
- bac-genomics-scripts (1)
- bacterial cancer therapy (1)
- bacterial fatty-acid biosynthesis (1)
- bacterial lipid rafts (1)
- bacterial nanocellulose (1)
- bacterial tumor targeting (1)
- bakterielle Flora (1)
- balanced steady state free precession (1)
- bark beetles (1)
- bee microbiota (1)
- bee-associated bacteria (1)
- bee-lining (1)
- bees (1)
- behavioral maturation (1)
- behavioral rhythms (1)
- beige adipocytes (1)
- benzimidazole (1)
- bestäuberfreundliche Pflanzen (1)
- beta actin (1)
- beta cell (1)
- beta-Arrestin2 (1)
- beta-Catenin (1)
- beta-adrenerge Signalwege (1)
- bicuculline (1)
- bilateral BAS model (1)
- binding mode (1)
- biochemistry (1)
- biodistribution (1)
- biodiversity (1)
- biofabrication (1)
- biofilm architecture (1)
- bioimage analysis (1)
- bioink (1)
- biokinetics (1)
- biolayerinterferometry (1)
- biological scaffolds (1)
- bioluminescence imaging (1)
- biomaterials (1)
- bioprocessing (1)
- bioreactor plattform (1)
- biosynthetic gene clusters (1)
- bipolar disorder (1)
- bipolare Störung (1)
- bispecific (1)
- bispezifisch (1)
- bitter taste (1)
- blood (1)
- blood cerebrospinal fluid barrier (1)
- blood glucose regulation (1)
- blood nerve barrier (1)
- blood-brain barrier (1)
- body axis (1)
- bone marrow niche (1)
- bone marrow transplantation (1)
- bone metastases (1)
- bone regeneration (1)
- brood rearing (1)
- building behavior (1)
- bumblebee*s (1)
- burn wound (1)
- butyrophilin 3A (1)
- c-Jun Phosphorylierung (1)
- c-myc (1)
- cAMP signaling (1)
- cadherin-13 (1)
- caffeine (1)
- calcium activity (1)
- calcium homeostasis (1)
- calcium imaging (1)
- cancer therapy (1)
- candida (1)
- candida albicans (1)
- canine (1)
- carbon dioxide (1)
- cardiac imaging (1)
- cardiac magnetic resonance imaging (1)
- cardiac tissue (1)
- cardiac tissue engineering (1)
- cardiovascular (1)
- carnivorous plants (1)
- cartilage (1)
- cartilage regeneration (1)
- cd28 superagonists (1)
- cell adhesion (1)
- cell cycle (1)
- cell filaments (1)
- cell migration (1)
- cell therapy (1)
- cellular model (1)
- cellular-trafficking (1)
- central complex (1)
- chaperone (1)
- chemotherapy (1)
- children (1)
- chimeric antigen receptor (1)
- chlamydia trachomatis (1)
- chondrogene Differenzierung (1)
- chromatin accessibility (1)
- chromosome conformation capture (1)
- chronic kidney disease (1)
- chronic pain (1)
- chronophin (1)
- cine loop (1)
- circadian clock (1)
- circadian clocks (1)
- circuitopathies (1)
- classical conditioning (1)
- claudin-12 (1)
- climate change (1)
- climate control (1)
- clock genes (1)
- closing of chromatin (1)
- co-culture (1)
- co-dependent expression (1)
- co-infection (1)
- coagulation factor XII (1)
- cochlea implant (1)
- cofactorbinding (1)
- cognitive decline (1)
- cognitive deficits (1)
- cognitive inhibition (1)
- cognitive remediation (1)
- cohesin (1)
- collective invasion (1)
- collybistin (1)
- colony recognition (1)
- color vision (1)
- comet assay (1)
- compartments (1)
- compound eyes (1)
- compressed sensing (1)
- conditional Knockout (1)
- confocal microscopy (1)
- conformational activation (1)
- context conditioning (1)
- contextual conditioning (1)
- contingency awareness (1)
- continuous wavelet analysis (1)
- control (1)
- convolutional neural network (1)
- corneal confocal microscopy (1)
- coronary heart disease (1)
- correlation (1)
- corticosteroids and cyclophosphamide (1)
- covalent inhibition (1)
- cryokonservation (1)
- crystal structure (1)
- crystallography (1)
- ctr (1)
- current source density (1)
- cushing's syndrome (1)
- cuticular conductance (1)
- cuticular hydrocarbons (1)
- cuticular leaf wax (1)
- cuticular transpiration barrier (1)
- cuticular water permeability (1)
- cuticular waxes (1)
- cyclase-associated protein (1)
- cyclase-associated protein 2 (1)
- cyclo-AMP (1)
- cytokine release syndrome (1)
- cytoskeletal reorganisation (1)
- dCIRL (1)
- dSTORM (1)
- decellularization (1)
- decision-making (1)
- defense (1)
- degeneratives Nervengewebe (1)
- delipidation (1)
- dendritic cells (1)
- dendritic cell-targeting (1)
- density weighting (1)
- desert plant (1)
- desiccation time (1)
- deubiquitinase (1)
- dexamethasone suppression test (1)
- diabetes (1)
- diabetic cardiomyopathy (1)
- diagnostic Microarray (1)
- diagnostic accuracy (1)
- diagnostics (1)
- diagnostischer Microarray (1)
- diastolic dysfunction (1)
- differential RNA-seq (1)
- differential coverage binning (1)
- differential geneexpression (1)
- differentiation status (1)
- differenzielle Genexpression (1)
- dilated cardiomyopathy with ataxia (DCMA) (1)
- dimerer Naphthylisochinolin-Alkaloide (1)
- discrimination training (1)
- disease model (1)
- dispersal (1)
- distance (1)
- distribution (1)
- disulfide bonds (1)
- diversity (1)
- double-strand break repair (1)
- drift-diffusion model (1)
- drug (1)
- dual RNA-seq (1)
- early detection (1)
- early neural precursors (1)
- early-life stress (1)
- early-onset isolated dystonia (1)
- eating behavior (1)
- eating disorders (1)
- echocardiography (1)
- ecoli_VF_collection (1)
- ecological validity (1)
- ectopic bone formation (1)
- ectopic release (1)
- effector protein (1)
- efflux pump (1)
- electroacupuncture (1)
- electrode scaffold (1)
- electroencephalogram (1)
- electron cryomicroscopy (1)
- electron tomography (1)
- electrospinning (1)
- embryonale Maus (1)
- emojis (1)
- emotional (1)
- emotional feedback (1)
- emotional information processing (1)
- emotional interference (1)
- emotional processing (1)
- emotionale Anspannung (1)
- emotionale Interferenz (1)
- emotions (1)
- endocytic recycling (1)
- endocytosis (1)
- endophyte (1)
- enhancers (1)
- enoyl ACP reductase (1)
- enoyl reductase (1)
- enoyl-ACP reductase (1)
- entero-aggregative-haemorrhagic Escherichia coli (EAHEC) (1)
- enteroinvasive (1)
- enzyme (1)
- eosinophil (1)
- epidemiology (1)
- epigenetic (1)
- epithelial to mesenchymal transition (1)
- epithelial-mesenchymal transition (1)
- ereigniskorreliertes Potential (1)
- etiology (1)
- evozierte Potentiale (1)
- exotische Pflanzen (1)
- experimentelle autoimmune Enzephalomyelitis (1)
- exposition training (1)
- exposure therapy (1)
- extinction (1)
- extinction dynamics (1)
- extracellular signal–regulated kinases 1/2 (1)
- extrazelluläre Matrix (1)
- eye contact (1)
- eye tracking (1)
- eye-tracking (1)
- eyetracking (1)
- fMRI / Neuroimaging (1)
- fabry disease (1)
- facial expressions (1)
- fast MR imaging (1)
- fatty acid biosynthesis (1)
- fatty acid synthesis (1)
- fear potentiated startle response (1)
- feasibility (1)
- feral bees (1)
- fgf (1)
- fibroblast growth factors (1)
- fibromyalgia sydrome (1)
- filtering (1)
- fitness (1)
- flagellum (1)
- fluorescence imaging (1)
- fluorescence microscopy (1)
- fluorescence resonance energy transfer (1)
- fluorescence resonance energy transfer (FRET) (1)
- fluorescent ligands (1)
- flytrap (1)
- fmri activity (1)
- foamy viruses (1)
- follicular regulatory T cell (1)
- follikuläre regulatorische T-Zelle (1)
- food craving (1)
- forager (1)
- foraging (1)
- foraging activity (1)
- forest landscape (1)
- fragment screening (1)
- frameshifting (1)
- freezing of gait (1)
- frequency modulation (1)
- frogs (1)
- fruit cuticle (1)
- frühe neurale Vorläufer (1)
- functional connectivity (1)
- functional imaging (1)
- functional membrane microdomains (1)
- functional modules (1)
- functional neuroimaging (1)
- functional resting-state connectivity (1)
- functional selectivity (1)
- functional studies (1)
- fungal endophytes of grasses (1)
- fungi (1)
- fungus (1)
- fungus farming (1)
- funktionale Bildgebung (1)
- funktionelle Magnetresonanztomographie (1)
- funktionelle Module (1)
- funktionelle Resting-State Konnektivität (1)
- g-factor (1)
- gait analysis (1)
- gait initiation (1)
- gametocyt (1)
- gametocyte (1)
- gametogenesis (1)
- gamma delta T cells (1)
- gastrointestinal infection (1)
- gastronintestinal microbiota (1)
- gene environment interaction (1)
- gene-environmental interaction (1)
- genes (1)
- genetic cytokine polymorphism (1)
- genetic modification (1)
- genetic screen (1)
- genome stability (1)
- genomic damage (1)
- genomic imaging (1)
- genomische Schäden (1)
- genotoxic agents (1)
- genotoxische Agenzien (1)
- gepaarte Vagusnerv-Stimulation (1)
- germinal center (1)
- germinative cell (1)
- gezielte Therapie (1)
- glioblastoma multiforme (1)
- glioma (1)
- glutamate decarboxylase 65 (1)
- glycine receptor (1)
- glycine receptor autoantibodies (1)
- glycophytes (1)
- glycoprotein GPV (1)
- gonococcal (1)
- gonococcal infection (1)
- grass (1)
- growth rate (1)
- guanine nucleotide exchange factor (1)
- guanylyl cyclase (GC) (1)
- guard cells (1)
- guide effiiciency (1)
- gustation (1)
- habitat (1)
- haloacid dehalogenase phosphatase (1)
- hearing (1)
- heart failure (1)
- heat shock proteins (1)
- hematopoiesis (1)
- hereditary spastic paraplegia (1)
- hiPSC aggregation (1)
- hibernation (1)
- high-pressure freezing/freeze substitution (1)
- high-throughput sequencing (1)
- histone variants (1)
- hnRNP (1)
- hnRNP R (1)
- homeostasis (1)
- homoFRET (1)
- honey bee density (1)
- honey bees (1)
- honeybee*s (1)
- honeybees (1)
- host colonization (1)
- huh6 (1)
- human (1)
- human adipose tissue (1)
- human chromosome 6 (1)
- human factor H (1)
- human induced pluripotent stem cells (1)
- human intestinal epithelium (1)
- human parthenogenetic neural stem cells (1)
- human parthenogenetic stem cells (1)
- human plasma (1)
- human primary cells (1)
- humanen induzierte pluripotente Stammzellen (1)
- humaner Faktor H (1)
- humans (1)
- hyaline cartilage (1)
- hyaluronic acid (1)
- hybrid (1)
- hybrid assembly (1)
- hydraulic efficiency (1)
- hydraulische Effizienz (1)
- hydrogel (1)
- hydroscape (1)
- hyperekplexia (1)
- iNKT cell (1)
- iPSC-derived CMs (iPSC-CMs) (1)
- iPSCs (1)
- icaADBC (1)
- imaging (1)
- immediate early genes (1)
- immune cell recruitment (1)
- immune escape (1)
- immune evasion (1)
- immune response (1)
- immune system (1)
- immunologic tolerance (1)
- immunological synapse (1)
- immunotherapy (1)
- imprinting. (1)
- imunology (1)
- in situ microscopy (1)
- in vitro Kulturmodelle (1)
- in vitro Modelle (1)
- in vitro Testmodell (1)
- in vitro Testsystem (1)
- in vitro model (1)
- in vitro model system of inherited cardiomyopathies (1)
- in vitro neural differentiation (1)
- in vitro-Testsystem (1)
- in vivo (1)
- in vivo cell tracking (1)
- in vivo genome editing (1)
- in vivo study (1)
- induced pluripotent stem cells (1)
- induced pluripotent stem cells (iPSCs) (1)
- induzierte Phosphatasen MKP-1 und MKP-2 (1)
- infection biology (1)
- infectionmodel (1)
- infectionprocess (1)
- inferior frontal gyrus (1)
- inferiore frontale Gyrus (1)
- inflammatorische Gewebeschäden (1)
- influenza A virus (1)
- information processing (1)
- information use (1)
- inherited macrothrombocytopenia (1)
- inhibitor residence time (1)
- inhibitory postsynapse (1)
- innate immunity (1)
- insect visual learning (1)
- insects (1)
- insertion-site deep sequencing (1)
- instrumentelle Aktivitäten des täglichen Lebens (1)
- insulin resistance (1)
- intact bone imaging (1)
- integrins (1)
- interaction stress and circadian system (1)
- interactions (1)
- interferon (1)
- interleukin-5 signaling (1)
- internal dosimetry (1)
- interphase gap (1)
- interpulse interval (1)
- intestinal mucus (1)
- intestine (1)
- intracellular calcium release (1)
- intracellular domain (1)
- intraoperative Ankopplungseffizienz (1)
- intravenöse Immunglobuline (1)
- intrazelluläre Domäne (1)
- invariant NKT cells (1)
- invariante NKT Zellen (1)
- invasive meningococcal diseases (1)
- invasive pulmonary aspergillosis (1)
- ion channel (1)
- iron oxide contrast agent (1)
- ischemia reperfusion injury (1)
- ischämischer Schlaganfall (1)
- islets of Langerhans (1)
- jasmonate (1)
- juvenile hormone (1)
- kardiales Gewebe (1)
- kardiales Tissue Engineering (1)
- kardiovaskuläre Risikofaktoren (1)
- ketamine anaesthesia (1)
- kidney development (1)
- kinesin (1)
- knockout (1)
- knockout-mice (1)
- kognitive Defizite (1)
- kognitive Remediation (1)
- kolorektale Karzinomzelllinien (1)
- konventionelle CD4 T Zellen (1)
- koronare Herzerkrankung (1)
- kutikuläre Kohlenwasserstoffe (1)
- kutikuläre Wasserpermeabilität (1)
- kutikuläres Blattwachs (1)
- l-type calcium channel antagonist (1)
- labeling techniques (1)
- lambdoid phage resistance (1)
- lambdoid prophage (1)
- laminar recording (1)
- lasiocarpine (1)
- lasp (1)
- late enhancement (1)
- late gadolinium-enhancement (1)
- leaf cuticle (1)
- leaf-cutting ants (1)
- learned helplessness (1)
- learning and behaviour (1)
- leishmaniasis (1)
- light sheet fluorescence microscopy (1)
- lightsheet microscopy (1)
- lipid remodeling (1)
- lipoprotein (1)
- liver (1)
- local point-spread function (1)
- local translation (1)
- locomotor network (1)
- logging (1)
- lokale Proteinsynthese (1)
- long-term memory formation (1)
- luciferase assay (1)
- lymph node stromal cells (1)
- lymph node transplantation (1)
- lymphocyte homing (1)
- lysosome (1)
- lytic infection (1)
- lytic phage resistance (1)
- mRNA (1)
- mRNA processing (1)
- mRNA translation (1)
- mRNA-Translation (1)
- mTOR (1)
- macrocolony (1)
- macrophage (1)
- macrophages (1)
- malnourishment (1)
- mammalian cells (1)
- marine sponges (1)
- mastitis (1)
- mastitis-associated Escherichia coli (MAEC) (1)
- mean first passage time (1)
- measles virus infection (1)
- mechanistische Modellierung (1)
- mechanosensing (1)
- mechanosensitive channels (1)
- medaka (1)
- medical device (1)
- megachilid bees (1)
- megakaryocytes (1)
- melanocytic nevi (1)
- melanoma cancer (1)
- melanoma dedifferentiation (1)
- melt electrowriting (1)
- membrane dynamics (1)
- membrane trafficking (1)
- memory (1)
- memory B cells (1)
- meniscus implant (1)
- menschliches Darmepithel (1)
- mental health (1)
- mesenteric lymph node (1)
- mesoscopic (1)
- metabolic modelling (1)
- metabolic theory of ecology (1)
- metabolische Aktivierung (1)
- metabolische Enzyme (1)
- metabolite repair (1)
- metabolomics (1)
- metallo protease (1)
- metapopulation (1)
- metatranscriptome (1)
- methionine biosynthesis (1)
- methylphenidate (1)
- miR-17~92 (1)
- miR-21 (1)
- miR-223-5p (1)
- miR-23a cluster (1)
- miR-26 (1)
- miRNA Biogenesis (1)
- miRNA target (1)
- mice (1)
- micro processor complex (1)
- microRNA biogenesis (1)
- microbial communities (1)
- microbial transmission (1)
- microbiology (1)
- microbiota (1)
- microcircuitry (1)
- microelectrode array (1)
- microglomeruli (1)
- microinjection (1)
- micronuclei (1)
- micronucleus (1)
- microphysiologic 3D tumour model (1)
- microprocessor complex (1)
- microrna (1)
- mild cognitive impairment (1)
- minimum leaf conductance (1)
- mitochondria (1)
- mitogen cascade (1)
- mitotische Störung (1)
- mobil phone radiation (1)
- molecular biology of cytokines (1)
- molecular mechanism (1)
- monarch butterfly (1)
- monoclonal antibody (1)
- monoclonal antibody 103.2 (1)
- monoclonal antibody 20.1 (1)
- monocyte-derived dendritic cells (1)
- monozytenderivierte dendritische Zellen (1)
- mossy fiber synapse (1)
- mossy fiber terminal (1)
- motoneurons (1)
- motor neuron (1)
- mouse platelets (1)
- movement disorders (1)
- movement interaction (1)
- mucormycosis (1)
- mukosale Immunantwort (1)
- multi-drug-resistance (1)
- multi-modal stimuli (1)
- multi-photon microscopy (1)
- multi-pinhole collimation (1)
- multiphoton microscopy (1)
- multiple sclerosis (1)
- murine (1)
- murine leishmaniasis (1)
- murines Modell der aufsteigenden Harnwegsinfektion (1)
- muscarinic m ACh receptors (1)
- mushroom body (1)
- mushroom body calyx microglomeruli (1)
- muskarinische Rezeptoren (1)
- mutualism (1)
- mutually exclusive expression (1)
- myelin barrier (1)
- myeloablation (1)
- myeloid derived suppressor cells (1)
- myocardial deformation (1)
- myocarditis (1)
- myokardiale Arbeit (1)
- nanotubes (1)
- ncRNA (1)
- near-infrared spectroscopy (1)
- nest climate (1)
- nesting behaviour (1)
- networkanalysis (1)
- neuer anti-infektiver Substanzen (1)
- neural biomarkers (1)
- neurodevelopment (1)
- neurodevelopmental disorders (1)
- neuroepithelial progenitors (1)
- neuroepitheliale Vorläufer (1)
- neurogenesis (1)
- neuroinflammation (1)
- neurologin-2 (1)
- neuromodulation (1)
- neuron (1)
- neuronal activation (1)
- neuronal cell death (1)
- neuronal excitability (1)
- neuronal network (1)
- neuronal nitric oxide synthase (1)
- neuronal visual system (1)
- neuronale Stickstoffmonoxidsynthase (1)
- neuropathic pain (1)
- neuropaticher Schmerz (1)
- neuropeptide S receptor gene (1)
- neuropeptide Y (1)
- neuropeptides (1)
- neuroprotection (1)
- neuropsychiatric disorders (1)
- neuropsychiatrische Störungen (1)
- neuroscience (1)
- neutrophil (1)
- neutrophils (1)
- next generation sequencing (1)
- nicht-viraler Gentransfer (1)
- nicht-visuell (1)
- nichtinvasive Bildgebung (1)
- nitric oxide (1)
- nitrogen regulation (1)
- nociception (1)
- nociceptors (1)
- non-coding RNA (1)
- non-ionizing radiation (1)
- non-visual (1)
- nuclear architecture (1)
- nuclear export signal (1)
- nuclear localization signal (1)
- nuclesosome positioning (1)
- nucleus (1)
- nurse bee (1)
- nutrients (1)
- nutrition (1)
- object segmentation (1)
- oilpalm plantation (1)
- older adults (1)
- oligopeptide transport (1)
- oncogenes (1)
- oncogenic signalling network (1)
- onkogenes Signalnetzwerk (1)
- opening of chromatin (1)
- opioid peptide (1)
- opioid receptor (1)
- optical clearing (1)
- optogenetics (1)
- orientation (1)
- oscillations (1)
- ovarian cancer (1)
- ovarian carcinoma (1)
- oxidative stress (1)
- oxidativer Stress (1)
- oxidierte Phospholipide (1)
- p34 (1)
- p38MAPK (1)
- p44 (1)
- pICln (1)
- pain (1)
- pain regulation (1)
- pancreatic cancer (1)
- pancreatic differentiation (1)
- panic disorder (1)
- parasitology (1)
- parathyroid hormone (1)
- parkinson's disease (1)
- pathophysiological mechanisms (1)
- pathotypes (1)
- pdxp (1)
- pea aphid (1)
- pediatric hematology oncology (1)
- peptide engineering (1)
- peptide-based interleukin-5 inhibitor (1)
- performance evaluation (1)
- perfused hydrogel (1)
- peripheral analgesia (1)
- peripheral nerve trauma (1)
- peripheral nervous system (1)
- permeability (1)
- permeance (1)
- permeation (1)
- personality traits (1)
- pflegende Angehörige (1)
- phage resistance (1)
- pharmacology (1)
- phenotypic plasticity (1)
- pheromone (1)
- phosphoantigen (1)
- phosphoglycolate phosphatase (1)
- phospholipase D (1)
- phosphorylation (1)
- phosphorylation sites (1)
- photoconversion (1)
- photoinduced electron transfer (1)
- photoinduzierter Elektronentransfer (1)
- phylogeny (1)
- plant defense (1)
- plant-bee visitation networks (1)
- platelet aggregation (1)
- platelet biogenesis (1)
- pluripotency (1)
- podosome formation (1)
- point-of-care (1)
- polarization (1)
- polarized epithelium (1)
- pollen (1)
- pollen analysis (1)
- pollen foraging (1)
- pollen metabarcoding (1)
- pollinator friendly plants (1)
- polyethism (1)
- polymer (1)
- polymorphism (1)
- polyradiculoneuropathy (1)
- population attributable fraction (1)
- population dynamics (1)
- post-transcriptional regulation (1)
- postradiogene Xerostomie (1)
- posttranscriptional regulation (1)
- potenzielles therapeutisches Target (1)
- precision medicine (1)
- preclinical PET (1)
- predictors and correlates (1)
- prefrontal cortex (1)
- prenatal stress (1)
- presynaptic (1)
- primary ciliary dyskinesia (1)
- primary-cell-derived immortalized cell line (1)
- primate (1)
- probiotica (1)
- proboscis extension response (1)
- profiles (1)
- progenitors (1)
- programmed ribosomal frameshifting (1)
- promoter invasion (1)
- proplatelets (1)
- prosocial (1)
- prosocial behavior (1)
- prosociality (1)
- protease activity (1)
- protease inhibitor (1)
- proteasome (1)
- protein (1)
- protein disulfide isomerase (1)
- protein folding (1)
- protein immobilization (1)
- protein kinase D1 (1)
- protein kinase a (1)
- protein regulation and expression (1)
- protein-DNA interactions (1)
- protein-lipid interactions (1)
- protein-protein-interaction (1)
- pränataler Stress (1)
- psychophysiology (1)
- psychosocial resilience (1)
- psychosocial stress (1)
- psychotherapeutic intervention (1)
- psychotherapeutische Intervention (1)
- pyrrolidine carboxamides (1)
- quiescence (1)
- rIFG (1)
- rRNA processing (1)
- rac1 inhibitors (1)
- radial MR imaging (1)
- radionuclide (1)
- radionuclide therapy (1)
- ranskranielle magnetische Stimulation (1)
- rapid evolution (1)
- rat (1)
- reactive oxygen species (1)
- real-time imaging (1)
- reception (1)
- receptor signaling (1)
- reciprocity (1)
- reconstruction (1)
- recurrence (1)
- reduction of ERK1/2 phosphorylation (1)
- reduction of cells proliferation (1)
- regenerative medicine (1)
- regional analgesia (1)
- regulatorische T Zellen (1)
- regulatory RNA (1)
- reinforcement sensitivity theory (1)
- relapse (1)
- renale Kalzifikationen (1)
- replication (1)
- reporter screen (1)
- research software (1)
- resilience (1)
- resin (1)
- resolution (1)
- responsiveness (1)
- resting tremor (1)
- resting-state fMRT (1)
- restriction factors (1)
- resveratrol (1)
- retinal development (1)
- reverse Transkription (1)
- reverse genetics (1)
- reverse transcription (1)
- reversible oxidation (1)
- rheumatoide Arthritis (1)
- rho gtpases (1)
- ribosomal RNA (1)
- ribosomale RNS (1)
- ribosome biogenesis (1)
- ribosome profiling (1)
- riboswitch (1)
- risk factors (1)
- rodent model (1)
- rtPA (1)
- safety-efficiency trade-off (1)
- salinen Wachstumsbedingungen (1)
- salt stress (1)
- sand mine (1)
- saure Sphingomyelinase (1)
- scale-up (1)
- schnelle Evolution (1)
- screening (1)
- second messenger (1)
- secondary metabolites (1)
- secondary prevention (1)
- secreted aspartic protease (1)
- secreted factors (1)
- secretion (1)
- secretory properties (1)
- seed coat (1)
- seed treatment (1)
- self-activation (1)
- self-regulation (1)
- self-targeting CRISPR-Cas (1)
- senecionine (1)
- seneciphylline (1)
- senescence (1)
- sensitivity (1)
- sensorische Neurone (1)
- sequence-structure (1)
- serine protease (1)
- serotonerges System (1)
- serotonin (1)
- serotonin deficiency (1)
- serotonin transporter (1)
- serum retention (1)
- sexual stage surface proteins (1)
- shoot capacitance (1)
- short neuropeptide F (1)
- sifA (1)
- sigma factor (1)
- signaling pathway (1)
- signaltransduction (1)
- similarity (1)
- single cell anatomy (1)
- single molecule microscopy (1)
- single-cell RNA sequencing (1)
- single-cell genomics (1)
- single-molecule imaging (1)
- single-molecule localization microscopy (1)
- single-molecule microscopy (1)
- site directed immobilization (1)
- site-specific immobilization (1)
- skin (1)
- skin biopsy (1)
- skin cancer (1)
- skin model (1)
- small RNA expression (1)
- small fiber pathology (1)
- small intestinal submucosa (1)
- small proteins (1)
- small-animal SPECT (1)
- smell (1)
- smells (1)
- snoRNA (1)
- social behaviour (1)
- social cognition (1)
- social interaction (1)
- social stimuli (1)
- social understanding (1)
- solid tumour (1)
- solitary bee nests (1)
- somatic resilience (1)
- somatostatin receptor antagonists (1)
- soziale Insekten (1)
- spatial organization (1)
- specific phobia (1)
- speckle tracking (1)
- spezifische Phobie (1)
- sphingolipid (1)
- spider phobia (1)
- spiral trajectory (1)
- splicing (1)
- sponge microbiome (1)
- spontaneous neuronal activity (1)
- ssVEP (1)
- stachellose Biene (1)
- stachellose Bienen (1)
- steady-state visually evoked potentials (1)
- stem (1)
- stem cells (1)
- stiff person syndrome (1)
- stingless bees (1)
- stomatal closure (1)
- store-operated calcium entry (1)
- strain (1)
- strain rate (1)
- stream (1)
- streptozotocin (1)
- stress response (1)
- striatum (1)
- stroop task (1)
- structural mechanism (1)
- structure analysis (1)
- structure based drug design (1)
- structure-based drug design (1)
- structure-function relationships (1)
- stx-Phagen (1)
- stx-phages (1)
- subcutaneous implanation (1)
- subthalamic nucleus (1)
- sugar perception (fructose, sucrose) (1)
- sugar receptor (1)
- sumo (1)
- sumoylation (1)
- superagonistische Funktion (1)
- superparamagnetische Eisenoxid Kontrastmittel (1)
- suspension culture (1)
- sustained fear (1)
- symbiont management (1)
- synaptische Plastizität (1)
- synthetic lethal interaction (1)
- synthetisch lethale Interaktion (1)
- systemic inflammation (1)
- systems biology (1)
- t cell (1)
- tactil (1)
- tactile (1)
- tapeworm (1)
- tdcs (1)
- telomere-associated protein (1)
- temperate zones (1)
- temporal information transfer (1)
- temporal organization (1)
- temporo-parietal junction (1)
- terahertz radiation (1)
- terpenes (1)
- test system (1)
- th1/th2 polarization (1)
- therapeutic strategy (1)
- therapeutisches Target (1)
- therapy (1)
- therapy of glioblastoma (1)
- therapy outcome (1)
- therapy simulation (1)
- thermal orientation (1)
- thermotolerance (1)
- theta burst stimulation (1)
- think/no-think (1)
- thiostrepton (1)
- threat conditioning (1)
- thrombin (1)
- thrombo-inflammation (1)
- thrombosis (1)
- thyroid stimulating hormone receptor (1)
- time-correlated single photon counting (TCSPC) (1)
- time-resolved anisotropy (1)
- timing (1)
- tissue model (1)
- tolerance (1)
- tolerogen (1)
- tolerogenic (1)
- tool (1)
- tool-use (1)
- torque meter (1)
- tracheal cytotoxin (1)
- trachomatis (1)
- trade-offs (1)
- trans-Golgi network (1)
- transcranial Direct Current Stimulation (tDCS) (1)
- transcranial direct current stimulation (1)
- transcription elongation factor A (SII)-like 1 (TCEAL1) (1)
- transcription factor (1)
- transcription regulator (1)
- transcription/replication conflicts (1)
- transcriptional termination site (1)
- transcriptome (1)
- transcriptome analysis (1)
- transcriptome data analysis (1)
- transcriptome profiling (1)
- transcriptomic analysis (1)
- transcutaneous vagus nerve stimulation (1)
- transfer (1)
- transgenes Modell (1)
- transient dynamics (1)
- transmission blocking vaccine (1)
- transpiration barrier (1)
- transport (1)
- transporter regulator (1)
- tuberculosis (1)
- tumor angiogenesis (1)
- tumor metabolism (1)
- tumor microenvironment (1)
- tumor vascular morphologie (1)
- tumorspezifische Therapie (1)
- tumour (1)
- tumour microenvironment (1)
- tumour stroma (1)
- two-component (1)
- type 1 diabetes (1)
- tyrosine kinase (1)
- ubiquitin (1)
- ubiquitin chain formation (1)
- ubiquitin linkage specificity (1)
- ubiquitin recognition (1)
- ultimatum game (1)
- unconventional T cells (1)
- unklarer Signifikanz (1)
- vaccine (1)
- vacuole (1)
- validation study (1)
- variant surface glycoprotein (1)
- variational network (1)
- varroa (1)
- vascular cell adhesion molecules (1)
- vascular smooth muscle cells (1)
- vascular structure (1)
- vascular system (1)
- vaskuläre Adhäsionsmoleküle (1)
- vaskuläre glatte Muskelzelle (1)
- vaskuläre glatte Muskelzellen (1)
- vasp (1)
- vav2 (1)
- vdr (1)
- ve-cadherin (1)
- venus (1)
- viral genome packaging (1)
- viral miRNAs (1)
- virological synapse (1)
- virtual reality T-maze (1)
- virulence factors (1)
- virus transmission (1)
- vision (1)
- visual attention (1)
- visual cue (1)
- visual perception (1)
- visuelles Langzeitgedächtnis (1)
- vitamin d (1)
- vitamin d receptor (1)
- vmPFC (1)
- vulnerability curve (1)
- v’Td (1)
- waggle dance (1)
- waggle dance decoding (1)
- water fat separation (1)
- water loss (1)
- wax (1)
- wild-living honey bees (1)
- workbench (1)
- x-ray micro computed tomography (1)
- xiphophorus (1)
- yeast (1)
- zebrafish (1)
- zeitgeber (1)
- zeitlich Informationsübertragung (1)
- zeitliche Organisation (1)
- zeitliche Trends (1)
- zentrale Spindel und Mittelkörper (1)
- zielgerichtete Therapien (1)
- zonal Hydrogels (1)
- zyklische Peptide (1)
- µ-Opioid Rezeptor (1)
- Ängstliche Depression (1)
- Ätiologie (1)
- Ölpalmenanbau (1)
- Überexpression (1)
- Übertragungsfunktion (1)
- Übung (1)
- ß-adrenerge Rezeptoren (1)
- ß-adrenergic Receptors (1)
- ΔNp63 (1)
- α-synuclein (1)
- β cell (1)
- β3 adrenergic receptor (1)
- γδ T cells (1)
Institute
- Graduate School of Life Sciences (1034)
- Theodor-Boveri-Institut für Biowissenschaften (101)
- Rudolf-Virchow-Zentrum (70)
- Medizinische Fakultät (44)
- Institut für Pharmakologie und Toxikologie (39)
- Institut für Virologie und Immunbiologie (35)
- Institut für Psychologie (34)
- Institut für Molekulare Infektionsbiologie (33)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (29)
- Julius-von-Sachs-Institut für Biowissenschaften (25)
Sonstige beteiligte Institutionen
- Helmholtz Institute for RNA-based Infection Research (HIRI) (7)
- Universitätsklinikum Münster (3)
- Rudolf Virchow Center for Integrative and Translational Bioimaging, University of Würzburg (2)
- Zentrum für Infektionsforschung (ZINF) Würzburg (2)
- Bio-Imaging Center Würzburg (1)
- Biomedical Center Munich, Department of Physiological Chemistry, Ludwig-Maximilians-Universität München (1)
- CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - the development agency of the Brazilian Federal Government (1)
- CBIO, University of Cape Town, South Africa (1)
- Carl-Ludwig-Institut für Physiologie, Universität Leipzig (1)
- Chair of Experimental Biomedicine I (1)
Parasitic helminths share a large degree of common genetic heritage with their various hosts. This includes cell-cell-communication mechanisms mediated by small peptide cytokines and lipophilic/steroid hormones. These cytokines are candidate molecules for host-parasite cross-communication in helminth diseases. In this work the function of two evolutionary conserved signaling pathways in the model cestode Echinococcus multilocularis has been studied. First, signaling mechanisms mediated through fibroblast growth factors (FGF) and their cognate receptors (FGFR) which influence a multitude of biological functions, like homeostasis and differentiation, were studied. I herein investigated the role of EmFR which is the only FGFR homolog in E. multilocularis. Functional analyses using the Xenopus oocyte expression system clearly indicate that EmFR can sense both acidic and basic FGF of human origin, resulting in an activation of the EmFR tyrosine kinase domain. In vitro experiments demonstrate that mammalian FGF significantly stimulates proliferation and development of E. multilocularis metacestode vesicles and primary cells. Furthermore, DNA synthesis and the parasite’s Erk-like MAPK cascade module was stimulated in the presence of exogenously added mammalian FGF. By using the FGFR inhibitor BIBF1120 the activity of EmFR in the Xenopus oocyte system was effectively blocked. Addition of BIBF1120 to in vitro cultivated Echinococcus larval material led to detrimental effects concerning the generation of metacestode vesicles from parasite stem cells, the proliferation and survival of metacestode vesicles, and the dedifferentiation of protoscoleces towards the metacestode. In conclusion, these data demonstrate the presence of a functional EmFR-mediated signaling pathway in E. multilocularis that is able to interact with host-derived cytokines and that plays an important role in larval parasite development. Secondly, the role of nuclear hormone receptor (NHR) signaling was addressed. Lipophilic and steroid hormone signaling contributes to the regulation of metazoan development. By means of in silico analyses I demonstrate that E. multilocularis expresses a set of 17 NHRs that broadly overlaps with that of the related flatworms Schistosoma mansoni and S. japonicum, but also contains several NHR encoding genes that are unique to this parasite. One of these, EmNHR1, is homolog to the DAF-12/HR-96 subfamily of NHRs which regulate cholesterol homeostasis in metazoans. Modified yeast-two hybrid analyses revealed that host serum contains a ligand which induces homodimerization of the EmNHR1 ligand-binding domain. Also, a HNF4-like homolog, EmHNF4, was characterized. Human HNF4 plays an important role in liver development. RT-PCR experiments showed that both isoforms of the EmHNF4 encoding gene are expressed stage-dependently suggesting distinct functions of the two isoforms in the parasite. Moreover, specific regulatory mechanisms on the convergence of NHR signaling and TGF-β/BMP signaling pathways in E. multilocularis have been identified. On the one hand, EmNHR1 directly interacted with the EmSmadC and on the other hand EmHNF4b interacted with EmSmadD, EmSmadE which are all downstream signaling components of the TGF-β/BMP signaling pathway. This suggests cross-communication in order to regulate target gene expression. With these results, further studies on the role of NHR signaling in the cestode will be facilitated. Also, the first serum-free in vitro cultivation system for E. multilocularis was established using PanserinTM401 as medium. Serum-free co-cultivation with RH-feeder cells and an axenic cultivation method have been established. With the help of this serum-free cultivation system investigations on the role of specific peptide hormones, like FGFs, or lipophilic/steroid hormones, like cholesterol, for the development of helminths will be much easier.
Background
Acute graft-versus-host disease (aGVHD) poses a major limitation for broader therapeutic application of allogeneic hematopoietic cell transplantation (allo-HCT). Early diagnosis of aGVHD remains difficult and is based on clinical symptoms and histopathological evaluation of tissue biopsies. Thus, current aGVHD diagnosis is limited to patients with established disease manifestation. Therefore, for improved disease prevention it is important to develop predictive assays to identify patients at risk of developing aGVHD. Here we address whether insights into the timing of the aGVHD initiation and effector phases could allow for the detection of migrating alloreactive T cells before clinical aGVHD onset to permit for efficient therapeutic intervention.
Methods
Murine major histocompatibility complex (MHC) mismatched and minor histocompatibility antigen (miHAg) mismatched allo-HCT models were employed to assess the spatiotemporal distribution of donor T cells with flow cytometry and in vivo bioluminescence imaging (BLI). Daily flow cytometry analysis of peripheral blood mononuclear cells allowed us to identify migrating alloreactive T cells based on homing receptor expression profiles.
Results
We identified a time period of 2 weeks of massive alloreactive donor T cell migration in the blood after miHAg mismatch allo-HCT before clinical aGVHD symptoms appeared. Alloreactive T cells upregulated α4β7 integrin and P-selectin ligand during this migration phase. Consequently, targeted preemptive treatment with rapamycin, starting at the earliest detection time of alloreactive donor T cells in the peripheral blood, prevented lethal aGVHD.
Conclusions
Based on this data we propose a critical time frame prior to the onset of aGVHD symptoms to identify alloreactive T cells in the peripheral blood for timely and effective therapeutic intervention.
Non-small cell lung cancer (NSCLC) is the deadliest form of lung cancer and has a poor prognosis due to its high rate of metastasis. Notably, metastasis is one of the leading causes of death among cancer patients. Despite the clinical importance, the cellular and molecular mechanisms that govern the initiation, establishment and progression of metastasis remain unclear. Moreover, knowledge gained on metastatic process was largely based on cultured or in vitro manipulated cells that were reintroduced into immune-compromised recipient mice. In the present study, a spontaneous metastasis mouse model for NSCLC was generated with a heritable fluorescent tag (DsRed) driven by CAG (combination of cytomegalovirus early enhancing element and chicken beta actin) promoter in alveolar type II cells (SpC-rtTA/TetO-Cre/LSL-DsRed). This approach is essential, keeping in mind the reprogramming nature of Myc oncogene (Rapp et al, 2009). Such genetic lineage tracing approach not only allowed us to monitor molecular and cellular changes during development of primary tumor but also led us to identify the different stages of secondary tumor development in distant organs. Upon combined expression of oncogenic C Raf-BXB and c-Myc (MYC-BXB-DsRed) in lung alveolar type II epithelial cells, macroscopic lung tumors arose comprising of both cuboidal and columnal cellular features. C Raf-BXB induced tumors (CRAF-DsRed) exhibit cuboidal morphology and is non-metastatic whereas Myc-BXB induced lung tumors (Myc-BXB-DsRed) present cuboidal-columnar cellular features and is able to undergo metastasis mainly in liver. Surprisingly, cystic lesions which were negative for SpC (Surfactant protein C) and CCSP (Clara cell secretory protein), strongly expressed DsRed proteins indicating its origin from lung alveolar type II cells. Moreover, early lung progenitor markers such as GATA4 (GATA-binding protein 4) and TTF1 (Thyroid Transcription Factor 1) were still expressed in these early cystic lesions suggesting metastasis as a faulty recapitulation of ontogeny (Rapp et al, 2008). Interestingly, mixed cystic lesions and metastatic tumors contained DsRed and SpC positive cells. These results demonstrate secondary tumor progression from cystic, mixed cystic to malignant transformation. Our results shed tremendous light on reprogramming of metastasizing cells during secondary tumor development. Moreover, such fluorescent tagged metastatic mice model can also be used to track the migration ability of metastatic cancer cell to different organs and its potential to differentiate into other cell types such as blood vessel or stromal cell within the primary tumor.
Synapsins are conserved synapse-associated hosphoproteins involved in the fine regulation of neurotransmitter release. The aim of the present project is to study the phosphorylation of synapsins and the distribution of phospho-synapsin in the brain of Drosophila melanogaster.
Three antibodies served as important tools in this work, a monoclonal antibody (3C11/α-Syn) that recognizes all known synapsin isoforms and two antisera against phosphorylated synapsin peptides (antiserum PSyn(S6) against phospho-serine 6 and antiserum PSyn(S464) against phospho-serine 464). These antisera were recently generated in collaboration with Bertram Gerber and Eurogentec. ...
Regulating our immediate feelings, needs, and urges is a task that we are faced with every day in our lives. The effective regulation of our emotions enables us to adapt to society, to deal with our environment, and to achieve long‐term goals. Deficient emotion regulation, in contrast, is a common characteristic of many psychiatric and neurological conditions. Particularly anxiety disorders and subclinical states of increased anxiety are characterized by a range of behavioral, autonomic, and neural alterations impeding the efficient down‐regulation of acute fear. Established fear network models propose a downstream prefrontal‐amygdala circuit for the control of fear reactions but recent research has shown that there are a range of factors acting on this network. The specific prefrontal cortical networks involved in effective regulation and potential mediators and modulators are still a subject of ongoing research in both the animal and human model. The present research focused on the particular role of different prefrontal cortical regions during the processing of fear‐relevant stimuli in healthy subjects. It is based on four studies, three of them investigating a different potential modulator of prefrontal top‐down function and one directly challenging prefrontal regulatory processes. Summarizing the results of all four studies, it was shown that prefrontal functioning is linked to individual differences in state anxiety, autonomic flexibility, and genetic predisposition. The T risk allele of the neuropeptide S receptor gene, a recently suggested candidate gene for pathologically elevated anxiety, for instance, was associated with decreased prefrontal cortex activation to particularly fear‐relevant stimuli. Furthermore, the way of processing has been found to crucially determine if regulatory processes are engaged at all and it was shown that anxious individuals display generally reduced prefrontal activation but may engage in regulatory processes earlier than non‐anxious subjects. However, active manipulation of prefrontal functioning in healthy subjects did not lead to the typical behavioral and neural patterns observed in anxiety disorder patients suggesting that other subcortical or prefrontal structures can compensate for an activation loss in one specific region. Taken together, the current studies support prevailing theories of the central role of the prefrontal cortex for regulatory processes in response to fear‐eliciting stimuli but point out that there are a range of both individual differences and peculiarities in experimental design that impact on or may even mask potential effects in neuroimaging research on fear regulation.
All animal and plant species must disperse in order to survive. Although this fact may seem trivial, and the importance of the dispersal process is generally accepted, the eco-evolutionary forces influencing dispersal, and the underlying movement elements, are far from being comprehensively understood. Beginning in the 1950s scientists became aware of the central role of dispersal behaviour and landscape connectivity for population viability and species diversity. Subsequently, dispersal has mainly been studied in the context of metapopulations. This has allowed researchers to take into account the landscape level, e.g. for determining conservation measures. However, a majority of theses studies classically did not include dispersal evolution. Yet, it is well known that dispersal is subject to evolution and that this process may occur (very) rapidly, i.e. over short ecological time-scales. Studies that do take dispersal evolution into account, mostly focus on eco-evolutionary forces arising at the level of populations - intra-specific competition or Allee effects, for example - and at the level of landscapes - e.g. connectivity, patch area and fragmentation. Yet, relevant ecological and evolutionary forces can emerge at all levels of biological complexity, from genes and individuals to populations, communities and landscapes. Here, I focus on eco-evolutionary forces arising at the gene- and especially at the individual level. Combining individual-based modelling and empirical field work, I explicitly analyse the influence of mobility trade-offs and information use for dispersal decisions - i.e. individual level factors - during the three phases of dispersal - emigration, transfer and immigration. I additionally take into account gene level factors such as ploidy, sexual reproduction (recombination) and dominance. Mobility-fertility trade-offs may shape evolutionarily stable dispersal strategies and lead to the coexistence of two or more dispersal strategies, i.e. polymorphisms and polyphenisms. This holds true for both dispersal distances (chapter 3) and emigration rates (chapter 4). In sessile organisms - such as trees or corals - maternal investment, i.e. transgenerational trade-offs between maternal fertility and propagule dispersiveness, can be the cause of bimodal and fat-tailed dispersal kernels. However, the coexistence of two or more dispersal strategies may be critically dependent on gene level factors, such as ploidy or dominance (chapter 4). Passively dispersing individuals may realize such multimodal dispersal kernels by mixing different dispersal vectors. Active choice of these vectors allows to optimize the kernel. As most animals have evolved some kind of memory and sensory apparatus - chemical, acoustic or optical sensors - it is obvious that these capacities should be used for dispersal decisions. Chapter 5 explores the use of chemical cues for vector choice in passively dispersed animals. I find that the neotropical phoretic flower mites Spadiseius calyptrogynae non-randomly mix different dispersal vectors, i.e. one short- and one long-distance disperser, in order to achieve fat-tailed dispersal kernels. Such kernels allow an optimal exploitation of patchily distributed habitats. In addition, this strategy increases the probability of successful immigration as the short-distance dispersal vectors show directed dispersal towards suitable habitats. Results from individual-based simulations support and explain my empirical findings. The use of memory and sensory apparatus in dispersal is also the main topic of chapter 6 which strives to bridge the gap between dispersal and movement ecology. In this part of my thesis I develop a model of non-random, memory-based animal movement strategies. Extending the movement ecology paradigm of Nathan (2008a) I postulate that four elements may be relevant for the emergence of efficient movement strategies: perception, memory, inference and anticipation. Movement strategies including these four elements optimize search efficiency at two scales: within patches and between patches. This leads to a significantly increased search efficiency over a comparable area restricted search strategy. These four chapters are completed by a general analysis of metapopulation dynamics (chapter 2). I find that although the metapopulation concept is very popular in theoretical ecology, classical metapopulations can be predicted to be rare in nature, as suggested by lacking empirical evidence. This is especially the case when gene level factors, such as ploidy and sex, are taken into account. In summary, my work analyses the effects of ecological and evolutionary forces arising at the gene- and individual level on the evolution of dispersal and movement strategies. I highlight the importance of including these limiting factors, mechanisms and processes and show how they impact the evolution of dispersal in spatially structured populations. All chapters demonstrate that these forces may have dramatic effects on resulting ecological and evolutionary dynamics. If we intend to understand animal and plant dispersal or movement, it is crucial to include eco-evolutionary forces emerging at all levels of complexity, from genes to communities and landscapes. This endeavour is certainly not purely academic. Particularly nowadays, with rapidly changing landscape structures and anticipated drastic shifts of climatic zones due to global change, dispersal is a factor that cannot be overestimated.
Tumor angiogenesis is essential for the growth of solid tumors as their proliferation and survival is dependent on consistent oxygen and nutrient supply. Anti-angiogenic treatments represent a therapeutic strategy to inhibit tumor growth by preventing the formation of new blood vessels leading to starvation of the tumor. One of the best characterized anti angiogenic therapeutics is the monoclonal antibody bevacizumab (Avastin), which targets and neutralizes VEGF leading to disruption of the VEGF signaling pathway. Until today, bevacizumab has found its way into clinical practice and has gained approval for treatment of different types of cancer including colorectal cancer, non-small cell lung cancer, breast cancer and renal cell carcinoma. Signaling of VEGF is mediated through VEGF receptors, mainly VEGFR2, which are primarily located on the cell surface of endothelial cells. However, there has been evidence that expression of VEGF receptors can also be found on tumor cells themselves raising the possibility of autocrine and/or paracrine signaling loops. Thus, tumor cells could also benefit from VEGF signaling, which would promote tumor growth. The aim of this study was to investigate if bevacizumab has a direct effect on tumor cells in vitro. To this end, tumor cell lines from the NCI-60 panel derived from four different tumor types were treated with bevacizumab and angiogenic gene and protein expression as well as biological outputs including proliferation, migration and apoptosis were investigated. Most of the experiments were performed under hypoxia to mimic the in vivo state of tumors. Overall, there was a limited measurable effect of bevacizumab on treated tumor cell lines according to gene and protein expression changes as well as biological functions when compared to endothelial controls. Minor changes in terms of proliferation or gene regulation were evident in a single tumor cell line after VEGF-A blockade by bevacizumab, which partially demonstrated a direct effect on tumor cells. However, the overall analysis revealed that tumor cell lines are not intrinsically affected in an adverse manner by bevacizumab treatment.
Besides the functional analysis of tumor cells, embryonic stem cell derived endothelial cells were characterized to delineate vascular Hey gene functions. Hey and Hes proteins are the best characterized downstream effectors of the evolutionary conserved Notch signaling pathway, which mainly act as transcriptional repressors regulating downstream target genes. Hey proteins play a crucial role in embryonic development as loss of Hey1 and Hey2 in mice in vivo leads to a severe vascular phenotype resulting in early embryonic lethality. The major aim of this part of the thesis was to identify vascular Hey target genes using embryonic stem cell derived endothelial cells utilizing a directed endothelial differentiation approach, as ES cells and their differentiation ability provide a powerful in vitro system to study developmental processes. To this end, Hey deficient and Hey wildtype embryonic stem cells were stably transfected with an antibiotic selection marker driven by an endothelial specific promoter, which allows selection for endothelial cells. ESC-derived endothelial cells exhibited typical endothelial characteristics as shown by marker gene expression, immunofluorescent staining and tube formation ability. In a second step, Hey deficient ES cells were stably transfected with doxycycline inducible Flag-tagged Hey1 and Hey2 transgenes to re-express Hey proteins in the respective cell line. RNA-Sequencing of Hey deficient and Hey overexpressing ES cells as well as ESC-derived endothelial cells revealed many Hey downstream target genes in ES cells and fewer target genes in endothelial cells. Hey1 and Hey2 more or less redundantly regulate target genes in ES cells, but some genes were regulated by Hey2 alone. According to Gene Ontology term analysis, Hey target genes are mainly involved in embryonic development and transcriptional regulation. However, the response of ESC-derived endothelial cells in regulating Hey downstream target genes was rather limited when compared to ES cells, which could be due to lower transgene expression in endothelial cells. The limited response also raises the possibility that target gene regulation in endothelial cells is not only dependent on Hey gene functions alone and thus loss or overexpression of Hey genes in this in vitro setting does not influence target gene regulation.
Als einer der ersten gegen HIV gerichteten Restriktionsfaktoren konnte die Cytidindeaminase APOBEC3G isoliert werden. Dieses zelluläre Enzym hemmt äußerst effizient die Replikation von HIV. Weiterführende Untersuchungen konnten demonstrieren, dass die Hemmung der Virusreplikation hauptsächlich auf einer Deaminase-katalysierten G zu A-Hypermutation des viralen Genoms während der Reversen Transkription beruht. Als Gegenstrategie zur antiretroviralen Wirkung von A3G kodiert HIV-1 das Protein Vif (virion infectivity factor), welches durch eine direkte Wechselwirkung den Ubiquitin-abhängigen proteasomalen Abbau von A3G bewirkt. Vor diesem Hintergrund wird der Inhibition des Vif induzierten A3G- Abbaus großes Potential als neuartiges Wirkstoffziel bei der Behandlung von HIV Infektionen vorhergesagt. Das Ziel der vorliegenden Arbeit bestand deshalb in der Etablierung von zellulären Screening-Assays für die Identifizierung von Inhibitoren des Vif induzierten A3G-Abbaus. Im Rahmen dieser Arbeit konnten insgesamt vier fluoreszenzbasierte zelluläre Assays erfolgreich entwickelt und als Screeningsysteme für die Wirkstoffsuche etabliert werden. Drei dieser Assays basieren auf stabilen Zelllinien, von denen eine Vif und ein mit EYFP markiertes A3G ko-exprimiert. Dieser sogenannte A3G-Abbauassay stellt den primären Assay für die Identifizierung von Inhibitoren des Vif induzierten A3G-Abbaus dar und wird durch zwei weitere Zelllinien-basierte Assays ergänzt. Diese sekundäre Assays erlauben die Detektion von Substanzen, die falsch-positive oder falsch-negative Signale im A3G-Abbauassays generieren. Zusammengenommen ermöglichen die drei Assays die präzise Identifizierung von Inhibitoren, die spezifisch auf den A3G-Abbau wirken und stellen damit eine wesentliche Verbesserung bereits existierender Screeningsysteme dar. Weiterhin wurde ein auf dem Prinzip der bimolekularen Fluoreszenzkomplementation (BiFC) basierendes Testsystem entwickelt. Besagtes System misst die direkte Interaktion zwischen Vif und ElonginC in lebenden Zellen und repräsentiert damit ein weiteres Testsystem für die Identifizierung von Inhibitoren der Vif induzierten A3G-Degradation. Den zweiten Teil dieser Arbeit umfasste die Analyse von Derivaten des Vif Antagonisten RN-18 und neu entwickelten niedermolekularen Inhibitoren der Vif-ElonginC- Interaktion. Als ein wichtiges Ergebnis der Derivat-Analyse ergab sich, dass RN-18 zytotoxisch wirkt und im hier etablierten A3G-Abbauassay ein falsch-positives Signal generiert. Unter den analysierten Vif-ElonginC-Interaktionsinhibitoren fand sich eine Verbindung, die in einem initialen Screening, unter Verwendung des A3G-Abbauassays, eine deutliche Inhibition der Vif induzierten A3G-Degradation bewirkte. Zusammenfassend konnten im Rahmen dieses Promotionsprojektes erfolgreich mehrere Screeningsysteme für die Identifizierung von spezifischen Inhibitoren des A3G-Abbaus etabliert werden. Diese Systeme werden zukünftig dazu beitragen, dass Auffinden von neuartigen Therapeutika für die Behandlung von HIV-Infektionen zu beschleunigen.
Die erfolgreiche therapeutische Beeinflussung pathophysiologischer Prozesse im Herzen nach myokardialem Infarkt stellt nicht zuletzt durch die steigenden Fallzahlen in der westlichen Welt und die vergleichsweise hohe Mortalität eine Herausforderung an Forschung und Entwicklung dar. In der vorliegenden Arbeit werden verschiedene therapeutische Strategien in klinisch relevanten Mausmodellen des Myokardinfarkts und des Ischämie-Reperfusions-Schadens getestet.
Zunächst wird untersucht, ob sich der Einsatz des NFκB-aktivierenden Zytokins TWEAK, welches weitreichende Funktionen in physiologischen Prozessen wie Wundheilung und Entzündung besitzt, als eine mögliche Therapiestrategie eignet. Die Expression von TWEAK wird nach myokardialem Infarkt stark im Herzgewebe induziert. Das gleiche gilt für den Rezeptor von TWEAK, Fn14, der vor allem auf kardialen Fibroblasten exprimiert wird. Daher wird angenommen, dass das TWEAK-Fn14-System am kardialen Remodelling und der Wundheilung im infarzierten Herzen beteiligt sein kann.
Eine rekombinante Variante von TWEAK - HSA-Flag-TWEAK - wird im Mausmodell des Myokardinfarkts getestet. Überraschenderweise zeigt sich hierbei, dass die therapeutische Behandlung von infarzierten Versuchstieren mit diesem Protein die Mortalität im Vergleich zu Placebo-behandelten Mäusen signifikant erhöht. Dies geht mit einem vermehrten Auftreten an linksventrikulären Rupturen einher, ohne dass Defekte im kardialen Remodelling oder eine erhöhte Apoptoserate im Herzen festgestellt werden können. HSA-Flag-TWEAK bewirkt eine Erhöhung der Gewebekonzentrationen an verschiedenen pro-inflammatorischen Zytokinen (IFN-γ, IL-5, IL-12, GITR, MCP-1/-5 und RANTES) und das vermehrte Einwandern von Immunzellen in das Myokard. Hierbei ist insbesondere die stark erhöhte Infiltration an neutrophilen Granulozyten auffällig. Ein kausaler Zusammenhang zwischen diesen Immunzellen und den auftretenden kardialen Rupturen kann durch die Depletion der Neutrophilen gezeigt werden: Nach der systemischen Applikation eines Ly6G-depletierenden Antikörpers ist das Auftreten von kardialen Rupturen nach TWEAK-Gabe vergleichbar mit der Placebo-behandelten Infarktgruppe. Die Tatsache, dass die Mortalität dennoch erhöht ist, deutet auf weitere negative Effekte durch TWEAK hin. Diese Ergebnisse legen die Vermutung nahe, dass eine Hemmung der TWEAK-Fn14-Achse positive Effekte auf die Wundheilung nach Herzinfarkt bewirken könnte.
Als zweite Therapiestrategie wird die pharmakologische Beeinflussung verschiedener Blutplättchen-spezifischer Zielstrukturen untersucht, um das Auftreten von Mikrothromben nach Myokardinfarkt zu reduzieren. Eine Hemmung über das Blutplättchen-Glykoprotein GPVI bewirkt in dem hier eingesetzten Mausmodell der kardialen Ischämie-Reperfusion eine signifikant verbesserte Mikrozirkulation sowie verringerte Infarktgrößen. GPVI stellt somit ein vielversprechendes Ziel für eine blutplättchenhemmende Therapie nach Myokardinfarkt dar.
Zusammengefasst werden in der vorliegenden Arbeit verschiedene neuartige Therapieoptionen untersucht, die die Auswirkungen ischämischer Erkrankungen des Herzens beeinflussen können. Die Ergebnisse besitzen daher das Potenzial, zur Entwicklung neuer Therapien nach Myokardinfarkt beizutragen.
Hyperinsulinemia, a condition with excessively high insulin blood levels, is related to an increased cancer incidence. Diabetes mellitus, metabolic syndrome, obesity and polycystic ovarian syndrome are the most common of several diseases accompanied by hyperinsulinemia. Since an elevated cancer risk especially for colon and kidney cancers, was reported for those patients, we investigated for the first time the induction of genomic damage by insulin mainly in HT29 (human colon cells), LLC-PK1 (pig kidney cells), HK2 (human kidney cells) and peripheral lymphocytes, and to confirm the genotoxicity of insulin in other cells from different tissues. To ascertain that the insulin effects were not only limited to permanent cell lines, rat primary colon, kidney, liver and fatty tissue cells were also studied. To connect the study and the findings to in vivo conditions, two in vivo models for hyperinsulinemia were used; Zucker diabetic fatty rats in a lean and diabetic state infused with different insulin concentrations and peripheral lymphocytes from type 2 diabetes mellitus patients. First, the human colon adenocarcinoma cells (HT29) showed significant elevation of DNA damage using comet assay and micronucleus frequency analysis upon treatment with 5 nM insulin in standard protocols. Extension of the treatment to 6 days lowered the concentration needed to reach significance to 0.5-1 nM. Insulin enhanced the cellular ROS production as examined by the oxidation of the dyes 2´,7´-dichlorodihydrofluorescein diacetate (H2DCF-DA) and dihydroethidium (DHE). The FPG modified comet assay and the reduction of damage by the radical scavenger tempol connected the insulin-mediatedDNA damage to ROS production. To investigate the sources of ROS upon insulin stimulation, apocynin and VAS2870 as NADPH oxidase inhibitors and rotenone as mitochondrial inhibitor were applied in combination with insulin and all of them led to a reduction of the genomic damage. Investigation of the signaling pathway started by evaluation of the binding of insulin to its receptor and to the IGF-1 receptor. The results showed the involvement of both receptors in the signaling mechanism. Following the activation of both receptors, PI3K activation occurs leading to phosphorylation of AKT which in turn activates two pathways for ROS production, the first related to mitochondria and the second through activation of Rac1 , resulting in the activation of Nox1. Both pathways could be activated through AKT or through the mitochondrial ROS which in turn could activates Nox1. Studying another human colon cancer cell line, Caco-2 and rat primary colon cells in vitro confirmed the effect of insulin on cellular chromatin. We conclude that pathophysiological levels of insulin can cause DNA damage in colon cells, which may contribute to the induction or progression of colon cancer. Second, in kidney cells, insulin at a concentration of 5 nM caused a significant increase in DNA damage in vitro. This was associated with the formation of reactive oxygen species (ROS). In the presence of antioxidants, blockers of the insulin and IGF-1 receptors, and a phosphatidylinositol 3-kinases (PI3K) inhibitor, the insulin mediated DNA damage was reduced. Phosphorylation of AKT was increased and p53 accumulated. Inhibition of the mitochondrial and NADPH oxidase related ROS production reduced the insulin mediated damage. In primary rat cells insulin also induced genomic damage. HK2 cells were used to investigate the mechanistic pathway in the kidney The signaling is identical to the one in the colon cells untill the activation of the mitochondrial ROS production, because after the activation of PI3K activation of Nox4 occurs at the same time across talk between mitochondria and Nox4 activation has been suggested and might play a role in the observed effects. In the in vivo model, kidneys from healthy, lean ZDF rats, which were infused with insulin to yield normal or high blood insulin levels, while keeping blood glucose levels constant, the amounts of ROS and p53 were elevated in the high insulin group compared to the control level group. ROS and p53 were also elevated in diabetic obese ZDF rats. The treatment of the diabetic rats with metformin reduced the DNA oxidation measured as 8-oxodG as well as the ROS production in that group. HL60 the human premyelocytic cells and cultured lymphocytes as models for the hemopoietic system cells showed a significant induction for DNA damage upon treatment with insulin. The diabetic patients also exhibited an increase in the micronucleus formation over the healthy individuals. In the present study, we showed for the first time that insulin induced oxidative stress resulting in genomic damage in different tissues, and that the source of the produced ROS differs between the tissues. If the same mechanisms are active in patients, hyperinsulinemia might cause genomic damage through the induction of ROS contributing to the increased cancer risk, against which the use of antioxidants as well as mitochondrial and NADPH oxidase inhibitors might exert protective effects with cancer preventive potential under certain conditions. Normal healthy human plasma insulin concentrations are in the order of 0.04 nM after overnight fasting and increase to less than about 0.2 nM after a meal. Pathophysiological levels can reach 1 nM and can stay above 0.2 nM for the majority of the daytime yielding condictions close to the insulin concentrations determined in the present study. Whether the observed effects also occur in vivo and whether they actually initiate or promote tumor formation remains to be determined. However, if proof of that can be obtained, our experiments with inhibitors indicate chances for pharmacological intervention applying antioxidants or enzyme inhibitors. It will not be the aim to reduce ROS in any case or as much as possible because ROS have now been recognized as important signaling molecules and participatants in immune defense, but a reduction to physiological levels instead of pathophysiological levels in the context of a disease associated with ROS overproduction might be beneficial.
Die Funktionalität β1- und β2-adrenerger Rezeptoren wird durch Polymorphismen in ihrer kodierenden Region moduliert. Wir haben uns die Technik des Fluoreszenz-Resonanz- Energie-Transfers (FRET) zu Nutze gemacht, um den Einfluss der am häufigsten vorkommenden Polymorphismen (Ser49Gly und Gly389Arg im β1AR, Arg16Gly und Gln27Glu im β2AR) auf die Rezeptorkonformation nach Aktivierung zu untersuchen. Dafür wurden FRET-Sensoren für die beiden βAR-Subtypen mit einem gelb-fluoreszierenden Protein (YFP) sowie einem cyan-fluoreszierenden Protein (CFP oder Cerulean) in der dritten intrazellulären Schleife bzw. am C-Terminus verwendet. Nach Stimulierung der βARSensoren konnte die Aktivierung der polymorphen Rezeptorvarianten in lebenden Zellen in Echtzeit untersucht werden. Dabei behielten die FRET-Sensoren sowohl die Bindungsaffinitäten der nativen Rezeptoren als auch eine intakte Funktionalität hinsichtlich der Bildung von sekundären Botenstoffen. Der Vergleich der Aktivierungskinetiken der verschieden polymorphen Varianten des β1AR und β2AR ergab keine signifikanten Unterschiede nach einer einmaligen Stimulation. Es zeigte sich jedoch, dass Rezeptorpolymorphismen die Aktivierungskinetik vorstimulierter βAR erheblich beeinflussen. So konnten wir im Vergleich zur ersten Aktivierung eine schnellere Aktivierung der Gly16-Varianten des β2AR sowie des Gly49Arg389-β1AR feststellen, während die Arg16-β2AR-Variante und der Ser49Gly389-β1AR dagegen bei einer wiederholten Stimulation langsamer aktiviert wurden. Diese Ergebnisse lassen auf ein "Rezeptorgedächtnis" schließen, das spezifisch für bestimmte polymorphe Rezeptorvarianten ist und eine βAR-Subtyp-spezische Ausprägung zeigt. Die Ausbildung der unterschiedlichen Aktivierungskinetiken hing von der Interaktion des Rezeptors mit löslichen intrazellulären Faktoren ab und bedurfte einer Phosphorylierung intrazellulärer Serin- und Threonin-Reste durch G-Protein-gekoppelte Rezeptorkinasen. Die Interaktion mit löslichen intrazellulären Faktoren scheint für den β1AR weniger stark ausgeprägt zu sein als für den β2AR. Die cAMP-Produktion war für die schneller werdenden, “hyperfunktionellen” Gly16-β2ARVarianten signifikant um mehr als 50% höher im Vergleich zur “hypofunktionellen” Arg16- Variante. Die unterschiedliche Funktionalität spiegelte sich im Therapieausgang bei Tokoysepatientinnen wider, dessen Erfolg mit dem Arg16Gly Polymorphismus verknüpft war. Die Daten implizieren eine intrinsische, polymorphismusabhängige Eigenschaft der βAR, die die Aktivierungskinetik der Rezeptoren bei wiederholten Stimulationen determiniert. Diese könnte auch für die zwischen Individuen variierende Ansprechbarkeit auf β-Agonisten und β-Blocker mitverantwortlich sein.
Pro-migratory signals mediated by the tumor microenvironment contribute to the cancer progression cascade, including invasion, metastasis and resistance to therapy. Derived from in vitro studies, isolated molecular steps of cancer invasion programs have been identified but their integration into the tumor microenvironment and suitability as molecular targets remain elusive. The purpose of the study was to visualize central aspects of tumor progression, including proliferation, survival and invasion by real-time intravital microscopy. The specific aims were to monitor the kinetics, mode, adhesion and chemoattraction mechanisms of tumor cell invasion, the involved guidance structures, and the response of invasion zones to anti-cancer therapy. To reach deeper tumor regions by optical imaging with subcellular resolution, near-infrared and infrared excited multiphoton microscopy was combined with a modified dorsal skinfold chamber model. Implanted HT-1080 fibrosarcoma and B16/F10 and MV3 melanoma tumors developed zones of invasive growth consisting of collective invasion strands that retained cell-cell contacts and high mitotic activity while invading at velocities of up to 200 μm per day. Collective invasion occurred predominantly along preexisting tissue structures, including blood and lymph vessels, collagen fibers and muscle strands of the deep dermis, and was thereby insensitive to RNAi based knockdown and/or antibody-based treatment against β1 and β3 integrins, chemokine (SDF-1/CXCL12) and growth factor (EGF) signaling. Therapeutic hypofractionated irradiation induced partial to complete regression of the tumor main mass, yet failed to eradicate the collective invasion strands, suggesting a microenvironmentally privileged niche. Whereas no radiosensitization was achieved by interference with EGFR or doxorubicin, the simultaneous inhibition of β1 and β3 integrins impaired cell proliferation and survival in spontaneously growing tumors and strongly enhanced the radiation response up to complete eradication of both main tumor and invasion strands. In conclusion, collective invasion in vivo is a robust process which follows preexisting tissue structures and is mainly independent of established adhesion and chemoattractant signaling. Due to its altered biological response to irradiation, collective invasion strands represent a microenvironmentally controlled and clinically relevant resistance niche to therapy. Therefore supportive regimens, such as anoikisinduction by anti-integrin therapy, may serve to enhance radio- and chemoefficacy and complement classical treatment regimens.
γ-Aminobutyric acid type A receptors (GABAARs) and glycine receptors (GlyRs) are the major mediators of fast synaptic inhibition in the central nervous system. For proper synaptic function their precise localization and exact concentration within the neuronal surface membrane is essential. These properties are mediated by scaffolding proteins which directly contact the large intracellular loops of the receptors and tether them to cytoskeletal elements of the neuronal cells. In my thesis I deciphered the molecular details of several underlying protein-protein interactions, namely the interaction of a subset of GABAAR and GlyR subunits with the scaffolding proteins gephyrin, radixin and collybistin. I determined short linear motifs within the large intracellular loops of the receptors that directly engage in subunit specific scaffold protein interactions. My quantitative binding studies revealed that gephyrins E domain primarily recognizes the GABAAR α1 (Kd = 17 M) and α3 (Kd = 5 M) subunits, in contrast, the SH3 domain of collybistin mainly interacts with the GABAAR α2 subunit (Kd = 1 µM), while the FERM domain of radixin tightly binds to the GABAAR α5 subunit (Kd = 8 µM). My work additionally demonstrated that this simple relationship is complicated by (i) missing or (ii) overlapping binding specificities between the scaffold proteins and the receptor subunits. Moreover, this thesis addressed the possibility of (iii) posttranslational negative regulation as well as amplification generated by (iv) avidity effects as summarized below. (i) First, using biochemical methods I mapped the radixin-GABAAR α5 interaction in detail. My structural analysis and competition assays suggest that radixin mediates the receptor subunit binding via a universal binding site within the F3 subdomain of its FERM domain. This binding site is formed by an α-helix that offers a large hydrophobic pocket, which accepts a variety of different hydrophobic residues adopting different conformations, and a β-strand that readily engages in peptide backbone interactions. Not surprisingly, this binding site has been implicated in a wide variety of different scaffold interactions, thus emphasizing the importance of the essential FERM activation mechanism described earlier and suggesting additional pathways to allow tight regulation of this interaction. (ii) Next, I analyzed in detail the process of gephyrin-mediated GABAAR clustering. My X-ray crystallographic studies and binding assays revealed that gephyrin mediates binding of the GABAAR α1, α2 and α3 subunit via a universal binding site that also mediates the interactions with the GlyR β subunit. Using structure-guided mutagenesis I identified key residues within gephyrin and the receptor subunits that act as major contributors to the overall binding strength. Namely, two conserved aromatic residues within the N-terminal half of the receptor binding region engage in crucial hydrophobic interactions with gephyrin. Accordingly, J. Mukherjee from the group of our collaborator Steven J. Moss verified a substantial decrease in GABAAR cluster number and size in primary hippocampal neurons upon exchange of these residues within the GABAAR α2 subunit. Extension of my studies to collybistin (CB) revealed an overlapping but reciprocal subunit preference for this protein in comparison to gephyrin. The GABAAR α3 subunit exclusively binds gephyrin, in contrast the GABAAR α1 subunit mainly targets gephyrin (Kd = 17 µM) but additionally displays a moderate affinity (Kd ≈ 400 µM) towards the SH3 domain of CB. The GABAAR α2 subunit binds tightly to the SH3 domain of CB (Kd = 1 µM) and additionally displays a weak gephyrin affinity (Kd ≈ 500 µM). Notably, I could exclude the possibility of synergistic effects between gephyrins E domain, the SH3 domain of CB and the GABAAR α2 subunit. Instead, I found that the GABAAR α2 subunit binds gephyrin and CB in a mutually exclusive manner. These results suggest that CBs role in receptor clustering is solely determined by competing binding events of its constituting domains. Namely, the intra-molecular association between the PH/DH domain and the SH3 domain within CB competes with different inter-molecular interactions of CB: GABAAR α2 binding to the SH3 domain, PIP2 binding to the PH domain and gephyrin presumably binding to the PH and DH domain of CB. (iii) Interestingly, the receptor motifs, which have been mapped in my thesis to directly interact with the scaffold proteins, were shown in earlier studies to be posttranslationally modified in vivo. In particular, the GABAAR α1 and GlyR β subunits have been implicated as targets of the ERK/MAPK and PKC phosphorylation-pathways, respectively, while the GABAAR α5 subunit motif was shown to be ubiquitinated. In this dissertation, I analyzed Thr348, a possible ERK phosphorylation site within GABAAR α1. My binding assays verified a severe reduction of the direct gephyrin binding strength upon introduction of the respective phosphomimetic residue. The relevance of this in vitro result was highlighted by J. Mukherjee who confirmed a significant reduction in GABAAR cluster number and size upon introduction of the same mutation. The ERK/MAPK pathway is therefore a promising candidate for regulation of GABAergic transmission. (iv) In vivo, gephyrin presumably forms a multivalent scaffold, which is based on the self-association of its G (GephG) and E domains (GephE). Given the multimeric nature of gephyrin and the pentameric receptor architecture, I tested the possibility of avidity in the clustering of inhibitory neurotransmitter receptors. Cocrystallization of selected minimum peptides with GephE and their crystal structure analyses enabled me to define a receptor-derived peptide that offers a maximized gephyrin affinity. The structure of the GephE-GlyR receptor complex reveals two receptor-binding sites in close spatial vicinity (15 Å). I therefore designed bivalent peptides that enable to target both GephE sites at the same time and, as expected, a variety of biophysical methods verified an avidity-potentiated and unmatched high gephyrin affinity for these bidentate compounds. Notably, I could extend the dimerization approach to low affinity gephyrin ligands, namely short GABAAR-derived peptides that could not be studied using conventional monomeric ligands. Additionally, I verified that this compound specifically targets GephEs receptor binding site, and that it thereby inhibits its receptor binding activity. Further development of this molecule may offer the possibility to specifically analyze the effect of uncoupling the gephyrin-receptor interaction in cell culture-based assays, without altering protein function or expression level that accompanies conventional methods such as protein knock-out, RNA interference or the usage of antibodies.
In this study we have investigated the possible role of c-Jun and it’s activation by the JNK pathway in neuronal cell death and in the inflammatory response of activated astrocytes. The first part of this thesis focuses on the role of site specific phosphorylation of c-Jun in neuronal cell death. The second part focuses on the function of c-Jun in LPS-mediated activation of Bergmann glia cells.
In the nervous system, activation of c-Jun transcription factor by different isoforms of c-Jun N-terminal kinase (JNK) functions in various cellular programs, including neurite outgrowth, repair and apoptosis. Yet, the regulatory mechanism underlying the functional dichotomy of c-Jun remains to be elucidated. Serine (S) 63/73 and threonine (T) 91/93 of c-Jun are the target phosphorylation sites for JNKs in response to various stimuli. Yet, these two groups of phosphorylation sites are differentially regulated in vivo, as the S63/73 sites are promptly phosphorylated upon JNK activation, whereas T91/93 phosphorylation requires a priming event at the adjacent T95 site. In our study, we used cerebellar granule cell (CGC) apoptosis by trophic/potassium (TK) deprivation as a model system to investigate the regulation and function of site-specific c-Jun phosphorylation at the S63 and T91/T93 JNK-sites in neuronal cell death. In this model system, JNK induces pro-apoptotic genes through the c-Jun/Ap-1 transcription factor. On the other side, a survival pathway initiated by lithium leads to repression of pro-apoptotic c-Jun/Ap-1 target genes without interfering with JNK activity. Yet, the mechanism by which lithium inhibits c-Jun activity remains to be elucidated. We found that TK-deprivation led to c-Jun phosphorylation at all three JNK sites. However, immunofluorescence analysis of c-Jun phosphorylation at single cell level revealed that the S63 site was phosphorylated in all c-Jun-expressing cells, whereas the response of T91/T93 phosphorylation was more sensitive, mirroring the switch-like apoptotic response of cerebellar granular cells (CGCs). Furthermore, we observed that lithium impaired c-Jun phosphorylation at T91/93, without interfering with S63/73 phosphorylation or JNK activation, suggesting that T91/T93 phosphorylation triggers c-Jun pro-apoptotic activity. Notably, expression of a c-Jun mutant lacking the T95-priming site for T91/93 phosphorylation (c-Jun A95) mimicked the effect of lithium on both cell death and c-Jun site-specific phosphorylation, whereas it was fully able to induce neurite outgrowth in naïve PC12 cells. Vice-versa, a c-Jun mutant bearing aspartate-substitution of T95 overwhelmed lithium-mediate protection of CGCs from TK-deprivation, validating that inhibition of T91/T93/T95 phosphorylation underlies the effect of lithium on cell death. Mass-spectrometry analysis confirmed that c-Jun is phosphorylation at T91/T93/T95 in cells. Moreover, recombinant-JNK phosphorylated c-Jun at T91/T93 in a T95-dependent manner. Based on our results, we propose that T91/T93/T95 phosphorylation of c-Jun functions as a sensitivity amplifier of the JNK cascade, setting the threshold for c-Jun pro-apoptotic activity in neuronal cells.
In the central nervous system (CNS), the c-Jun transcription factor has been mainly studied in neuronal cells and coupled to apoptotic and regenerative pathways following brain injury. Besides, several studies have shown a transcriptional role of c-Jun in activated cortical and spinal astrocytes. In contrast, little is known about c-Jun expression and activation in Bergmann glial (BG) cells, the radial cerebellar astrocytes playing crucial roles in cerebellar development and physiology. In this study, we used neuronal/glial cerebellar cultures from neonatal mice to assess putative functions of c-Jun in BG cells. By performing double immunocytochemical staining of c-Jun and two BG specific markers, S100 and GLAST, we observed that c-Jun was highly expressed in radial glial cells derived from Bergmann glia. Bergmann glia-derived cells expressed toll-like receptor (TLR 4) and treatment with bacterial lipopolysaccharide (Le et al.) induced c-Jun phosphorylation at S63, exclusively in BG cells. Moreover, LPS induced IL-1β expression and inhibition of JNK activity abolished both c-Jun phosphorylation and the increase of IL-1β mRNA. Notably, we also observed that LPS failed to induce IL-1β mRNA in neuronal/glial cerebellar cultures generated from conditional knockout mice lacking c-Jun expression in the CNS. These results indicate that c-Jun plays a central role in c-Jun in astroglial-specific induction of IL-1β. Furthermore, we confirmed in vivo that c-Jun is expressed in BG cells, during the formation of the BG monolayer. Altogether, our finding underlines a putative role of c-Jun in astroglia-mediated neuroinflammatory dysfunctions of the cerebellum.
Thrombus formation at sites of vascular lesions is a dynamic process that requires a defined series of molecular events including the action of platelet adhesion/activation receptors, intracellular signal transduction, cytoskeletal rearrangements and activation of plasma coagulation factors. This process is essential to limit post-traumatic blood loss but may also contribute to acute thrombotic diseases such as myocardial infarction and stroke. With the help of genetically modified mice and the use of specific protein inhibitors and receptordepleting antibodies, the work presented in this thesis identified novel mechanisms underlying thrombus formation in hemostasis and thrombosis. In the first part of the study, it was shown that von Willebrand Factor (vWF) binding to glycoprotein (GP)Iba is critical for the formation of stable pathological thrombi at high shear rates, suggesting GPIba as an attractive pharmacological target for antithrombotic therapy. The subsequent analysis of recently generated phospholipase (PL)D1-deficient mice identified this enzyme, whose role in platelet function had been largely unknown, as a potential target protein downstream of GPIba. This was based on the finding that PLD1- deficient mice displayed severely defective GPIba-dependent thrombus stabilization under high shear conditions in vitro and in vivo without affecting normal hemostasis. The second part of the thesis characterizes the functional relevance of the immunoreceptor tyrosine-based activation motif (ITAM)-bearing collagen receptor GPVI and the recently identified hemITAM-coupled C-type lectin-like receptor 2 (CLEC-2) for in vivo thrombus formation. Genetic- and antibody-induced GPVI deficiency was found to similarly protect mice from arterial vessel occlusion in three different thrombosis models. These results confirmed GPVI as a promising antithrombotic target and revealed that antibody-treatment had no obvious off-target effects on platelet function. Similarly, immunodepletion of CLEC-2 by treating mice with the specific antibody INU1 resulted in markedly impaired thrombus growth and stabilization under flow in vitro and in vivo. Furthermore, it could be demonstrated that double-immunodepletion of GPVI and CLEC-2 resulted in severely decreased arterial thrombus formation accompanied by dramatically prolonged bleeding times. These data revealed an unexpected redundant function of the two receptors for in vivo thrombus formation and might have important implications for the potential development of anti-GPVI and anti-CLEC-2 antithrombotic agents. The third part of the thesis provides the first functional analysis of megakaryocyte- and platelet-specific RhoA knockout mice. RhoA-deficient mice displayed a defined signaling defect in platelet activation, leading to a profound protection from arterial thrombosis andand ischemic brain infarction, but at the same time also strongly increased bleeding times. These findings identified the GTPase as an important player for thrombus formation in hemostasis and thrombosis. Based on the previous proposal that the coagulation factor (F)XII might represent an ideal target for safe antithrombotic therapy without causing bleeding side effects, the last part of this thesis assesses the antithrombotic potential of the newly generated FXIIa inhibitor rHAInfestin- 4. It was found that rHA-Infestin-4 injection into mice resulted in virtually abolished arterial thrombus formation but no change in bleeding times. Moreover, rHA-Infestin-4 was similarly efficient in a murine model of ischemic stroke, suggesting that the inhibitor might be a promising agent for effective and safe therapy of cardio- and cerebrovascular diseases.
In their natural environment animals face complex and highly dynamic olfactory input. This requires fast and reliable processing of olfactory information, in vertebrates as well as invertebrates. Parallel processing has been shown to improve processing speed and power in other sensory systems like auditory or visual. In the olfactory system less is known about olfactory coding in general and parallel processing in particular. With its elaborated olfactory system and due to their specialized neuroanatomy, honeybees are well-suited model organism to study parallel olfactory processing. The honeybee possesses a unique neuronal architecture - a dual olfactory pathway. Two mirror-imaged output projection neuron (PN) pathways connect the first olfactory processing stage, the antennal lobe (analog to the vertebrates olfactory bulb, OB), with the second, the mushroom body (MB) known to be involved in orientation and learning and memory, and the lateral horn (LH). The medial antennal lobe-protocerebral tract (m-APT) first innervates the MB and thereafter the LH, while the other, the lateral-APT (l-APT) projects in opposite direction. The neuroanatomy and evolution of these pathways has been analyzed, yet little is known about its physiology. To analyze the function of the dual olfactory pathway a new established recording method was designed and is described in the first chapter of this thesis (multi-unit-recordings). This is now the first time where odor response from several PNs of both tracts is recorded simultaneously and with high temporal precision. In the second chapter the PN odor responses are analyzed. The major findings are: both tracts responded to all tested odors but with differing characteristics. Since recent studies describe the input to the two tracts being rather similar, the results now indicate differential odor processing along the tracts, therefore this is a good indicator for parallel processing. PNs of the m-APT process odors in a sparse manner with delayed response latencies, but with high odor-specificity. PNs of the l-APT in contrast respond to several odor stimuli and respond in general faster. In some PN originating from both tracts, characteristics of odor-identity coding via response latencies were found. Analyzing the over-all dynamic range of the PNs both l- and m-APT PNs were tested over a large odor concentration range (10-6 to 10-2) (3. chapter). The PNs responded with linear and non-linear correlation of the response strength to the odor concentration. In most cases the l-APT is comparatively more sensitive to low odor concentrations. Response latency decreases with increasing odor concentration in both tracts. Alternative coding principles and elaboration on the hypothesis whether the dual olfactory pathway may contribute coincidental innervation to the next higher-order neurons, the Kenyon cells (KC), is subject of the 4. chapter. Cross-correlations and synchronous responses of both tracts show that in principle odors may be coded via temporal coding. Results suggest that odor processing is enhanced if both tracts contribute to olfactory coding together. In another project the distribution of the inhibitory neurotransmitter GABA (gamma-aminobutyric acid) was measured in the bee’s MB during adult maturation (5. chapter). GABAergic inhibition is of high importance in odor coding. An almost threefold decrease in the total amount of GABAergic innervation was found during adult maturation in the l- and m-APT target region, in particular at the change in division of labor during the transition from a young nurse bee to an older forager bee. The results fit well into the current understanding of brain development in the honeybee and other social insects during adult maturation, which was described as presynaptic pruning and KC dendritic outgrowth. Combining anatomical and functional properties of the bee’s dual olfactory pathway suggests that both rate and temporal coding are implemented along two parallel streams. Comparison with recent work on analog output pathways of the vertebrate’s OB indicates that parallel processing of olfactory information may be a common principle across distant taxa.
Scientific surveys provide sufficient evidence that anxiety disorders are one of the most common psy-chiatric disorders in the world. The lifetime prevalence rate of anxiety disorder is 28.8% (Kessler, et al., 2005). The most widely studied anxiety disorders are as follows panic disorder (PD), post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), social phobia (or social anxiety disorder), specific phobias, and generalized anxiety disorder (GAD). (NIMH Article, 2009). Classical conditioning is the stable paradigm used from the last one century to understand the neurobi-ology of fear learning. Neurobiological mechanism of fear learning is well documented with the condi-tioning studies. In the therapy of anxiety disorders, exposure based therapies are known to be the most effective approaches. Flooding is a form of exposure therapy in which a participant is exposed to the fear situation and kept in that situation until their fear dissipates. The exposure therapy is based on the phenomena of extinction; this means that a conditioned response diminishes if the conditioned stimulus (CS) is repeatedly presented without an unconditioned stimulus (UCS). One problem with extinction as well as with exposure-based therapy is the problem of fear return (for e.g. renewal, spontaneous recov-ery and reinstatement) after successful extinction. Therefore, extinction does not delete the fear memory trace. It has been well documented that memory processes can be modulated or disrupted using several sci-entific paradigms such as behavioral (for e.g. exposure therapy), pharmacological (for e.g. drug manipu-lation), non-invasive stimulation (for e.g. non-invasive stimulation such as electroconvulsive shock (ECS), transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), etc. However, modulation of memory processes after reactivation or via non-invasive stimulation is still not clear, which is the focus of the current study. In addition, study of genetic variant suggests that genetic differences play a vital role in the psychiatric disorder especially in fear learning. Hence, it is also one of the concerns of the current dissertation to investigate the interaction between gene and reconsolidation of memory. With respect to fear-conditioning, there are three findings in the current dissertation, which are as fol-lows: (i) In the first study we investigated that non-invasive weak electrical stimulation interferes with the consolidation process and disrupts the fear consolidation to attain stable form. This might offer an effective treatment in the pathological memories, for e.g. PTSD, PD, etc. (ii) In the second study we demonstrated whether a brief single presentation of the CS will inhibit the fear recovery. Like earlier studies we also found that reactivation followed by reconsolidation douses fear return. Attenuation of fear recovery was observed in the reminder group compared to the no-reminder group. (iii) Finally, in our third study we found a statistically significant role of brain derived neurotrophic factor (BDNF) polymorphism in reconsolidation. Results of the third study affirm the involvement of BDNF variants (Met vs. Val) in the modulation of conditioned fear memory after its reactivation. In summary, we were able to show in the current thesis modulation of associative learning and recon-solidation via transcranial direct current stimulation and genetic polymorphism.
Bone Morphogenetic Proteins (BMPs) are key regulators for a lot of diverse cellular processes. During embryonic development these proteins act as morphogens and play a crucial role particularly in organogenesis. BMPs have a direct impact on distinct cellular fates by means of concentration-gradients in the developing embryos. Using the diverse signaling input information within the embryo due to the gradient, the cells transduce the varying extracellular information into distinct gene expression profiles and cell fate decisions. Furthermore, BMP proteins bear important functions in adult organisms like tissue homeostasis or regeneration. In contrast to TGF-ß signaling, currently only little is known about how cells decode and quantify incoming BMP signals. There is poor knowledge about the quantitative relationships between signal input, transducing molecules, their states and location, and finally their ability to incorporate graded systemic inputs and produce qualitative responses. A key requirement for efficient pathway modulation is the complete comprehension of this signaling network on a quantitative level as the BMP signaling pathway, just like many other signaling pathways, is a major target for medicative interference. I therefore at first studied the subcellular distribution of Smad1, which is the main signal transducing protein of the BMP signaling pathway, in a quantitative manner and in response to various types and levels of stimuli in murine c2c12 cells. Results indicate that the subcellular localization of Smad1 is not dependent on the initial BMP input. Surprisingly, only the phospho-Smad1 level is proportionally associated to ligand concentration. Furthermore, the activated transducer proteins were entirely located in the nucleus. Besides the subcellular localization of Smad1, I have analyzed the gene expression profile induced by BMP signaling. Therefore, I examined two endogenous immediate early BMP targets as well as the expression of the stably transgenic Gaussia Luciferase. Interestingly, the results of these independent experimental setups and read-outs suggest oscillating target gene expression. The amplitudes of the oscillations showed a precise concentration-dependence for continuous and transient stimulation. Additionally, even short-time stimulation of 15’ activates oscillating gene-expression pulses that are detectable for at least 30h post-stimulation. Only treatment with a BMP type I receptor kinase inhibitor leads to the complete abolishment of the target gene expression. This indicated that target gene expression oscillations depend directly on BMP type I receptor kinase activity.
Dilated cardiomyopathy (DCM) represents an important subgroup of patients suffering from heart failure. The disease is supposed to be associated with autoimmune mechanisms in about one third of the cases. In the latter patients functionally active conformational autoantibodies directed against the second extracellular loop of the β1-adrenergic receptor (AR, β1ECII-aabs) have been detected. Such antibodies chronically stimulate the β1-AR thereby inducing the adrenergic signaling cascade in cardiomyocytes, which, in the long run, contributes to heart failure progression. We analyzed the production of cAMP after aab-mediated β1-AR activation in vitro using a fluorescence resonance energy transfer (FRET) assay. This assay is based on HEK293 cells stably expressing human β1-AR as well as the cAMP-sensor Epac1-camps. The assay showed a concentration-dependent increase in intracellular cAMP upon stimulation with the full agonist (-) isoproterenol. This response was comparable to results obtained in isolated adult murine cardiomyocytes and was partially blockable by a selective β1-AR antagonist. In the same assay poly- and monoclonal anti-β1ECII-abs (induced in different animals) could activate the adrenergic signaling cascade, whereas isotypic control abs had no effect on intracellular cAMP levels. Using the same method, we were able to detect functionally activating aabs in the serum of heart failure patients with ischemic and hypertensive heart disease as well as patients with DCM, but not in sera of healthy control subjects. In patients with DCM we observed an inverse correlation between the stimulatory potential of anti-β1-aabs and left ventricular pump function. To adopt this assay for the detection of functionally activating anti-β1ECII-aabs in clinical routine we attempted to establish an automated large-scale approach. Neither flow cytometry nor FRET detection with a fluorescence plate reader provided an acceptable signal-to-noise ratio. It was possible to detect (-) isoproterenol in a concentration-dependent manner using two different FRET multiwell microscopes. However, due to focus problems large-scale detection of activating anti-β1ECII-abs could not be implemented. Neutralization of anti-β1-aabs with the corresponding epitope-mimicking peptides is a possible therapeutic approach to treat aab-associated autoimmune DCM. Using our FRET assay we could demonstrate a reduction in the stimulatory potential of anti-β1ECII-abs after in vitro incubation with β1ECII-mimicking peptides. Cyclic (and to a lesser extent linear) peptides in 40-fold molar excess acted as efficient ab-scavengers in vitro. Intravenously injected cyclic peptides in a rat model of DCM also neutralized functionally active anti-β1ECII-abs efficiently in vivo. For a detailed analysis of the receptor-epitope targeted by anti-β1ECII-abs we used sequentially alanine-mutated β1ECII-mimicking cyclic peptides. Our data revealed that the disulfide bridge between the cysteine residues C209 and C215 of the human β1-AR appears essential for the formation of the ab-epitope. Substitution of further amino acids relevant for ab-binding in the cyclic scavenger peptide by alanine reduced its affinity to the ab and the receptor-activating potential was blocked less efficiently. In contrast, the non-mutant cyclic peptide almost completely blocked ab-induced receptor activation. Using this ala-scan approach we were able to identify a “NDPK”-epitope as essential for ab binding to the β1ECII. In summary, neutralization of conformational activating anti-β1ECII-(a)abs by cyclic peptides is a plausible therapeutic concept in heart failure that should be further exploited based on the here presented data.
Das Signal-zu-Rausch-Verhältnis (SNR) stellt bei modernen Bildgebungstechniken in der Magnetresonanz-Tomographie heutzutage oftmals die entscheidende Limitation dar. Eine Verbesserung durch Modifikation der Hardware ist kostspielig und führt meistens zu einer Verstärkung anderer Probleme, wie zum Beispiel erhöhte Energiedeposition ins Gewebe. Im Gegensatz dazu ist Dichtegewichtung eine Methode, die eine SNR-Erhöhung durch Modifikation der Aufnahmetechnik ermöglicht. In der MR-Bildgebung erfolgt oftmals eine retrospektive Filterung des aufgenommenen Signalverlaufs, beispielsweise zur Artefaktreduktion. Damit einhergehend findet eine Veränderung der Modulationstransferfunktion (MTF) bzw. ihrer Fouriertransformierten, der räumlichen Antwortfunktion (SRF), statt. Optimales SNR wird nach dem Matched Filter-Theorem erzielt, wenn die nachträgliche Filterung dem aufgenommenen Signalverlauf proportional ist. Dies steht dem Ziel der Artefaktreduktion entgegen. Bei Dichtegewichtung steht durch nicht-kartesische Abtastung des k-Raums mit der k-Raum-Dichte ein zusätzlicher Freiheitsgrad zur Verfügung. Dieser ermöglicht es, im Falle eines konstanten Signalverlaufs eine gewünschte MTF ohne Filterung zu erreichen. Bei veränderlichem Signalverlauf kann ein SNR Matched Filter angewendet werden, dessen negative Einflüsse auf die MTF durch Dichtegewichtung kompensiert werden. Somit ermöglicht Dichtegewichtung eine vorgegebene MTF und gleichzeitig ein optimales SNR. In der vorliegenden Arbeit wurde Dichtegewichtung erstmals bei den schnellen Multi-Echo-Sequenzen Turbo-Spin-Echo und Echoplanar-Bildgebung (EPI) angewendet. Im Gegensatz zu bisherigen Implementierungen muss hier der Signalabfall durch T2- bzw. T2*-Relaxation berücksichtigt werden. Dies führt dazu, dass eine prospektiv berechnete dichtegewichtete Verteilung nur bei einer Relaxationszeit optimal ist. Bei Geweben mit abweichenden Relaxationszeiten können sich wie auch bei den kartesischen Varianten dieser Sequenzen Änderungen an SRF und SNR ergeben. Bei dichtegewichteter Turbo-Spin-Echo-Bildgebung des Gehirns konnte mit den gewählten Sequenzparametern ein SNR-Vorteil von 43 % gegenüber der kartesischen Variante erzielt werden. Die Akquisition wurde dabei auf die T2-Relaxationszeit von weißer Substanz optimiert. Da die meisten Gewebe im Gehirn eine ähnliche Relaxationszeit aufweisen, blieb der visuelle Gesamteindruck identisch zur kartesischen Bildgebung. Der SNR-Gewinn konnte in der dichtegewichteten Implementierung zur Messzeithalbierung genutzt werden. Dichtegewichtete EPI weist eine hohe Anfälligkeit für geometrische Verzerrungen, welche durch Inhomogenitäten des Hauptmagnetfeldes verursacht werden, auf. Die Verzerrungen konnten erfolgreich mit einer Conjugate Phase-Methode korrigiert werden. Dazu muss die räumliche Verteilung der Feldinhomogenitäten bekannt sein. Dazu ist zusätzlich zur eigentlichen EPI-Aufnahme die zeitaufwendige Aufnahme einer sogenannten Fieldmap erforderlich. Im Rahmen dieser Arbeit konnte eine Methode entwickelt werden, welche die zur Erlangung einer Fieldmap notwendige Aufnahmedauer auf wenige Sekunden reduziert. Bei dieser Art der Fieldmap-Aufnahme müssen jedoch durch Atmung hervorgerufene Effekte auf die Bildphase berücksichtigt werden. Die Fieldmap-Genauigkeit kann durch Aufnahme unter Atempause, Mittelung oder retrospektiver Phasenkorrektur erhöht werden. Für die gewählten EPI-Sequenzparameter wurde mit Dichtegewichtung gegenüber der kartesischen Variante ein SNR-Gewinn von 14 % erzielt. Anhand einer funktionellen MRT (fMRI)-Fingertapping-Studie konnte demonstriert werden, dass die SNR-Steigerung auch zu einer signifikant erhöhten Aktivierungsdetektion in Teilen der Hirnareale führt, die bei der Fingerbewegung involviert sind. Die Verwendung von zusätzlicher EPI-Phasenkorrektur und iterativer Optimierung der dichtegewichteten k-Raum-Abtastung führt zu weiteren Verbesserungen der dichtegewichteten Bildgebung mit Multi-Echo-Sequenzen.
Stimulatory or superagonistic (SA) CD28-specific monoclonal antibodies (mAbs) are potent polyclonal activators of regulatory T cells and have proven highly effective as treatment in a wide range of rodent models for autoimmune and inflammatory diseases. In these models, a preferential activation of regulatory T cells was observed by in vivo administration of CD28SA. In stark contrast, human volunteers receiving TGN1412, a humanized CD28-specific mAb, experienced a life-threatening cytokine release syndrome during the first-in-man trial. Preclinical tests employing human peripheral blood mononuclear cells (PBMC) failed to announce the rapid cytokine release measured in the human volunteers in response to TGN1412. The aim of this thesis project was to find an explanation of why standard PBMC assays failed to predict the unexpected TGN1412-induced "cytokine storm" observed in human volunteers. CD28 superagonists can activate T cells without T cell receptor (TCR) ligation. They do depend, however, on “tonic” TCR signals received by MHC scanning, signals that they amplify. PBMC do not receive these signals in the circulation. Short-term in vitro preculture of human PBMC at a high cell density (HDC) resulted in massive cytokine release during subsequent TGN1412 stimulation. Restoration of reactivity was cell-contact dependent, associated with TCR polarization and tyrosine-phosphorylation, and blocked by HLA-specific mAb. In HDC, both CD4 T cells and monocytes functionally mature in a mutually dependent fashion. However, only CD4 memory T-cells proliferate upon TGN1412 stimulation, and were identified as the main source of pro-inflammatory cytokines. Importantly, responses to other T-cell activating agents were also enhanced if PBMC were first allowed to interact under tissue-like conditions. A new in vitro protocol is provided that returns circulating T-cells to a tissue-like status where they respond to TGN1412 stimulation, and it might represent a more reliable preclinical in vitro test for both activating and inhibitory immunomodulatory drugs. Finally, the surprising observation was made that the IgG1 “sibling” of TGN1412, which is of the poorly Fc receptor-binding IgG4 isotype, has a much lower stimulatory activity. We could exclude steric hindrance as an explanation and provide evidence for removal of TGN1112 from the T-cell surface by trans-endocytosis.
b-adrenergic receptors (b-ARs) participate strongly in the development of cardiac hypertrophy and human heart failure. Stimulation of b-adrenergic receptors with catecholamines as well as cardiac overexpression of b1-ARs or of Gas-proteins in transgenic mice induces cardiac hypertrophy. However, direct activation of their downstream targets, such as adenylyl cyclase (AC) or protein kinase A do not promote a significant degree of cardiac hypertrophy. These findings suggest that additional events may occur and that these events require Gas-protein activation. A hypertrophic pathway involving Gaq-protein coupled receptors has recently been described. Upon activation of Gaq-coupled receptors Gbg-subunits are released from Gaq and bind directly to the activated Raf/Mek/Erk cascade. Direct interaction between bg-subunits and activated Erk1/2 leads to an additional autophosphorylation of Erk2 at threonine 188, which mediates cardiac hypertrophy. Murine hearts, as well as isolated cardiomyocytes present an increase in Erk2Thr188-phosphorylation upon b-AR activation. Similarly overexpression of phosphorylation deficient Erk2 mutants (Erk2T188S and Erk2T188A) reduces b-AR mediated cardiomyocyte hypertrophy. Increase in left ventricular wall thickness, fibrosis and up-regulation of natriuretic peptide synthesis, which are physiological features for cardiac hypertrophy, are strongly inhibited in transgenic mice with a cardiac expression of Erk2T188S after two weeks of sustained isoproterenol treatment. It could further be shown in this work that b-AR mediated cardiac hypertrophy requires two distinct pathways initiated by Gs-protein activation: the canonical phosphorylation of Erk1/2 via adenylyl cyclase and the direct interaction of released bg-subunits with activated Erk1/2. Coincidence of both events leads to Erk2Thr188-phosphorylation, which activates then different transcription factors responsible for cardiac hypertrophy. Sequestration of bg-subunits by overexpression of the C-terminus of GRK2 bark-ct and inhibition of adenylyl cyclase efficiently reduced the hypertrophic response to isoproterenol, whereas direct activation of AC by forskolin failed to induce Erk2Thr188-phosphorylation and cardiomyocyte hypertrophy. These findings may help to develop new therapeutic strategies for the prevention of cardiac hypertrophy and maladaptive remodeling of the heart.
Platelet activation and aggregation are essential to limit posttraumatic blood loss at sites of vascular injury, but also contribute to arterial thrombosis, leading to myocardial infarction and stroke. Thrombus formation is the result of well-defined molecular events, including agonist-induced elevation of intracellular calcium ([Ca2+]i) and series of cytoskeletal rearrangements. With the help of genetically modified mice, the work presented in this thesis identified novel mechanisms underlying the process of platelet activation in hemostasis and thrombosis. Store-operated calcium entry (SOCE) through Orai1 was previously shown to be the main Ca2+ influx pathway in murine platelets. The residual Ca2+ entry in the Orai1 deficient platelets suggested a role for additional non-store-operated Ca2+ (non-SOC) and receptor operated Ca2+ entry (ROCE) in maintaining platelet calcium homeostasis. Canonical transient receptor potential channel 6 (TRPC6), which is expressed in both human and murine platelets, has been attributed to be involved in SOCE as well as in diacylglycerol (DAG)-triggered ROCE. In the first part of the study, the function of TRPC6 in platelet Ca2+ signaling and activation was analyzed by using the TRPC6 knockout mice. In vitro agonist induced Ca2+ responses and in vivo platelet function were unaltered in Trpc6-/- mice. However, Trpc6-/- mice displayed a completely abolished DAG mediated Ca2+-influx but a normal SOCE. These findings identified TRPC6 as the major DAG operated ROC channel in murine platelets, but DAG mediated ROCE has no major functional relevance for hemostasis and thrombosis. In the second part of the thesis, the involvement of the PDLIM family member CLP36 in the signaling pathway of the major platelet collagen receptor glycoprotein (GP) VI was investigated. The GPVI/FcR-chain complex initiates platelet activation through a series of tyrosine phosphorylation events downstream of the FcR-chain-associated immunoreceptor tyrosine-based activation motif (ITAM). GPVI signaling has to be tightly regulated to prevent uncontrolled intravascular platelet activation, but the underlying mechanisms are not fully understood. The present study reports the adaptor protein CLP36 as a major inhibitor of GPVI-ITAM signaling in platelets. Platelets from mice expressing a truncated form of CLP36, (Clp36ΔLIM) and platelets from mice lacking the entire protein (Clp36-/-) displayed profound hyper-activation in response to GPVI-specific agonists, whereas GPCR signaling pathways remained unaffected. These alterations translated into accelerated thrombus formation and enhanced pro-coagulant activity of Clp36ΔLIM platelets and a pro-thrombotic phenotype in vivo. These studies revealed an unexpected inhibitory function of CLP36 in GPVI-ITAM signaling and established it as a key regulator of arterial thrombosis.
Objective: Brain Computer Interfaces (BCI) provide a muscle independent interaction channel making them particularly valuable for individuals with severe motor impairment. Thus, different BCI systems and applications have been proposed as assistive technology (AT) solutions for such patients. The most prominent system for communication utilizes event-related potentials (ERP) obtained from the electroencephalogram (EEG) to allow for communication on a character-by-character basis. Yet in their current state of technology, daily life use cases of such systems are rare. In addition to the high EEG preparation effort, one of the main reasons is the low information throughput compared to other existing AT solutions. Furthermore, when testing BCI systems in patients, a performance drop is usually observed compared to healthy users. Patients often display a low signal-to-noise ratio of the recorded EEG and detection of brain responses may be aggravated due to internally (e.g. spasm) or externally induced artifacts (e.g. from ventilation devices). Consequently, practical BCI systems need to cope with mani-fold inter-individual differences. Whilst these high demands lead to increasing complexity of the technology, daily life use of BCI systems requires straightforward setup including an easy-to-use graphical user interface that nonprofessionals can handle without expert support. Research questions of this thesis: This dissertation project aimed at bringing forward BCI technology toward a possible integration into end-users' daily life. Four basic research questions were addressed: (1) Can we identify performance predictors so that we can provide users with individual BCI solutions without the need of multiple, demanding testing sessions? (2) Can we provide complex BCI technology in an automated, user-friendly and easy-to-use manner, so that BCIs can be used without expert support at end-users' homes? (3) How can we account for and improve the low information transfer rates as compared to other existing assistive technology solutions? (4) How can we prevent the performance drop often seen when bringing BCI technology that was tested in healthy users to those with severe motor impairment? Results and discussion: (1) Heart rate variability (HRV) as an index of inhibitory control (i.e. the ability to allocate attention resources and inhibit distracting stimuli) was significantly related to ERP-BCI performance and accounted for almost 26% of variance. HRV is easy to assess from short heartbeat recordings and may thus serve as a performance predictor for ERP-BCIs. Due to missing software solutions for appropriate processing of artifacts in heartbeat data (electrocardiogram and inter-beat interval data), our own tool was developed that is available free of charge. To date, more than 100 researchers worldwide have requested the tool. Recently, a new version was developed and released together with a website (www.artiifact.de). (2) Furthermore, a study of this thesis demonstrated that BCI technology can be incorporated into easy-to-use software, including auto-calibration and predictive text entry. Naïve, healthy nonprofessionals were able to control the software without expert support and successfully spelled words using the auto-calibrated BCI. They reported that software handling was straightforward and that they would be able to explain the system to others. However, future research is required to study transfer of the results to patient samples. (3) The commonly used ERP-BCI paradigm was significantly improved. Instead of simply highlighting visually displayed characters as is usually done, pictures of famous faces were used as stimulus material. As a result, specific brain potentials involved in face recognition and face processing were elicited. The event-related EEG thus displayed an increased signal-to-noise ratio, which facilitated the detection of ERPs extremely well. Consequently, BCI performance was significantly increased. (4) The good results of this new face-flashing paradigm achieved with healthy participants transferred well to users with neurodegenerative disease. Using a face paradigm boosted information throughput. Importantly, two users who were highly inefficient with the commonly used paradigm displayed high accuracy when exposed to the face paradigm. The increased signal-to-noise ratio of the recorded EEG thus helped them to overcome their BCI inefficiency. Significance: The presented work at hand (1) successfully identified a physiological predictor of ERP-BCI performance, (2) proved the technology ready to be operated by naïve nonprofessionals without expert support, (3) significantly improved the commonly used spelling paradigm and (4) thereby displayed a way to effectively prevent BCI inefficiency in patients with neurodegenerative disease. Additionally, missing software solutions for appropriate handling of artifacts in heartbeat data encouraged development of our own software tool that is available to the research community free of charge. In sum, this thesis significantly improved current BCI technology and enhanced our understanding of physiological correlates of BCI performance.
Der Hitzeschock-Transkriptionsfaktor 1 (HSF1) als neues potenzielles Ziel im Multiplen Myelom
(2013)
Die evolutionär hoch konservierte Hitzeschock-Antwort (heat shock stress response, HSR) ermöglicht Zellen sich an Stresssituationen anzupassen und so dem programmierten Zelltod zu entgehen. Die Regulation der HSR unterliegt dem Hitzeschock-Transkriptionsfaktor 1 (HSF1), der nach einem Stress-Impuls umgehend die Synthese der Hitzeschock-Proteine (HSP) initiiert. Als molekulare Chaperone assistieren die HSP bei der Faltung und den intrazellulären Transport ihrer Klientenproteine und erhalten so die lebensnotwendigen zellulären Funktionen aufrecht. Während das HSF1/HSP-System vorteilhaft für normale Zellen ist, kann es aber auch den Prozess der malignen Transformation unterstützen. In verschiedenen Tumorentitäten wurde eine Abhängigkeit der malignen Zellen von HSP, vereinzelt auch von HSF1, beschrieben. Im multiplen Myelom (MM) stabilisieren HSP u.a. Klientenproteine in einem komplexen onkogenen Signalnetzwerk und erhalten so eine aberrante Signalweiterleitung aufrecht. Wegen dieser wichtigen Funktion ist die Inhibition der HSP (insbesondere HSP90) bereits ein therapeutischer Ansatzpunkt, der jedoch im MM noch nicht zu dem erhofften Erfolg führte. Darüber hinaus wurde beobachtet, dass es zu einer Induktion der HSP nach einer Behandlung mit neuen, antitumoralen Medikamenten (Proteasom-, HDAC- und HSP90-Inhibitoren) kommt. Diese kompensatorische Hochregulation der HSP ist assoziiert mit einem Resistenzverhalten gegenüber der Therapie und ist somit unerwünscht. Die bisherigen Untersuchungen legen aber auch nahe, dass HSF1 selbst eine wichtige Funktion bei der malignen Transformation einnimmt. So wurde gezeigt, dass der funktionelle Verlust von HSF1 vor der onkogenen Ras oder mutierten Trp53 getriebenen Tumorigenese schützt. In der vorliegenden Arbeit wurden daher die Expression von HSF1, seine Rolle in der HSP-Regulierung und den Beitrag zum Überleben und Resistenzen in MM-Zellen analysiert. Untersuchungen der HSF1-Expression in Knochenmarkbiopsien von Myelompatienten und in Myelomzelllinien zeigten, dass in ca. 50 % der untersuchten Biopsien und Zelllinien eine hohe HSF1-Expression vorhanden ist. Sowohl der shRNA-vermitteltem Knockdown von HSF1 als auch die pharmakologische Inhibition mit Triptolid induzierten Apoptose in MM-Zellen. Durch Microarrayanalysen nach shRNA-vermitteltem Knockdown und der anschließenden Verifikation über Western Blot konnte gezeigt werden, dass nach der HSF1-Depletion zahlreiche HSP (HSP90, HSP70, HSP40 and HSP27) vermindert exprimiert wurden. Einzelne Knockdown Experimente der HSP40 und HSP27 führten zu moderaten Zellsterben, so dass geschlussfolgert werden kann, dass die gleichzeitige Minderung multipler HSP, durch die Depletion von HSF1, zu einem summierten starken apoptotischen Effekt führt. In weiteren Studien stellte sich heraus, dass in MM-Zellen, trotz des deregulierten Systems und der aberrant hohen Expression der HSP, eine Stressantwort ausgelöst werden kann. Dies konnte durch den „klassischen“ Hitzschock und durch die Behandlung mit pharmakologischen Inhibitoren von HSP90 und des Proteasoms erreicht werden. Diese unerwünschte Reaktion auf Therapeutika wird vermutlich durch einen kompensatorischen Zellrettungsmechanismus ausgelöst, der zu Resistenzen gegenüber der Behandlung führen kann. Durch die Inhibition von HSF1 mit Triptolid und durch shRNA-vermitteltem Knockdown, konnte diese zelluläre Antwort unterbunden werden. Darüber hinaus führte die pharmakologische Inhibition von HSF1 in Kombination mit HSP90 (mit NVP-AUY922) oder Proteasom-Inhibition (mit Bortezomib) zu einem verstärkten apoptotischen Effekt in MM-Zellen. Zusammenfassend deuten diese Ergebnisse darauf hin, dass HSF1 essenziell für die Regulation der HSP im MM ist. Darüber hinaus kann die Inhibition von HSF1, besonders in Kombination mit HSP90- oder Proteasom-Inhibition, eine neue hoffnungsvolle Therapieoption für Myelompatienten darstellen.
The superfamily of G protein-coupled receptors (GPCR) regulates numerous physiological and pathophysiological processes. Hence GPCRs are of significant interest for pharmacological therapy. Embedded into cytoplasmic membranes, GPCRs represent the core of large signaling complexes, which are critical for transduction of exogenous stimuli towards activation of downstream signaling pathways. As a member of the GPCR family B, the parathyroid hormone receptor (PTHR) activates adenylyl cyclases, phospholipases C β as well as mitogen-activated protein kinase-dependent signaling pathways, thereby mediating endocrine and paracrine effects of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP), respectively. This regulates, calcium homeostasis, bone metabolism and bone development. Paradoxically, PTH is able to induce both catabolic and anabolic bone metabolism. The anabolic effect of PTH is successfully applied in the therapy of severe osteoporosis. Domination of anabolic or catabolic bone-metabolism is entailed by temporal and cell-type specific determinants. The molecular bases are presumably differential arrangements of adaptor proteins within large signaling complexes that may lead to differential activation of signaling pathways, thereby regulating physiological effects. The molecular mechanisms are largely unclear; thus, there is significant interest in revealing a better understanding of PTHR-related adaptor proteins. To identify novel adaptor proteins which direct PTHR signaling pathways, a proteomic screening approach was developed. In this screening, vav2, a guanine-nucleotide exchange factor (GEF) for small GTPases which regulates cytoskeleton reorganization, was found to interact with intracellular domains of PTHR. Evidence is provided that vav2 impairs PTH-mediated phospholipase C β (PLCβ) signaling pathways by competitive interactions with G protein αq subunits. Vice versa, PTH was shown to regulate phosphorylation and subsequent GEF activity of vav2. These findings may thus shed new light on the molecular mechanisms underlying the effects of PTH on bone metabolism by PLC-signaling, cell migration and cytoskeleton organization. In addition to the understanding of intracellular molecular signaling processes, screening for ligands is a fundamental and demanding prerequisite for modern drug development. To this end, ligand binding assays represent a fundamental technique. As a substitution for expensive and potentially harmful radioligand binding, fluorescence-based ligand-binding assays for PTHR were developed in this work. Based on time-resolved fluorescence, several assay variants were established to facilitate drug development for the PTHR.
Der Catechol-O-Methyltransferase (COMT) Val158Met Polymorphismus (rs4680) ist am Abbau von Dopamin und Noradrenalin im menschlichen Gehirn beteiligt. In bisherigen Studien konnte gezeigt werden, dass das Met-Allel mit einer erhöhten Reaktivität auf negative Stimuli assoziiert ist. Auf Basis der Tonischen/ Phasischen Dopaminhypothese wird postuliert, dass diese erhöhte Reaktivität auf negative Reize durch defizitäre Disengagementprozesse verursacht sein könnte. Das Ziel dieser Arbeit war es daher, diese theoretische Annahme mithilfe von Blickbewegungsmessungen zu überprüfen und zu untersuchen, ob die erhöhte Reaktivität sich auch in verlängerten Disengagementlatenzen von negativen Reizen widerspiegelt. Es wurden dafür drei Studien durchgeführt, in denen eine adaptierte Version der emotionalen Antisakkadenaufgabe in Verbindung mit einer Blickbewegungsmessung eingesetzt wurde. In der zweiten Studie wurde zusätzlich eine EEG-Messung durchgeführt. Außerdem wurde in der dritten Studie die Aufmerksamkeitslokation manipuliert. In der ersten und zweiten Studie zeigte sich nicht wie erwartet ein linearer Effekt in Relation zum COMT Val158Met Polymorphismus, sondern ein Heterosiseffekt. Dieser Effekt zeigte sich nur in der einfacheren Prosakkadenbedingung. In der ersten Studie wurde der Heterosiseffekt bei negativen Reizen gefunden, wohingegen in der zweiten Studie der Heterosiseffekt nur in einer EEG- Komponente, der Early Posterior Negativity (EPN), aber sowohl bei positiven als auch negativen Reizen gefunden wurde. In der dritten Studie zeigte sich kein Genotypeffekt. Es wird vermutet, dass der COMT Effekt in der emotionalen Verarbeitung aufgabenspezifisch sein könnte und daher, neben linearen Zusammenhängen, unter bestimmten Umständen auch ein Heterosiseffekt auftreten kann. Die Ergebnisse sollten nicht auf eine männliche Stichprobe generalisiert werden, da in allen Studien lediglich weibliche Versuchspersonen teilnahmen.
Serotonin (5-HT) has been implicated in the regulation of emotions as well as in its pathological states, such as anxiety disorders and depression. Mice with targeted deletion of genes encoding various mediators of central serotonergic neurotransmission therefore provides a powerful tool in understanding contributions of such mediators to homeostatic mechanisms as well as to the development of human emotional disorders. Within this thesis a battery of electrophysiological recordings were conducted in the dorsal raphe nucleus (DRN) and the hippocampus of two murine knockout lines with deficient serotonergic systems. Serotonin transporter knockout mice (5-Htt KO), which lack protein responsible for reuptake of 5-HT from the extracellular space and tryptophan hydroxylase 2 knockout (Tph2 KO) mice, which lack the gene encoding the neuronal 5-HT-synthesising enzyme. First, 5-HT1A receptor-mediated autoinhibition of serotonergic neuron firing in the DRN was assessed using the loose-seal cell-attached configuration. Stimulation of 5-HT1A receptors by a selective agonist, R-8-hydroxy-2-(di-n-propylamino)tetralin (R-8-OH-DPAT), showed a mild sensitisation and a marked desensitisation of these receptors in Tph2 KO and 5-Htt KO mice, respectively. While application of tryptophan, a precursor of 5-HT and a substrate of Tph2, did not cause autoinhibition in Tph2 KO mice due to the lack of endogenously produced 5-HT, data from 5-Htt KO mice as well as heterozygous mice of both KO mice lines demonstrated the presence of autoinhibitory mechanisms as normal as seen in wildtype (WT) controls. When the Tph2-dependent step in the 5-HT synthesis pathway was bypassed by application of 5-hydroxytryptophan (5-HTP), serotonergic neurons of both Tph2 KO and 5-Htt KO mice showed decrease in firing rates at lower concentrations of 5-HTP than in WT controls. Elevated responsiveness of serotonergic neurons from Tph2 KO mice correspond to mild sensitisation of 5-HT1A receptors, while responses from 5-Htt KO mice suggest that excess levels of extracellular 5-HT, created by the lack of 5-Htt, stimulates 5-HT1A receptors strong enough to overcome desensitisation of these receptors. Second, the whole-cell patch clamp recording data from serotonergic neurons in the DRN showed no differences in basic electrophysiological properties between Tph2 KO and WT mice, except lower membrane resistances of neurons from KO mice. Moreover, the whole-cell patch clamp recording from CA1 pyramidal neurons in the hippocampus of 5-Htt KO mice showed increased conductance both at a steady state and at action potential generation. Lastly, magnitude of long-term potentiation (LTP) induced by the Schaffer collateral/commissural pathway stimulation in the ventral hippocampus showed no differences among Tph2 KO, 5-Htt KO, and WT counterparts. Taken together, lack and excess of extracellular 5-HT caused sensitisation and desensitisation of autoinhibitory 5-HT1A receptors, respectively. However, this may not directly translate to the level of autoinhibitory regulation of serotonergic neuron firing when these receptors are stimulated by endogenously synthesised 5-HT. In general, KO mice studied here showed an astonishing level of resilience to genetic manipulations of the central serotonergic system, maintaining overall electrophysiological properties and normal LTP inducibility. This may further suggest existence of as-yet-unknown compensatory mechanisms buffering potential alterations induced by genetic manipulations.
Nitrogen-regulated pathogenesis describes the expression of virulence attributes as direct response to the quantity and quality of an available nitrogen source. As consequence of nitrogen availability, the opportunistic human fungal pathogen Candida albicans changes its morphology and secretes aspartic proteases [SAPs], both well characterized virulence attributes. C. albicans, contrarily to its normally non-pathogenic relative Saccharomyces cerevisiae, is able to utilize proteins, which are considered as abundant and important nitrogen source within the human host. To assimilate complex proteinaceous matter, extracellular proteolysis is followed by uptake of the degradation products through dedicated peptide transporters (di-/tripeptide transporters [PTRs] and oligopeptide transporters [OPTs]). The expression of both traits is transcriptionally controlled by Stp1 - the global regulator of protein utilization - in C. albicans. The aim of the present study was to elucidate the regulation of virulence attributes of the pathogenic fungus C. albicans by nitrogen availability in more detail. Within a genome wide binding profile of Stp1, during growth with proteins, more than 600 Stp1 target genes were identified, thereby confirming its role in the usage of proteins, but also other nitrogenous compounds as nitrogen source. Moreover, the revealed targets suggest an involvement of Stp1 in the general adaption to nutrient availability as well as in the environmental stress response. With the focus on protein utilization and nitrogen-regulated pathogenesis, the regulation of the major secreted aspartic protease Sap2 - additionally one of the prime examples of allelic heterogeneity in C. albicans - was investigated in detail. Thereby, the heterogezygous SAP2 promoter helped to identify an unintended genomic alteration as the true cause of a growth defect of a C. albicans mutant. Additionally, the promoter region, which was responsible for the differential activation of the SAP2 alleles, was delimited. Furthermore, general Sap2 induction was demonstrated to be mediated by distinct cis-acting elements that are required for a high or a low activity of SAP2 expression. For the utilization of proteins as nitrogen source it is also crucial to take up the peptides that are produced by extracellular proteolysis. Therefore, the function and importance of specific peptide transporters was investigated in C. albicans mutants, unable to use peptides as nitrogen source (opt1Δ/Δ opt2Δ/Δ opt3Δ/Δ opt4Δ/Δ opt5Δ/Δ ptr2Δ/Δ ptr22Δ/Δ septuple null mutants). The overexpression of individual transporters in these mutants revealed differential substrate specificities and expanded the specificity of the OPTs to dipeptides, a completely new facet of these transporters. The peptide-uptake deficient mutants were further used to elucidate, whether indeed proteins and peptides are an important in vivo nitrogen source for C. albicans. It was found that during competitive colonization of the mouse intestine these mutants exhibited wild-type fitness, indicating that neither proteins nor peptides are primary nitrogen sources required to efficiently support growth of C. albicans in the mouse gut. Adequate availability of the preferred nitrogen source ammonium represses the utilization of proteins and other alternative nitrogen sources, but also the expression of virulence attributes, like Sap secretion and nitrogen-starvation induced filamentation. In order to discriminate, whether ammonium availability is externally sensed or determined inside the cell by C. albicans, the response to exterior ammonium concentrations of ammonium-uptake deficient mutants (mep1Δ/Δ mep2Δ/Δ null mutants) was investigated. This study showed that presence of an otherwise suppressing ammonium concentration did not inhibit Sap2 proteases secretion and arginine-induced filamentation in these mutants. Conclusively, ammonium availability is primarily determined inside the cell in order to control the expression of virulence traits. In sum, the present work contributes to the current understanding of how C. albicans regulates expression of virulence-associated traits in response to the presence of available nitrogen sources - especially proteins and peptides - in order to adapt its lifestyle within a human host.
Toleranz gegenüber Selbstantigenen in den peripheren Geweben kann durch CD4+ CD25+ Foxp3+ regulatorische T-Zellen (Tregs) vermittelt werden. Diese Zellen entstehen entweder in Folge der thymischen T-Zellselektion (natürlich vorkommende Tregs, nTreg) oder durch Konversion aus naiven T-Zellen in den peripheren lymphatischen Organen (induzierte Tregs, iTregs). Im Vorfeld der Arbeit war bereits bekannt, dass Dendritische Zellen (DZ) eine wichtige Rolle bei der Generierung von iTreg spielen. Allerdings bestand weitestgehend Unklarheit darüber, welche DZ in welchem Reifungszustand dazu in der Lage sind, iTregs gegen peripher-exprimierte Selbstantigene zu induzieren. Steady-state migratorische DZ (ssmDZ) gelten in dieser Hinsicht als potentielle Kandidaten, da bekannt ist, dass diese DZ bereits unter homöostatischen Bedingungen Selbstantigene aus peripheren Geweben in die drainierenden Lymphknoten transportieren und dort T-Zellen präsentieren können. Ein Ziel der vorliegenden Arbeit war daher, den Phänotyp und die tolerogene Kapazität der ssmDZ in den hautdrainierenden Lymphknoten näher zu untersuchen. Es konnte gezeigt werden, dass ssmDZ einen semireifen MHC IIint CD40hi CD80/CD86int CCR7+ Phänotyp aufweisen und in vitro mit Hilfe von endogenem TGF-β iTregs induzieren können. Darüber hinaus belegt diese Arbeit zusammen mit weiteren Daten aus unserer Arbeitsgruppe, dass ssmDZ in transgenen K5mOVA-Mäusen zellassoziertes epidermales OVA aus der Haut in die drainierenden Lymphknoten transportieren und dort an CD4+ OVA-spezifische TZR-transgene OT-II T-Zellen präsentieren können. Innerhalb der ssmDZ konnten die Langerin+ dermalen DZ als die DZ-Subpopulation eingegrenzt werden, die für die Konversion von naiven OT-II T-Zellen in CD4+ CD25+ Foxp3+ iTregs verantwortlich war. Ferner zeigte sich, dass CD103 nicht als Marker für ssmDZ in den hautdrainierenden Lymphknoten herangezogen werden kann. Ein weiteres Ziel dieser Arbeit war, herauszufinden, welchen Einfluss der Transkriptionsfaktor RelB auf die partielle Reifung und Migration der ssmDZ hat. RelB ist ein Mitglied der NF-κB-Familie und wird mit der Reifung von DZ in Verbindung gebracht. Erste Experimente zeigten eine nukleäre Translokation von RelB in ssmDZ sowie eine verringerte Frequenz dieser DZ in den hautdrainierenden Lymphknoten von relB+/- Mäusen und Mäusen mit einer Defizienz für den RelB-Bindungspartner p52. Allerdings konnte bei Mäusen mit einer DZ-spezifischen RelB-Inaktivierung (RelBDCko Mäuse) eine erhöhte Frequenz an ssmDZ in den hautdrainierenden Lymphknoten festgestellt, die nicht auf einer Zunahme an DZ in der Haut der Tiere zurückzuführen war. Diese Ergebnisse legen einerseits die Vermutung nahe, dass es sich bei den beobachteten Effekte in den relB+/- Mäusen um DZ-extrinsische Auswirkungen auf die ssmDZ handelt. Andererseits scheint RelB unter homöostatischen Bedingungen die Erhaltung und Migration der ssmDZ eher negativ zu beeinflussen. Weitere durchflusszytometrische Analysen wiesen zudem darauf hin, dass RelB in ssmDZ die Expression von Reifungsmarkern nur partiell reguliert. So konnte auf den ssmDZ in den hautdrainierenden Lymphknoten von RelBDCko Mäusen eine erhöhte Expression von CD40 beobachtet werden, während andere Reifungsmarker wie MHC II, CD80 und CD86 nicht signifikant in ihrer Expression betroffen waren. Im Rahmen dieser Arbeit wurde zudem untersucht, wie sich eine RelB-Defizienz in DZ auf die Homöostase und Induktion von Tregs auswirkt. Die hierzu analysierten RelBDCko Mäuse wiesen eine erhöhte Frequenz und absolute Zellzahl an Tregs in allen untersuchten lymphatischen Organen (hautdrainierende Lymphknoten, Milz und Thymus) auf. Darüber hinaus war in diesen Organen auch eine verstärkte Proliferation der Tregs gegenüber den Kontrolltieren festzustellen. Weitere Untersuchungen zeigten, dass die Proliferation der Tregs in RelBDCko Mäusen in den hautdrainierenden Lymphknoten sogar stärker ausfiel als in der Milz. RelB scheint somit die tolerogene Kapazität der DZ zur Regulation der Treg-Expansion im Thymus und in der Peripherie zu beeinflussen. Unter Verwendung von neutralisierenden αIL-2-Antikörpern konnte zudem belegt werden, dass die periphere Proliferation der Tregs in den RelBDCko Mäusen von IL-2 abhängig ist. Damit einhergehend zeigten erste Vorversuche eine erhöhte IL-2-Produktion in den peripheren lymphatischen Organen von RelBDCko Mäusen. Zusammenfassend legen die Daten dieser Arbeit den Schluss nahe, dass ssmDZ in den hautdrainierenden Lymphknoten in der Lage sind, Toleranz durch Induktion von iTregs gegen epidermale Selbstantigene zu induzieren. Untersuchungen an neuartigen Mäusen mit einer konditionalen RelB-Inaktivierung spezifisch in DZ deuten darauf hin, dass die Migration und Reifung von ssmDZ partiell durch RelB reguliert wird. Da Tregs eine Schlüsselrolle bei der Erhaltung der peripheren Toleranz einnehmen, ist die Beobachtung, dass eine RelB-Defizienz in allen DZ zu einer verstärkten Treg-Proliferation und somit zu einer veränderten Treg-Homöostase führt, ein intererssanter Ausgangspunkt für weitere Untersuchungen.
Der Hefepilz Candida albicans gehört zu den opportunistischen Infektionserregern. Er ist Teil der natürlichen Mikroflora der Schleimhäute des Gastrointestinal- und Urogenitaltraktes des Menschen. Bei Störungen des natürlichen Gleichgewichts dieser Flora kann es zu oberflächlichen Mykosen, z. B. der oropharyngealen Candidiasis (Mundsoor), kommen. Besonders immunsupprimierte Patienten, wie AIDS-Patienten, leiden häufig unter immer wiederkehrenden Infektionen, die mitunter auch zu schwerwiegenden Infektionsverläufen, bis hin zu lebensbedrohlichen systemischen Mykosen führen können. Zur Therapie solcher Erkrankungen werden oft Ergosterolbiosyntheseinhibitoren, wie Fluconazol, eingesetzt. Besonders bei wiederkehrenden Infektionen und wiederholender Therapie ist C. albicans in der Lage, gegen diese häufig verabreichten Antimykotika Resistenzen zu entwickeln. Hierbei spielen Zink-Cluster-Transkriptionsfaktoren eine zentrale Rolle. Zink-Cluster-Proteine gehören zu einer pilzspezifischen Familie von Transkriptionsfaktoren, die ein großes Spektrum an zellulären Prozessen regulieren. Die gut charakterisierten Regulatoren Upc2, Tac1 und Mrr1 gehören zu den Zink-Cluster-Transkriptionsfaktoren, die maßgeblich zur Resistenzentwicklung von C. albicans beitragen. Upc2 kontrolliert die Expression vieler Ergosterolbiosynthesegene, besonders die von ERG11, welches für die Zielstruktur des gängigen Antimykotikums Fluconazol kodiert. Tac1 und Mrr1 hingegen regulieren die Expression von Multidrug-Effluxpumpen, den ABC-Transportern CDR1 und CDR2 bzw. dem Major Facilitator MDR1. Gain-of-function-Mutationen in diesen Transkriptionsfaktoren resultieren in einer konstitutiven Überexpression ihrer Zielgene und sind verantwortlich für die Resistenz vieler klinischer Isolate. In dieser Arbeit wurde gezeigt, dass die Fusion von Mrr1 mit der Gal4-Aktivierungsdomäne von Saccharomyces cerevisiae zu einem konstitutiv aktiven Hybridtranskriptionsfaktor führte, der eine MDR1-Überexpression bewirkte und Fluconazolresistenz vermittelte. Dieses Hybridprotein vermittelte sogar eine höhere Resistenz als ein Mrr1 mit natürlich vorkommenden gain-of-function-Mutationen. Analoge Fusionen mit Tac1 und Upc2 resultierten ebenfalls in einer konstitutiven Aktivierung dieser Transkriptionsfaktoren, die einen starken Anstieg der Fluconazolresistenz zur Folge hatte. Daraus ergab sich die Schlussfolgerung, dass dies eine generelle Methode sein könnte, die Zink-Cluster-Transkriptionsfaktoren künstlich zu aktivieren und so ihre biologischen Funktionen zu offenbaren, ohne die genauen Bedingungen für ihre Aktivität zu kennen. Deshalb wurde auf der Basis dieser Strategie eine Bibliothek von C.-albicans-Stämmen konstruiert, in der alle 82 putativen Zink-Cluster-Transkriptionsfaktoren in dieser möglicherweise hyperaktiven Form exprimiert werden. Untersuchungen dieser Bibliothek offenbarten neue Transkriptionsfaktoren, die Fluconazolresistenz vermittelten, aber auch noch unbekannte Regulatoren der Morphogenese und andere Phänotypen konnten beobachtet werden. Um einen tieferen Einblick in die Funktionsweise zu bekommen, wurden die Transkriptionsprofile der vier Transkriptionsfaktoren ermittelt, die in ihrer hyperaktiven Form die höchste Fluconazolresistenz bewirkten. Dabei stellte sich heraus, dass die zwei künstlich aktivierten (*) Regulatoren ZCF34* und ZNC1* die Expression der wichtigsten Multidrug-Effluxpumpe CDR1 stark hochregulierten. Der Transkriptionsfaktor mit dem vorläufigen Namen ZCF34 konnte im Verlauf dieser Arbeit als ein wichtiger Regulator für die CDR1-Expression identifiziert werden. Er ist sowohl an der Aktivierung der Expression von CDR1 beteiligt als auch für die basale CDR1-Promotoraktivität notwendig. Aus diesem Grund wurde er in MRR2 (multidrug resistance regulator 2) umbenannt. Mit der Entdeckung eines neuen Regulators der wichtigsten Multidrug-Effluxpumpe von C. albicans wurde ein wichtiger Beitrag zum Verständnis der Regulation solcher Transporter geleistet. Die Überexpression dieser Pumpen ist einer der häufigsten Resistenzmechanismen in C. albicans. Auf diesem Wege kann Resistenz gegen strukturell völlig unterschiedliche Antimykotika bewirkt werden. Somit stellen sowohl diese Effluxpumpen, als auch deren Regulatoren mögliche Angriffsziele für die Entwicklung neuer oder Weiterentwicklung bereits vorhandener Antimykotika dar.
Attention-Deficit/Hyperactivity Disorder (ADHD) endophenotypes as a link between phenotype and genotype were the focus of the present work. Candidate endophenotypes were investigated via neuropsychological tasks during the simultaneous recording of a 21-channel electroencephalogram. Since endophenotypes are assumed to more closely reflect genetic variation, the influence of ADHD-associated genes Catechol-O-methyl transferase (COMT), the dopamine transporter (DAT, SLC6A3) and Latrophilin-3 (LPHN3) was analysed. Response inhibition was assessed with a cued Continuous Performance Test, for working memory we used an n-back task, sensory gating was measured via the paired clicks paradigm and response time variability (RTV) was quantified by the standard deviation of reaction times. The sample comprised medicated (N=36) and unmedicated (N=42) ADHD patients and matched control children and adolescents (N=41). The electrophysiological correlate of response inhibition was the centroid location during response execution and inhibition, and the degree of anteriorization (NGA). Sensory gating reflects the attenuation of the P50 response to the second of two auditory stimuli presented in short succession. Working memory was examined during target and non-target trials, reflecting specific information processing stages: early sensory processing (P100 and N100), selection of material (P150), memory retrieval (N300), event categorization (P300) and updating of working memory content (P450). Performance was quantified in terms of omission errors reflecting inattention and false alarms reflecting impulsivity, as well as speed and variability of reactions. Unmedicated ADHD patients had more omission errors and more variable reaction times, pointing to difficulties with attention and state regulation. NGA did not prove an optimal endophenotype candidate, since it was not yet developed in approximately half of the examined children and adolescents. It was independent of diagnosis; however ADHD risk alleles for DAT conferred lower NGA as well as more variable reaction times across groups. DAT genotype interacted with diagnosis on the level of centroid location, however, it did not manifest in performance deficits. In the case of sensory gating, homozygosity for the DAT allele associated with ADHD (10R) conferred impairment. ADHD was only relevant in participants without genetic risk, where patients without medication struggled most with suppression. In the working memory task, DAT modulated the timing of material selection in interaction with cognitive load and diagnosis: under high load unmedicated patients showed delayed responses, while under low load risk carriers on medication had faster responses than controls. Early processing and event-categorization were stronger in unmedicated ADHD with risk genotype, but dampened without risk. An interesting trend emerged for LPHN3, where carrying all risk variants was associated with higher NGA in ADHD patients irrespective of medication. This warrants further study, as the haplotype also exerts a positive influence on sensory gating specifically in patients. At the same time within the genetic risk group, unmedicated patients had the weakest NGA. However, the LPHN3 risk haplotype effected more posterior Go centroids, putatively facilitating response execution, which is supported by a higher number of false alarms. When inhibition was required, the risk variants led to more posterior centroids in unmedicated compared to medicated patients as well as controls, speaking to differences in inhibition-related brain activation. While as expected the risk haplotype led to compromised gating in unmedicated ADHD, this was reversed in healthy controls where the haplotype was acting in a protective manner with enhanced filtering. During working memory operations, the risk haplotype showed stronger N300 responses suggesting investment of more resources. While COMT did not exert an influence on NGA directly, carriers of the risk allele (met) had more posterior centroids both during response execution and inhibition, and displayed more variable responses in addition to being more prone to false alarms. Unmedicated patients produced smaller P300 during successful execution of responses than controls in absence of the risk allele, while with risk they had shorter latencies and presumably tend towards premature reactions. Additionally, it brought out impairments in sensory gating, thus making unmedicated patients less able to filter out irrelevant information, while they were able to compensate with the protective genotype. The influence of COMT on sensory gating seems to be specific for ADHD, as this gene was of no consequence in healthy controls. In the working memory task, met was beneficial for updating as reflected by P450 amplitude. In ADHD irrespective of medication COMT did not change P450 strength, but for controls this effect was observed.
The seed coat is the barrier controlling exchange of solutes between the plant embryo and its environment. This exchange is of importance for example in the uptake of germination inhibitors or in the uptake of agrochemicals applied as seed treatment. A thorough understanding of the basic mechanisms underlying solute permeation across the seed coat would help to improve the effectiveness of seed treatment formulations. In seed treatment formulations, additives can be used to enhance or decrease mobility or uptake of the active ingredient (AI). In the present study the seed coat barrier properties and the seed coat permeation process was examined with the model species Pisum sativum and with a set of model solutes. The lipophilic fraction of the seed coat was analysed by gas chromatography and mass spectrometry and it was found that the total lipophilic compartment of the seed coat represents 0.61 % of the weight of a swollen seed coat. The seed is covered by a lipophilic cuticle. The seed coat coverage with cuticular waxes is ten to 18-fold lower than wax coverage of pea leaves, though. In order to examine sorption of solutes in the small lipophilic compartment of the seed coat, seed coat/water partition coefficients were determined. These cover a much smaller range than the corresponding n-octanol/water partition coefficients. The lipophilic sorption compartment as calculated from the seed coat/water partition coefficient data is smaller than the analysed total lipophilic compartment of the seed coat since not all of the lipid components can act as sorption compartment. During seed swelling, the pea seed nearly doubles its weight. The uptake of water is driven by the very low water potential of the dry seed and controlled by the seed coat hydraulic conductivity both of which increase during seed swelling. Depending on the available form of water, water uptake can take place by diffusion from air humidity or by mass flow from liquid water. Water uptake by a seed in moist sand takes place by a combination of both uptake mechanisms. The basic transport mechanism underlying solute permeation of seed coats was analysed by steady-state experiments with a newly devised experimental setup. The permeance P for permeation of the set of model compounds across isolated seed coat halves ranged from 3.34 x 10-8 m s-1 for abamectin to 18.9 x 10-8 m s-1 for caffeine. It was found that solute permeation across the seed coat takes aqueous pathways. This was concluded from the facts that molar volume instead of lipophilicity of the solutes determine permeation and that the temperature effect on permeation is very small. This is in contrast to typical leaf and fruit cuticular uptake where lipophilic pathways dominate. Solute uptake across the seed coat can take place by two different mechanisms both of which take aqueous pathways. Uptake can be by diffusion and in the presence of a bulk flow of water driven by a water potential difference also by solvent drag. The presence of the solvent drag uptake mechanism shows that the aqueous pathways form an aqueous continuum across the seed coat. These findings indicate that the seed coat covering cuticle does not form a continuous barrier enclosing the seed. In order to examine solute uptake across the seed coat under conditions close to a situation taking place in the field, the process of uptake of a seed treatment AI in the field was simulated. In the situation of a treated seed in the field, the seed treatment residue dissolves and then the AI can move either into the surrounding soil or across the seed coat into the seed. Uptake across the seed coat can take place either by diffusion or during seed swelling by the solvent drag mechanism. Since the seed treatment residue depletes over time, non-steady-state uptake takes place. To simulate these processes, laboratory scale seed treatment methods were established to produce treated seeds and isolated treated seed coat halves. Experimental setups for non-steady-state uptake experiments were established with whole treated seeds and with isolated treated seed coat halves as simplified screening tool. By modelling of the AI uptake as a first-order process the rate constant k and the final relative uptake amount Mt→∞ M0-1 were obtained. With k and Mt→∞ M0-1 a quantification and comparison of the uptake curves was possible. Both in the experiments with whole treated seeds and with isolated treated seed coats, uptake of metalaxyl-M was much faster than uptake of sedaxane. In the uptake of a seed treatment AI, not only the solute's molar volume but also its water solubility determine uptake. The solute's water solubility is important for dissolution of the AI from the seed treatment residue and thus determines availability of the AI for uptake. Water solubility also controls the possible concentration in solution and thus the driving force for diffusive uptake. Furthermore, the AI amount taken up by solvent drag is determined by concentration in the inflowing water and thus by water solubility. In the experiments with whole treated seeds the additive effects on uptake were smaller than in the experiments with isolated treated seed coats or not significant. Adigor functions as an emulsifier and can lead to a slight increase of AI mobilisation from the seed treatment residue. NeoCryl A-2099 can cause a slowed down release of the AI from the seed treatment residue. The effects of both additives were smaller than the effect caused by different AI physico-chemical properties. Therefore, the most important factor determining uptake of a seed treatment AI are the AI's physico-chemical properties, especially its water solubility.
Melanoma is the most aggressive skin cancer with very limited treatment options. Upon appearance of metastases chemotherapeutics are used to either kill or slow down the growth of cancer cells by inducing apoptosis or senescence, respectively. With melanomas originating from melanocytes, it is vital to elucidate the mechanisms that distinguish senescence induction from proliferation and tumourigenicity. Xmrk (Xiphophorus melanoma receptor kinase), the fish orthologue of the human epidermal growth factor receptor (EGFR), causes highly aggressive melanoma in fish. Using an inducible variant, HERmrk, I showed that high receptor levels result in melanocyte senescence, whereas low and medium expression allows for cell proliferation and tumourigenicity. Mechanistically, HERmrk leads to increased reactive oxygen species (ROS) levels, which trigger a DNA damage response. Consequently, multinucleated, senescent cells develop by both endomitosis and fusion. Furthermore, oncogenic N‐RAS (N-‐RAS61K) induces a similar multinucleated phenotype in melanocytes. In addition, I found that both overexpression of C‐MYC and the knockdown of miz‐1 (Myc‐interacting zinc finger protein 1) diminished HERmrk‐induced senescence entry. C‐MYC prevent ROS induction, DNA damage and senescence, while acting synergistically with HERmrk in conveying tumourigenic features to melanocytes. Further analyses identified cystathionase (CTH) as a novel target gene of Myc and Miz-1 crucial for senescence prevention. CTH encodes an enzyme involved in the synthesis of cysteine from methionine, thereby allowing for increased ROS detoxification. Even though senescence was thought to be irreversible and hence tumour protective, I demonstrated that prolonged expression of the melanoma oncogene N‐RAS61K in pigment cells overcomes initial OIS by triggering the emergence of tumour‐initiating, mononucleated stem‐like cells from multinucleated senescent cells. This progeny is dedifferentiated, highly proliferative, anoikis‐resistant and induces fast‐growing, metastatic tumours upon transplantation into nude mice. Our data demonstrate that induction of OIS is not only a cellular failsafe mechanism, but also carries the potential to provide a source for highly aggressive, tumour‐initiating cells.
Investigation on Distinct Roles of Smad Proteins in Mediating Bone Morphogenetic Proteins Signals
(2011)
Bone morphogenetic proteins (BMPs) belong to the transforming growth factor-β (TGF-β) superfamily and play important roles in numerous biological events in the development of almost all multi-cellular organisms. Dysregulated BMP signaling is the underlying causes of numerous heritable and non-heritable human diseases including cancer. The vast range of biological responses induced by BMPs converges on three closely related Smad proteins that convey intracellular signals from BMP receptors to the nucleus. The specificity of BMP signaling has been intensively investigated at the level of ligand-receptor interactions, but how the different Smad proteins contribute to differential signals elicited by BMPs remains unclear. In this work, we investigated the BMP/Smad signaling in different aspects. In search for an appropriate fluorescence reporter in zebrafish, we compared different photo-switchable proteins and found EosFP the best candidate this model system for its fast maturation and fluorescence intensity. We modified and created appropriate vectors enabling Tol2-transposon based trangenesis in zebrafish, with which transgenic zebrafish lines were generated. We combined fluorescence protein tagging with high resolution microscopy and investigate the dynamics of Smad proteins in model system zebrafish. We observed that Smad5 undergoes nucleo-translocation as BMP signal transmitter during zebrafish gastrulation. We explored the Smad involvement during myogenic-to-osteogenic conversion of C2C12 cell line induced by BMP4. We created transient loss-of-function of Smads by siRNA-mediated knockdowns and analyzed the effects on these coupled yet distinct procedures by quantitative real-time PCR and terminal marker staining. We found that different Smad-complex stoichiometry might be responsible for distinct cellular signals elicited by BMPs.
Platelet activation and adhesion results in thrombus formation that is essential for normal hemostasis, but can also cause irreversible vessel occlusion leading to myocardial infarction or stroke. The C-type lectin-like receptor 2 (CLEC-2) was recently identified to be expressed on the platelet surface, however, a role for this receptor in hemostasis and thrombosis had not been demonstrated. In the current study, the involvement of CLEC-2 in platelet function and thrombus formation was investigated using mice as a model system. In the first part of the thesis, it was found that treatment of mice with a newly generated monoclonal antibody against murine CLEC-2 (INU1) led to the complete and highly specific loss of the receptor in circulating platelets (a process termed “immunodepletion”). CLEC-2-deficient platelets were completely unresponsive to the CLEC-2-specific agonist rhodocytin, whereas activation induced by all other tested agonists was unaltered. This selective defect translated into severely decreased platelet aggregate formation under flow ex vivo; and in vivo thrombosis models revealed impaired stabilization of formed thrombi with enhanced embolization. Consequently, CLEC-2 deficiency profoundly protected mice from occlusive arterial thrombus formation. Furthermore, variable bleeding times in INU1-treated mice indicated a moderate hemostatic defect. This reveals for the first time that CLEC-2 significantly contributes to thrombus stability in vitro and in vivo and plays a crucial role in hemostasis and arterial thrombosis. Thus, CLEC-2 represents a potential novel anti-thrombotic target that can be functionally inactivated in vivo. This in vivo down-regulation of platelet surface receptors might be a promising approach for future anti-thrombotic therapy. The second part of the work investigated the effect of double-immunodepletion of the immunoreceptor tyrosine-based activation motif (ITAM)- and hemITAM-coupled receptors, platelet glycoprotein (GP) VI and CLEC-2, on hemostasis and thrombosis using a combination of the GPVI- and CLEC-2-specific antibodies, JAQ1 and INU1, respectively. Isolated targeting of either GPVI or CLEC-2 in vivo did not affect expression or function of the respective other receptor. However, simultaneous treatment with both antibodies resulted in the sustained loss of GPVI and CLEC-2 signaling in platelets, while leaving other activation pathways intact. In contrast to single deficiency of either receptor, GPVI/CLEC-2 double-deficient mice displayed a dramatic hemostatic defect. Furthermore, this treatment resulted in profound impairment of arterial thrombus formation that far exceeded the effects seen in single-depleted animals. Importantly, similar results were obtained in Gp6-/- mice that were depleted of CLEC-2 by INU1-treatment, demonstrating that this severe bleeding phenotype was not caused by secondary effects of combined antibody treatment. These data suggest that GPVI and CLEC-2 can be independently or simultaneously down-regulated in platelets in vivo and reveal an unexpected functional redundancy of the two receptors in hemostasis and thrombosis. Since GPVI and CLEC-2 have intensively been discussed as potential anti-thrombotic targets, these results may have important implications for the development of novel, yet save anti-GPVI or anti-CLEC-2-based therapies.
Acute graft-versus-host disease (aGvHD) is an immune syndrome associated with allogeneic hematopoietic cell transplantation (allo-HCT) that is mediated by alloreactive donor T cells attacking the gastrointestinal tract, liver, and skin of the host. Early diagnosis remains problematic and to date mainly relies on clinical symptoms and histopathology. Previously, different groups demonstrated that in order to cause aGvHD, alloreactive T cells require the expression of appropriate homing receptors to efficiently migrate from their priming sites to their target tissues. Therefore, the development of a predictive test based on the homing receptor expression profile of peripheral blood T cells seems attractive to identify patients at risk before the onset of aGvHD. The aim of this study was to analyze migrating alloreactive donor T cell kinetics in the peripheral blood early after allo-HCT in a murine model across minor histocompatibility antigens (miHAg) followed by a precise characterization of the homing receptor expression profile of migrating donor lymphocytes in order to identify suitable predictive markers. Combining daily bioluminescence imaging (BLI) and flow cytometry (FC) allowed defining two weeks of massive alloreactive donor T cell migration before clinical aGvHD symptoms became apparent. Peripheral blood donor T lymphocytes highly up-regulated the homing markers α4β7 integrin, and P- and E-selectin-ligand at peak time points of cell migration. The combination with the activation markers CD25 and CD69 and low expression levels of L-selectin allowed alloreactive donor T cell definition. Based on this migration phase we postulated a potential diagnostic window to precisely identify alloreactive donor T cells upon their homing receptor expression profile. Consequently, targeted pre-emptive treatment with rapamycin starting at the earliest detection time point of alloreactive donor T cells in the peripheral blood (day+6) significantly prolonged survival of treated mice. Based on this data, we propose a potential diagnostic window for alloreactive cell detection based on their homing receptor expression profile for a timely and effective therapeutic intervention before the clinical manifestation of aGvHD.
Optical in vivo imaging methods have advanced the fields of stem cell transplantation, graft-versus–host disease and graft-versus-tumor responses. Two well known optical methods, based on the transmission of light through the test animal are bioluminescence imaging (BLI) and fluorescence imaging (FLI). Both methods allow whole body in vivo imaging of the same animal over an extended time span where the cell distribution and proliferation can be visualized. BLI has the advantages of producing almost no unspecific background signals and no necessity for external excitation light. Hence, BLI is a highly sensitive and reliable detection method. Yet, the BLI reporter luciferase is not applicable with common microscopy techniques, therefore abolishing this method for cellular resolution imaging. FLI in turn, presents the appealing possibility to use one fluorescent reporter for whole body imaging as well as cellular resolution applying microscopy techniques. The absorption of light occurs mainly due to melanin and hemoglobin in wavelengths up to 650 nm. Therefore, the wavelength range beyond 650 nm may allow sensitive optical imaging even in deep tissues. For this reason, significant efforts are undertaken to isolate or develop genetically enhanced fluorescent proteins (FP) in this spectral range. “Katushka” also called FP635 has an emission close to this favorable spectrum and is reported as one of the brightest far-red FPs. Our experiments also clearly showed the superiority of BLI for whole body imaging over FLI. Based on these results we applied the superior BLI technique for the establishment of a pre-clinical multiple myeloma (MM) mouse model. MM is a B-cell disease, where malignant plasma cells clonally expand in the bone marrow (BM) of older people, causing significant morbidity and mortality. Chromosomal abnormalities, considered a hallmark of MM, are present in nearly all patients and may accumulate or change during disease progression. The diagnosis of MM is based on clinical symptoms, including the CRAB criteria: increased serum calcium levels, renal insufficiency, anemia, and bone lesions (osteolytic lesions or osteoporosis with compression fractures). Other clinical symptoms include hyperviscosity, amyloidosis, and recurrent bacterial infections. Additionally, patients commonly exhibit more than 30% clonal BM plasma cells and the presence of monoclonal protein is detected in serum and/or urine. With current standard therapies, MM remains incurable and patients diagnosed with MM between 2001 and 2007 had a 5-year relative survival rate of only 41%. Therefore, the development of new drugs or immune cell-based therapies is desirable and necessary. To this end we developed the MOPC-315 cell line based syngeneic MM mouse model. MOPC-315 cells were labeled with luciferase for in vivo detection by BLI. We validated the non-invasively obtained BLI data with histopathology, measurement of idiotype IgA serum levels and flow cytometry. All methods affirmed the reliability of the in vivo BLI data for this model. We found that this orthotopic MM model reflects several key features of the human disease. MOPC-315 cells homed efficiently to the BM compartment including subsequent proliferation. Additionally, cells disseminated to distant skeletal parts, leading to the typical multifocal MM growth. Osteolytic lesions and bone remodeling was also detected. We found evidence that the cell line had retained plasticity seen by dynamic receptor expression regulation in different compartments such as the BM and the spleen.
Introduction: Colon cancer is one of the major human malignancies worldwide, and much effort has been applied to understand the process of colon carcinogenesis, as well as the role of potential treatments and co-therapeutical agents against it. A growing body of evidence suggests that the use of fluoxetine (FLX), an antidepressant belonging to the selective serotonin reuptake inhibitors (SSRIs), may be associated with a reduced colon cancer risk. However, controversial opinions have been published and an identification of the mechanisms of the activity of FLX on colon cells would help in the clarification of this controversy. Objectives: Using several in vitro and in vivo-based methods and analyses, we aimed to verify whether FLX has antioxidant, pro-oxidant or DNA-damaging potential in standard toxicological assays; to check whether and how FLX could prevent and reduce colon preneoplastic lesions; to ascertain whether FLX has any oncostatic potential against colon tumors; and, to investigate whether FLX activity could be comparable with a known and current applied chemotherapeutic agent against colon cancer. Results: FLX did not have any antioxidant potential in our experiments. Although it did not induce reactive oxygen species (ROS) generation or DNA-damage in fibroblast and colon tumor cell lines, FLX reduced dysplasia and proliferation in two different carcinogen models. Further, a significant decrease in colon stromal reactivity and angiogenesis was found in both carcinogen-induced preneoplasia models. In a xenograft model of colon cancer, FLX shrank tumors, reduced tumor proliferation, arrested cancer cells at the G0/G1 cell-cycle phase, and took ROS generation under control. Such effects were detected together with an intracellular acidification and loss of mitochondrial membrane potential in FLX-treated cells. Modulating mitochondrial respiratory chain, HIF-1 expression and Akt/mTOR signaling pathway, FLX was found to reduce colon tumors similar to the widely used chemotherapeutic agent 5-Fluoracil activity. Conclusion: Our collective data suggest that FLX is a remarkable chemopreventive and oncostatic agent against colon preneoplastic lesions and tumors, acting without DNA-damage or ROS generation.
Die komplexe Pathogenese von Angst und insbesondere der Panikstörung wird sowohl von genetischen Faktoren wie dem Adenosin A2A Rezeptorgen (ADORA2A) 1976T/C Polymorphismus (rs5751876) als auch von neuropsychologischen Faktoren wie einer verzerrten Emotionsverarbeitung und Defiziten in der frühen Informationsverarbeitung beeinflusst. Ziel der vorliegenden doppelblinden, Placebo-kontrollierten Studie war, ein mehrstufiges pathogenetisches Angstmodell zu etablieren, in dem der Einfluss von 300 mg Koffeinzitrat – einem Antagonisten am Adenosin A2A Rezeptor – versus Placebo 1) auf den emotionspotenzierten Startlereflex (negative, neutrale und positive Bilder aus dem International Affective Picture System (IAPS) sowie zusätzlich panikspezifisches Bildmaterial) an 115 gesunden Probanden (m = 57, w = 58) und 2) auf die frühe Informationsverarbeitung (Prepulse-Modifikation (PPM)-Paradigma mit Interstimulus Intervallen (ISI) von 60, 120, 240, 480 und 2000 ms) an vorwiegend derselben Stichprobe von 114 gesunden Probanden (m = 57, w = 57) getestet wurde. Die Probanden wurden dabei für die genetische ADORA2A 1976T/C Variante stratifiziert und mittels des Angstsensitivitäts-Index (ASI) für Angstsensitivität (AS) charakterisiert. Zusätzlich zum erwarteten Haupteffekt der Bildkategorien (höchste Startlemagnituden für negative, niedrigste für positive Bilder) konnte eine Genotyp X Intervention Interaktion auf die Bildkategorien beobachtet werden: Sowohl Trägerschaft des ADORA2A 1976TT Risikogenotyps unter Placebo als auch der Konsum von Koffein bei ADORA2A 1976CC/CT Nicht-Risikogenotypträgerschaft stellten ein Risiko für eine ähnliche, d.h. undifferenzierte physiologische Erregung in Antwort auf negative und neutrale Reize und damit womöglich für eine erhöhte Angstbereitschaft dar. In Übereinstimmung mit dem hypothetisierten multifaktoriellen Risikomodell potenzierte Koffein in Synergie mit dem ADORA2A 1976TT Risikogenotyp die Startlereaktion spezifisch für negative emotionale Reize. Dieser Effekt wurde maßgeblich durch eine hohe Angstsensitivität verursacht. Die höchsten Startlemagnituden nach Koffeineinnahme bei negativen Bildern zeigten sich insbesondere in der weiblichen Stichprobe. Bei panikspezifischen Bildern führte Koffein bei ADORA2A 1976CC/CT Nicht-Risikogenotypträgern dazu, dass im Vergleich zu Placebo weniger zwischen negativen und Panikbildern unterschieden wurde. Bei ADORA2A 1976TT Risikogenotypträgern ergaben sich bzgl. der panikspezifischen Bilder weder unter Koffein- noch unter Placebobedingungen Unterschiede. Bezüglich der frühen Informationsverarbeitung konnte eine Vierfachinteraktion zwischen Genotyp, Intervention, Geschlecht und ISI beobachtet werden. Eine Stratifikation nach ISI ergab, dass die Prepulse Inhibition (PPI) nach Koffeineinnahme für das ISI von 120 ms und von 240 ms bei weiblichen ADORA2A 1976TT Risikogenotypträgern im Vergleich zu männlichen ADORA2A 1976TT Homozygoten eingeschränkt war, während es keine signifikanten Effekte bei ADORA2A 1976CC/CT Nicht-Risikogenotypträgern oder in der Placebogruppe gab. Nur bei hoch ängstlichen Probanden konnte ein signifikanter Interventionseffekt mit verminderter Prepulse Fazilitation (PPF; ISI von 2000 ms) unter Koffein beobachtet werden. Unsere Ergebnisse weisen auf ein komplexes, mehrstufiges und potenziell geschlechtsspezifisches pathogenetisches Angstmodell hin, bei dem genetische und biochemische Faktoren interaktiv das Risiko für defizitäre emotionale Verarbeitungsprozesse und somit möglicherweise auch für Angststörungen erhöhen. Die Ergebnisse zeigen weiterhin, dass weibliche ADORA2A 1976TT Homozygote unter Koffein eine eingeschränkte Fähigkeit haben, irrelevante sensorische Informationen zu filtern, was die Rolle des adenosinergen Systems bei der Pathogenese von Angst zusätzlich stützt. Durch die Definition von multifaktoriellen Risikoprofilen für Angst und insbesondere die Panikstörung, wie in der vorliegenden Arbeit exemplarisch demonstriert, können in Zukunft Fortschritte in der individuellen Primär- und Sekundärprävention erzielt werden.
Upon synthesis, nascent polypeptide chains are subject to major rearrangements of their side chains to obtain an energetically more favorable conformation in a process called folding. About one third of all cellular proteins pass through the secretory pathway and undergo oxidative folding in the endoplasmic reticulum (ER). During oxidative folding, the conformational rearrangements are accompanied by the formation of disulfide bonds – covalent bonds between cysteine side chains that form upon oxidation. Protein disulfide isomerase (PDI) assists in the folding of substrates by catalyzing the oxidation of pairs of cysteine residues and the isomerization of disulfide bonds as well as by acting as chaperones. In addition to PDI itself, a family of related ER-resident proteins has formed. All PDI family members share the thioredoxin fold in at least one of their domains and exhibit a subset of the PDI activities. Despite many studies, the role of most PDI family members remains unclear. The project presented in this thesis was aimed to establish tools for the biochemical characterization of single members of the PDI family and their role in the folding process. A combination of fluorescence based assays was developed to selectively study single functions of PDI family members and relate their properties of either catalysis of oxidation or catalysis of isomerization or chaperone activity to the rest of the protein family. A binding assay using isothermal titration calorimetry (ITC) was established to complement the activity assays. Using ITC we could show for the first time that members of the PDI family can distinguish between folded and unfolded proteins selectively binding the latter. The unique information provided by this method also revealed a two-site binding of unfolded proteins by PDI itself. In addition to the functional characterization, experiments were conducted to further investigate the oligomeric state of PDI. We could show that the equilibrium between structurally different states of PDI is heavily influenced by the redox state of the protein and its environment. This new data could help to further our understanding of the interplay between oxidases like PDI and their regenerative enzymes like Ero1, which may be governed by structural changes in response to the change in redox status. Another structural approach was the screening of all investigated PDI family members for suitable crystallization conditions. As a result of this screening we could obtain protein crystals of human ERp27 and were able to solve the structure of this protein with X-ray crystallography. The structure gives insight into the mechanisms of substrate binding domains within the PDI family and helps to understand the interaction of ERp27 with the redox active ERp57. In collaboration with the group of Heike Hermanns we could further show the physiological importance of this interaction under oxidative stress. In conclusion, the project presented in this thesis provides novel tools for an extensive analysis of the activities of single PDI family members as well as a useful set of methods to characterize novel oxidoreductases and chaperones. The initial results obtained with the our novel methods are very promising. At the same time, the structural approach of this project could successfully solve the structure of a PDI family member and give information about the interplay within the PDI family.
Die MRT des Herzens wird aufgrund hoher Reproduzierbarkeit und geringer Variabilität als Referenzstandard für die Bestimmung der kardialen Funktion betrachtet. Auch in der präklinischen Forschung bietet die MRT eine ausgezeichnete Charakterisierung der kardialen Funktion und ermöglicht eine exzellente Analyse modellierter Krankheitsbilder. In beiden Fällen besteht jedoch weiterhin Optimierungsbedarf. Die klinische Herz-MRT stellt ein aufwendiges Verfahren mit relativ langer Messzeit dar und ist dadurch mit hohen Untersuchungskosten verbunden. In der präklinischen Kleintierbildgebung müssen zum Erreichen der notwendigen höheren Orts- und Zeitauflösung ebenfalls lange Aufnahmezeiten in Kauf genommen werden. Um die kardiale MRT dort routinemäßig in großen Studienkollektiven anwenden zu können, ist eine schnellere Bildgebung essentiell. Neben einer Verbesserung der Tomographen-Hardware und der Optimierung von Bildgebungssequenzen standen im letzten Jahrzehnt vermehrt informationstheoretische Ansätze zur Beschleunigung der MR-Datenakquisition im Fokus der Entwicklung. Während zu Beginn des Jahrtausends die Parallele Bildgebung (PI) einen Forschungsschwerpunkt repräsentierte, spielte sich in den letzten fünf Jahren vermehrt die von Donoho und Candès eingeführte Compressed Sensing (CS) Theorie in den Vordergrund. Diese ermöglicht eine Signalrekonstruktion aus unvollständig gemessenen Koeffizienten einer linearen Messung (z.B. Fouriermessung) unter Ausnutzung der Sparsität des Signals in einer beliebigen Transformationsbasis. Da sich die MRT hervorragend für den Einsatz von CS eignet, wurde die Technik in der Forschung bereits vielfach angewendet. Die zur Rekonstruktion unterabgetasteter Aufnahmen nötigen CS-Algorithmen haben jedoch eine signifikante Veränderung des Bildgebungsprozesses der MRT zur Folge. Konnte dieser zuvor in guter Näherung als linear und stationär betrachtet werden, so repräsentiert die CS-Rekonstruktion eine nichtlineare und nichtstationäre Transformation. Objektinformation wird nicht mehr ortsunabhängig und proportional zur Intensität in die Abbildung transportiert. Das Bild ist viel mehr das Ergebnis eines Optimierungsprozesses, der sowohl die Konsistenz gegenüber der unterabgetasteten Messung als auch die Sparsität des Signals maximiert. Der erste Teil dieser Dissertation beschreibt eine Methode, die eine objektive Einschätzung der Bildqualität CS-rekonstruierter MR-Bilder ermöglicht. Die CS-Beschleunigung verspricht eine Verkürzung der Messzeit ohne Verlust an Bildqualität, wobei letztere bisher größtenteils qualitativ bzw. quantitativ nur unzureichend beurteilt wurde. Konnte der Bildgebungsprozess der klassischen MRT (linear und stationär) durch die Bestimmung einer Punktspreizfunktion (PSF) robust und effektiv validiert und optimiert werden, erlauben die CS-Algorithmen aufgrund ihres nichtlinearen und nichtstationären Verhaltens ohne Weiteres keine äquivalente Analyse. Um dennoch eine entsprechende Evaluierung des CS-Bildgebungsprozesses zu ermöglichen, wurde die Anwendung einer lokalen Punktspreizfunktion (LPSF) für den in der Folge verwendeten Iterative Soft Thresholding Algorithmus untersucht. Die LPSF berücksichtigt die Ortsabhängigkeit der CS-Rekonstruktion und muss daher für jeden Ort (Pixel) eines Bildes bestimmt werden. Darüber hinaus wurde die LPSF im linearen Bereich der CS-Transformation ermittelt. Dazu wurde das zu bewertende Bild nach Anwenden einer kleinen lokalen Störung rekonstruiert. Die Breite des Hauptmaximums der LPSF wurde schließlich verwendet, um ortsaufgelöste Auflösungsstudien durchzuführen. Es wurde sowohl der Einfluss typischer Unterabtastschemata für CS als auch der Einsatz diskreter Gradienten zur Sparsifizierung eines Phantombildes untersucht. Anschließend wurde die Prozedur zur Bestimmung der räumlichen und zeitlichen Auflösung in der Herzbildgebung getestet. In allen Beispielen ermöglichte das vorgeschlagene Verfahren eine solide und objektive Analyse der Bildauflösung CS-rekonstruierter Aufnahmen. Wurde zuvor meist ausschließlich auf Vergleiche mit einer vollständig abgetasteten Referenz zur Qualitätsbeurteilung zurückgegriffen, so stellt die vorgestellte Auflösungsbestimmung einen Schritt in Richtung einer standardisierten Bildanalyse bei der Verwendung der Beschleunigung mittels CS dar. Die Analyse der Abtastmuster zeigte, dass auch bei der Anwendung von CS die Berücksichtigung der nominell höchsten Frequenzen k_max unerlässlich ist. Frühere Publikationen schlagen Abtastfolgen mit einer teils starken Gewichtung der Messpunkte zum k-Raum-Zentrum hin vor. Die Ergebnisse der vorliegenden Arbeit relativieren ein derartiges Vorgehen, da zumindest bei den durchgeführten Untersuchungen ein Auflösungsverlust bei analoger Vorgehensweise zu verzeichnen war. Ebenso zeigten sich dynamische Aufnahmen, die unter Verwendung des x-f-Raums als sparse Basis rekonstruiert wurden, durchaus anfällig für zeitliches Blurring. Dieses resultiert aus der Unterdrückung hoher zeitlicher Frequenzen und konnte durch die ortsaufgelösten Auflösungskarten sichtbar gemacht werden. Neben der Auflösung ist für eine umfassende Analyse der Bildqualität auch die Untersuchung potentieller Aliasing-Artefakte sowie des Signal-zu-Rausch-Verhältnisses (SNR) notwendig. Während Aliasing mit Hilfe der Einträge der LPSF außerhalb des Hauptmaximums untersucht werden kann, wurde in Kap. 5 eine Modifikation der Multi-Replika-Methode von Robson et al. zur Rauschanalyse bei Verwendung nichtlinearer Algorithmen vorgestellt. Unter Einbeziehung aller genannten Qualitätsparameter ist eine robuste Bewertung der Bildqualität auch bei einer Verwendung von CS möglich. Die differenzierte Evaluierung ebnet den Weg hin zu einem objektiven Vergleich neuer Entwicklungen mit bisherigen Standard-Techniken und kann dadurch den Einzug von CS in die klinische Anwendung vorantreiben. Nach den theoretischen Betrachtungen der Bildqualität behandelt die Dissertation die erstmalige Anwendung von CS zur Beschleunigung der funktionellen Herzdiagnostik in der präklinischen MR-Kleintierbildgebung. Diese Studien wurden in Zusammenarbeit mit der British Heart Foundation Experimental Magnetic Resonance Unit (BMRU) der University of Oxford durchgeführt. Die Algorithmen für eine Beschleunigung mittels der CS-Theorie wurden anhand der dort am 9,4T Tomographen gemessenen (unterabgetasteten) Datensätze entwickelt und optimiert. Zunächst wurde eine Beschleunigung ausschließlich mittels CS untersucht. Dazu wurde die segmentierte, EKG- und Atemgetriggerte kartesische Cine-Aufnahme in Phasenkodierrichtung unterabgetastet und mittels CS rekonstruiert. Die sparse Darstellung wurde durch Ermitteln zeitlicher Differenzbilder für jede Herzphase erhalten. Durch Variation der Abtastmuster in der zeitlichen Dimension konnte ein vollständig abgetastetes zeitliches Mittelbild bestimmt werden, das anschließend von jedem einzelnen Herzphasenbild subtrahiert wurde. In einer Validierungsphase wurden an der Maus vollständig aufgenommene Cine-Akquisitionen retrospektiv unterabgetastet, um die maximal mögliche Beschleunigung mittels CS zu ermitteln. Es wurden u.a. funktionelle Herz-Parameter für jede Gruppe des jeweiligen Beschleunigungsfaktors bestimmt und mittels einer statistischen Analyse verglichen. Die Gesamtheit aller Ergebnisse zeigte die Möglichkeit einer dreifachen Beschleunigung ohne eine Degradierung der Genauigkeit der Methode auf. Die ermittelte Maximalbeschleunigung wurde in einer unterabgetastet gemessenen Bilderserie mit anschließender CS-Rekonstruktion validiert. Die Abtastschemata wurden dazu mit Hilfe der Transformations-Punktspreizfunktion weiter optimiert. In einer Erweiterung der Studie wurde zum Zweck einer noch höheren Beschleunigung die CS-Technik mit der PI kombiniert. Erneut fand eine Unterabtastung der Phasenkodierrichtung einer kartesischen Trajektorie statt. Die Messungen erfolgten mit einer 8-Kanal-Mäusespule an einem 9,4T Tomographen. Um das Potential beider Beschleunigungstechniken auszunutzen, wurden die Methoden CS und PI in serieller Weise implementiert. Für die PI-Beschleunigung wurde der vollständig abgetastete k-Raum zunächst gleichmäßig unterabgetastet. Auf dem resultierenden Untergitter wurde zusätzlich eine Unterabtastung nach Pseudo-Zufallszahlen durchgeführt, um eine Beschleunigung mittels CS zu ermöglichen. Die entwickelte Rekonstruktion erfolgte ebenfalls seriell. Zunächst wurde mittels CS das äquidistante Untergitter rekonstruiert, um anschließend mittels GRAPPA die noch fehlenden Daten zu berechnen. Um eine zusätzliche Messung zur Kalibrierung der GRAPPA-Faktoren zu umgehen, wurde das äquidistant unterabgetastete Untergitter von Herzphase zu Herzphase um je einen Phasenkodierschritt weitergeschoben. Dieses Vorgehen erlaubt die Ermittlung eines vollständig abgetasteten k-Raums mit einer geringeren zeitlichen Auflösung, der die notwendige Bestimmung der Wichtungsfaktoren ermöglicht. Folgende Kombinationen von Beschleunigungsfaktoren wurden mittels retrospektiver Unterabtastung eines vollständig aufgenommenen Datensatzes untersucht: R_CS x R_PI = 2 x 2, 2 x 3, 3 x 2 und 3 x 3. Die Analyse des Bildrauschens, des systematischen Fehlers und der Auflösung führte zu dem Schluss, dass eine sechsfache Beschleunigung mit Hilfe der hybriden Rekonstruktionstechnik möglich ist. Während mit steigender CS-Beschleunigung der systematische Fehler leicht anstieg, führte ein höherer PI-Beschleunigungsfaktor zu einer leichten Verstärkung des statistischen Fehlers. Der statistische Fehler zeigte jedoch ebenfalls eine Verringerung bei steigender Beschleunigung mittels CS. Die Fehler waren allerdings stets auf einem Niveau, das durchaus auch Beschleunigungen bis R_CS x R_PI =3 x 3 zulässt. Die LPSF-Analyse zeigte einen Verlust der räumlichen Auflösung von ca. 50 % bei R=6 sowie einen mittleren Verlust von 64 % bei R=9. Offensichtlich ging die ebenfalls beobachtete Minimierung des Bildrauschens durch den CS-Algorithmus im Falle der relativ stark verrauschten Kleintieraufnahmen zu Lasten der Bildauflösung. Die mit zunehmender Beschleunigung stärker geblurrten Grenzen zwischen Blutpool und Myokardgewebe erschweren die Segmentierung und stellen eine mögliche Fehlerquelle dar. Unter Beachtung aller Ergebnisse ist eine sechsfache Beschleunigung (R_CS x R_PI = 2 x 3, 3 x 2) vertretbar. Die Hinzunahme der PI ermöglicht somit im Vergleich zur alleinigen Verwendung von CS eine weitere Beschleunigung um einen Faktor von zwei. Zusammenfassend ermöglicht der Einsatz von CS in der präklinischen funktionellen Herzbildgebung am Kleintier eine deutliche Reduktion der Messzeit. Bereits ohne Vorhandensein von Mehrkanalspulen kann die notwendige Datenmenge ohne signifikante Beeinflussung der Messergebnisse auf ein Drittel reduziert werden. Ist der Einsatz von Spulenarrays möglich, kann die mit PI mögliche dreifache Beschleunigung um einen weiteren Faktor zwei mittels CS auf R=6 erweitert werden. Dementsprechend kann CS einen wesentlichen Beitrag dazu leisten, dass das Potential Herz-MRT am Kleintier in großen Studienkollektiven effektiver abgerufen werden kann. Im letzten Teil der Arbeit wurde eine Technik für die funktionelle klinische MR-Herzbildgebung entwickelt. Hier wurde eine Beschleunigung mittels CS verwendet, um die Aufnahme des gesamten Herzens innerhalb eines Atemstillstandes des Patienten zu ermöglichen. Bei der derzeitigen Standardmethode werden üblicherweise 10-15 2D-Schichten des Herzens akquiriert, wobei jede einzelne Aufnahme einen Atemstillstand des Patienten erfordert. Für die notwendige Beschleunigung wurde eine unterabgetastete 3D-Trajektorie verwendet. Durch Phasenkodierung einer Richtung sowie radiale Projektionen in den beiden anderen Dimensionen konnte eine effiziente Aufnahme unterhalb des Nyquist-Kriteriums erreicht werden. Die Sparsifizierung erfolgte, wie bereits in der beschriebenen präklinischen Anwendung, durch die Subtraktion eines zeitlichen Mittelbildes. In einer Simulation anhand eines retrospektiv unterabgetasteten Datensatzes konnte die theoretische Funktionalität der Rekonstruktionstechnik bei einer Beschleunigung bezüglich der Nyquist-Abtastung von R ~ 10 validiert werden. Die Unterschiede zum vollständig abgetasteten Datensatz waren vernachlässigbar klein, so dass die vorgeschlagene Abtastfolge am Tomographen implementiert wurde. Mit dieser Sequenz wurde anschließend eine funktionelle Bilderserie an einem gesunden Probanden mit vollständiger Herzabdeckung innerhalb eines Atemstopps aufgenommen. Fehlende Daten wurden analog zur Simulation mit Hilfe des vorgeschlagenen Algorithmus rekonstruiert. Im Vergleich zur Simulation ergaben sich aufgrund des Schichtprofils der 3D-Slab-Anregung zusätzliche Aliasing-Artefakte in den äußeren Partitionen. Die für radiale Aufnahmen typischen Streifenartefakte waren im rekonstruierten Bild, wenn auch mit sehr geringer Amplitude, noch erkennbar. Davon abgesehen wurde die Dynamik jedoch über das gesamte Herz hinweg gut dargestellt. Der hohe Kontrast zwischen Myokard und Blutpool bescheinigt den Bildern eine hervorragende Eignung für die Bestimmung funktioneller Herzparameter mittels einer Segmentierung. Zusammengefasst erlaubt die entwickelte Methode aufgrund der drastischen Reduktion der notwendigen Atemstopps des Patienten einen deutlich erhöhten Patientenkomfort sowie einen schnelleren Durchsatz aufgrund der verkürzten Messzeit.
Platelet activation induces cytoskeletal rearrangements involving a change from discoid to spheric shape, secretion, and eventually adhesion and spreading on immobilized ligands. Small GTPases of the Rho family, such as Rac1 and Cdc42, are known to be involved in these processes by facilitating the formation of lamellipodia and filopodia, respectively. This thesis focuses on the role Rac1 and Cdc42 for platelet function and formation from their precursor cells, the megakaryocytes (MKs), using conditional knock-out mice. In the first part of the work, the involvement of Rac1 in the activation of the enzyme phospholipase (PL) C2 in the signaling pathway of the major platelet collagen receptor glycoprotein (GP) VI was investigated. It was found that Rac1 is essential for PLC2 activation independently of tyrosine phosphorylation of the enzyme, resulting in a specific platelet activation defect downstream of GPVI, whereas signaling of other activating receptors remains unaffected. Since Rac1-deficient mice were protected from arterial thrombosis in two different in vivo models, the GTPase might serve as a potential target for the development of new drugs for the treatment and prophylaxis of cardio- and cerebrovascular diseases. The second part of the thesis deals with the first characterization of MK- and platelet-specific Cdc42 knock-out mice. Cdc42-deficient mice displayed mild thrombo-cytopenia and platelet production from mutant MKs was markedly reduced. Unexpectedly, Cdc42-deficient platelets showed increased granule content and release upon activation, leading to accelerated thrombus formation in vitro and in vivo. Furthermore, Cdc42 was not generally required for filopodia formation upon platelet activation. Thus, these results indicate that Cdc42, unlike Rac1, is involved in multiple signaling pathways essential for proper platelet formation and function. Finally, the outcome of combined deletion of Rac1 and Cdc42 was studied. In contrast to single deficiency of either GTPase, platelet production from double-deficient MKs was virtually abrogated, resulting in dramatic macrothrombocytopenia in the animals. Formed platelets were largely non-functional leading to a severe hemostatic defect and defective thrombus formation in double-deficient mice in vivo. These results demonstrate for the first time a functional redundancy of Rac1 and Cdc42 in the hematopoietic system.
Das Y-Box-bindende Protein 1 (YB-1) ist ein Vertreter der hochkonservierten Familie eukaryotischer Kälteschockproteine und ein DNA/RNA-bindendes Protein. In Abhängigkeit von seiner Lokalisation übernimmt es Aufgaben bei der DNA-Transkription oder mRNA-Translation. YB-1 ist ein potentielles Onkogen beim Multiplen Myelom (MM), dass in primären MM-Zellen exprimiert ist. Für die funktionellen Untersuchungen von YB-1 in der vorliegenden Arbeit wurden humane Myelomzelllinien (HMZL) verwendet, die als in vitro Modell dieser malignen B Zell-Erkrankung dienen. Aufgrund der potentiellen Expression von YB-1 im Zellkern und/oder Zytoplasma von HMZL, wurde zunächst die Lokalisation des Proteins bestimmt. Es konnte gezeigt werden, dass YB 1 in den HMZL ausschließlich im Zytoplasma lokalisiert ist. Eine Translokation von YB-1 in den Nukleus kann durch die Serin-Phosphorylierung (Aminosäure 102) in der Kälteschockdomäne induziert werden. Die analysierten Myelomzelllinien zeigen jedoch kein nukleäres YB 1 und keine S102-Phosphorylierung. Diese Ergebnisse stützen die These, dass die Regulation der mRNA-Translation im Zytoplasma die vorherrschende Funktion von YB-1 beim MM ist. YB-1 könnte über diesen Mechanismus seine anti-apoptotische Wirkung vermitteln und die MM-Zellen vor genotoxischem Stress schützen. Um YB-1-regulierte mRNAs zu identifizieren wurden YB 1-Immunpräzipitationen mit zwei HMZL, einer Maus-Plasmozytomzelllinie und einem primären Maus-Plasmazelltumor durchgeführt. Zu den YB-1-gebundenen mRNAs gehören Translationsfaktoren und ribosomale Proteine, die eine starke Beteiligung von YB-1 beim RNA-Metabolismus bestätigen. In der vorliegenden Arbeit wurden spezifisch zwei mRNA-Kandidaten untersucht, die für den malignen Phänotyp von MM-Zellen wichtig sein können: das translationell kontrollierte Tumorprotein TCTP und MYC. Sowohl TCTP als auch MYC wurden bereits in Zusammenhang mit der Proliferation und Apoptose-Resistenz von malignen Zellen beschrieben. Die immunhistochemische Untersuchung der Knochenmarkbiopsien von MM-Patienten ergab eine gute Ko-Expression von YB-1 und TCTP in intramedullären MM-Zellen, während MYC erst in extramedullärem MM-Tumormaterial verstärkt mit der hohen YB 1-Expression korreliert. Die funktionellen Analysen der Arbeit haben gezeigt, dass YB 1 für die Translation der TCTP- und MYC-mRNA essentiell ist. Es kontrolliert die Verteilung dieser mRNAs zwischen translationell aktiven und inaktiven messenger Ribonukleoprotein-Partikeln. Die shRNA-vermittelte Reduktion von YB-1 führte zur Hemmung der TCTP- und MYC-Translation in der Phase der Initiation. Um den Einfluss der Kandidaten auf das Überleben der HMZL zu untersuchen, wurden proteinspezifische Knockdown-Experimente durchgeführt. Beim shRNA-vermittelten TCTP-Knockdown konnten keine Auswirkungen auf die Proliferation oder Viabilität von MM-Zellen beobachtet werden. Im Gegensatz dazu ist MYC für das Überleben und Wachstum der HMZL ausschlaggebend, denn der MYC-Knockdown induzierte Apoptose. Wie beim YB 1-Knockdown war ein Anstieg der Caspase-Aktivität und der Zusammenbruch des mitochondrialen Membranpotentials in den HMZL nachweisbar. Da es beim MYC-Knockdown gleichzeitig zur einer Reduktion der YB 1-Protein- und mRNA-Expression kam, wurde der Einfluss von MYC auf die Transkription des YB-1-Gens untersucht. Mit Hilfe von embryonalen Mausfibroblasten, die ein induzierbares MYC als Transgen besitzen, konnte gezeigt werden, dass die Aktivierung von MYC mit einer Zunahme der YB-1-mRNA einher geht. YB-1 ist somit ein direktes Zielgen des Transkriptionsfaktors MYC. Die Ergebnisse der vorliegenden Arbeit haben zum ersten Mal ein gegenseitiges regulatorisches Netzwerk aufgezeigt, in dem YB 1 transkriptionell durch MYC reguliert wird und YB-1 für die Translation der MYC-mRNA essentiell ist. Die Ko-Expression beider Proteine trägt zum Wachstum und Überleben von malignen Plasmazellen bei.
Effective T cell immunity was believed to occur by mature DC, whereas tolerogenicity was attributed strictly to immature DC phenotypes. However, intermediate DC maturation stages were identified conditioned by inflammatory mediators like TNF. Furthermore, the T cell tolerance mechanisms are dependent on distinct modes and intensities of co-stimulation. Therefore, in this study it was addressed how distinct DC maturation signatures instruct CD4+ T cell tolerance mechanisms. DC acquire antigens from apoptotic cells for self-peptide-MHC presentation and functionally adapt presumed tolerogenic DC phenotypes. Here, immature murine bone-marrow derived DC representing both inflammatory and conventional DC subsets adapted a maturationresistant DC signature upon apoptotic cell recognition but no additional tolerogenic features. Immature DC instruct CD4+ FoxP3+ regulatory T cells in a TGF-β prone micro-environment or generate anergic CD4+ T cells hampered in the TCR-induced proliferation and IL-2 secretion. Secondary stimulation of such anergic CD4+ T cells by immature DC increased primarily IL-10 production and conferred regulatory function. These IL-10+ regulatory T cells expressed high levels of CTLA-4, which is potently induced by immature DC in particular. Data in this work showed that anergic T cells can be re-programmed to become IL-10+ regulatory T cells upon ligation of CTLA-4 and CD28 signalling cascades by B7 costimulatory ligands on immature DC. In contrast, semi-mature DC phenotypes conditioned by the inflammatory mediator TNF prevented autoimmune disorders by induction of IL-10+ Th2 responses as demonstrated previously. Here, it was shown that TNF as an endogenous maturation stimulus and pathogenic Trypanosoma brucei variant-specific surface glycoproteins (VSG) induced highly similar DC gene expression signatures which instructed default effector Th2 responses. Repetitive administration of the differentially conditioned semi-mature DC effectively skewed T cell immunity to IL-10+ Th2 cells, mediating immune deviation and suppression. Collectively, the data presented in this work provide novel insights how immature and partially mature DC phenotypes generate T cell tolerance mechanisms in vitro, which has important implications for the design of effective DC-targeted vaccines. Unravelling the DC maturation signatures is central to the long-standing quest to break tolerance mimicked by malignant tumours or re-establish immune homeostasis in allergic or autoimmune disorders.
Imprinted genes play important roles in brain development. As the neural developmental capabilities of human parthenogenetic embryonic stem cells (hpESCs) with only a maternal genome were not assessed in great detail, hence here the potential of hpESCs to differentiate into various neural subtypes was determined. In addition DNA methylation and expression of imprinted genes upon neural differentiation was also investigated. The results demonstrated that hpESC-derived neural stem cells (hpNSCs) showed expression of NSC markers Sox1, Nestin, Pax6, and Musashi1 (MS1), the silencing of pluripotency genes (Oct4, Nanog) and the absence of activation of neural crest (Snai2, FoxD3) and mesodermal (Acta1) markers. Moreover, confocal images of hpNSC cultures exhibited ubiquitous expression of NSC markers Nestin, Sox1, Sox2 and Vimentin. Differentiating hpNSCs for 28 days generated neural subtypes with neural cell type-specific morphology and expression of neuronal and glial markers, including Tuj1, NeuN, Map2, GFAP, O4, Tau, Synapsin1 and GABA. hpNSCs also responded to region-specific differentiation signals and differentiated into regional phenotypes such as midbrain dopaminergic- and motoneuron-type cells. hpESC-derived neurons showed typical neuronal Na+/K+ currents in voltage clamp mode, elicited multiple action potentials with a maximum frequency of 30 Hz. Cell depicted a typical neuron-like current pattern that responded to selective pharmacological blockers of sodium (tetrodotoxin) and potassium (tetraethylammonium) channels. Furthermore, in hpESCs and hpNSCs the majority of CpGs of the differentially methylated regions (DMRs) KvDMR1 were methylated whereas DMR1 (H19/Igf2 locus) showed partial or complete absence of CpG methylation, which is consistent with a parthenogenetic (PG) origin. Upon differentiation parent-of-origin-specific gene expression was maintained in hpESCs and hpNSCs as demonstrated by imprinted gene expression analyses. Together this shows that despite the lack of a paternal genome, hpNSCs are proficient in differentiating into glial- and neuron-type cells, which exhibit electrical activity similar to newly formed neurons. Moreover, maternal-specific gene expression and imprinting-specific DNA-methylation are largely maintained upon neural differentiation. hpESCs are a means to generate histocompatible and disease allele-free ESCs. Additionally, hpESCs are a unique model to study the influence of imprinting on neurogenesis.
Die Unterscheidung zwischen körpereigenen und körperfremden Strukturen ist eine grundlegende Herausforderung der spezifischen Immunantwort. Pathologische Veränderungen dieser Abgrenzung können zu schwerwiegenden Autoimmunerkrankungen wie beispielsweise Diabetes Mellitus, Rheumatischer Arthritis oder Multipler Sklerose führen. Um unerwünschte (Auto-) Immunreaktionen zu verhindern, existieren verschiedene Formen von peripheren Toleranzmechanismen, die durch viele Transkriptionsfaktoren wie z. B. ICER (inducible cAMP early repressor), NFAT (nuclear factor of activated T cells) und Foxp3 (forkhead box protein p3) kontrolliert werden. Foxp3+ regulatorische T-Zellen (Tregs) sind spezialisierte immun-suppressive Lymphozyten, welche die Aktivierung anderer Immunzellen unterdrücken können. Einer der möglichen Mechanismen ist der Transfer zyklischen Adenosin-Monophosphats (cAMP) von Tregs in konventionelle T- und B-Lymphozyten. Die erhöhte intrazelluläre Konzentration an cAMP führt in Effektorzellen zur Induktion und Kerntranslokation von ICER. Der transkriptionelle Repressor ICER supprimiert die Expression vieler NFAT-regulierter Gene und hemmt darüber hinaus die Induktion der NFATc1/αA-Isoform selbst. Diese Isoform wird speziell in pro-inflammatorischen Effektorzellen hochreguliert und ist maßgeblich an deren spezifischem transkriptionellen Programm beteiligt. Foxp3 ist ein zentraler Faktor für die Bildung und Funktion sowohl Thymus-generierter nTregs als auch peripher (TGFβ-) induzierter iTregs. Die Kontrolle des Foxp3-Gens wird in iTregs – überraschenderweise aber nicht in nTregs – durch NFAT-Faktoren reguliert. Allerdings hemmt Foxp3 durch eine negative Rückkopplung wiederum die Induktion und Aktivität von NFATc1/αA. Dies stellt somit ein weiteres Regulativ dar, wobei Foxp3 nicht nur die Plastizität, sondern auch die Funktion von immun-suppressiven T-Zellen steuert. Zusätzlich regulieren die verschiedenen NFAT-Faktoren auch die Antigen präsentierenden dendritischen Zellen (DCs). Während NFATc1 und NFATc2 die Differenzierung und Proliferation von DCs beeinflussen, reguliert NFATc3 deren Zytokinexpression und steuert indirekt auch die nachfolgende T-Zell-Immunantwort. Die Kontrolle der Genregulation in Immunzellen durch die Transkriptionsfaktoren ICER, NFAT und Foxp3 erfüllt somit spezifische Funktionen der Immunität, reguliert aber gleichzeitig wichtige Aspekte der peripheren Toleranz, um schädliche (Auto-) Immunreaktionen zu verhindern.
Die asexuellen Sporen von Aspergillus fumigatus sind ubiquitär verbreitete Luftkeime. Als Saprophyt ist dieser opportunistisch humanpathogene Pilz darauf spezialisiert, polymere Substanzen aus dem umgebenden Milieu zu zersetzen, um daraus die von ihm benötigten Nährstoffe zu generieren und aufzunehmen. Die Fähigkeit, verschiedene Stickstoff- und Kohlenstoffquellen zu verwerten, trägt dabei zu seiner Virulenz bei und hierbei scheint die extrazelluläre Proteolyse eine wichtige Rolle zu spielen. Sekretierte Proteasen, die das umgebende Gewebe während einer Infektion mit A. fumigatus erschließen, könnten somit zu dessen Pathogenität beitragen. Dementsprechend sollte im Rahmen dieser Arbeit die Bedeutung einer Regulation der extrazellulären proteolytischen Aktivität von A. fumigatus für dessen Virulenz untersucht werden. Dies geschah durch Untersuchungen eines konservierten Transkriptionsfaktors, PrtT. Dabei stellte sich heraus, dass PrtT die Expression der drei Hauptproteasen von A. fumigatus, Alp, Mep und Pep stark beeinflusst, in einem murinen Tiermodell der pulmonaren Aspergillose scheint dieser Regulator jedoch keine Rolle für die Pathogenität von A. fumigatus zu spielen. Um einen weiteren Aspekt des pilzlichen Aminosäurestoffwechsels zu beleuchten, wurde die Biosynthese der aromatischen Aminosäuren als mögliche Virulenzdeterminate untersucht. Für den Menschen sind diese Aminosäuren essentiell, weshalb dieser Syntheseweg ein mögliches Ziel für antimykotische Substanzen darstellen könnte. Es konnten mehrere für A. fumigatus essentielle Komponenten des Shikimatweges identifiziert werden, des Weiteren wurden Deletionsmutanten in den Genen aroC und trpA, die für die Chorismatmutase bzw. Anthranilatsynthase der Biosynthese von Phenylalanin und Tyrosin bzw. Tryptophan kodieren, erzeugt und phänotypisch charakterisiert. Deren Untersuchung in einem alternativen Tiermodell der Aspergillose zeigte eine deutlich attenuierte Virulenz. Diese Ergebnisse verdeutlichen, wie wichtig die Biosynthese der aromatischen Aminosäuren für das Wachstum von A. fumigatus ist, und dass ein Eingriff in diesen Syntheseweg eine lohnende Strategie zur Entwicklung neuer Antimykotika sein könnte. Die hier präsentierten Ergebnisse unterstreichen die für den Schimmelpilz A. fumigatus typische Redundanz bezüglich extrazellulärer proteolytischer Enzyme und dass diese nur bedingt hinsichtlich ihres Virulenzbeitrags untersucht werden können. Im Gegensatz hierzu lassen sich bestimmte Stoffwechselwege, die oftmals durch einzigartige Genprodukte katalysiert werden, unter Umständen besser als unspezifische aber vielversprechende Virulenzdeterminanten identifizieren.
XPD is a 5‘-3‘ helicase of the superfamily 2. As part of the transcription factor IIH it functions in transcription initiation and nucleotide excision repair. This work focus on the role of XPD in nucleotide excision repair. NER is a DNA repair pathway unique for its broad substrate range. In placental mammals NER is the only repair mechanism able to remove lesions induced by UV-light. NER can be divided into four different steps that are conserved between pro- and eukaryotes. Step 1 consists of the initial damage recognition, during step 2 the putative damage is verified, in step 3 the verified damage is excised and in the 4th and final step the resulting gap in the DNA is refilled. XPD was shown to be involved in the damage verification step. It was possible to solve the first apo XPD structure by a MAD approach using only the endogenous iron from the iron sulfur cluster. Based on the apo XPD structure several questions arise: where is DNA bound? Where is DNA separated? How is damage verification achieved? What is the role of the FeS cluster? These questions were addressed in this work. Hypothesis driven structure based functional mutagenesis was employed and combined with detailed biochemical characterization of the variants. The variants were analyzed by thermal unfolding studies to exclude the possibility that the overall stability could be affected by the point mutation. DNA binding assays, ATPase assays and helicase assays were performed to delineate amino acid residues important for DNA binding, helicase activity and damage recognition. A structure of XPD containing a four base pair DNA fragment was solved by molecular replacement. This structure displays the polarity of the translocated strand with respect to the helicase framework. Moreover the properties of the FeS cluster were studied by electron paramagnetic resonance to get insights into the role of the FeS cluster. Furthermore XPD from Ferroplasma acidarmanus was investigated since it was shown that it is stalled at CPD containing lesions. The data provide the first detailed insight into the translocation mechanism of a SF2B helicase and reveal how polarity is achieved. This provides a basis for further anlayses understanding the combined action of the helicase and the 4Fe4S cluster to accomplish damage verification within the NER cascade.
Cutaneous leishmaniasis is endemic in tropical and subtropical regions of the world. Effective vaccination strategies are urgently needed because of the emergence of drug-resistant parasites and severe side effects of chemotherapy. The research group of Heidrun Moll previously established a DC-based vaccination strategy to induce complete and long-lasting immunity to experimental leishmaniasis using LmAg-loaded and CpG ODN-activated DC as a vaccine carrier. Prevention of tissue damages at the site of L. major inoculation can be achieved if the BALB/c mice were systemically given LmAg-loaded BMDC that had been exposed to CpG ODN. The interest in further exploring the role of IL-4 aroused as previous studies allowed establishing that IL-4 was involved in the redirection of the immune response towards a type 1 profile. Thus, wt BALB/c mice or DC-specific CD11ccreIL-4Rα-/lox BALB/c mice were given either wt or IL-4Rα-deficient LmAg-loaded BMDC exposed or not to CpG ODN prior to inoculation of 2 x 105 stationary phase L. major promastigotes into the BALB/c footpad. The results provide evidence that IL4/IL-4Rα-mediated signaling in the vaccinating DC is required to prevent tissue damages at the site of L. major inoculation, as properly conditioned wt DC but not IL-4Rα-deficient DC were able to confer resistance. Furthermore, uncontrolled L. major population size expansion was observed in the footpad and the footpad draining LN in CD11ccreIL-4Rα-/lox mice immunized with CpG ODN-exposed LmAg-loaded IL-4Rα-deficient DC, indicating the influence of IL-4R-mediated signaling in host DC to control parasite replication. In addition, no footpad damage was observed in BALB/c mice that were systemically immunized with LmAg-loaded wt DC doubly exposed to CpG ODN and recombinant IL-4. Discussing these findings allow the assumption that triggering the IL4/IL4Rα signaling pathway could be a precondition when designing vaccines aimed to prevent damaging processes in tissues hosting intracellular microorganisms.
Dendritic cell-based vaccination is a well established technique for preventive and therapeutic instruction of the immune system where conservative vaccine formulations fail to cure or prevent diseases, respectively. Efficiency of this technique already was demonstrated in infectious diseases as well as for cancer in animal or human studies. Well controlled manipulation and antigen-loading of immature DC is most beneficial to this technique. But, time-consuming and cost-extensive procedures for preparation of DC precursors, expansion and stimulation of DC and inpatient administration are big disadvantages regarding vaccine development for pandemic infectious diseases that occur mainly in underdeveloped countries. Therefore vaccines are needed that are pathogen-tailored and able to induce equal immune responses as their DC-based vaccine models. For vaccination against Leishmania parasites such a DC-based vaccine is feasible and its efficacy to induce protective Th1-based immune responses was already demonstrated in several animal studies. But, one of our own studies indicated supportive activity of host cells exceeding the allocation of T cells to become activated by transferred DC. IL-12, an important cytokine for the induction of Th1-related immune responses, has to be produced by host cells. Therefore, the aim of this study was to investigate the mechanism of BMDC-based vaccination with regard to simplification of the vaccine formulation. Key questions that have been addressed are: Which cells process the information that is transferred by the injected DC and what are the key components of this information? Further more, it was looked at whether altered vaccine formulations are able to induce protective immunity and whether they share equal molecular mechanisms. The current paradigm of BMDC-based vaccination proposes direct interaction of transferred BMDC with host T cells. These BMDC have to be antigen-loaded for stimulation via antigen-peptide-MHC molecule-complexes and they have to be activated for proper co-stimulation of T cells. Here, this study demonstrates that neither activation for co-stimulation nor direct interaction with adequate MHC molecules is needed for the induction of protective immunity against infection with Leishmania-parasites. Disrupted antigen-loaded BMDC are able to induce protective immunity in BALB/c mice without pre-stimulation via CpG ODN. Beyond, if BMDC were used with a different MHC-background than recipient mice then the vaccine still would be efficient in terms of reduction of footpad swelling and parasite load in draining lymph nodes. Even more, DC-specific features are no key component that leads to protective immunity as vaccination with disrupted antigen-loaded MΦ shows equal properties than before mentioned vaccine formulations. Further more, it was found that host DC play a major role in transforming the incoming signal, received from transferred antigen-loaded DC, into Th1-related stimuli and Leishmania-antigen-specific T cell activation. Suspensions of disrupted antigen-loaded DC resemble a combination of laid off soluble molecules together with exosome-like vesicles that formed after disruption of membranes. Here it was shown that separation of the membranous and soluble fractions and subsequent transfer into BALB/c mice will lead to protection of these mice against infection with L. major promastigotes only if the membranous fraction is used as vaccine. More, this vaccine formulation takes advantage of easy storage at -80°C with no need of fresh production. This clearly demonstrates that the immunity-inducing principle of disrupted DC-based vaccination lies within the membrane enclosed fraction. On a molecular level, disrupted antigen-loaded DC induce Th1-related cytokines during vaccination and as response on pathogen encounter. In vivo assays revealed IL-12 production and antigen-specific T cell proliferation among splenocytes that were stimulated with disrupted antigen-loaded DC. Splenocytes of accordingly vaccinated mice produce tremendous amounts of IFNγ after stimulation with Leishmania parasites. In summary, disrupted antigen-loaded BMDC fulfil all characteristics of DC-based vaccination against Leishmania major. But, while purification of membranes of antigen-loaded DC and subsequent transfer to BALB/c mice leads to control of the disease in the animal model, only slight levels of Th1-related cytokines are seen in the in vivo assays. Whether this points towards a loss of vaccine activity on unseen levels or unknown sites where Th1-related immunity is induced by both, complete solution and purified membranes, still has to be determined.
Type 1 diabetes is an autoimmune disease that leads to the destruction of insulin-producing pancreatic beta cells and consequently to hyperglycemia. In the last 60 years, the prevalence of type 1 diabetes has been increasing constantly and is predicted to continue rising. About 80% of the disease risk is attributable to the genetic variation. Thanks to genome wide association studies the number of known disease-associated polymorphisms climbed from five to 53 in the last 10 years. As these studies reveal possible candidate genes but not underlying mechanisms we strove to take the next step and explore the association of two genes suggested by these studies with type 1 diabetes. As a method of choice we decided to use lentiviral RNAi in non obese diabetic (NOD) mice, a widely-used model for type 1 diabetes, introducing a shRNA directed against the target message into the genome of this mouse strain via a lentivirus. This allowed us to study the partial loss-of-function of the target gene within the context of diabetes, directly seeing its effect on autoimmune mechanisms. In this thesis we examined two different genes in this manner, Ctla4 and Clec16a. A type 1 diabetes associated polymorphism in the CTLA4 gene had been found to alter the splicing ratio of its variants soluble CTLA-4 (sCTLA-4) and full length CTLA-4, the associated allele producing less sCTLA-4 than the protective allele. We mimicked this effect by specifically targeting the sCtla4 mRNA via lentiviral RNAi in the NOD model. As a result we could confirm the reduction of sCTLA-4 to accelerate type 1 diabetes development. Furthermore we could show a function of sCTLA-4 in regulatory T cells, more specifically at least partly in their ability to modulate costimulation by antigen presenting cells. The second candidate gene, Clec16a was targeted with the shRNA in a way that was designed to knock down most splice variants. As the gene function and the effect of the associated SUMMARY 10 polymorphism was unknown, we reasoned this method to be feasible to investigate its role in type 1 diabetes. The knockdown of Clec16a in NOD mice resulted in an almost complete protection from diabetes development that could be attributed to T cells dysfunction. However, as expression patterns and a study of the Drospophila orthologue suggested a possible role of CLEC16A in antigen presentation we also examined antigen presenting cells in the thymus and periphery. Although we did not detect any effect of the knockdown on peripheral antigen presenting cells, thymic epithelial cells were clearly affected by the loss of CLEC16A, rendering them more activated and shifting the ratio of cortical to medullary epithelial cells in favor of cortical cells. We therefore suggest a role of CLEC16A in the selection of T cells, that needs, however, to be further investigated. In this thesis we provided a feasible and fast method to study function of genes and even of single splice variants within the NOD mouse model. We demonstrate its usefulness on two candidate genes associated with type 1 diabetes by confirming and unraveling the cause of their connection to the disease.
Based on genetic association and functional imaging studies, reduced function of tryptophan hydroxylase-2 (TPH2) has been shown to be critically involved in the pathophysiology of anxiety-disorders and depression. In order to elucidate the impact of a complete neuronal 5-HT deficiency, mice with a targeted inactivation of the gene encoding Tph2 were generated. Interestingly, survival of Tph2-/- mice, the formation of serotonergic neurons and the pathfinding of their projections was not impaired. Within this thesis, I investigated the influence of 5-HT deficiency on the γ-amino butyric acid (GABA) system. The GABAergic system is implicated in the pathophysiology of anxiety disorders. Therefore, measurement of GABA concentrations in different limbic brain regions was carried out. These measurements were combined with immunohistochemical estimation of GABAergic cell subpopulations in the dorsal hippocampus and amygdala. In Tph2-/- mice GABA concentrations were increased exclusively in the dorsal hippocampus. In heterozygous Tph2+/- mice concentrations of GABA were increased in the amygdala compared to Tph2-/- and wt control mice, while the reverse was found in the prefrontal cortex. The changes in GABA concentrations were accompanied by altered cell density of GABAergic neurons within the basolateral complex of the amygdala and parvalbumin (PV) neurons of the dorsal hippocampus and by adaptational changes of 5-HT receptors. Thus, adaptive changes during the development on the GABA system may reflect altered anxiety-like and depressive-like behavior in adulthood. Moreover, chronic mild stress (CMS) rescues the depressive-like effects induced by 5-HT deficiency. In contrast, 5-HT is important in mediating an increased innate anxiety-like behavior under CMS conditions. This is in line with a proposed dual role of 5-HT acting through different mechanisms on anxiety and depressive-like behavior, which is influenced by gene-environment interaction effects. Further research is needed to disentangle these complex networks in the future.
Escherichia coli Nissle 1917 (EcN) gehört zu den am besten untersuchten und charakterisierten probiotischen Bakterienstämmen. Seit Beginn des letzten Jahrhunderts wird er als Medikament eingesetzt, um verschiedene Darmerkrankungen wie z.B. Diarrhöe, entzündliche Darmerkrankungen und Verstopfung zu behandeln. Die Flagelle des EcN vermittelt Beweglichkeit und kann die Produktion von humanem β-Defensin 2 (hBD2) durch Epithelzellen induzieren. Somit ist dieses Organell direkt in die probiotische Funktion des EcN involviert. Es konnte gezeigt werden, dass die Flagellen anderer Bakterien, wie z.B. dem probiotischen Stamm Bacillus cereus CH oder den pathogenen Stämmen Pseudomonas aeruginosa und Clostridium difficile, die Adhäsion an intestinalen Mucus, welcher von Epithelzellen sekretiert wird, vermitteln. Allerdings blieb unklar, welcher Teil der Flagelle an welche Mucuskomponente bindet. Die Fähigkeit effizient an Wirtgewebe zu adhärieren wird als wichtiges Attribut eines probiotischen Stammes angesehen. Ex vivo Adhäsionsstudien mit Kryoschnitten humaner Darmbiopsien haben gezeigt, dass die Flagelle des EcN in die effiziente Adhäsion an humanes Darmgewebe involviert sein muss. Aus diesem Grund wurde in dieser Arbeit die Funktion der Flagelle des EcN als Adhäsin untersucht. Zunächst wurde die hyperflagellierte Variante EcN ATHF isoliert und durch verschiedene Experimente, z.B. Schwärmagartests und Elektronenmikroskopie, charakterisiert. Weitere ex vivo Adhäsionsstudien mit EcN ATHF zeigten eine höhere Adhäsionseffizienz dieser hyperflagellierten Variante und bestätigten damit die Rolle der Flagelle bei der effizienten Adhäsion von EcN an die Kryoschnitte der humanen Darmbiopsien. Interessanterweise fungierte die Flagelle in in vitro Studien mit den humanen Epithelzellen Caco-2 und T24 nicht als Adhäsin. Diese Unterschiede zwischen den in vitro und ex vivo Studien führten zu der Annahme, dass die Flagelle des EcN in vivo die Adhäsion an Mucus vermittelt, welcher von den Caco-2- und T24-Zellen nicht produziert wird, aber in den Kryoschnitten der Darmbiopsien nachgewiesen wurde. Diese Vermutung wurde durch in vitro Adhäsionsstudien mit der Mucin-produzierenden Epithelzelllinie LS174-T bestätigt, da die Flagellen für eine effektive Adhäsion an diese Zellen essentiell waren. Zudem reduzierte die Präinkubation flagellierter EcN-Stämme mit Mucin2 ihre Adhäsionseffizienz an Kryoschnitte humaner Darmbiopsien. Um die direkte Interaktion zwischen Flagellen des EcN Wildtyps und Mucus zu zeigen, wurde ein ELISA etabliert. Es konnte eine direkte konzentrationsabhängige Interaktion zwischen isolierten Flagellen des EcN Wildtyps und Mucin2, bzw. humanem Mucus (Kolon) beobachtet werden. Interessanterweise konnte keine Interaktion zwischen isolierten Flagellen des EcN Wildtyps und murinem Mucus (Duodenum, Ileum, Caecum, Colon) festgestellt werden. Dies weist darauf hin, dass die Mucuszusammensetzung zwischen verschiedenen Spezies variiert. Verschiedene Kohlenhydrate, welche bekannte Mucusbestandteile sind, wurden auf ihre Interaktion mit der Flagelle von EcN getestet und Gluconat wurde als ein Rezeptor identifiziert. Die Präinkubation isolierter Flagellen mit Gluconat reduzierte ihre Interaktion mit Mucin2, bzw. humanem Mucus signifikant. Zudem wurde die oberflächenexponierte Domäne D3 des Flagellins, der Hauptuntereinheit der Flagelle, als möglicher Interaktionspartner von Mucin2, bzw. humanem Mucus ausgeschlossen. Flagellen, die aus einer Domäne D3 Deletionsmutante isoliert wurden, zeigten sogar eine effizientere Bindung an Mucin2, bzw. humanen Mucus. Weiterhin konnte gezeigt werden, dass Änderungen des pH-Wertes signifikante Effekte auf die Interaktion zwischen Mucus und isolierten Flagellen hatten, vermutlich aufgrund von Konformationsänderungen. Zusammenfassend wurde in dieser Arbeit die Flagelle als neues und scheinbar wichtigstes Adhäsin in vivo für den probiotischen Stamm EcN identifiziert. Hierfür wurden sowohl eine hyperflagellierte Variante, eine ΔfliC Mutante, sowie der dazugehörige komplementierte Stamm verwendet. EcN ist zudem der erste probiotische Stamm für den eine direkte Bindung der Flagellen an humanen Mucus nachgewiesen werden konnte. Die Mucuskomponente Gluconat konnte dabei als wichtiger Rezeptor identifiziert werden. Da einige pathogene Bakterien ihre Flagelle zur Adhäsion an Wirtsgewebe nutzen, könnte dieses Organell EcN dazu befähigen, mit Pathogenen um die erfolgreiche Kolonisierung des Darms zu konkurrieren, was als wichtige Eigenschaft eines Probiotikums betrachtet wird.
Early-life stress has been shown to influence the development of the brain and to increase the risk for psychiatric disorders later in life. Furthermore, variation in the human serotonin transporter (5-HTT, SLC6A4) gene is suggested to exert a modulating effect on the association between early-life stress and the risk for depression. At the basis of these gene x environment (G x E) interactions, epigenetic mechanisms, such as DNA-methylation, seem to represent the primary biological processes mediating early-life programming for stress susceptibility or resilience, respectively. The exact molecular mechanisms however remain to be elucidated, though. In the present study, we used two different stress paradigms to assess the molecular mechanisms mediating the relationship between early-life stress and disorders of emotion regulation later in life. First, a 5-Htt x prenatal stress (PS) paradigm was applied to investigate whether the effects of PS are dependent on the 5-Htt genotype. For this purpose, the effects of PS on cognition and anxiety- / depression-related behavior were examined using a maternal restraint stress paradigm of PS in C57BL/6 wild-type (WT) and heterozygous 5-Htt deficient (5-Htt+/-) mice. Additionally, in female offspring, a genome-wide hippocampal gene expression and DNA methylation profiling was performed using the Affymetrix GeneChip® Mouse Genome 430 2.0 Array and the AffymetrixGeneChip® Mouse Promoter 1.0R Array. Some of the resulting candidate genes were validated by quantitative real-time PCR. Further, the gene expression of these genes was measured in other brain regions of the PS animals as well as in the hippocampus of offspring of another, 5-Htt x perinatal stress (PeS) paradigm, in which pregnant and lactating females were stressed by an olfactory cue indicating infanticide. To assess resilience to PS and PeS, correlation studies between gene expression and behaviour were performed based on an initial performance-based LIMMA analysis of the gene expression microarray. 5-Htt+/- offspring of the PS paradigm showed enhanced memory performance and signs of reduced anxiety as compared to WT offspring. In contrast, exposure of 5-Htt+/- mice to PS was associated with increased depression-like behavior, an effect that tended to be more pronounced in female offspring. Further, 5-Htt genotype, PS and their interaction differentially affected the expression and DNA methylation of numerous genes and related pathways within the female hippocampus. Specifically, MAPK and neurotrophin signaling were regulated by both the 5-Htt+/- genotype and PS exposure, whereas cytokine and Wnt signaling were affected in a 5-Htt genotype x PS manner, indicating a gene x environment interaction at the molecular level. The candidate genes of the expression array could be validated and their expression patterns were partly consistent in the prefrontal cortex and striatum. Furthermore, the genotype effect of XIAP associated factor 1 (Xaf1) was also detected in the mice of the PeS paradigm. Concerning resilience, we found that the expression of growth hormone (Gh), prolactin (Prl) and fos-induced growth factor (Figf) were downregulated in WTPS mice that performed well in the forced swim test (FST). At the same time, the results indicated that Gh and Prl expression correlated positively with adrenal weight, whereas Figf expression correlated positively with basal corticosteron concentration, indicating an intricate relationship between depression-like behavior, hippocampal gene expression and the hypothalamo-pituitary-adrenal (HPA) axis activity. Correlation studies in the PeS animals revealed a link between Gh / Prl expression and anxiety-like behavior. In conclusion, our data suggest that although the 5-Htt+/- genotype shows clear adaptive capacity, 5-Htt+/- mice, particularly females, appear to be more vulnerable to developmental stress exposure when compared to WT offspring. Moreover, hippocampal gene expression and DNA methylation profiles suggest that distinct epigenetic mechanisms at the molecular level mediate the behavioral effects of the 5-Htt genotype, PS exposure, and their interaction. Further, resilience to early-life stress might be conferred by genes whose expression is linked to HPA axis function.
Der Tumornekrosefaktor (TNF) entfaltet seine vielfältigen biologischen Aktivitäten durch die Stimulation der beiden TNF-Rezeptoren TNFR1 und TNFR2. Die TNFR1-vermittelte Signaltransduktion ist in vielen Details gut verstanden, wohingegen die TNFR2-vermittelte Signaltransduktion bis heute kaum untersucht ist. Mit Hilfe einer in unserer Gruppe entwickelten hochaktiven TNFR2-spezifischen TNF-Variante sowie einer bereits länger bekannten TNFR1-spezifischen TNF-Variante wurde in dieser Arbeit die TNF-Signaltransduktion insbesondere im Mutiplen Myelom untersucht. Mit Hilfe der beiden TNF-Varianten konnte gezeigt werden, dass die alleinige Stimulation des TNFR2 die Aktivierung des alternativen NFkappaB-Signalweges vermittelt, wohingegen TNFR1 nicht dazu in der Lage ist. So zeigte sich im Einklang mit der inhibitorischen Funktion des Adapterproteins TRAF2 in der Signaltransduktion des alternativen NFkappaB-Signalweges, dass die TNFR2-Stimulation in einer TRAF2-Depletion resultiert. Dies führt weiterhin zur Akkumulation von NIK und der Prozessierung von p100 zu seiner aktiven Form p52, den klassischen biochemisch nachweisbaren Ereignissen der Aktivierung des alternativen NFkappaB-Signalweges. Aufgrund der Rolle des NFkappaB-Systems im Multiplen Myelom (MM) und der stimulierenden Wirkung des TNFR1 und TNFR2 auf das NFkappaB-System wurde die Expression und Funktion dieser beiden Rezeptoren auf Myelomzelllinien untersucht. Insbesondere wurde analysiert, welchen Effekt eine spezifische Stimulation der beiden TNF-Rezeptoren auf die apoptotische Sensitivität von Myelomzellen hat. Mit einer Ausnahme wiesen alle untersuchten Myelomzelllinien eine eindeutige TNFR2-Oberflächenexpression auf, die TNFR1-Expression hingegen war heterogen. Die TNFR1-Stimulation in den TNFR1-positiven Zelllinien zeigte keinen wesentlichen Einfluss auf die Zellviabilität. Allerdings resultierte eine Vorstimulation mit TNF in einer gesteigerten Sensitivität für den CD95L-induzierten Zelltod, schützte aber gleichzeitig vor der TRAIL-vermittelten Induktion der Apoptose. Der gegenläufige Effekt der TNF-Vorstimulation auf den CD95L- und TRAIL-induzierten Zelltod konnte auf die Hochregulation der CD95-Oberflächenexpression und der gesteigerten Expression des antiapoptotischen cFLIPLong-Proteins zurückgeführt werden. Beide Effekte basieren auf der TNF-induzierten Aktivierung des klassischen NFkappaB-Signalweges. Im CD95L-induzierten Zelltod überkompensierte die Induktion der CD95-Expression offensichtlich die Hochregulation von cFLIPLong und resultierte in gesteigertem Zelltod. Der TRAIL-induzierte Zelltod hingegen wurde durch die TNF-Vorstimulation abgeschwächt, da hier lediglich die durch den klassischen NFkappaB-Signalweg vermittelte gesteigerte Expression des antiapoptotischen cFLIPLong eine Rolle spielte. Desweiteren zeigten die Analysen in dieser Arbeit, dass die TNFR2-Stimulation zu einer Depletion von TRAF2 und z. B. in JJN3-Zellen zu einer Sensitivierung für den TNFR1-induzierten Zelltod führte. Die Ergebnisse dieser Arbeit zeigten in der Summe somit, dass das TNF-TNFR-Signaling durch verschiedene Mechanismen Einfluss auf den Ausgang der extrinsischen Apoptoseinduktion hat, und dass der Effekt von TNF auf das Überleben von MM-Zellen kontextabhängig ist.
RKIP reguliert Proteinkinasen der Signaltransduktionskaskaden von G Protein-gekoppelten Rezeptoren, der Raf/MEK/ERK-MAPK, des Transkriptionsfaktors NFκB und von GSK3β. Unklar war bisher, wie die spezifische Interaktion von RKIP mit seinen mannigfaltigen Interaktionspartnern ermöglicht und reguliert wird. Raf1 und GRK2 sind die einzigen bekannten direkten Interaktionspartner von RKIP und wurden deshalb gewählt, um die zugrundeliegenden molekularen Mechanismen dieser Interaktion genauer zu untersuchen. In dieser Arbeit wurde gezeigt, dass RKIP nach PKC-vermittelter Phosphorylierung von Serin153 dimerisiert und dass diese Dimerisierung für die RKIP/Raf1-Dissoziation und die RKIP/GRK2-Interaktion essentiell ist. Co-Immunpräzipitationsexperimente mit einer phosphorylierungsdefizienten Mutante zeigten, dass für diese Dimerisierung die Phosphorylierung von beiden RKIP-Molekülen notwendig ist. Als Dimerinteraktionsfläche wurden die Aminosäuren 127-146 von RKIP identifiziert, da das Peptid RKIP127-146 die Dimerisierung von RKIP spezifisch und effizient hemmte. Um die Bedeutung dieser phosphorylierungsinduzierten Dimerisierung von RKIP für seine Interaktion mit Raf1 und GRK2 zu untersuchen, wurden eine phosphomimetische Mutante (RKIPSK153/7EE) und eine Mutante von RKIP generiert, welche bereits unphosphoryliert dimerisiert (RKIP∆143-6). Folgende Ergebnisse legen nahe, dass die Dimerisierung von RKIP für die spezifische Interaktion mit Raf1 bzw. GRK2 entscheidend ist: (i) Die Dimerisierung von phosphoryliertem RKIP ging mit der Dissoziation von RKIP und Raf1 und der Assoziation von RKIP und GRK2 einher; (ii) die Mutanten RKIPSK153/7EE und RKIP∆143-6, die bereits in unstimulierten Zellen eine starke Dimerisierung zeigten, hatten eine höhere Affinität zu GRK2 als zu Raf1; (iii) die Hemmung der RKIP-Dimerisierung interferierte nur mit der RKIP/GKR2- aber nicht mit der RKIP/Raf1-Interaktion; (iv) in vitro und in Mausherzen konnte ein RKIP- und GRK2-immunreaktiver Komplex nachgewiesen werden; (v) Untersuchungen zur RKIP-vermittelten Hemmung der Kinaseaktivität von GRK2 und Raf implizierten, dass dimerisiertes RKIP nur die Aktivität von GRK2, nicht aber von Raf hemmt. Diese Arbeit zeigt, dass die phosphorylierungsinduzierte Dimerisierung von RKIP die spezifische Interaktion von RKIP mit Raf1 und GRK2 koordiniert. Die Aufklärung dieses Mechanismus erweitert unser Verständnis der spezifischen Interaktion von Kinasen mit ihren Regulatorproteinen.
PTPN22 encodes the lymphoid tyrosine phosphatase Lyp that can dephosphorylate Lck, ZAP-70 and Fyn to attenuate TCR signaling. A single-nucleotide polymorphism (C1858T) causes a substitution from arginine (R) to tryptophan (W) at 620 residue (R620W). Lyp-620W has been confirmed as a susceptible allele in multiple autoimmune diseases, including type 1 diabetes (T1D). Several independent studies proposed that the disease-associated allele is a gain-of-function variant. However, a recent report found that in human cells and a knockin mouse containing the R620W homolog that Ptpn22 protein degradation is accelerated, indicating Lyp-620W is a loss-of-function variant. Whether Lyp R620W is a gain- or loss-of-function variant remains controversial. To resolve this issue, we generated two lines (P2 and P4) of nonobese diabetic (NOD) mice in which Ptpn22 can be inducibly silenced by RNAi. We found long term silencing of Ptpn22 increased spleen cellularity and regulatory T (Treg) cell numbers, replicating the effect of gene deletion reported in the knockout (KO) B6 mice. Notably, Ptpn22 silencing also increased the reactivity and apoptotic behavior of B lymphocytes, which is consistent with the reduced reactivity and apoptosis of human B cells carrying the alleged gain-of-function PTPN22 allele. Furthermore, loss of Ptpn22 protected P2 KD mice from spontaneous and Cyclophosphamide (CY) induced diabetes. Our data support the notion that Lyp-620W is a gain-of-function variant. Moreover, Lyp may be a valuable target for the treatment of autoimmune diseases.
Die Anzahl neurologischer Erkrankungen bei denen Autoantikörper gegen zentralnervöse An-tigene bekannt sind, hat in den letzten Jahren deutlich zugenommen. Allerdings gibt es nur für wenige dieser Erkrankungen hinreichende experimentelle Belege für eine pathogene Wir-kung der Autoantikörper. Zwei dieser Erkrankungen wurden im Rahmen dieser Arbeit näher untersucht: die Juvenile Neuronale Zeroid-Lipofuszinose (JNCL) mit Autoantikörpern gegen die 65 kD Isoform der Glutamatdecarboxylase und das Stiff Person Syndrom (SPS) mit Auto-antikörpern gegen Amphiphysin. Die phänotypische Charakterisierung der cln3 knockout-Maus, einem Mausmodell für die JNCL, zeigte eine progressive Verschlechterung der motorischen und koordinativen Fä-higkeiten, eingeschränktes reizbedingtes Lernen und gesteigertes angstähnliches Verhalten. Diese Symptome ähneln denen der humanen Erkrankung. Elektrophysiologisch konnte eine Antikörper-induzierte zerebelläre Dysfunktion identifiziert werden, die einer verminderten lokalen GABAergen Hemmung zugeordnet wird. Eine Reduktion der Antiköperproduktion im Tiermodell durch eine Depletion der Plasmazellen durch den Proteseinhibitor Bortezomib hatte einen positiven Effekt auf die Krankheitsentwicklung. Im zweiten experimentellen Teil der Arbeit wurde der Einfluss von Autoantikörpern gegen Amphiphysin von Patienten mit SPS auf die synaptische Transmission untersucht. Es zeigte sich hierbei in Patch-Clamp Experimenten eine Störung der GABAergen Übertragung v.a. bei hochfrequenter Stimulation, was im Einklang mit dem vermuteten Antikörper-induzierten Endozytosedefekt steht. Passiver Transfer von humanen Autoantikörpern gegen Amphiphysin induzierte angst-ähnliches Verhalten in Ratten, einem weiteren Kernsymptom des SPS. Aktive Immunisierung gegen Amphiphysin und anschließende Öffnung der Blut-Hirn-Schranke in Mäusen führte zu einer subklinischen Veränderung der Reflexverarbeitung von Ia Afferenzen auf Motoneurone im Rückenmark der Mäuse. Insgesamt konnten in zwei Erkrankungen des ZNS autoimmune Mechanismen identifi-ziert werden, die zu einer Antikörper-induzierten Fehlregulation der zentralen synaptischen Transmission führen. Diese Ergebnisse können wegweisend sein auch für die Erforschung der Pathophysiologie anderer Antikörper-assoziierte Erkrankungen des ZNS.
Die Stimulation des CD95-Todesrezeptors durch seinen natürlichen membranständigen Li-ganden CD95L führt zur kontextabhängigen Aktivierung von sowohl apoptotischen als auch nicht-apoptotischen Signalwegen. Durch Proteolyse wird aus dem membranständigen CD95L löslicher trimerer CD95L freigesetzt. Die Bindung von löslichem trimerem CD95L an CD95 ist nicht ausreichend, um die CD95-Signaltransduktion effizient zu stimulieren. Die Fähigkeit von löslichen CD95L-Trimeren CD95-vermittelte Signalwege robust zu aktivieren kann jedoch durch Oligomerisierung und artifizielle Immobilisierung an eine Oberfläche drastisch gesteigert werden. In dieser Arbeit wurde zunächst bestätigt, dass nur oligomere CD95L-Varianten, die z.B. durch Antikörpervernetzung von N-terminal getaggten rekombinanten CD95L-Varianten oder durch eine gentechnisch erzwungene Hexamerisierung von CD95L-Molekülen erhalten wur-den, in der Lage sind, effizient apoptotische und nicht-apoptotische Signalwege zu aktivieren. Ferner zeigte sich dann, dass die Bindung von löslichen CD95L-Trimeren nicht ausreichend ist, um die Translokation von CD95-Molekülen in detergenzunlösliche „Lipid Raft“- Membrandomänen zu stimulieren. Die „Lipid Raft“-Translokation ist ein zentrales Ereignis bei der CD95-Aktivierung und vor allem für die Induktion der Apoptose bedeutsam. Dabei ist ein selbstverstärkender Prozess aus Caspase-8-Aktivierung und „Lipid Raft“-Assoziation des CD95 von Bedeutung. Um die Interaktion von CD95 und CD95L mit Hilfe von hoch sensitiven zellulären Bindungs-studien analysieren zu können, wurden in dieser Arbeit desweiteren CD95L-Fusionsproteine entwickelt und hergestellt, an welche N-terminal eine Gaussia princeps Luziferase (GpL)- Reporterdomäne gekoppelt ist. So konnte mit den GpL-CD95L-Fusionsproteinen gezeigt werden, dass die Oligomerisierung von CD95L-Trimeren keinen Effekt auf die Ligandenbele-gung des CD95 hat. Dies spricht dafür, dass die höhere spezifische Aktivität von oligomeri-sierten CD95L-Trimeren nicht auf einer Aviditäts-vermittelten Zunahme der apparenten Affi-nität beruht, sondern dies deutet darauf hin, dass die sekundäre Aggregation von sich initial bildenden trimeren CD95L-CD95-Komplexen eine entscheidende Rolle in der CD95-Aktivierung spielt. Durch Scatchard-Analysen zeigte sich ferner, dass trimerer CD95L mit mindestens zwei zellulären Bindungsstellen unterschiedlicher Affinität interagiert. Bindungs-studien mit löslichen monomeren und trimeren GpL-CD95-Rezeptoren an membranständigen CD95L, als auch Inhibitionsstudien ergaben, dass trimerer CD95 weitaus besser an CD95L bindet. Dies legt nahe, dass es sich bei den zuvor beobachteten hoch- und niederaffinen Bindungsstellen für CD95L um monomere bzw. prä-assemblierte CD95-Moleküle handelt. Die GpL-CD95L-Fusionsproteine wurden auch genutzt, um die CD95-Translokation in „Lipid Rafts“ zu analysieren. So wurde trimerer GpL-CD95L als „Tracer“ zur Markierung von inaktiven CD95-Molekülen eingesetzt. Nach Aktivierung der übrigen freien CD95-Moleküle mit hoch aktivem hexameren Fc-CD95L konnte eine Zunahme der inaktiven GpL-CD95L-markierten Rezeptoren in „Lipid Rafts“ beobachtet werden. Offensichtlich stimulieren also aktivierte CD95-Moleküle in „trans“ die Ko-Translokation inaktiver CD95-Rezeptoren in „Lipid Rafts“. Dies bestätigte sich auch in Experimenten mit Transfektanten, die einen chimären CD40-CD95-Rezeptor exprimieren. Letzterer ist nach Stimulation mit CD40L in der Lage, intrazellu-läre CD95-vermittelte Signalwege zu aktivieren. Die Aktivierung von CD95-assoziierten Sig-nalwegen durch Stimulation von endogenem CD95 in CD40-CD95-Transfektanten resultierte nun in der Ko-Translokation von unstimulierten CD40-CD95-Rezeptoren in „Lipid Rafts“. Vice versa zeigte sich die Ko-Translokation von endogenem CD95 nach spezifischer Aktivierung des chimären CD40-CD95-Rezeptors. Schlussendlich erwiesen sich eine funktionsfähige Todesdomäne und die Aktivierung der Caspase-8 als essentiell für die „Lipid Raft“-Assoziation von aktivierten CD95-Molekülen und auch für die durch diese Rezeptorspezies induzierte Ko-Translokation von inaktiven Rezeptoren in „Lipid Rafts“.
Dendritische Zellen (DCs) sind Antigen-präsentierende Zellen, die Pathogene erkennen und nach erfolgreicher Reifung spezifische adaptive Immunität induzieren. Die Infektion unreifer DCs durch Masernviren (MV) erfolgt CD150-abhängig und DC-SIGN-unterstützt. Infizierte DCs vermitteln wahrscheinlich den MV-Transport vom Respirationstrakt in sekundäre lym-phatische Gewebe, wo die MV-spezifische Immunität und die generalisierte Immunsuppressi-on initiiert werden sowie die MV-Transmission an T-Zellen stattfinden kann, die wesentlich für die Dissemination des Virus ist. Die MV-Infektion von iDCs initiierte deren Ausreifung begleitet von der moderaten Hochre-gulierung der CD150-Oberflächenexpression. Die Akkumulation viraler Proteine als auch die Freisetzung viraler Partikel waren in DCs im Vergleich zu Virus-produzierenden B-Zelllinie B95a beeinträchtigt. Diese Arbeit verglich die subzelluläre Verteilung der viralen Proteine in DCs und B95a-Zellen. In DC wiesen Matrix (M)-Proteine eine prominente Assoziation mit den Komponenten des Ribonukleoprotein (RNP)-Komplexes auf. Die ausgeprägte Relokali-sierung des Tetraspanins CD81 zu Phospho (P)-Protein-Kompartimenten und die Inhibition der räumliche Interaktion der untersuchten Tetraspanine waren spezifisch für B95a-Zellen. Weder in B95a-Zellen noch für DC konnte für MV ein virus-containing compartment (VCC) detektiert werden, das für HIV-1 zuvor beschrieben wurde. Um den zellulären Transport des M-Proteins in infizierten, lebenden DCs untersuchen zu können, wurde das Protein carboxyterminal mit dem Tetracystein (TC)-Tag fusioniert. Das M-TC Fusionsprotein zeigte alle untersuchten biologischen Eigenschaften des Wildtyp-Proteins bezüglich seiner subzellulären Verteilung, der Assoziation mit DRMs sowie der Generierung und Freisetzung von virus-like particles (VPLs). Innerhalb des Viruskontextes interferierte der TC-Tag allerdings stark mit der Virusreplikation bzw. Freisetzung. Durch die Verminderung der Partikelproduktion in DCs wird eine spezielle MV-Transmissionsstruktur für die effiziente Übertragung an T-Zellen benötigt. Die MV-Transmission an autologe T-Zellen basierte vorwiegend auf Infektion von DCs (cis-Infektion) und weniger auf DC-SIGN-gebundenen Virus (trans-Infektion). Die Interaktion zwischen dem MV-Glykoprotein H mit seinem Rezeptor CD150 war wichtig für die Transmission. Die Transmission von MV erfolgte hauptsächlich durch die Bildung von Kontaktflächen, entspre-chend den beschriebenen virologischen Synapsen, wo virale Proteine akkumulierten und CD150 aktinabhängig rekrutiert wurde, und seltener über aktinreiche Filopodien. Die HIV-VS Markerproteine ICAM-1, aktiviertes LFA-1, CD81, DC-SIGN und der phosphorylierte Ezrin / Radixin / Moesin (ERM)-Proteinkomplex polarisierten zur MV-VS. Moesin und der Substanz P Rezeptor (SPR), die Prozesse des MV-Eintritts oder der Aufnahme unterstützen, akkumulierten ebenfalls in den Transmissionsstrukturen. Zusammengefasst zeigte diese Arbeit, dass die gebildete Plattform für MV-Transmission (MV-VS) wichtige Gemeinsamkeiten mit der HIV-VS teilt. In der MV-VS akkumulierten Proteine, die Aktindynamiken regulieren, die die Konjugatstabilität verstärken und die die Membranfusion unterstützen, die einen effizienten Eintritt des MV in T-Zellen ermöglichen.
During the past years, the internal transcribed spacer 2 (ITS2) was established as a commonly used molecular phylogenetic marker for the eukaryotes. Its fast evolving sequence is predestinated for the use in low-level phylogenetics. However, the ITS2 also consists of a very conserved secondary structure. This enables the discrimination between more distantly related species. The combination of both in a sequence-structure based analysis increases the resolution of the marker and enables even more robust tree reconstructions on a broader taxonomic range. But, performing such an analysis required the application of different programs and databases making the use of the ITS2 non trivial for the typical biologist. To overcome this hindrance, I have developed the ITS2 Workbench, a completely web-based tool for automated phylogenetic sequence-structure analyses using the ITS2 (http://its2.bioapps.biozentrum.uni-wuerzburg.de). The development started with an optimization of length modelling topologies for Hidden Markov Models (HMMs), which were successfully applied on a secondary structure prediction model of the ITS2 marker. Here, structure is predicted by considering the sequences' composition in combination with the length distribution of different helical regions. Next, I integrated HMMs into the sequence-structure generation process for the delineation of the ITS2 within a given sequence. This re-implemented pipeline could more than double the number of structure predictions and reduce the runtime to a few days. Together with further optimizations of the homology modelling process I can now exhaustively predict secondary structures in several iterations. These modifications currently provide 380,000 annotated sequences including 288,000 structure predictions. To include these structures in the calculation of alignments and phylogenetic trees, I developed the R-package "treeforge". It generates sequence-structure alignments on up to four different coding alphabets. For the first time also structural bonds were considered in alignments, which required the estimation of new scoring matrices. Now, the reconstruction of Maximum Parsimony, Maximum Likelihood as well as Neighbour Joining trees on all four alphabets requires just a few lines of code. The package was used to resolve the controversial chlorophyceaen dataset and could be integrated into future versions of the ITS2 workbench. The platform is based on a modern, feature-rich Web 2.0 user interface equipped with the latest AJAX and Web-service technologies. It performs HMM-based sequence annotation, structure prediction by energy minimization or homology modelling, alignment calculation and tree reconstruction on a flexible data pool that repeats calculations according to data changes. Further, it provides sequence motif detection to control annotation and structure prediction and a sequence-structure based BLAST search, which facilitates the taxon sampling process. All features and the usage of the ITS2 workbench are explained in a video tutorial. However, the workbench bears some limitations regarding the size of datasets. This is caused mainly due to the immense computational power needed for such extensive calculations. To demonstrate the validity of the approach also for large-scale analyses, a fully automated reconstruction of the Chlorophyta (Green Algal) Tree of Life was performed. The successful application of the marker even on large datasets underlines the capabilities of ITS2 sequence-structure analysis and suggests its utilization on further datasets. The ITS2 workbench provides an excellent starting point for such endeavours.
Upon oncogenic stress, the tumor suppressor Arf can induce irreversible cell cycle arrest or apoptosis, depending on the oncogenic insult. In this study, it could be shown that Arf interacts with Myc and the Myc-associated zinc-finger protein Miz1 to facilitate repression of genes involved in cell adhesion. Formation of a DNA-binding Arf/Myc/Miz1 complex disrupts interaction of Miz1 with its coactivator nucleophosmin and induces local heterochromatinisation, causing cells to lose attachment and undergo anoikis. The assembly of the complex relies on Myc, which might explain why high Myc levels trigger apoptosis and not cell cycle arrest in the Arf response. This mechanism could play an important role in eliminating cells harboring an oncogenic mutation. Arf furthermore induces sumoylation of Miz1 at a specific lysine by repressing the desumoylating enzyme Senp3. A sumoylation-deficient mutant of Miz1 however does not show phenotypic differences under the chosen experimental conditions. Myc can also be modified by Sumo by multisumoylation at many different lysines, which is unaffected by Arf. The exact mechanism and effect of this modification however stays unsolved.
Single-molecule microscopy is one of the decisive methodologies that allows one to clarify cellular signaling in both spatial and temporal dimentions by tracking with nanometer precision the diffusion of individual microscopic particles coupled to relevant biological molecules. Trajectory analysis not only enables determination of the mechanisms that drive and constrain the particles motion but also to reveal crucial information about the molecule interaction, mobility, stoichiometry, all existing subpopulations and unique functions of particular molecules. Efficacy of this technique depends on two problematic issues the usage of the proper fluorophore and the type of biochemical attachment of the fluorophore to a biomolecule. The goal of this study was to evolve a highly specific labeling method suitable for single molecule tracking, internalization and trafficking studies that would attain a calculable 1:1 fluorophore-to-receptor stoichiometry. A covalent attachment of quantum dots to transmembrane receptors was successfully achieved with a techinque that amalgamates acyl carrier protein (ACP) system as a comparatively small linker and coenzyme A (CoA)-functionalized quantum dots. The necessity of optimization of the quantum dot usage for more precise calculation of the membrane protein stoichiometries in larger assemblies led to the further study in which methods maximizing the number of signals and the tracking times of diverse QD types were examined. Next, the optimized techniques were applied to analyze behavior of interleukin-5 β-common chain receptor (IL-5Rβc) receptors that are endogenously expressed at low level on living differentiated eosinophil-like HL-60 cells. Obtained data disclosed that perused receptors form stable and higher order oligomers. Additionally, the mobility analysis based on increased in number (>10%) uninterrupted 1000-step trajectories revealed two patterns of confined motion. Thereupon methods were developed that allow both, determination of stoichiometries of cell surface protein complexes and the acquisition of long trajectories for mobility analysis. Sequentially, the aforementioned methods were used to scrutinize on the mobility, internalization and recycling dynamics characterization of a G protein-coupled receptor (GPCRs), the parathyroid hormone receptor (PTHR1) and several bone morphogenetic proteins (BMPs), a member of the TGF-beta superfamily of receptors. These receptors are two important representatives of two varied membrane receptor classes. BMPs activate SMAD- and non-SMAD pathways and as members of the transforming growth factor β (TGF-β) superfamily are entailed in the regulation of proliferation, differentiation, chemotaxis, and apoptosis. For effective ligand induced and ligand independent signaling, two types of transmembrane serine/threonine kinases, BMP type I and type II receptors (BMPRI and BMPRII, respectively) are engaged. Apparently, the lateral mobility profiles of BMPRI and BMPRII receptors differ markedly, which determinate specificity of the signal. Non-SMAD signaling and subsequent osteoblastic differentiation of precursor cells particularly necessitate the confinement of the BMP type I receptor, resulting in the conclusion that receptor lateral mobility is a dominative mechanism to modulate SMAD versus non-SMAD signaling during differentiation. Confined motion was also predominantly observed in the studies devoted to, entailed in the regulation of calcium homeostasis and in bone remodeling, the parathyroid hormone receptor (PTHR1), in which stimulation with five peptide ligands, specific fragments of PTH: hPTH(1–34), hPTHrP(107–111)NH2; PTH(1–14); PTH(1–28) G1R19, bPTH(3–34), first four belonging to PTH agonist group and the last to the antagonist one, were tested in the wide concentration range on living COS-1 and AD293 cells. Next to the mobility, defining the internalization and recycling rates of the PTHR1 receptor maintained in this investigation one of the crucial questions. Internalization, in general, allows to diminish the magnitude of the receptor-mediated G protein signals (desensitization), receptor resensitization via recycling, degradation (down-regulation), and coupling to other signaling pathways (e.g. MAP kinases). Determinants of the internalization process are one of the most addressed in recent studies as key factors for clearer understanding of the process and linking it with biological responses evoked by the signal transduction. The internalization of the PTH-receptor complex occurs via the clathrin-coated pit pathway involving β-arrestin2 and is initiated through the agonist occupancy of the PTHR1 leading to activation of adenylyl cyclase (via Gs), and phosphatidylinositol-specific phospholipase Cβ (via Gq). Taken together, this work embodies complex study of the interleukin-5 β-common chain receptor (IL-5Rβc) receptors, bone morphogenetic proteins (BMPs) and the parathyroid hormone receptor with the application of single-molecule microscopy with the newly attained ACP-quantum dot labeling method and standard techniques.
Plant-derived natural products and their analogs continue to play an important role in the discovery of new drugs for the treatment of human diseases. Potentially promising representatives of secondary metabolites are the naphthylisoquinoline alkaloids, which show a broad range of activities against protozoan pathogens, such as plasmodia, leishmania, and trypanosoma. Due to the increasing resistance of those pathogens against current therapies, highly potent novel agents are still urgently needed. Thus, it is worthy to discover new naphthylisoquinoline alkaloids hopefully with pronounced bioactivities by isolation from plants or by synthesis. The naphthylisoquinoline alkaloids are biosynthetically related to another class of plant-derived products, the naphthoquinones, some of which have been recently found to display excellent anti-multiple myeloma activities without showing any cytotoxicities on normal blood cells. Multiple myeloma still remains incurable, although remissions may be induced with co-opted therapeutic treatments. Therefore, more potent naphthoquinones are urgently required, and can be obtained by isolation from plants or by synthesis. In detail, the results in this thesis are listed as follows: 1) Isolation and characterization of naphthylisoquinoline alkaloids from the stems of a Chinese Ancistrocladus tectorius species. Nine new naphthylisoquinoline alkaloids, named ancistectorine A1 (60), N-methylancistectorine A1 (61), ancistectorine A2 (62a), 5-epi-ancistectorine A2 (62b), 4'-O-demethylancistectorine A2 (63), ancistectorine A3 (64), ancistectorine B1 (65), ancistectorine C1 (66), and 5-epi-ancistrolikokine D (67) were isolated from the Chinese A. tectorius and fully characterized by chemical, spectroscopic, and chiroptical methods. Furthermore, the in vitro anti-infectious activities of 60-62 and 63-66 have been tested. Three of the metabolites, 61, 62a, and 62b, exhibited strong antiplasmodial activities against the strain K1 of P. falciparum without showing significant cytotoxicities. With IC50 values of 0.08, 0.07, and 0.03 μM, respectively, they were 37 times more active than the standard chloroquine (IC50 = 0.26 μM). Moreover, these three compounds displayed high antiplasmodial selectivity indexes ranging from 100 to 3300. According to the TDR/WHO guidelines, they could be considered as lead compounds. In addition, seven alkaloids, 69-74 (structures not shown here), were isolated from A. tectorius that were known, but new to the plant, together with another fourteen known compounds (of these, only the structures of the three main alkaloids, 5a, 5b, and 78 are shown here), which had been previously found in the plant. The three metabolites ancistrocladine (5a), hamatine (5b), and (+)-ancistrocline (78) were found to show no or moderate activities against the MM cell lines. 2) Isolation and characterization of naphthylisoquinoline alkaloids from the root bark of a new, botanically yet undescribed Congolese Ancistrocladus species. An unprecedented dimeric Dioncophyllaceae-type naphthylisoquinoline alkaloid, jozimine A2 (84), as first recognized by G. Bauckmann from an as yet undescribed Ancistrocladus species, was purified and characterized as part of this thesis. Its full structural assignment was achieved by spectroscopic and chiroptical methods, and further confirmed by an X-ray diffraction analysis, which had never succeeded for any other dimeric naphthylisoquinoline alkaloids before. Structurally, the dimer is composed of two identical 4'-O-demethyldioncophylline A halves, coupled through a sterically hindered central axis at C-3',3'' of the two naphthalene moieties. Pharmacologically, jozimine A2 (84) showed an extraordinary antiplasmodial activity (IC50 = 1.4 nM) against the strain NF54 of P. falciparum. Beside jozimine A2 (85), another new alkaloid, 6-O-demethylancistrobrevine C (84), and four known ones, ancistrocladine (5a), hamatine (5b), ancistrobrevine C (86), and dioncophylline A (6) were isolated from the Ancistrocladus species, the latter in a large quantity (~500 mg), showing that the plant produces Ancistrocladaceae-type, mixed-Ancistrocladaceae/Dioncophyllaceae-type, and Dioncophyllaceae-type naphthyl- isoquinoline alkaloids. Remarkably, it is one of the very few plants, like A. abbreviatus, and A. barteri, that simultaneously contain typical representatives of all the above three classes of alkaloids. 3) Semi-synthesis of jozimine A2 (85), 3'-epi-85, jozimine A3 (93) and other alkaloids from dioncophylline A (6). The dimeric naphthylisoquinoline alkaloids, jozimine A2 (85) and 3'-epi-85, constitute rewarding synthetic targets for a comparative analysis of their antiplasmodial activities and for a further confirmation of the assigned absolute configurations of the isolated natural product of 85. They were semi-synthesized in a four-step reaction sequence from dioncophylline A (6) in cooperation with T. Büttner. The key step was a biomimetic phenol-oxidative dimerization at C-3' of the N,O-dibenzylated derivative of 89 by utilizing Pb(OAc)4. This is the first time that the synthesis of such an extremely sterically hindered (four ortho-substituents) naphthylisoquinoline alkaloid – with three consecutive biaryl axes! – has been successfully achieved. A novel dimeric naphthylisoquinoline, jozimine A3 (93), bearing a 6',6''-central biaryl axis, was semi-synthesized from 5'-O-demethyldioncophylline A (90) by a similar biomimetic phenol-oxidative coupling reaction as a key step, by employing Ag2O. HPLC analysis with synthetic reference material of 3'-epi-85 and 93 for co-elution revealed that these two alkaloids clearly are not present in the crude extract of the Ancistrocladus species from which jozimine A2 (85) was isolated. This evidences that jozimine A2 (85) is very specifically biosynthesized by the plant with a high regio- and stereoslectivity. Remarkably, the two synthetic novel dimeric naphthylisoquinoline alkaloids 3'-epi-85 and 93 were found to display very good antiplasmodial activities, albeit weaker than that of the natural and semi-synthetic product 85. Additionally, the two compounds 3'-epi-85 and 93 possessed high or moderate selectivity indexes, which were much lower than that of 85. However, they can still be considered as new lead structures. Two unprecedented oxidative products of dioncophylline A, the diastereomeric dioncotetralones A (94a) and B (94b), were synthesized from dioncophylline A (6) in a one-step reaction. Remarkably, the aromatic properties in the “naphthalene” and the “isoquinoline” rings of 94a and 94b are partially lost and the “biaryl” axis has become a C,C-double bond, so that the two halves are nearly co-planar to each other, which has never been found among any natural or synthetic naphthylisoquinoline alkaloid. Their full structural characterization was accomplished by spectroscopic methods and quantum-chemical CD calculations (done by Y. Hemberger). The presumed reaction mechanism was proposed in this thesis. In addition, one of the two compounds, 94a, exhibited a highly antiplasmodial activity (IC50 = 0.09 μM) with low cytotoxicity, and thus, can be considered as a new promising lead structure. Its 2'-epi-isomer, 94b, was inactive, evidencing a significant effect of chirality on the bioactivity. Of a number of naphthylisoquinoline alkaloids tested against the multiple-myeloma cell lines, the three compounds, dioncophylline A (6), 4'-O-demethyldioncophylline A (89), and 5'-O-demethyldioncophylline A (90) showed excellent activities, even much stronger than dioncoquinones B (10), C (102), the epoxide 175, or the standard drug melphalan. 4) Isolation and characterization of bioactive naphthoquinones from cell cultures of Triphyophyllum peltatum. Three new naphthoquinones, dioncoquinones C (102), D (103), and E (104), the known 8-hydroxydroserone (105), which is new to this plant, and one new naphthol dimer, triphoquinol A (107), were isolated from cell cultures of T. peltatum in cooperation with A. Irmer. Dioncoquinone C (102) showed an excellent activity against the MM cells, very similar to that of the previously found dioncoquinone B (10), without showing any inhibitory effect on normal cells. The other three naphthoquinones, 103105, were inactive or only weakly active. 5) Establishment of a new strategy for a synthetic access to dioncoquinones B (10) and C (102) on a large scale for in vivo experiments and for the synthesis of their analogs for first SAR studies. Before the synthesis of dioncoquinone B (10) described in this thesis, two synthetic pathways had previously been established in our group. The third approach described here involved the preparation of the joint synthetic intermediate 42 with the previous two routes. The tertiary benzamide 135 was ortho-deprotonated by using s-BuLi/TMEDA, followed by transmetallation with MgBr2▪2Et2O, and reaction with 2-methylallyl bromide (139). It resulted in the formation of ortho-allyl benzamide 140, which was cyclized by using methyl lithium to afford the naphthol 42. This strategy proved to be the best among the established three approaches with regard to its very low number of steps and high yields. By starting with 136, this third strategy yielded the related bioactive natural product, dioncoquinone C (102), which was accessed by total synthesis for the first time. To identify the pharmacophore of the antitumoral naphthoquinones, a library of dioncoquinone B (10) and C (102) analogs were synthesized for in vitro testing. Among the numerous naphthoquinones tested, the synthetic 7-O-demethyldioncoquinone C (or 7-O-hydroxyldioncoquinone B) (145), constitutes another promising basic structure to develop a new anti-MM agent. Furthermore, preliminary SAR results evidence that the three hydroxy functions at C-3, C-5, and C-6 are essential for the biological properties as exemplarily shown through the compounds 10, 102, and 145. All other mixed OH/OMe- or completely OMe-substituted structures were entirely inactive. By a serendipity the expoxide 175 was found to display the best anti-MM activity of all the tested isolated metabolites from T. peltatum, the synthesized naphthoquinones, and their synthetic intermediates. Toxic effects of 175 on normal cells were not observed, in contrast to the high toxicities of all other epoxides. Thus, the anti-MM activity of 175 is of high selectivity. The preliminary SAR studies revealed that the 6-OMe group in 175 is required, thus differed with the above described naphthoquinones (where 6-OH is a requisite in 10, 102, and 145), which evidenced potentially different modes of action for these two classes of compounds. 6) The first attempted total synthesis of the new naturally occurring triphoquinone (187a), which was recently isolated from the root cultures of T. peltatum in our group. A novel naphthoquinone-naphthalene dimer, 187a (structure shown in Chapter 10), was isolated in small quantities from the root cultures of T. peltatum. Thus, its total synthesis was attempted for obtaining sufficient amounts for selected biotestings. The key step was planned to prepare the extremely sterically hindered (four ortho-substituents) binaphthalene 188 by a coupling reaction between the two 2-methylnaphthalene derivatives. Test reactions involving a system of two simplified 2-methylnaphthylboron species and 2-methylnaphthyl bromide proved the Buchwald ligand as most promising. The optimized conditions were then applied to the two true - highly oxygenated - coupling substrates, between the 2-methylnaphthylboron derivatives 210, 211, 213, or 214 and the 2-methylnaphthyl iodides (or bromides) 215 (206), 215 (206), 212 (205), or 212 (205), respectively. Unfortunately, this crucial step failed although various bases and solvent systems were tested. This could be due to the high electron density of the two coupling substrates, both bearing strongly OMOM/OMe-donating function groups. Therefore, a more powerful catalyst system or an alternative synthetic strategy must be explored for the total synthesis of 187a. 7) Phytochemical investigation of the Streptomyces strain RV-15 derived from a marine sponge. Cyclodysidins A-D (216-219), four new cyclic lipopeptides with a- and ß-amino acids, were isolated from the Streptomyces strain RV15 derived from a marine sponge by Dr. U. Abdelmohsen. Their structures were established as cyclo-(ß-AFA-Ser-Gln-Asn-Tyr-Asn-Ser-Thr) by spectroscopic analysis using 2D NMR techniques and CID-MS/MS in the course of this thesis. In conclusion, the present work contributes to the discovery of novel antiplasmodial naphthylisoquinoline alkaloids and antitumoral naphthoquinones, which will pave the way for future studies on these two classes of compounds.
Autoimmune diseases, unwanted overshooting immune responses against self antigens, are due to an imbalance in immunity and tolerance. Although negatively impacting cancer prognosis, myeloid derived suppressor cells (MDSC), with their potent suppressive capabilities, might be applicable in a more beneficial light when applied in to autoimmunity. As previous shown MDSC have protective roles in Experimental Autoimmune Encephalomyelitis (EAE) (Zhu et al., 2007), the established inducible mouse model for the autoimmune disease multiple sclerosis (MS). This decrease in disease severity indicates in vitro generated immature myeloid cells (IMC) from bone marrow (BM) as precursors of MDSC are promising candidates for cellular therapy. Important to any cellular therapy by adoptive transfer, the major questions regarding IMC efficacy was addressed within the thesis. This thesis attempts to elucidate how IMC operate in EAE. This thesis defines the factors within the autoimmune microenvironment that lead to the activation of MDSC, where IMC home once delivered in vivo, and the protective mechanisms BMIMC employ. To emulate BM cells when they first enter circulation through the blood, IMC were injected intravenously (i.v.). IMC are protective with no regard to the various routes delivered (i.v., i.p.). They protect to a lesser extent when pre-activated before injection. IMC suppress by causing a delay and/or by decreasing the severity of the disease via a mechanism yet determined. To understand the migration pattern of IMC after i.v. injection, in vivo kinetics experiments employing bioluminescence imaging were performed. This techinique allows for whole in vivo mouse imaging daily, allowing the tracking of cell migration over days within a single mouse. During steady-state, BMIMC circulate and appear to accumulate in the spleen by day 4 after injection, whereas they alternatively home to inflammatory sites (immunization site), draining lymph nodes, and the spleen within mice with low grade EAE. Visualization of CMDiI-labelled BMIMC by fluorescence microscopy could locate IMC injected cells outside the white pulp, as they were colocalizing in the regions stained with CD169 or outside, but not within the follicles of spleens on day 4. Consistant with these findings, the attempt to analyze the phenotype of these cells by flow cytometry was problematic as these cells seem to adhere strongly to collagen also indicating the cells are located in the collagenous area of the marginal zone and the red pulp.To determine factors influencing MDSC activation, we utilized different stimuli through a high throughput method detecting release of nitric oxide (NO). Extracts from yeast, fungi, and bacteria were observed to activate MDSC to produce nitric oxide. Surprisingly, material mimicking viral DNA (CpG) and RNA (poly I:C), and several self glycolipids, could not activate the MDSC to produce NO. Upon attempts to understand synergistic effects between microbial pathogens and host cytokines, IFNg was determined to boost the signal of pathogen stimuli, whereas IL17, another cytokine which causes pathology during EAE, and IFNb, a drug used in therapy to treat MS, did not cause any additional effects. Activation of MDSC was determined by the microbial pathogens components LPS, curdlan, and zymosan, to induce upregulation of B7H1 on the cell surface. MDSC did not increase any co-stimulatory markers, such as CD40, CD80, CD86, CD70, or the co-inhibitory marker, PDL2. On day 1 after EAE induction, endogenous MDSC populations when stimulated showed an increase in B7H1 expression and a downregulation of CD80. After further analysis, these cells were concluded to be mostly granulocytic cells (Ly6G+). As the B7H1 ligand PD1 is upregulated in chronic diseases and correlates to an exhausted phenotype, the PD1 : B7H1 interaction was a good candidate for the mechanism our cells may employ for their suppressive capacity. To investigate this interaction, fixed BM-IMC deficient in B7H1 were incubated with restimulated memory T cells. IMC deficient in B7H1 resulted in a significant loss of T cell suppression, as compared to the wildtype control BMIMC. To assess this interaction in vivo, we injected wildtype (WT) and B7H1-/- IMC into mice followed by induction of EAE to assess whether B7H1 mediated this suppression. The lack of B7H1 did not alter their suppressive capacity under these conditions, contrary to other findings which have described this interaction to be important in their suppressive capacity when administered post EAE induction (Ioannou et al., 2012). Interestingly, EAE mice pre-treated with IMC had similar amounts of cytokine production in the CNS after restimulation. Spleens from IMC injected mice had increased amounts of Arg-1 suggesting suppression is via oxidation or recruitment by soluble mediators may lead to this protection. We speculate this may inhibit T cell reactivation in the CNS.
Cancer is one of the leading causes of death all over the world. Malnutrition and toxic contaminations of food with substances such as mycotoxins have been thought to account for a high percentage of cancers. However, human diet can deliver both mutagens and components that decrease the cancer risk. Genomic damage could be reduced by food components through different mechanisms such as scavenging of reactive oxygen species. In the first part of this study we tried to investigate the effects of patulin and resveratrol on DNA stability in V79 cells. Patulin is a mycotoxin, which is frequently found in spoiled apples and other fruits. The WHO has established a safety level of 50 µg/L, which is indeed not observed by all manufacturers. The acute toxicity of patulin in high concentrations is well known, however its potential carcinogenicity is still a matter of debate. Therefore we wanted to investigate further steps in the mechanism of patulin-induced genotoxicity. Patulin caused the formation of micronuclei and nucleoplasmic bridges in a dose-dependent manner. Further analysis revealed that patulin induced both kinetochore-negative and positive micronuclei. Time course of incubation indicate a new mechanism for patulin-induced nucleoplasmic bridge formation. We hypothized a mechanism via cross-linking of DNA, which was confirmed by a modified version of comet assay. Incubations of cells with patulin led to an increased number of multinucleated cells and multipolar mitoses. Cell cytometry revealed a G2 arrest by patulin, which might explain the amplification of centrosomes and patulin-induced aneuploidy. Patulin cause a dose-dependent DNA damage in comet assay which was influenced by the cellular GSH content. However, an induction of oxidative stress was just seen with higher concentrations of patulin. Levels of cellular glutathione were increased after 24 h incubation indicating an adaptive response to patulin-induced stress. There is growing interest in polyphenols such as resveratrol which have shown many positive effects on human health. The beneficial properties are partially attributed to their ability to scavenge reactive oxygen species. Co-incubation of V79 cells with patulin and 10 µM of the antioxidant resveratrol led to a slight reduction of micronucleus frequency compared to cells which were just treated with patulin. However, in higher concentrations resveratrol themselves caused the formation of micronuclei in V79 cells. Kinetochore analysis indicated only clastogenic properties for resveratrol but no disturbance of mitosis. The antioxidant properties of resveratrol were shown in ferric reducing antioxidant power (FRAP) assay. However, in cellular system resveratrol in higher concentrations revealed also prooxidative properties, as shown in 2,7-dichlordihydrofluorescein (DCF) assay. The increased level of glutathione after resveratrol treatment might reflect an adaptive response to resveratrol-induced oxidative stress. For the second part of this thesis we investigated the effects of an anthocyanin-rich grape extract on hypertensive Ren-2 rats. Ren-2 rats are an accepted genetically modified rat model for the investigation of hypertension and increased oxidative stress. We divided 23 female Ren-2 rats into three groups. One group was fed with an anthocyanin-rich Dacapo grape extract, one group was treated with the angiotensin converting enzyme (ACE) inhibitor ramipril and the third group was kept without medication during the experiment. After one week untreated group showed a clear increase in systolic and diastolic blood pressure compared to the ramipril treated rats. This was in part attenuated in the animals fed with anthocyanin-rich Dacapo grape extract. Effects on blood pressure were also reflected in an increased thirst of untreated and extract fed animals. Comet assay with cells of kidney and liver revealed a slight protective impact of Dacapo extract on DNA damage compared to the other groups. Similar results were obtained after evaluation of ɣ-H2AX-staining of kidney and heart sections. However, in the small intestine oppositional effects were seen, indicating an increased number of double strand breaks probably due to the high local concentration of polyphenols after oral ingestion. Antioxidative properties of the extract were shown in FRAP assay. However, this effect was not reflected in an increased antioxidative capacity in serum or a protective impact in the dihydroethidium (DHE) assay. The extract showed protective effects on DNA damage in comet assay and ɣ-H2AX-staining, but was not able to reduce hypertension back to the control level of ramipril treated animals. High local concentrations could also result in an increased damage of the affected tissue. Therefore, the administration of such concentrated compounds should be handled with care.
The sexual phase of Plasmodium falciparum begins with the differentiation of intraerythrocytic sexual stages, termed gametocytes, in the human host. Mature gametocytes circulate in the peripheral blood and are taken up by the mosquito during the blood meal. These stages are essential for the spread of the malaria disease and form gametes in the mosquito midgut within minutes. A highly conserved family of six secreted proteins has been identified in Plasmodium falciparum. They comprise multiple adhesive domains and are termed PfCCp1 through PfCCp5, and PfFNPA. It was revealed in this work that PfCCp multi-domain adhesion proteins form protein complexes in gametocytes and on the surface of newly emerged macrogametes by adhesion domain-mediated binding. Co-Immunoprecipitation assays with activated gametocyte lysates show interactions between PfCCp proteins and indicate surface association via Pfs230 and Pfs25. Pfs230 is connected with the plasma membrane of the parasite by its interaction partner Pfs48/45. This protein is linked to the plasma membrane by a GPI anchor and presumably retains the multi-protein complex on the surface of newly emerged macrogametes in the mosquito midgut. A WD40 domain containing protein was identified to be part of this protein complex. It might serve as platform for the assembly of the multi protein complex or mediate the interplay among proteins, as suggested from known functions of the WD40 domain repeats. During egress from the host erythrocyte, the emerging gametes become vulnerable to factors of the human complement, which is taken up with the blood meal. In this thesis it was found that the complement system is active for about one hour post feeding. Macrogametes defend against complement-mediated lysis by co-opting the human complement regulators Factor H and FHL-1 from the blood-meal. These serum proteins bind via its SCR domains 5-7 to the surface of macrogametes. Once bound, they trigger complement inactivation of the alternative pathway, which prevents induction of complement lysis on the surface of the malaria parasite. Antibodies against Factor H are able to impair the sexual development in vitro and are able to block transmission to the mosquito. Interaction studies on endogenous proteins and immobilized recombinant proteins revealed the PfGAP50 protein as binding partner of Factor H and FHL-1. This protein was hitherto described as a glideosome-associated protein in invasive parasite stages, but has not yet been characterized in gametes. First localization studies indicate a relocation of PfGAP50 from the inner membrane complex to the surface of macrogametes. Malaria still persists as one of the deadliest infectious diseases worldwide. Investigations on the essential transmissive stages, gametocytes and gametes of Plasmodium falciparum, stood in the background of research for a long time. This work deciphered details on protein interactions on the surface of the malaria parasite and provides first information about coactions between the parasite and the human complement in the mosquito midgut.
When there is an imbalance between reactive oxygen species (ROS) and endogenous antioxidants (glutathione (GSH), superoxide dismutase (SOD), catalase etc.) the oxidative stress is increased and results in the oxidation of lipids, proteins and DNA. Although oxidation of lipids and proteins may also accumulates with age, only DNA oxidation leads to altered genomic information. As one pathway for increased ROS production, many endogenous and exogenous substances activate NADPH oxidase (NOX) enzyme and produce ROS. p47phox is a cytosolic organizer protein which plays an important role in NOX activation. Angiotensin II (Ang II) is an example for an endogenous compound which causes ROS through NOX activation. Rosuvastatin is an example for a drug with antioxidative capacity (upregulation of endogenous antioxidants). It is a lipid lowering drug which also reduces an elevated level of angiotensin II type 1 receptor (AT1R). Commonly, oxidative stress is elevated in ageing and age related diseases (eg. Parkinson’s disease (PD)). The aim of the present study was to investigate the role of NOX derived ROS induced oxidative DNA damage and the influence of ROS in ageing and age related diseases, using different in vitro and in vivo models.
There is evidence that pheromones are communicative signals in animals. However, the existence and function of human pheromones are still under discussion. During the last years several substances have been labeled as putative human pheromones and especially 4,16–androstadien-3-one (androstadienone), found in male and female sweat, became subject of intense investigation. In contrast to common odors androstadienone presumably modulates human physiological and psychological reactions. Data suggest that androstadienone might influence the processing of visual cues, specifically faces or affective stimuli, via projections from the fusiform gyrus and the amygdala. Moreover, attentional processes may be modulated, which is supported by explicit and implicit behavioral data. This thesis includes three experimental studies examining effects of androstadienone exposure on behavioral and cortical reactions to visual and emotional stimuli. The main hypotheses were that androstadienone might influence human behavior to and perception of visual cues. The first study sought to clarify androstadienone effects on attention-related reactions as well as on behavioral tendencies. Motoric approach-avoidance reactions in response to happy and angry facial expressions were investigated in 30 women and 32 men. Participants either inhaled androstadienone or a control solution, without knowing the real content, while performing the following task: they had to push away or to pull towards them a joystick as fast as possible in reaction to either an angry or a happy cartoon face, which was presented on a computer screen. Results showed that androstadienone modulated the participant´s task performance by accelerating the reaction speed compared to the control compound. Faster reactions were observed particularly when reacting to angry faces but not when reacting to happy faces. This might be explained by the finding that human body odors, the source of androstadienone, were found to activate the human fear system, i.e. modulating fear-related attentional processes. Therefore, the quicker reaction towards angry faces with exposure to androstadienone could be due to an enhanced allocation of attentional resources towards fear-related cues like angry faces. Results also showed that androstadienone enhanced men´s approach tendency towards faces independent of emotional expressions. This observation might be explained by androstadienone´s former shown ability to improve attractiveness ratings of other persons. In this regard, the endogenous odor might enhance evaluations of faces in men and, thus, might improve their willingness to approach social stimuli. In contrast to men, women already showed in the control condition higher approach tendency towards faces. Therefore, androstadienone might rather maintain than enhance the approach score in women. In the second study event-related brain potentials (ERPs) triggered by social and non-social visual stimuli were investigated by means of electroencephalography. In a double-blind between-subjects design 51 women participated. Twenty-eight women inhaled androstadienone, whereas 23 women inhaled a control solution. Four different picture categories, i.e. real faces, pictures with couples, pictures with social and non-social scenes, each including three different valence categories, i.e. positive, negative and neutral, should clarify the stimulus type or context androstadienone is acting on. The androstadienone compared to the control odor did not influence brain responses significantly. Explorative analyses, however, suggested that androstadienone influences the processing of faces. While in the control group angry faces elicited larger P300 amplitudes than happy faces, the androstadienone group showed similar P300 amplitudes concerning all emotional expressions. This observation tentatively indicates that the endogenous odor might indeed affect the neuronal responses to emotional facial stimuli, especially late components reflecting evaluative processes. However, this observation has to be verified and further investigated, in particular whether androstadienone caused reduced responses to angry faces or enhanced responses to happy faces. The third study investigated androstadienone effects on face processing especially in men. ERPs elicited by happy, angry and neutral cartoon faces, which were presented on a computer screen, were measured while 16 men, not knowing the applicated odor, inhaled either androstadienone or a control solution. Exposure to androstadienone significantly increased later neuronal responses, the P300 amplitude. This belated component of the ERP reflects attention allocation and evaluative processes towards important stimuli. Therefore, androstadienone might facilitate central nervous face processing by enhancing attention towards these stimuli. In sum, the current results corroborate the notion of androstadienone as an active social chemosignal. In minute amounts and not detectable as an odor it influenced cortical and motoric reactions. Therefore, it might be concluded that androstadienone indeed affects cognitive functions like attentional processes and in turn affects our behavior. The current results further support the notion that androstadienone acts like a human modulator pheromone, namely modulating ongoing behavior or a psychological reaction to a particular context, changing stimulus sensitivity, salience and sensory-motor integration. However, these conclusions remain tentative until further replication takes place, best in ecologically valid environments. Furthermore, one has to keep in mind that the current studies could not replicate several previous findings and could not verify some hypotheses assuming communicative effects of androstadienone. Thus, the main assumption of this thesis that androstadienone is an active chemosignal is still challenged. Also, whether the term “pheromone” is indeed suitable to label androstadienone remains open.
ATP dependent chromatin remodeling complexes are multifactorial complexes that utilize the energy of ATP to rearrange the chromatin structure. The changes in chromatin structure lead to either increased or decreased DNA accessibility. SWI/SNF is one of such complex. The SWI/SNF complex is involved in both transcription activation and transcription repression. The ATPase subunit of SWI/SNF is called SWI2/SNF2 in yeast and Brahma, Brm, in Drosophila melanogaster. In mammals there are two paralogs of the ATPase subunit, Brm and Brg1. Recent studies have shown that the human Brm is involved in the regulation of alternative splicing. The aim of this study was to investigate the role of Brm in pre-mRNA processing. The model systems used were Chironomus tentans, well suited for in situ studies and D. melanogaster, known for its full genome information. Immunofluorescent staining of the polytene chromosome indicated that Brm protein of C. tentans, ctBrm, is associated with several gene loci including the Balbiani ring (BR) puffs. Mapping the distribution of ctBrm along the BR genes by both immuno-electron microscopy and chromatin immunoprecipitation showed that ctBrm is widely distributed along the BR genes. The results also show that a fraction of ctBrm is associated with the nascent BR pre-mRNP. Biochemical fractionation experiments confirmed the association of Brm with the RNP fractions, not only in C. tentans but also in D. melanogaster and in HeLa cells. Microarray hybridization experiments performed on S2 cells depleted of either dBrm or other SWI/SNF subunits show that Brm affects alternative splicing and 3´ end formation. These results indicated that BRM affects pre-mRNA processing as a component of SWI/SNF complexes. 1
In cultured motoneurons of a mouse model for the motoneuron disease spinal muscular atrophy (SMA), reduced levels of the protein SMN (survival of motoneurons) cause defects in axonal growth. This correlates with reduced β-actin mRNA and protein in growth cones, indicating that anterograde transport and local translation of β-actin mRNA are crucial for motoneuron function. However, direct evidence that indeed local translation is a physiological phenomenon in growth cones of motoneurons was missing. Here, a lentiviral GFP-based reporter construct was established to monitor local protein synthesis of β-actin mRNA. Time-lapse imaging of fluorescence recovery after photobleaching (FRAP) in living motoneurons revealed that β-actin is locally translated in the growth cones of embryonic motoneurons. Interestingly, local translation of the β-actin reporter construct was differentially regulated by different laminin isoforms, indicating that laminins provide extracellular cues for the regulation of local translation in growth cones. Notably, local translation of β-actin mRNA was deregulated when motoneurons of a mouse model for type I SMA (Smn-/-; SMN2) were analyzed. In situ hybridization revealed reduced levels of β-actin mRNA in the axons of Smn-/-; SMN2 motoneurons. The distribution of the β-actin mRNA was not modified by different laminin isoforms as revealed by in situ hybridization against the mRNA of the eGFP encoding element of the β-actin reporter. In case of the mRNA of α-actin and γ-actin isoforms, the endogenous mRNA did not localize to the axons and the localization pattern was not affected by the SMN levels expressed in the cell. Taken together our findings suggest that regulation of local translation of β-actin in growth cones of motoneurons critically depends on laminin signaling and the amount of SMN protein. Embryonic stem cell (ESC)-derived motoneurons are an excellent in vitro system to sort out biochemical and cellular pathways which are defective in neurodegenerative diseases like SMA. Here, a protocol for the differentiation and antibody-mediated enrichment of ESC-derived motoneurons is presented, which was optimized during the course of this study. Notably, this study contributes the production and purification of highly active recombinant sonic hedgehog (Shh), which was needed for the efficient differentiation of mouse ESCs to motoneurons. ESC-derived motoneurons will now offer high amounts of cellular material to allow the biochemical identification of disease-relevant molecular components involved in regulated local protein synthesis in axons and growth cones of motoneurons.
While beneficial sponge-microbe associations have received much attention in recent years, less effort has been undertaken to investigate the interactions of sponges with potentially pathogenic microorganisms. Thus, the aim of this study was to examine two selected Caribbean disease conditions, termed “Sponge Orange Band” and “Sponge White Patch”, via ecological and molecular methods. Sponge Orange Band (SOB) disease affects the prominent Caribbean barrel sponge Xestospongia muta that is counted among the high-microbial-abundance (HMA) sponges, whereas Sponge White Patch (SWP) disease affects the abundant rope sponge Amphimedon compressa that belongs to the low-microbial-abundance (LMA) sponges. I have documented for both Caribbean sponge diseases a disease progression going along with massive tissue destruction as well as loss of the characteristic microbial signatures. Even though new bacteria were shown to colonize the bleached areas, the infection trials revealed in both cases no indication for the involvement of a microbial pathogen as an etiologic agent of disease leaving us still in the dark about the cause of Sponge Orange Band as well as Sponge White Patch disease.
Streptococcus pneumoniae (Pneumococcus) is one of the leading causes of childhood meningitis,pneumonia and sepsis. Despite the availability of childhood vaccination programs and antimicrobial agents, childhood pneumococcal meningitis is still a devastating illness with mortality rates among the highest of any cause of bacterial meningitis. Especially in low-income countries, where medical care is less accessible, mortality rates up to 50 % have been reported. In surviving patients, neurological sequelae, including hearing loss, focal neurological deficits and cognitive impairment, is reported in 30 to 50 %. Growing resistance of pneumococci towards conventional antibiotics emphasize the need for effective therapies and development of effective vaccines against Streptococcus pneumoniae. One major virulence factor of Streptococcus pneumoniae is the protein toxin Pneumolysin (PLY). PLY belongs to a family of structurally related toxins, the so-called cholesterol-dependent cytolysins (CDCs). Pneumolysin is produced by almost all clinical isolates of the bacterium. It is expressed during the late log phase of bacterial growth and gets released mainly through spontaneous autolysis of the bacterial cell. After binding to cholesterol in the host cell membranes, oligomerization of up to 50 toxin monomers and rearrangement of the protein structure, PLY forms large pores, leading to cell lysis in higher toxin concentrations. At sub-lytic concentrations, however, PLY mediates several other effects, such as activation of the classic complement pathway and the induction of apoptosis. First experiments with pneumococcal strains, deficient in pneumolysin, showed a reduced virulence of the organism, which emphasizes the contribution of this toxin to the course of bacterial meningitis and the urgent need for the understanding of the multiple mechanisms leading to invasive pneumococcal disease. The aim of this thesis was to shed light on the contribution of pneumolysin to the course of the disease as well as to the mental illness patients are suffering from after recovery from pneumococcal meningitis. Therefore, we firstly investigated the effects of sub-lytic pneumolysin concentrations onto primary mouse neurons, transfected with a GFP construct and imaged with the help of laser scanning confocal microscopy. We discovered two major morphological changes in the dendrites of primary mouse neurons: The formation of focal swellings along the dendrites (so-called varicosities) and the reduction of dendritic spines. To study these effects in a more complex system, closer to the in vivo situation, we established a reproducible method for acute brain slice culturing. With the help of this culturing method, we were able to discover the same morphological changes in dendrites upon challenge with sub-lytic concentrations of pneumolysin. We were able to reverse the seen alterations in dendritic structure with the help of two antagonists of the NMDA receptor, connecting the toxin´s mode of action to a non-physiological stimulation of this subtype of glutamate receptors. The loss of dendritic spines (representing the postsynapse) in our brain slice model could be verified with the help of brain slices from adult mice, suffering from pneumococcal meningitis. By immunohistochemical staining with an antibody against synapsin I, serving as a presynaptic marker, we were able to identify a reduction of synapsin I in the cortex of mice, infected with a pneumococcal strain which is capable of producing pneumolysin. The reduction of synapsin I was higher in these brain slices compared to mice infected with a pneumococcal strain which is not capable of producing pneumolysin, illustrating a clear role for the toxin in the reduction of dendritic spines. The fact that the seen effects weren´t abolished under calcium free conditions clarifies that not only the influx of calcium through the pneumolysin-pore is responsible for the alterations. These findings were further supported by calcium imaging experiments, where an inhibitor of the NMDA receptor was capable of delaying the time point, when the maximum of calcium influx upon PLY challenge was reached. Additionally, we were able to observe the dendritic beadings with the help of immunohistochemistry with an antibody against MAP2, a neuron-specific cytoskeletal protein. These observations also connect pneumolysin´s mode of action to excitotoxicity, as several studies mention the aggregation of MAP2 in dendritic beadings in response to excitotoxic stimuli. All in all, this is the first study connecting pneumolysin to excitotoxic events, which might be a novel chance to tie in other options of treatment for patients suffering from pneumococcal meningitis.
The probiotic Escherichia coli strain Nissle 1917 (EcN) is one of the few probiotics licensed as a medication in several countries. Best documented is its effectiveness in keeping patients suffering from ulcerative colitis (UC) in remission. This might be due to its ability to induce the production of human beta defensin 2 (HBD2) in a flagellin-dependent way in intestinal epithelial cells. In contrast to ulcerative colitis, for Crohn´s disease (CD) convincing evidence is lacking that EcN might be clinically effective, most likely due to the genetically based inability of sufficient defensin production in CD patients. As a first step in the development of an alternative approach for the treatment of CD patients, EcN strains were constructed which were able to produce human alpha-defensin 5 (HD5) or beta-defensin 2 (HBD2). For that purpose codon-optimized defensin genes encoding either the proform with the signal sequence or the mature form of human alpha defensin 5 (HD5) or the gene encoding HBD2 with or without the signal sequence were cloned in an expression vector plasmid under the control of the T7 promoter. Synthesis of the encoded defensins was shown by Western blots after induction of expression and lysis of the recombinant EcN strains. Recombinant mature HBD2 with an N-terminal His-tag could be purified by Ni-column chromatography and showed antimicrobial activity against E. coli, Salmonella enterica serovar Typhimurium and Listeria monocytogenes. In a second approach, that part of the HBD2-gene which encodes mature HBD2 was fused with yebF gene. The resulting fusion protein YebFMHBD2 was secreted from the encoding EcN mutant strain after induction of expression. Presence of YebFMHBD2 in the medium was not the result of leakage from the bacterial cells, as demonstrated in the spent culture supernatant by Western blots specific for ß-galactosidase and maltose-binding protein. The dialyzed and concentrated culture supernatant inhibited the growth of E. coli, Salmonella enterica serovar Typhimurium and Listeria monocytogenes in radial diffusion assays as well as in liquid coculture. This demonstrates EcN to be a suitable probiotic E. coli strain for the production of certain defensins.
Der Hefepilz Candida albicans gehört zu den fakultativ pathogenen Infektionserregern und ist Teil der natürlichen Mikroflora der Schleimhäute des Verdauungs- und Urogenitaltraktes der meisten gesunden Menschen. Ist das Gleichgewicht der Flora gestört, kann es zu oberflächlichen Mykosen kommen, wie z.B. der oropharyngealen Candidiasis (Mundsoor), die in der Regel durch die Gabe eines Antimykotikums in wenigen Tagen zu behandeln sind. In seltenen Fällen kann es auch zu schwerwiegenden Infektionsverläufen bis hin zu lebensbedrohlichen systemischen Mykosen kommen. Hauptsächlich immunsupprimierte Patienten, wie z.B. AIDS-Patienten oder Personen, die kürzlich einer Organ- oder Knochenmarkstransplantation unterzogen wurden, leiden häufig an oberflächlichen C. albicans-Infektionen. Insbesondere bei wiederkehrenden Infektionen ist der Pilz in der Lage, gegen das häufig verabreichte Medikament Fluconazol eine Resistenz zu entwickeln. Ein wichtiger Mechanismus dieser Resistenzentwicklung ist die Überexpression von Effluxpumpen, die das Medikament aus der Zelle heraustransportieren. Zwei Arten von Effluxpumpen, die eine Rolle in der Resistenzentwicklung in C. albicans spielen, konnten bisher identifiziert werden, die ABC (ATP binding cassette)-Transporter Cdr1 und Cdr2 sowie der MFS (major facilitator superfamily)-Transporter Mdr1. Der Zinc-Cluster Transkriptionsfaktor Mrr1 spielt eine wichtige Rolle in der Regulation der MDR1-E¬ffluxpumpe. Er kontrolliert die MDR1-Expression in Anwesenheit induzierender Substanzen und sogenannte "gain-of-function" Mutationen in MRR1 konnten als die Ursache der konstitutiven MDR1-Hochregulierung und der "Multidrug-Resistance" in C. albicans identifiziert werden. In dieser Arbeit konnte ein Ortholog zu MRR1 aus C. albicans in Candida dubliniensis, einer zu C. albicans nahe verwandten Hefe, identifiziert werden. Es wurde gezeigt, dass in den untersuchten klinischen und in vitro generierten Fluconazol-resistenten C. dubliniensis-Stämmen ebenfalls gain-of-funcion Mutationen in MRR1 die MDR1-Überexpression und eine Resistenz bewirken. Die Ergebnisse demonstrieren, dass der Transkriptionsfaktor Mrr1 eine wichtige Rolle in der Entwicklung der Resistenz in diesen humanpathogenen Pilzen spielt. Bisher ist nicht bekannt, wie der Zinc-Cluster Transkriptionsfaktor MRR1 durch induzierende Substanzen oder gain-of-function Mutationen aktiviert wird. Um zu verstehen, wie die Mrr1- Aktivität reguliert wird, wurden in dieser Arbeit durch Deletionsstudien funktionelle Domänen des Transkriptionsfaktors identifiziert. Um einen besseren Einblick in die Regulation der MDR1-vermittelten Resistenz in C. albicans zu bekommen, wurde in dieser Arbeit die gegenseitige Abhängigkeit von Mrr1 und Cap1 bzw. Upc2 in Bezug auf die MDR1-Expression untersucht. Es wurden ChIP-on-chip Analysen und Transkriptionsprofile mit aktiviertem Mrr1 durchgeführt, um direkte Targets von Mrr1 zu identifizieren. Mit der vorliegenden Arbeit wurde ein wichtiger Beitrag zum Verständnis der Entwicklung der Multidrug-Resistenz in C. albicans geleistet. E¬ffluxpumpen und deren Regulatoren stellen in der Bekämpfung von C. albicans-Infektionen ein interessantes Angriffsziel für die Entwicklung neuer Medikamente und die Weiterentwicklung bereits vorhandender Antimykotika dar.
Malaria and HIV are among the most important global health problems of our time and together are responsible for approximately 3 million deaths annually. These two diseases overlap in many regions of the world including sub-Saharan Africa, Southeast Asia and South America, leading to a higher risk of co-infection. In this study, we generated and characterized hybrid molecules to target P. falciparum and HIV simultaneously for a potential HIV/malaria combination therapy. Hybrid molecules were synthesized by covalent fusion between azidothymidine (AZT) and dihydroartemisinin (DHA), tetraoxane or chloroquine (CQ); and a small library was generated and tested for antiviral and antimalarial activity. Our data suggest that dihyate is the most potent molecule in vitro, with antiplasmodial activity comparable to that of DHA (IC50 = 26 nM, SI > 3000), a moderate activity against HIV (IC50 = 2.9 µM; SI > 35) and safe to HeLa cells at concentrations used in the assay (CC50 > 100 µM). Pharmacokinetic studies further revealed that dihyate is metabolically unstable and is cleaved following an O-dealkylation once in contact with cytochrome P450 enzymes. The later further explains the uneffectiveness of dihyate against the CQ-sensitive P. berghei N strain in mice when administered by oral route at 20 mg/kg. Here, we report on a first approach to develop antimalarial/anti-HIV hybrid molecules and future optimization efforts will aim at producing second generation hybrid molecules to improve activity against HIV as well as compound bioavailability. With the emergence of resistant parasites against all the counterpart drugs of artemisinin derivatives used in artemisinin based combination therapies (ACTs), the introduction of antibiotics in the treatment of malaria has renewed interest on the identification of antibiotics with potent antimalarial properties. In this study we also investigated the antiplasmodial potential of thiostrepton and derivatives, synthesized using combinations of tail truncation, oxidation, and addition of lipophilic thiols to the terminal dehydroamino acid. We showed that derivatives SS231 and SS234 exhibit a better antiplasmodial activity (IC50 = 1 µM SI > 59 and SI > 77 respectively) than thiostrepton (IC50 = 8.95 µM, SI = 1.7). The antiplasmodial activity of these derivatives was observed at concentrations which are not hemolytic and non-toxic to human cell lines. Thiostrepton and derivatives appeared to exhibit transmission blocking properties when administered at their IC50 or IC90 concentrations and our data also showed that they attenuate proteasome activity of Plasmodium, which resulted in an accumulation of ubiquitinated proteins after incubation with their IC80 concentrations. Our results indicate that the parasite’s proteasome could be an attractive target for therapeutic intervention. In this regard, thiostrepton derivatives are promising candidates by dually acting on two independent targets, the proteasome and the apicoplast, with the capacity to eliminate both intraerythrocytic asexual and transmission stages of the parasite. To further support our findings, we evaluated the activity of a new class of antimalarial and proteasome inhibitors namely peptidyl sulfonyl fluorides on gametocyte maturation and analogues AJ34 and AJ38 were able to completely suppress gametocytogenesis at IC50 concentrations (0.23 µM and 0.17 µM respectively) suggesting a strong transmission blocking potential. The proteasome, a major proteolytic complex, responsible for the degradation and re-cycling of non-functional proteins has been studied only indirectly in P. falciparum. In addition, an apparent proteasome-like protein with similarity to bacterial ClpQ/hslV threonine-peptidases was predicted in the parasite. Antibodies were generated against the proteasome subunits alpha type 5 (α5-SU), beta type 5 (β5-SU) and pfhslV in mice and we showed that the proteasome is expressed in both sexual and asexual blood stages of P. falciparum, where they localize in the nucleus and in the cytoplasm. However, expression of PfhslV was only observed in trophozoites and shizonts. The trafficking of the studied proteasome subunits was further investigated by generating parasites expressing GFP tagged proteins. The expression of α5-SU-GFP in transgenic parasite appeared to localize abundantly in the cytoplasm of all blood stages, and no additional information was obtained from this parasite line. In conclusion, our data highlight two new tools towards combination therapy. Hybrid molecules represent promising tools for the cure of co-infected individuals, while very potent antibiotics with a wide scope of activities could be useful in ACTs by eliminating resistant parasites and limiting transmission of both, resistances and disease.
SUMMARY Mast cell activation in allergic and inflammatory disease causes increased vascular permeability and edema. This thesis identifies a paracrine mechanism, by which heparin released from intracellular granules, is involved in mast cell-evoked alteration of endothelial barrier function in vivo. Negatively charged heparin initiated factor XII-driven contact activation. Activated factor XII triggered the formation of the inflammatory mediator bradykinin in plasma. Congenital deficiency and pharmacological targeting of factor XII and kinin B2 receptor provided protection from mast cell-heparin-induced leukocyte-endothelial adhesion and hypotension in rats and mice. Intravital laser scanning microscopy and tracer measurements showed that heparin increased leakage with fluid extravasation in skin microvessels in mice. Deficiency in factor XII or kinin B2 receptor conferred resistance to heparin-induced skin edema and largely protected mice from endothelial barrier dysfunction, caused by allergen-induced mast cell activation and anaphylactic reactions. In contrast, heparin and mast cell activation caused excessive edema formation in mice, deficient in the major inhibitor of factor XII, C1 esterase inhibitor. Hereditary angioedema patients, lacking C1 esterase inhibitor, suffered from allergeninduced edema. The data indicate that mast cell-heparin-initiated bradykinin formation plays a fundamental role in defective barrier function of pathological mast cell-mediated inflammation, hypotension and edema formation.
Urinary tract infection (UTI) is one of the most serious health problems worldwide. It accounts for a million hospital visits annually in the United States. Among the many uropathogenic bacteria, uropathogenic Escherichia coli (UPEC) is the most common causative agent of UTI. However, not all E. coli that inhabit the urinary tract can cause UTI. Some of them thrive for long periods of time in the urinary bladder without causing overt symptoms of infection. This carrier state is called asymptomatic bacteriuria (ABU). E. coli ABU isolates can live in the host without inducing host response due to deletions, insertions and point mutations in the genome leading to the attenuation of virulence genes. They therefore behave in the same way as commensals. Since bacteria that inhabit the urinary tract are said to originate from the lower intestinal tract and ABU behave in a similar way as commensals, this study compared various phenotypic and genotypic characteristics of ABU and commensal E. coli fecal isolates. The two groups did not show a strict clustering with regards to phylogenetic lineage since there appears to be overlaps in their distribution in some clonal complexes. In addition, it was observed that the UPEC virulence genes were more frequently inactivated in ABU than in fecal isolates. Hence, ABU tend to have less functional virulence traits compared to the fecal isolates. The ABU model organism E. coli 83972 which is known not only for its commensal behavior in the urinary bladder but its ability to outcompete other bacteria in the urinary tract is currently being used as prophylactic treatment in patients who have recurrent episodes of UTI at the University Hospital in Lund, Sweden. The pilot studies showed that upon deliberate long-term colonization of the patients with E. coli 83972, they become protected from symptomatic UTI. In this study, the phenotypic and genotypic characteristics of eight re-isolates taken from initially asymptomatically colonized patients enrolled in the deliberate colonization study who reported an episode of symptoms during the colonization period were investigated. Two out of the eight re-isolates were proven to be a result of super infection by another uropathogen. Six re-isolates, on the other hand, were E. coli 83972. The urine re-isolates confirmed to be E. coli 83972 were phenotypically heterogeneous in that they varied in colony size as well as in swarming motility. Four of these re-isolates were morphologically homogenous and similar to the parent isolate E. coli 83972 whereas one of them appeared phenotypically heterogenous as a mixture of smaller and normal-sized colonies. Still another re-isolate phenotypically resembled small colony variants. Meanwhile, three of the six re-isolates did not differ from the parent isolate with regards to motility. On the other hand, three exhibited a markedly increased motility compared to the parent isolate. Transcriptome analysis demonstrated the upregulation of a cascade of genes involved in flagellar expression and biosynthesis in one of the three motile re-isolates. However, upon further investigation, it was found out that the expression of flagella had no effect on bacterial adhesion to host cells in vitro as well as to the induction of host inflammatory markers. Thus, this implies that the increased motility in the re-isolates is used by the bacteria as a fitness factor for its benefit and not as a virulence factor. In addition, among the various deregulated genes, it was observed that gene regulation tends to be host-specific in that there is no common pattern as to which genes are deregulated in the re-isolates. Taken together, results of this study therefore suggest that the use of E. coli 83972 for prophylactic treatment of symptomatic UTI remains to be very promising.
In this thesis I studied psychological aspects in the behaviour of Drosophila, and especially Drosophila larvae. After an introduction where I present the general scientific context and describe the mechanisms of olfactory perception as well as of classical and operant conditioning, I present the different experiments that I realised during my PhD. Perception The second chapter deals with the way adult Drosophila generalise between single odours and binary mixtures of odours. I found that flies perceive a mixture of two odours as equally similar to the two elements composing it; and that the intensity as well as the physico-chemical nature of the elements composing a mixture affect the degree of generalisation between this mixture and one of its elements. These findings now call for further investigation on the physiological level, using functional imaging. Memory The third chapter presents a series of experiments in Drosophila larvae in order to define some characteristics of a new protocol for classical aversive learning which involves associating odours with mechanical disturbance as a punishment. The protocol and the first results should open new doors for the study of classical conditioning in Drosophila larvae, by allowing the comparison between two types of aversive memory (gustatory vs. mechanical reinforcement), including a comparison of their neurogenetic bases. It will also allow enquiries into the question whether these respective memories are specific for the kind of reinforcer used. Agency The fourth chapter documents our attempts to establish operant memory in Drosophila larvae. By analysing the first moments of the test, I could reveal that the larvae modified their behaviour according to their previous operant training. However, this memory seems to be quickly extinguished during the course of the test. We now aim at repeating these results and improving the protocol, in order to be able to systematically study the mechanisms allowing and underlying operant learning in Drosophila larvae. In the fifth chapter, I use the methods developed in chapter four for an analysis of larval locomotion. I determine whether larval locomotion in terms of speed or angular speed is affected by a treatment with the “cognitive enhancer” Rhodiola rosea, or by mutations in the Synapsin or SAP47 genes which are involved in the formation of olfactory memory. I also characterize the modifications induced by the presence of gustatory stimuli in the substrate on which the larvae are crawling. This thesis thus brings new elements to the current knowledge of Drosophila
Der Fluoreszenz-Resonanz-Energie-Transfer ist ein Phänomen, welches erstmals 1948 von Theodor Förster beschrieben wurde. Mit der Entwicklung von Fluoreszenzproteinen konnten in Kombination mit Mikroskopietechniken Einblicke in zellbiologische Vorgänge gewonnen werden, die durch biochemische oder physiologische Experimente nicht möglich sind. Dabei spielt die hohe zeitliche und räumliche Auflösung eine wichtige Rolle. Auf dem Forschungsgebiet der GPCR, welche die größte Gruppe von Membranproteinen bei den Säugetieren darstellen, wurden insbesondere Erkenntnisse über Konformationsänderungen der Rezeptoren, die Kinetik der Rezeptoraktivierung und die Interaktion mit intrazellulären Signalproteinen gewonnen. Der µ-Opioidrezeptor gehört zur Familie der GPCR und stellt aufgrund seiner analgetischen Wirkungen eine wichtige pharmakologische Zielstruktur dar. Das Ziel dieser Arbeit war sowohl den Rezeptor als auch seine Signalwege mittels FRET-Mikroskopie zu untersuchen. Zunächst sollte ein intramolekularer FRET-Sensor des µ-Opioidrezeptors entwickelt werden, dazu wurden basierend auf den Kenntnissen über die Tertiärstruktur und dem Aufbau bereits bekannter GPCR-Sensoren verschiedene Rezeptorkonstrukte kloniert. Bei den Konstrukten wurden entweder zwei Fluoreszenzproteine oder ein Fluoreszenzprotein und ein Fluorophor-bindendes Tetracysteinmotiv kombiniert. Auch die Positionen der eingefügten Sequenzen wurden in den intrazellulären Domänen variiert, da der Rezeptor auf die Modifikationen mit beeinträchtigter Membranlokalisation reagierte. Durch die Optimierung wurden Rezeptoren konstruiert, die an der Zellmembran lokalisiert waren. Jedoch zeigte keines der Rezeptorkonstrukte Funktionalität im Hinblick auf die Rezeptoraktivierung. Im zweiten Teil wurden die pharmakologischen Effekte der Metabolite von Morphin am humanen µ-Opioidrezeptor systematisch analysiert. Dazu wurde die Fähigkeit der Metabolite, Gi-Proteine zu aktivieren und β-Arrestin2 zu rekrutieren, mittels FRET-basierter Messungen an lebenden Zellen untersucht. Außerdem wurde die Affinität der Metabolite zum humanen µ Opioidrezeptor anhand der Verdrängung eines radioaktiven Liganden analysiert. Meine Experimente identifizierten eine Gruppe mit stark agonistischen und eine mit schwach agonistischen Eigenschaften. Die starken Partialagonisten aktivieren den Rezeptor bereits bei nanomolaren Konzentrationen, während die schwachen Metabolite den Rezeptor erst bei Konzentrationen im mikromolaren Bereich aktivieren. Die Metabolite Normorphin, Morphin-6-Glucuronid und 6-Acetylmorphin zeigen geringere Potenz als Morphin bei der Gi-Aktivierung aber überraschenderweise höhere Potenz und Effizienz für die β-Arrestin-Rekrutierung. Dies deutet auf eine bevorzugte Aktivierung von β-Arrestin2 hin. Die aus diesen Studien gewonnenen Ergebnisse liefern Hinweise darauf, welche Metabolite bei der Signalverarbeitung am µ Opioidrezeptor in vivo beteiligt sind.
Pneumolysin, a protein toxin, represents one of the major virulence factors of Streptococcus pneumoniae. This pathogen causes bacterial meningitis with especially high disease rates in young children, elderly people and immunosuppressed patients. The protein toxin belongs to the family of cholesterol-dependent cytolysins, which require membrane cholesterol in order to bind and to be activated. Upon activation, monomers assemble in a circle and undergo conformational change. This conformational change leads to the formation of a pore, which eventually leads to cell lysis. This knowledge was obtained by studies that used a higher concentration compared to the concentration of pneumolysin found in the cerebrospinal fluid of meningitis patients. Thus, a much lower concentration of pneumolysin was used in this work in order to investigate effects of this toxin on primary mouse astrocytes. Previously, a small GTPase activation, possibly leading to cytoskeletal changes, was found in a human neuroblastoma cell line. This led to the hypothesis that pneumolysin can lead to similar cytoskeletal changes in primary cells. The aim of this work was to investigate and characterise the effects of pneumolysin on primary mouse astrocytes in terms of a possible pore formation, cellular trafficking and immunological responses. Firstly, the importance of pore-formation on cytoskeletal changes was to be investigated. In order to tackle this question, wild-type pneumolysin and two mutant variants were used. One variant was generated by exchanging one amino acid in the cholesterol recognising region, the second variant was generated by deleting two amino acids in a protein domain that is essential for oligomerisation. These variants should be incapable of forming a pore and were compared to the wild-type in terms of lytic capacities, membrane binding, membrane depolarisation, pore-formation in artificial membranes (planar lipid bilayer) and effects on the cytoskeleton. These investigations resulted in the finding that the pore-formation is required for inducing cell lysis, membrane depolarisation and cytoskeletal changes in astrocytes. The variants were not able to form a pore in planar lipid bilayer and did not cause cell lysis and membrane depolarisation. However, they bound to the cell membrane to the same extent as the wild-type toxin. Thus, the pore-formation, but not the membrane binding was the cause for these changes. Secondly, the effect of pneumolysin on cellular trafficking was investigated. Here, the variants showed no effect, but the wild-type led to an increase in overall endocytotic events and was itself internalised into the cell. In order to characterise a possible mechanism for internalisation, a GFP-tagged version of pneumolysin was used. Several fluorescence-labelled markers for different endocytotic pathways were used in a co-staining approach with pneumolysin. Furthermore, inhibitors for two key-players in classical endocytotic pathways, dynamin and myosin II, were used in order to investigate classical endocytotic pathways and their possible involvement in toxin internalisation. The second finding of this work is that pneumolysin is taken up into the cell via dynamin- and caveolin-independent pinocytosis, which could transfer the toxin to caveosomes. From there, the fate of the toxin remains unknown. Additionally, pneumolysin leads to an overall increase in endocytotic events. This observation led to the third aim of this work. If the toxin increases the overall rate of endocytosis, the question arises whether toxin internalisation favours bacterial tissue penetration of the host or whether it serves as a defence mechanism of the cell in order to degrade the protein. Thus, several proinflammatory cytokines were investigated, as previous studies describe an effect of pneumolysin on cytokine production. Surprisingly, only interleukin 6-production was increased after toxin-treatment and no effect of endocytotic inhibitors on the interleukin 6-production was observed. The conclusion from this finding is that pneumolysin leads to an increase of interleukin 6, which would not depend on the endocytotic uptake of pneumolysin. The production of interleukin 6 would enhance the production of acute phase proteins, T-cell activation, growth and differentiation. On the one hand, this activation could serve pathogen clearance from infected tissue. On the other hand, the production of interleukin 6 could promote a further penetration of pathogen into host tissue. This question should be further investigated.
Streptococcus pneumoniae is one of the major causes of bacterial meningitis, which mainly affects young infants in the developing countries of Africa, Asia (esp. India) and South America, and which has case fatality rates up to 50% in those regions. Bacterial meningitis comprises an infection of the meninges and the sub-meningeal cortex tissue of the brain, whereat the presence of pneumolysin (PLY), a major virulence factor of the pneumococcus, is prerequisite for the development of a severe outcome of the infection and associated tissue damage (e. g. apoptosis, brain edema, and ischemia). Pneumolysin belongs to the family of pore forming, cholesterol-dependent cytolysins (CDCs), bacterial protein toxins, which basically use membrane-cholesterol as receptor and oligomerize to big aggregates, which induce cell lysis and cell death by disturbance of membrane integrity. Multiple recent studies, including this work, have revealed a new picture of pneumolysin, whose cell-related properties go far beyond membrane binding, pore formation and the induction of cell death and inflammatory responses. For a long time, it has been known that bacteria harm the tissues of their hosts in order to promote their own survival and proliferation. Many bacterial toxins aim to rather hijack cells than to kill them, by interacting with cellular components, such as the cytoskeleton or other endogenous proteins. This study was able to uncover a novel capacity of pneumolysin to interact with components of the actin machinery and to promote rapid, actin-dependent cell shape changes in primary astrocytes. The toxin was applied in disease-relevant concentrations, which were verified to be sub-lytic. These amounts of toxin induced a rapid actin cortex collapse in horizontal direction towards the cell core, whereat membrane integrity was preserved, indicating an actin severing function of pneumolysin, and being consistent with cell shrinkage, displacement, and blebbing observed in live cell imaging experiments. In contrast to neuroblastoma cells, in which pneumolysin led to cytoskeleton remodeling and simultaneously to activation of Rac1 and RhoA, in primary astrocytes the cell shape changes were seen to be primarily independent of small GTPases. The level of activated Rac1 and RhoA did not increase at the early time points after toxin application, when the initial shape changes have been observed, but at later time points when the actin-dependent displacement of cells was slower and less severe, probably presenting the cell’s attempt to re-establish proper cytoskeleton function. A GUV (giant unilamellar vesicle) approach provided insight into the effects of pneumolysin in a biomimetic system, an environment, which is strictly biochemical, but still comprises cellular components, limited to the factors of interest (actin, Arp2/3, ATP, and Mg2+ on one side, and PLY on the other side). This approach was able to show that the wildtype-toxin, but not the Δ6 mutant (mutated in the unfolding domain, and thus non-porous), had the capacity to exhibit its functions through a membrane bilayer, meaning it was able to aggregate actin, which was located on the other side of the membrane, either via direct interaction with actin or in an Arp2/3 activating manner. Taking a closer look at these two factors with the help of several different imaging and biochemical approaches, this work unveiled the capacity of pneumolysin to bind and interact both with actin and Arp2 of the Arp2/3 complex. Pneumolysin was capable to slightly stabilize actin in an actin-pyrene polymerization assay. The same experimental setup was applied to show that the toxin had the capacity to lead to actin polymerization through activation of the Arp2/3 complex. This effect was additionally confirmed with the help of fluorescent microscopy of rhodamine (TRITC)-tagged actin. Strongest Arp2/3 activation, and actin nucleation/polymerization is achieved by the VCA domain of the WASP family proteins. However, addition of PLY to the Arp2/3–VCA system led to an enhanced actin nucleation, suggesting a synergistic activation function of pneumolysin. Hence, two different effects of pneumolysin on the actin cytoskeleton were observed. On the one hand an actin severing property, and on the other hand an actin stabilization property, both of which do not necessarily exclude each other. Actin remodeling is a common feature of bacterial virulence strategies. This is the first time, however, that these properties were assigned to a toxin of the CDC family. Cytoskeletal dysfunction in astrocytes leads to dysfunction and unregulated movement of these cells, which, in context of bacterial meningitis, can favor bacterial penetration and spreading in the brain tissue, and thus comprises an additional role of pneumolysin as a virulence factor of Streptococcus pneumonia in the context of brain infection.
Melanoma arises from the malignant transformation of melanocytes and is one of the most aggressive forms of human cancer. In fish of the genus Xiphophorus, melanoma development, although very rarely, happens spontaneously in nature and can be induced by interspecific crossing. The oncogenic receptor tyrosine kinase, Xmrk, is responsible for melanoma formation in these fishes. Since Xiphophorus are live-bearing fishes and therefore not compatible with embryonic manipulation and transgenesis, the Xmrk melanoma model was brought to the medaka (Oryzias latipes) system. Xmrk expression under the control of the pigment cell specific mitf promoter leads to melanoma formation with 100% penetrance in medaka. Xmrk is an orthologue of the human epidermal growth factor receptor (EGFR) and activates several downstream signaling pathways. Examples of these pathways are the direct phosphorylation of BRAF and Stat5, as well as the enhanced transcription of C-myc. BRAF is a serine-threonine kinase which is found mutated at high frequencies in malignant melanomas. Stat5 is a transcription factor known to be constitutively activated in fish melanoma. C-myc is a transcription factor that is thought to regulate the expression of approximately 15% of all human genes and is involved in cancer progression of a large number of different tumors. To gain new in vivo information on candidate factors known to be involved in melanoma progression, I identified and analysed BRAF, Stat5 and C-myc in the laboratory fish model system medaka. BRAF protein motifs are highly conserved among vertebrates and the results of this work indicate that its function in the MAPK signaling is maintained in medaka. Transgenic medaka lines carrying a constitutive active version of BRAF (V614E) showed more pigmented skin when compared to wild type. Also, some transiently expressing BRAF V614E fishes showed a disrupted eye phenotype. In addition, I was able to identify two Stat5 copies in medaka, named Stat5ab/a and Stat5ab/b. Sequence analysis revealed a higher similarity between both Stat5 sequences when compared to either human Stat5a or Stat5b. This suggests that the two Stat5 copies in medaka arose by an independent duplication processes. I cloned these two Stat5 present in medaka, produced constitutive active and dominant negative gene versions and successfully established transgenic lines carrying each version under the control of the MITF promoter. These lines will help to elucidate questions that are still remaining in Stat5 biology and its function in melanoma progression, like the role of Stat5 phosphorylation on tumor invasiveness. In a third project during my PhD work, I analysed medaka C-myc function and indentified two copies of this gene in medaka, named c-myc17 and c-myc20, according to the chromosome where they are located. I produced conditional transgenic medaka lines carrying the c-myc17 gene coupled to the hormone binding domain of the estrogen receptor to enable specific transgene activation at a given time point. Comparable to human C-myc, medaka C-myc17 is able to induce proliferation and apoptosis in vivo after induction. Besides that, C-myc17 long-term activation led to liver hyperplasia. In summary, the medaka models generated in this work will be important to bring new in vivo information on genes involved in cancer development. Also, the generated transgenic lines can be easily crossed to the melanoma developing Xmrk medaka lines, thereby opening up the possibility to investigate their function in melanoma progression. Besides that, the generated medaka fishes make it possible to follow the whole development of melanocytes, since the embryos are transparent and can be used for high throughput chemical screens.
Growth factor induced signaling cascades are key regulatory elements in tissue development, maintenance and regeneration. Deregulation of the cascades has severe consequences, leading to developmental disorders and neoplastic diseases. As a major function in signal transduction, activating mutations in RAF family kinases are the cause of many human cancers. In the first project described in this thesis we focused on B-RAF V600E that has been identified as the most prevalent B-RAF mutant in human cancer. In order to address the oncogenic function of B-RAF V600E, we have generated transgenic mice expressing the activated oncogene specifically in lung alveolar epithelial type II cells. Constitutive expression of B-RAF V600E caused abnormalities in alveolar epithelium formation that led to airspace enlargements. These lung lesions showed signs of tissue remodeling and were often associated with chronic inflammation and low incidence of lung tumors. Inflammatory cell infiltration did not precede the formation of emphysema-like lesions but was rather accompanied with late tumor development. These data support a model where the continuous regenerative process initiated by oncogenic B-RAF-driven alveolar disruption provides a tumor-promoting environment associated with chronic inflammation. In the second project we focused on wild type B-RAF and its role in an oncogenic-C-RAF driven mouse lung tumor model. Toward this aim we have generated compound mice in which we could conditionally deplete B-RAF in oncogenic-C-RAF driven lung tumors. Conditional elimination of B-RAF did not block lung tumor formation however led to reduced tumor growth. The diminished tumor growth was not caused by increased cell death instead was a consequence of reduced cell proliferation. Moreover, B-RAF ablation caused a reduction in the amplitude of the mitogenic signalling cascade. These data indicate that in vivo B-RAF is dispensable for the oncogenic potential of active C-RAF; however it cooperates with oncogenic C-RAF in the activation of the mitogenic cascade.
Die Therapie von bakteriellen Infektionen beruht heutzutage zum Großteil auf dem Einsatz von Antibiotika. Die schnelle Entwicklung und rasche Verbreitung von resistenten Stämmen mancher Erreger gegen diese Antibiotika stellt ein enormes Problem für das Gesundheitswesen dar. Da momentan zur Antibiotikatherapie keine Alternativen bestehen, kommt der Erforschung neuer potenzieller Wirkstoffe eine sehr große Bedeutung zu. In einem Screening-Verfahren lagen die minimalen Hemmkonzentrationen einiger bisquartärer Bisnaphthalimide gegen Staphylococcus aureus und S. epidermidis im Bereich von 0,6 bis 2,5 µg/ml. Die Substanz mit den geringsten minimalen Hemmkonzentrationen war MT02. Daraufhin wurde das Wirkungsspektrum von MT02 gegen Bakterien detaillierter untersucht und gefunden, dass die Substanz vorwiegend gegen Gram-positive Erreger und nicht gegen Gram-negative Bakterien wirksam ist. Zytotoxizitätstests ergaben eine geringe bis nicht nachweisbare Toxizität gegen verschiedene Zelllinien im Bereich von 73 bis mehr als 150 µg/ml. Um die Wirkungsweise von MT02 genauer zu untersuchen wurden zunächst DNA-Microarray-Untersuchungen an S. aureus durchgeführt. Deren Ergebnisse ließen einen Einfluss der Substanz auf viele Gene des DNA-Metabolismus erkennen. Inkorporationsstudien mittels radioaktiver Ganzzellmarkierung bestätigten die Auswirkung von MT02 auf den DNA-Stoffwechsel. Durch kompetitive Inkubation wurde festgestellt, dass MT02 in der Lage ist Ethidiumbromid von DNA zu verdrängen bzw. dessen Bindung zu verhindern. Genauere Untersuchungen mittels Oberflächen-Plasmon-Resonanz ergaben, dass MT02 konzentrationsabhängig, reversibel und sequenzunspezifisch an DNA bindet. Die thermodynamischen Dissoziationskonstanten lagen im Mittel bei ca. 4 x 10-8 mol/l und beschrieben somit eine relativ starke Bindung von MT02 an DNA. Neben diesem primären Wirkungsmechanismus der DNA-Bindung gaben mehrere Befunde Hinweise auf einen sekundären Wirkmechanismus, der die Zellwand-Struktur bzw. Zellwand-Biosynthese beinhaltet. Eine MT02-resistente Mutante von S. aureus HG001 konnte durch vielfaches Passagieren in MT02-haltigem Medium generiert werden. Diese erzeugte bei Wachstum mit hohen Konzentrationen an MT02 einen roten Phänotyp. Die Natur dieses roten Farbstoffes konnte bislang nicht aufgeklärt werden, jedoch gibt es Hinweise, dass dieser auf Abbauprodukte von MT02 zurückzuführen ist. In einem weiteren Projekt wurde mittels Transkriptionsstudien die Auswirkung von verschiedenen bekannten Antibiotika sowie von neuen Wirkstoffen auf das Transkriptom von S. epidermidis untersucht. Die Ergebnisse dieser Studien können durch vergleichende Analysen als Grundlage für die Einordnung des Wirkmechanismus neuer Substanzen dienen.
The Nucleotide Excision Repair (NER) pathway is able to remove a vast diversity of structurally unrelated DNA lesions and is the only repair mechanism in humans responsible for the excision of UV induced DNA damages. The NER mechanism raises two fundamental questions: 1) How is DNA damage recognition achieved discriminating damaged from non damaged DNA? 2) How is DNA incision regulated preventing endonucleases to cleave DNA non specifically but induce and ensure dual incision of damaged DNA? Thus, the aim of this work was to investigate the mechanisms leading from recognition to incision of damaged DNA. To decipher the underlying process of damage recognition in a prokaryotic model system, the intention of the first part of this work was to co crystallize the helicase UvrB form Bacillus caldotenax together with a DNA substrate comprising a fluorescein adducted thymine as an NER substrate. Incision assays were performed to address the question whether UvrB in complex with the endonuclease UvrC is able to specifically incise damaged DNA employing DNA substrates with unpaired regions at different positions with respect to the DNA lesion. The results presented here indicate that the formation of a specific pre incision complex is independent of the damage sensor UvrA. The preference for 5’ bubble substrate suggests that UvrB is able to slide along the DNA favorably in a 5’ → 3’ direction until it directly encounters a DNA damage on the translocating strand to then recruit the endonuclease UvrC. In the second part of this work, the novel endonuclease Bax1 from Thermoplasma acidophilum was characterized. Due to its close association to archaeal XPB, a potential involvement of Bax1 in archaeal NER has been postulated. Bax1 was shown to be a Mg2+ dependent, structure specific endonuclease incising 3’ overhang substrates in the single stranded region close to the ssDNA/dsDNA junction. Site directed mutagenesis of conserved amino acids was employed to identify putative active site residues of Bax1. In complex with the helicase XPB, however, incision activity of Bax1 is altered regarding substrate specificity. The presence of two distinct XPB/Bax1 complexes with different endonuclease activities indicates that XPB regulates Bax1 incision activity providing insights into the physical and functional interactions of XPB and Bax1.
In this study I investigate the role of Schwann cell and axon-derived trophic signals as modifiers of axonal integrity and sprouting in motoneuron disease and diabetic neuropathy (DNP). The first part of this thesis focuses on the role of the Schwann-cell-derived ciliary neurotrophic factor (CNTF) for compensatory sprouting in a mouse model for mild spinal muscular atrophy (SMA). In the second part, the role of the insulin-like growth factor 1 (IGF-1) and its binding protein 5 (IGFBP-5) is examined in the peripheral nerves of patients with DNP and in two corresponding mouse models. Proximal SMA is caused by homozygous loss or mutation of the SMN1 gene on human chromosome 5. The different forms of SMA can be divided into four groups, depending on the levels of SMN protein produced from a second SMN gene (SMN2) and the severity of the disease. Patients with milder forms of the disease, type III and type IV SMA, normally reach adulthood and regularly show enlargement of motor units, signifying the reinnervation of denervated muscle fibers. However, the underlying mechanisms are not understood. Smn+/- mice, a model of type III/IV SMA, are phenotypically normal, but they reveal progressive loss of motor neurons and denervation of motor endplates starting at 4 weeks of age. The progressive loss of spinal motor neurons reaches 50% at 12 months but muscle strength is not reduced. The first evidence for axonal sprouting as a compensatory mechanism in these animals was the more than 2-fold increase in amplitude of single motor unit action potentials (SMUAP) in the gastrocnemius muscle. Confocal analysis confirmed pronounced sprouting of innervating motor axons. As CNTF is highly expressed in Schwann cells and known to be involved in sprouting, its role for this compensatory sprouting response and the maintenance of muscle strength in Smn+/- mice was investigated. Deletion of CNTF in this mouse model results in reduced sprouting and decline of muscle strength in Smn+/- Cntf-/- mice. These findings indicate that CNTF is necessary for a sprouting response and thus enhances the size of motor units in skeletal muscles of Smn+/- mice. DNP afflicting motor and sensory nerve fibers is a major complication in diabetes mellitus. The underlying cellular mechanisms of motor axon degeneration are poorly understood. IGFBP-5, an inhibitory binding protein for IGF-1, is highly upregulated in peripheral nerves in patients with DNP. The study investigates the pathogenic relevance of this finding in transgenic mice overexpressing IGFBP-5 in motor axons. These mice develop motor axonopathy similar to that seen in DNP. Motor axon degeneration is also observed in mice in which the IGF-1 receptor (IGF-1R) was conditionally depleted in motoneurons, indicating that reduced activity of IGF-1 on IGF-1R in motoneurons is responsible for the observed effect. These data provide evidence that elevated expression of IGFBP-5 in diabetic nerves reduces the availability of IGF-1 for IGF-1R on motor axons leading to progressive neurodegeneration, and thus offers novel treatment strategies.
In recent years high-throughput experiments provided a vast amount of data from all areas of molecular biology, including genomics, transcriptomics, proteomics and metabolomics. Its analysis using bioinformatics methods has developed accordingly, towards a systematic approach to understand how genes and their resulting proteins give rise to biological form and function. They interact with each other and with other molecules in highly complex structures, which are explored in network biology. The in-depth knowledge of genes and proteins obtained from high-throughput experiments can be complemented by the architecture of molecular networks to gain a deeper understanding of biological processes. This thesis provides methods and statistical analyses for the integration of molecular data into biological networks and the identification of functional modules, as well as its application to distinct biological data. The integrated network approach is implemented as a software package, termed BioNet, for the statistical language R. The package includes the statistics for the integration of transcriptomic and functional data with biological networks, the scoring of nodes and edges of these networks as well as methods for subnetwork search and visualisation. The exact algorithm is extensively tested in a simulation study and outperforms existing heuristic methods for the calculation of this NP-hard problem in accuracy and robustness. The variability of the resulting solutions is assessed on perturbed data, mimicking random or biased factors that obscure the biological signal, generated for the integrated data and the network. An optimal, robust module can be calculated using a consensus approach, based on a resampling method. It summarizes optimally an ensemble of solutions in a robust consensus module with the estimated variability indicated by confidence values for the nodes and edges. The approach is subsequently applied to two gene expression data sets. The first application analyses gene expression data for acute lymphoblastic leukaemia (ALL) and differences between the subgroups with and without an oncogenic BCR/ABL gene fusion. In a second application gene expression and survival data from diffuse large B-cell lymphomas are examined. The identified modules include and extend already existing gene lists and signatures by further significant genes and their interactions. The most important novelty is that these genes are determined and visualised in the context of their interactions as a functional module and not as a list of independent and unrelated transcripts. In a third application the integrative network approach is used to trace changes in tardigrade metabolism to identify pathways responsible for their extreme resistance to environmental changes and endurance in an inactive tun state. For the first time a metabolic network approach is proposed to detect shifts in metabolic pathways, integrating transcriptome and metabolite data. Concluding, the presented integrated network approach is an adequate technique to unite high-throughput experimental data for single molecules and their intermolecular dependencies. It is flexible to apply on diverse data, ranging from gene expression changes over metabolite abundances to protein modifications in a combination with a suitable molecular network. The exact algorithm is accurate and robust in comparison to heuristic approaches and delivers an optimal, robust solution in form of a consensus module with confidence values. By the integration of diverse sources of information and a simultaneous inspection of a molecular event from different points of view, new and exhaustive insights into biological processes can be acquired.
There is such vast amount of visual information in our surroundings at any time that filtering out the important information for further processing is a basic requirement for any visual system. This is accomplished by deploying attention to focus on one source of sensory inputs to the exclusion of others (Luck and Mangun 2009). Attention has been studied extensively in humans and non human primates (NHPs). In Drosophila, visual attention was first demonstrated in 1980 (Wolf and Heisenberg 1980) but this field remained largely unexplored until recently. Lately, however, studies have emerged that hypothesize the role of attention in several behaviors but do not specify the characteristic properties of attention. So, the aim of this research was to characterize the phenomenon of visual attention in wild-type Drosophila, including both externally cued and covert attention using tethered flight at a torque meter. Development of systematic quantifiable behavioral tests was a key aspect for this which was not only important for analyzing the behavior of a population of wild-type flies but also for comparing the wild-type flies with mutant flies. The latter would help understand the molecular, genetic, and neuronal bases of attention. Since Drosophila provides handy genetic tools, a model of attention in Drosophila will serve to the greater questions about the neuronal circuitry and mechanisms involved which might be analogous to those in primates. Such a model might later be used in research involving disorders of attention. Attention can be guided to a certain location in the visual field by the use of external cues. Here, using visual cues the attention of the fly was directed to one or the other of the two visual half-fields. A simple yet robust paradigm was designed with which the results were easily quantifiable. This paradigm helped discover several interesting properties of the cued attention, the most substantial one being that this kind of external guidance of attention is restricted to the lower part of the fly’s visual field. The guiding cue had an after-effect, i.e. it could occur at least up to 2 seconds before the test and still bias it. The cue could also be spatially separated from the test by at least 20° and yet attract the attention although the extent of the focus of attention (FoA) was smaller than one lower visual half-field. These observations excluded the possibility of any kind of interference between the test and the cue stimuli. Another interesting observation was the essentiality of continuous visibility of the test stimulus but not the cue for effective cuing. When the contrast of the visual scene was inverted, differences in response frequencies and cuing effects were observed. Syndirectional yaw torque responses became more frequent than the antidirectional responses and cuing was no longer effective in the lower visual field with inverted contrast. Interestingly, the test stimulus with simultaneous displacement of two stripes not only effectuated a phasic yaw torque response but also a landing response. A 50 landing response was produced in more than half of the cases whenever a yaw torque response was produced. Elucidation of the neuronal correlates of the cued attention was commenced. Pilot experiments with hydroxyurea (HU) treated flies showed that mushroom bodies were not required for the kind of guidance of attention tested in this study. Dopamine mutants were also tested for the guidance of attention in the lower visual field. Surprisingly, TH-Gal4/UAS-shits1 flies flew like wild-type flies and also showed normal optomotor response during the initial calibration phase of the experiment but did not show any phasic yaw torque or landing response at 18 °C, 25 °C or 30 °C. dumb2 flies that have almost no D1 dopamine receptor dDA1 expression in the mushroom bodies and the central complex (Kim et al. 2007) were also tested and like THGal4/ UAS-shits1 flies did not show any phasic yaw torque or landing response. Since the dopamine mutants did not show the basic yaw torque response for the test the role of dopamine in attention could not be deduced. A different paradigm would be needed to test these mutants. Not only can attention be guided through external cues, it can also be shifted endogenously (covert attention). Experiments with the windows having oscillating stripes nicely demonstrated the phenomenon of covert attention due to the production of a characteristic yaw torque pattern by the flies. However, the results were not easily quantifiable and reproducible thereby calling for a more systematic approach. Experiments with simultaneous opposing displacements of two stripes provide a promising avenue as the results from these experiments showed that the flies had a higher tendency to deliver one type of response than when the responses would be produced stochastically suggesting that attention increased this tendency. Further experiments and analysis of such experiments could shed more light on the mechanisms of covert attention in flies.
The acquired immunodeficiency syndrome (AIDS) is currently the most infectious disease worldwide. It is caused by the human immunodeficiency virus (HIV). At the moment there are ~33.3 million people infected with HIV. Sub-Saharan Africa, with ~22.5 million people infected accounts for 68% of the global burden. In most African countries antiretroviral therapy (ART) is administered in limited-resource settings with standardised first- and second-line ART regimens. During this study I analysed the therapy-naïve population of Cape Town, South Africa and Mwanza, Tanzania for any resistance associated mutations (RAMs) against protease inhibitors, nucleoside reverse transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors. My results indicate that HIV-1 subtype C accounts for ~95% of all circulating strains in Cape Town, South Africa. I could show that ~3.6% of the patient derived viruses had RAMs, despite patients being therapy-naïve. In Mwanza, Tanzania the HIV drug resistance (HIVDR) prevalence in the therapy-naïve population was 14.8% and significantly higher in the older population, >25 years. Therefore, the current WHO transmitted HIVDR (tHIVDR) survey that is solely focused on the transmission of HIVDR and that excludes patients over 25 years of age may result in substantial underestimation of the prevalence of HIVDR in the therapy-naïve population. Based on the prevalence rates of tHIVDR in the study populations it is recommended that all HIV-1 positive individuals undergo a genotyping resistance test before starting ART. I also characterized vif sequences from HIV-1 infected patients from Cape Town, South Africa as the Vif protein has been shown to counteract the antiretroviral activity of the cellular APOBEC3G/F cytidine deaminases. There is no selective pressure on the HIV-1 Vif protein from current ART regimens and vif sequences was used as an evolutionary control. As the majority of phenotypic resistance assays are still based on HIV-1 subtype B, I wanted to design an infectious HIV-1 subtype C proviral molecular clone that can be used for in vitro assays based on circulating strains in South Africa. Therefore, I characterized an early primary HIV-1 subtype C isolate from Cape Town, South Africa and created a new infectious subtype C proviral molecular clone (pZAC). The new pZAC virus has a significantly higher transient viral titer after transfection and replication rate than the previously published HIV-1 subtype C virus from Botswana. The optimized proviral molecular clone, pZAC could be used in future cell culture and phenotypic HIV resistance assays regarding HIV-1 subtype C.
Die Amygdala ist ein Kernkomplex, der dicht von serotonergen Afferenzen innerviert wird. Sowohl bei Tieren als auch beim Menschen spielen Interaktionen zwischen dem serotonergen System und der Amygdala bei der Verarbeitung von Reizen, die mit Angst oder Stress assoziiert sind, eine zentrale Rolle. Genetische Variationen im serotonergen System und/oder dauerhafter Stress können dazu führen, dass diese Verarbeitungsprozesse fehlerhaft ablaufen, wodurch Verhaltensanormalitäten bzw. die Entstehung psychiatrischer Erkrankungen begünstigt werden. Die Zielneurone der serotonergen Transmission in der Amygdala, die molekularen Mechanismen möglicher Interaktionen und strukturelle Konsequenzen der Störungen dieser Interaktionen sind jedoch bis zum heutigen Zeitpunkt noch nicht vollständig bekannt. Daher bestand ein Ziel der vorliegenden Arbeit darin, den Einfluss eines Ungleichgewichts im serotonergen System (5-Htt KO) sowie von wiederholtem, sozialem Stress auf die neuronale Morphologie der Amygdala zu analysieren und Zielneurone serotonerger Afferenzen zu identifizieren und zu charakterisieren, um die neuronalen Netzwerke der Emotionsverarbeitung besser verstehen zu können. Um vom 5-Htt–Genotyp abhängige und stressbedingte neuromorphologische Veränderungen zu untersuchen, wurden dreidimensionale Rekonstruktionen von Neuronen der laterobasalen Amygdala von männlichen, adulten Wildtyp (WT)- und 5-Htt KO-Mäusen angefertigt und bezüglich verschiedener morphologischer Parameter ausgewertet. An den Pyramidenzellen wurden nur geringfügige Veränderungen der dendritischen Komplexität, jedoch, im Vergleich zu WT-Mäusen, eine wesentliche Erhöhung der Dornendichte an spezifischen dendritischen Kompartimenten bei gestressten WT-Mäusen, sowie nicht gestressten und gestressten 5-Htt KO-Mäusen nachgewiesen. Im Vergleich zu nicht gestressten WT–Mäusen war die dendritische Dornendichte aller anderen Gruppen gleichermaßen erhöht. Die Sternzelle, zeigten bezüglich der untersuchten Parameter keine morphologischen Veränderungen auf. Eine besondere Subpopulation der Interneurone stellen die NeuropeptidY (NPY)–Neurone der laterobasalen Amygdala dar, da sie in diesen Nuclei anxiolytisch wirken. Es gibt nur wenige Anhaltspunkte darüber, durch welche Systeme NPY–Neurone moduliert werden. Da sowohl NPY–Neurone in der laterobasalen Amygdala als auch das serotonerge System an angstregulierenden Prozessen beteiligt sind, sollte im zweiten Teil der vorliegenden Arbeit untersucht werden, ob es sich bei diesen Neuronen um Zielstrukturen des serotonergen Systems handelt. Mittels licht- und elektronenmikroskopischer Analysen wurden synaptische Kontakte zwischen serotonergen Afferenzen und NPY-immunreaktiven Neuronen in der laterobasalen Amygdala von Ratten verifiziert. Da der funktionelle Einfluss der serotonergen Innervation auf diese Zielneurone von deren Serotoninrezeptor (5-HTR)-Ausstattung abhängt, wurden Koexpressionsanalysen von NPY mRNA mit den mRNAs verschiedener 5-HTR durchgeführt. Die Analysen ergaben, dass NPY mRNA–reaktive Neurone in der laterobasalen Amygdala 5-HT1A und 5-HT2C, jedoch nicht 5-HT3 mRNA koexprimieren. Die in der vorliegenden Arbeit erzielten Resultate liefern neue Erkenntnisse über den Einfluss des serotonergen Systems auf die laterobasale Amygdala von Mäusen und Ratten. Bei den Veränderungen der dendritischen Dornendichte nach sozialen Stresserfahrungen könnte es sich um neuroadaptive bzw. kompensatorische Mechanismen der Pyramidenzellen handeln, die WT-Mäusen eine Anpassung an sich ändernde, negative Umweltbedingungen ermöglicht. Die erhöhte Dornendichte könnte dabei die Ausbildung eines „emotionalen Gedächtnisses“ repräsentieren, das eine flexible Verhaltensantwort auf ein erneutes Auftauchen von Gefahr erlaubt. Eine solche Modulation der Erregbarkeit der laterobasalen Amygdala könnte beispielsweise über eine situationsentsprechende Hemmung des Outputs der Pyramidenzellen durch differentiell aktive inhibitorische Netzwerke erfolgen. Eine differentielle Aktivierung kann z. B. über unterschiedliche Rezeptorausstattungen, wie es in der Subpopulation der NPY–Neurone in der vorliegenden Arbeit nachgewiesen wurde, erfolgen. Das erhöhte angstähnliche Verhalten der 5-Htt KO-Mäuse nach wiederholtem Stress könnte mit der Unfähigkeit zusammenhängen, in entsprechenden Situationen durch Neubildung von Dornen zu reagieren, da die Dornendichte bei diesen Tieren schon unter stressarmen Umweltbedingungen ihr Maximum erreicht hat. Sowohl Fehlfunktionen der neuronalen Plastizität als auch mögliche Fehlfunktionen der differentiellen Inhibierung der Pyramidenzellen durch Interneurone, die durch genetische Variationen und/oder Stress bedingt sein können, könnten eine „offene Tür“ repräsentieren, die zu manifesten Auffälligkeiten im Verhalten bei Tieren führt bzw. auch zur Entstehung bestimmter psychiatrischer Erkrankungen beim Menschen beiträgt.
Attention-deficit/hyperactivity disorder (ADHD) is a genetically complex childhood onset neurodevelopmental disorder which is highly persistent into adulthood. Several chromo-somal regions associated with this disorder were identified previously in genome-wide linkage scans, association (GWA) and copy number variation (CNV) studies. In this work the results of case-control and family-based association studies using a can-didate gene approach are presented. For this purpose, possible candidate genes for ADHD have been finemapped using mass array-based SNP genotyping. The genes KCNIP4, CDH13 and DIRAS2 have been found to be associated with ADHD and, in addition, with cluster B and cluster C personality disorders (PD) which are known to be related to ADHD. Most of the associations found in this work would not withstand correction for multiple testing. However, a replication in several independent populations has been achieved and in conjunction with previous evidence from linkage, GWA and CNV studies, it is assumed that there are true associations between those genes and ADHD. Further investigation of DIRAS2 by quantitative real-time PCR (qPCR) revealed expression in the hippocampus, cerebral cortex and cerebellum of the human brain and a significant increase in Diras2 expression in the mouse brain during early development. In situ hybrid-izations on murine brain slices confirmed the results gained by qPCR in the human brain. Moreover, Diras2 is expressed in the basolateral amygdala, structures of the olfactory system and several other brain regions which have been implicated in the psychopatholo-gy of ADHD. In conclusion, the results of this work provide further support to the existence of a strong genetic component in the pathophysiology of ADHD and related disorders. KCNIP4, CDH13 and DIRAS2 are promising candidates and need to be further examined to get more knowledge about the neurobiological basis of this common disease. This knowledge is essential for understanding the molecular mechanisms underlying the emergence of this disorder and for the development of new treatment strategies.
For a large fraction of the proteins expressed in the human brain only the primary structure is known from the genome project. Proteins conserved in evolution can be studied in genetic models such as Drosophila. In this doctoral thesis monoclonal antibodies (mAbs) from the Wuerzburg Hybridoma library are produced and characterized with the aim to identify the target antigen. The mAb ab52 was found to be an IgM which recognized a cytosolic protein of Mr ~110 kDa on Western blots. The antigen was resolved by two-dimensional gel electrophoresis (2DE) as a single distinct spot. Mass spectrometric analysis of this spot revealed EPS-15 (epidermal growth factor receptor pathway substrate clone 15) to be a strong candidate. Another mAb from the library, aa2, was already found to recognize EPS-15, and comparison of the signal of both mAbs on Western blots of 1D and 2D electrophoretic separations revealed similar patterns, hence indicating that both antigens could represent the same protein. Finally absence of the wild-type signal in homozygous Eps15 mutants in a Western blot with ab52 confirmed the ab52 antigen to be EPS-15. Thus both the mAbs aa2 and ab52 recognize the Drosophila homologue of EPS-15. The mAb aa2, being an IgG, is more suitable for applications like immunoprecipitation (IP). It has already been submitted to the Developmental Studies Hybridoma Bank (DSHB) to be easily available for the entire research community. The mAb na21 was also found to be an IgM. It recognizes a membrane associated antigen of Mr ~10 kDa on Western blots. Due to the membrane associated nature of the protein, it was not possible to resolve it by 2DE and due to the IgM nature of the mAb it was not possible to enrich the antigen by IP. Preliminary attempts to biochemically purify the endogenously expressed protein from the tissue, gave promising results but could not be completed due to lack of time. Thus biochemical purification of the protein seems possible in order to facilitate its identification by mass spectrometry. Several other mAbs were studied for their staining pattern on cryosections and whole mounts of Drosophila brains. However, many of these mAbs stained very few structures in the brain, which indicated that only a very limited amount of protein would be available as starting material. Because these antibodies did not produce signals on Western blots, which made it impossible to enrich the antigens by electrophoretic methods, we did not attempt their purification. However, the specific localization of these proteins makes them highly interesting and calls for their further characterization, as they may play a highly specialized role in the development and/or function of the neural circuits they are present in. The purification and identification of such low expression proteins would need novel methods of enrichment of the stained structures.
Die chronische Herzinsuffizienz stellt nach wie vor eine der häufigsten Todesursachen weltweit dar. Trotz intensiver Forschung ist es bisher nicht möglich die pathophysiologischen Prozesse aufzuhalten. Es wird nach neuen Strategien gesucht, hier therapeutisch eingreifen zu können. Kleine nicht-kodierende RNAs, sogenannte microRNAs (miRNAs), wurden als wichtige Faktoren bei verschiedenen Herzkrankheiten beschrieben. Die Mehrzahl der bisherigen Studien fokussierte sich dabei auf die am stärksten deregulierten miRNAs im erkrankten Herz. In einer automatisierten Analyse im 96 Well-Format untersuchten wir 230 miRNAs auf ihr Potential, in das Größenwachstum von primären Kardiomyozyten einzugreifen. Aus den miRNAs mit den größten Effekten selektierten wir diejenigen, die eine hohe endogene Expression aufwiesen, und unterzogen sie einem Validierungsprozess. Hier konnten wir die Effekte aller pro- (miR-22, miR-30c, miR-30d, miR-212, miR-365) und anti-hypertrophen (miR-27a, miR-27b, miR-133a) miRNAs bestätigen. Die Mehrzahl dieser miRNAs wurde hiermit erstmalig beschrieben, dass sie eine wichtige Rolle beim Größenwachstum von Kardiomyozyten spielen. Sie wären daher interessante Kandidaten für detaillierte funktionelle Studien mit dem Ziel ihr therapeutisches Potential zu evaluieren. In einem früheren genetischen Screen zur Identifizierung von kardialen, sezernierten Faktoren wurde der Protease Inhibitor 16 (PI16) entdeckt, der sich im insuffizienten Herz durch eine starke Akkumulation auszeichnet. Gegenstand des zweiten Teils dieser Arbeit war es, eine Mauslinie zu generieren, in der PI16 global oder konditionell mit Hilfe des Cre/LoxP-Systems ausgeschaltet werden kann. Nach Elektroporation des Pi16floxneo Targeting Vektors in embryonale Stammzellen und Blastozysteninjektion erhielten wir eine Mauslinie, die Träger der zielgerichteten Modifikation des Pi16 Allels war. Mit der globalen genetischen Deletion des LoxP-flankierten Abschnitts von Exon 3 bis 4 konnten wir die Expression des Pi16 Gens komplett unterbinden. Die PI16 Defizienz führte weder im Herz noch in anderen Organen per se zu pathologischen Veränderungen. Zudem war unbekannt, dass PI16 in der gesunden Maus in der kardialen Fibroblastenfraktion enthalten sowie in den Zilien der Epididymis und der Trachea und im Lumen der Schilddrüse lokalisiert ist. Im insuffizienten Herz bestätigten wir eine Akkumulation von PI16, die sich vor allem auf die fibrotischen Bereiche beschränkte. Das lässt Grund zur Annahme, dass die kardiale Funktion von PI16 erst dann offensichtlich wird, wenn man die defizienten Mäuse zukünftig entsprechenden Stressmodellen aussetzt. Das wird zu einem umfassenden Verständnis der kardialen Funktion von PI16 und dessen Potential als therapeutisches Zielmolekül führen.
Type 1 diabetes affects around 0.5% of the population in developed countries and the incidence rates have been rising over the years. The destruction of beta cells is irreversible and the current therapy available to patients only manages the symptoms and does not prevent the associated pathological manifestations. The patients need lifelong therapy and intensive research is being carried out to identify ways to eliminate autoimmune responses directed against pancreatic beta cells and to replace or regenerate beta cells. The work presented herein aimed at analyzing the role of the Th17 T cell subset, characterized by secretion of the pro- inflammatory cytokine IL-17A, in autoimmune diabetes and also at generating a beta cell reporter mouse line in the NOD background, the most widely- used mouse model for type 1 diabetes. We generated IL- 17A knockdown (KD) NOD mice, using RNAi in combination with lentiviral transgenesis. We analyzed diabetes frequency in IL-17A deficient mice and found that the loss of IL-17A did not protect the transgenic mice from diabetes. Based on these observations, we believe that Th17 cells do not play a critical role in type 1 diabetes through the IL-17A pathway, though they might still be involved in the disease process through alternate pathways. We also generated NOD and NOD-SCID mice with a transgene that drives the beta cell specific expression of a luciferase reporter gene. We used a lentiviral construct, which combined a luciferase sequence and a short- hairpin RNA (shRNA) expression cassette, allowing gene- knockdown under the beta cell specific rat insulin promoter (RIP). These mice will be of use in studying beta cell phenotypes resulting from the knockdown of target genes, using non- invasive bioimaging. We believe that the generation of these reporter mouse lines for diabetes studies will prove valuable in future investigations. Furthermore, the demonstration that the loss of IL-17A does not alter susceptibility to type 1 diabetes should help clarify the controversial involvement of Th17 cells in this disease.
According to a changing environment it is crucial for animals to make experience and learn about it. Sensing, integrating and learning to associate different kinds of modalities enables animals to expect future events and to adjust behavior in the way, expected as the most profitable. Complex processes as memory formation and storage make it necessary to investigate learning and memory on different levels. In this context Drosophila melanogaster represents a powerful model organism. As the adult brain of the fly is still quite complex, I chose the third instar larva as model - the more simple the system, the easier to isolate single, fundamental principles of learning. In this thesis I addressed several kinds of questions on different mechanism of olfactory associative and synaptic plasiticity in Drosophila larvae. I focused on short-term memory throughout my thesis. First, investigating larval learning on behavioral level, I developed a one-odor paradigm for olfactory associative conditioning. This enables to estimate the learnability of single odors, reduces the complexity of the task and simplify analyses of "learning mutants". It further allows to balance learnability of odors for generalization-type experiments to describe the olfactory "coding space". Furthermore I could show that innate attractiveness and learnability can be dissociated and found finally that paired presentation of a given odor with reward increase performance, whereas unpaired presentations of these two stimuli decrease performance, indicating that larva are able to learn about the presence as well as about the absence of a reward. Second, on behavioral level, together with Thomas Niewalda and colleagues we focussed on salt processing in the context of choice, feeding and learning. Salt is required in several physiological processes, but can neither be synthesized nor stored. Various salt concentrations shift the valence from attraction to repulsion in reflexive behaviour. Interestingly, the reinforcing effect of salt in learning is shifted by more than one order of magnitude toward higher concentrations. Thus, the input pathways for gustatory behavior appear to be more sensitive than the ones supporting gustatory reinforcement, which is may be due to the dissociation of the reflexive and the reinforcing signalling pathways of salt. Third, in cooperation with Michael Schleyer we performed a series of behavioral gustatory, olfactory preference tests and larval learning experiments. Based on the available neuroanatomical and behavioral data we propose a model regarding chemosensory processing, odor-tastant memory trace formation and the 'decision' like process. It incorporates putative sites of interaction between olfactory and gustatory pathways during the establishment as well as behavioral expression of odor-tastant memory. We claim that innate olfactory behavior is responsive in nature and suggest that associative conditioned behavior is not a simple substitution like process, but driven more likely by the expectation of its outcome. Fourth, together with Birgit Michels and colleagues we investigated the cellular site and molecular mode of Synapsin, an evolutionarily conserved, presynaptic vesicular phosphoprotein and its action in larval learning. We confirmed a previously described learning impairment upon loss of Synapsin. We localized this Synapsin dependent memory trace in the mushroom bodies, a third-order "cortical" brain region, and could further show on molecular level, that Synapsin is as a downstream element of the AC-cAMP-PKA signalling cascade. This study provides a comprehensive chain of explanation from the molecular level to an associative behavioral change. Fifth, in the main part of my thesis I focused on molecular level on another synaptic protein, the Synapse associated protein of 47kDa (Sap47) and its role in larval behavior. As a member of a phylogenetically conserved gene family of hitherto unknown function. It is localized throughout the whole neuropil of larval brains and associated with presynaptic vesicles. Upon loss of Sap47 larvae exhibit normal sensory detection of the to-be-associated stimuli as well as normal motor performance and basic synaptic transmission. Interestingly, short-term plasticity is distorted and odorant–tastant associative learning ability is reduced. This defect in associative function could be rescued by restoring Sap47 expression. Therefore, this report is the first to suggest a function for Sap47 and specifically argues that Sap47 is required for synaptic as well as for behavioral plasticity in Drosophila larva. This prompts the question whether its homologs are required for synaptic and behavioral plasticity also in other species. Further in the last part of my thesis I contributed to the study of Ayse Yarali. Her central topic was the role of the White protein in punishment and relief learning in adult flies. Whereas stimuli that precede shock during training are subsequently avoided as predictors for punishment, stimuli that follow shock during training are later on approached, as they predict relief. Concerning the loss of White we report that pain-relief learning as well as punishment learning is changed. My contribution was a comparison between wild type and the white1118 mutant larvae in odor-reward learning. It turned out that a loss of White has no effect on larval odorant-tastant learning. This study, regarding painrelief learning provides the very first hints concerning the genetic determinants of this form of learning.
Honeybees (Apis mellifera) forage on a great variety of plant species, navigate over large distances to crucial resources, and return to communicate the locations of food sources and potential new nest sites to nest mates using a symbolic dance language. In order to achieve this, honeybees have evolved a rich repertoire of adaptive behaviours, some of which were earlier believed to be restricted to vertebrates. In this thesis, I explore the mechanisms involved in honeybee learning, memory, numerical competence and navigation. The findings acquired in this thesis show that honeybees are not the simple reflex automats they were once believed to be. The level of sophistication I found in the bees’ memory, their learning ability, their time sense, their numerical competence and their navigational abilities are surprisingly similar to the results obtained in comparable experiments with vertebrates. Thus, we should reconsider the notion that a bigger brain automatically indicates higher intelligence.
The present work investigated the neural mechanisms underlying cognitive inhibition/thought suppression in Anderson’s and Green’s Think/No-Think paradigm (TNT), as well as different variables influencing these mechanisms at the cognitive, the neurophysiological, the electrophysiological and the molecular level. Neurophysiological data collected with fNIRS and fMRI have added up to the existing evidence of a fronto-hippocampal network interacting during the inhibition of unwanted thoughts. Some evidence has been presented suggesting that by means of external stimulation of the right dlPFC through iTBS thought suppression might be improved, providing further evidence for an implication of this region in the TNT. A combination of fNIRS with ERP has delivered evidence of a dissociation of early condition-independent attentional and later suppression-specific processes within the dlPFC, both contributing to suppression performance. Due to inconsistencies in the previous literature it was considered how stimulus valence would influence thought suppression by manipulating the emotional content of the to-be-suppressed stimuli. Findings of the current work regarding the ability to suppress negative word or picture stimuli have, however, been inconclusive as well. It has been hypothesized that performance in the TNT might depend on the combination of valence conditions included in the paradigm. Alternatively, it has been suggested that inconsistent findings regarding the suppression of negative stimuli or suppression at all might be due to certain personality traits and/or genetic variables, found in the present work to contribute to thought inhibition in the TNT. Rumination has been shown to be a valid predictor of thought suppression performance. Increased ruminative tendencies led to worse suppression performance which, in the present work, has been linked to less effective recruitment of the dlPFC and in turn less effective down-regulation of hippocampal activity during suppression trials. Trait anxiety has also been shown to interrupt thought suppression despite higher, however, inefficient recruitment of the dlPFC. Complementing the findings regarding ruminative tendencies and decreased thought inhibition a functional polymorphism in the KCNJ6 gene, encompassing a G-to-A transition, has been shown to disrupt thought suppression despite increased activation of the dlPFC. Through the investigation of thought suppression at different levels, the current work adds further evidence to the idea that the TNT reflects an executive control mechanism, which is sensitive to alterations in stimulus valence to some extent, neurophysiological functioning as indicated by its sensitivity to iTBS, functional modulations at the molecular level and personality traits, such as rumination and trait anxiety.
Ziel der vorliegenden Arbeit war es, zu untersuchen, ob nichtionisierende elektromagnetische Strahlung verschiedener Frequenzbereiche Genomschaden hervorrufen kann. Im Rahmen der vorliegenden Arbeit wurde eine Biomonitoring-Studie zu dieser Thematik konzipiert und durchgeführt. Es wurden 131 Probanden detailliert zu ihrer Mobilfunknutzung befragt. Anschließend wurden Mundschleimhautzellen entnommen und für eine mikroskopische Untersuchung aufbereitet und angefärbt. In den Zellen wurden Mikrokerne und andere Kernanomalien quantifiziert. Es zeigte sich keine Erhöhung der Mikrokernfrequenz in Abhängigkeit von der Dauer der Mobiltelefonnutzung. Auch die anderen abgefragten Parameter hatten keinen Einfluss auf die Höhe des Genomschadens. Als Positivkontrollen wurden vier Patienten, die eine lokale Strahlentherapie (ionisierende Strahlung) erhielten, eingeschlossen. Hier zeigte sich eine deutliche Erhöhung der Mikrokernfrequenz. Um festzustellen, ob die Mikrokerninduktion erst bei höheren Leistungsflussdichten als denen, die beim Mobilfunk verwendet werden, auftritt, wurden in-vitro-Versuche durchgeführt, bei denen verschiedene Zelllinien einer Strahlung von 900 MHz ausgesetzt wurden. Nach Exposition und einer Postinkubationsperiode wurden die Zellen fixiert und die Mikrokernfrequenz bestimmt. Neben den Leistungen wurden hier auch die Expositionszeiten und die Postinkubationsperioden variiert. In keinem Fall konnte eine Erhöhung der Mikrokernfrequenz festgestellt werden. Insgesamt konnte ein Einfluss elektromagnetischer Strahlung auf das Genom weder am Menschen im Rahmen einer Biomonitoring-Studie noch an verschiedenen Zelllinien im Rahmen von in-vitro-Versuchen festgestellt werden. Terahertzstrahlung ist elektromagnetische Strahlung im Bereich von 0,1 bis 10 THz, d. h. sie liegt zwischen Mikrowellen und Infrarotlicht. Derzeit wird sie hauptsächlich für spektroskopische Untersuchungen und zur Qualitätskontrolle im Herstellungs-prozess verschiedener Produkte verwendet. Anwendungen in der Sicherheitstechnik (z. B. Ganzkörperscanner) und in der Medizintechnik (z. B. Bildgebung) stehen kurz vor der Markteinführung bzw. sind bereits etabliert. Diese Anwendungen bringen eine Exposition der betroffenen Menschen mit sich. Außerdem wird an weiteren Techniken wie etwa der Datenübertragung gearbeitet. Die Wirkungen auf biologische Systeme sind im Gegensatz zum Mobilfunkbereich bisher nur unzureichend untersucht. Da bisher keine vollständigen Literaturübersichten vorlagen, wurde eine umfassende Literaturrecherche durchgeführt. Ziel war es, alle bisher durchgeführten Studien zu diesem Thema aufzulisten. Um diese Datenbasis zu verbreitern wurden in-vitro-Versuche bei verschiedenen Frequenzen durchgeführt. Als Strahlungsquellen wurden eine Frequenzvervielfacherkaskade (0,106 THz), ein Rückwärtswellen-Oszillator (0,380 THz) und ein Ferninfrarot-Laser (2,520 THz) eingesetzt. Die Strahlung wurde in einen modifizierten Inkubator geführt, so dass die Expositionen bei definierter Temperatur und konstantem CO2-Gehalt durchgeführt werden konnten. Da Terahertzstrahlung durch Wasser sehr stark absorbiert wird, sind bei einer Exposition des Menschen primär die obersten Hautschichten betroffen. Aus diesem Grund wurden primäre Hautfibroblasten und HaCaT-Zellen, eine Keratinozyten-Zelllinie, als biologische Systeme verwendet. Die Zellen wurden für unterschiedliche Zeitperioden mit verschiedenen Leistungsflussdichten exponiert. Anschließend wurden die Zellen für den Comet Assay aufbereitet und analysiert. Der Comet Assay ist eine Methode zur Quantifizierung von Einzel- und Doppelstrangbrüchen der DNA. Weiterhin wurden die Zellen nach einer Postinkubationsperiode für den Mikrokerntest aufbereitet. Neben unbehandelten Kontrollen und Sham-Expositionen wurden auch Positivkontrollen durchgeführt. Es konnte keine Erhöhung der Anzahl der DNA-Strangbrüche bzw. der Mikrokernfrequenz festgestellt werden. Da bekannt war, dass im Mobilfunkbereich unter bestimmten Bedingungen Störungen der Mitose, nicht aber Erhöhungen der Mikrokernfrequenz, auftreten, wurden Mitosestörungen nach Exposition bei 0,106 THz untersucht. Hierzu wurden AL-Zellen für 30 Minuten exponiert und anschließend ohne Postinkubation direkt fixiert. Analysiert wurden Störungen in allen Phasen der Mitose. Es zeigte sich, dass die Frequenz der Störungen in der Pro- und Metaphase unverändert blieb. Die Störungen in der Ana- und Telophase nahmen dagegen mit steigender Leistungsflussdichte zu. Insgesamt konnte im Terahertzbereich unter den gewählten Expositionsbedingungen kein DNA-Schaden beobachtet werden. Bei 0,106 THz konnten Mitosestörungen als Folge der Exposition gezeigt werden. Der Zusammenhang zwischen diesen Mitosestörungen und DNA-Schäden, insbesondere der Mikrokerninduktion, konnte bisher nicht abschließend geklärt werden und bleibt Gegenstand weiterer Untersuchungen.